Researcher Profile and Settings

Researcher

• Name

  SUZUKI Kazuhiro

Affiliation

• Urology, Professor

Profile and Settings

• Name

  Suzuki, Kazuhiro

Foreign language

• Use in presentation

  English

• Use in publication

  English

Affiliation

• Gunma University, Professor
• Gunma University, Professor

Affiliation

• Affiliation

  Graduate School of Medicine, Urology

• Job title

  Professor

Education

• 1996, Gunma University
• 1988, Gunma University, Faculty of Medicine
• 1996, Gunma University, Graduate School, Division of Medicine

Degree

• (BLANK)
• (BLANK)

Association Memberships

• Europen Society of Medical Oncology
• American Society of Clinical Oncoogy

Research Experience

• 1997, 1999, Post-doctoral fellow, Hematology/Oncology, OHIO STATE UMV
• 1997, 1999, The Ohio State University

Research Activities

Research Areas

• Life sciences, Urology

Research Interests

• 前立腺癌

Published Papers

• A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS., Miyazawa Y, Nakamura T, Takezawa Y, Shimizu N, Matsuo Y, Ogura H, Takei T, Sekine Y, Arai S, Suzuki K., 2023, Prostate, 83, 8, 759, 764, Scientific journal
• Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin., Miyazawa Y, Shimizu T, Sekine Y, Arai S, Ohtsu A, Fujizuka Y, Nomura M, Koike H, Matsui H, Suzuki K., 2022, IJU Case Rep, 6, 1, 37, 40, Scientific journal
• Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer., Kazama H, Kawaguchi O, Seto T, Suzuki K, Matsuyama H, Matsubara N, Tajima Y, Fukao T., 2022, BMC Cancer., 22, 1, 470
• Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells., Ohtsu A, Arai S, Sawada T, Kato M, Maeno Y, Miyazawa Y, Fujizuka Y, Sekine Y, Koike H, Matsui H, Suzuki K., 2022, Biochem Biophys Res Commun., 628, 76, 83, Scientific journal
• Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study., Uemura H, Kobayashi K, Yokomizo A, Hinotsu S, Horie S, Kakehi Y, Nonomura N, Ogawa O, Oya M, Suzuki K, Saito A, Asakawa K, Uno S, Naito S., Int J Clin Oncol, 27, 10, 1632, 1643, Scientific journal
• Variants in HOXB13, G132E and F127C, Are Associated With Prostate Cancer Risk in Japanese Men., Kurihara S, Matsui H, Ohtake N, Aoki M, Sekine Y, Arai S, Koike H, Suzuki K, Miyazawa Y, 2022, Cancer Diagn Progn, 2, 5, 542, 548, Doctoral thesis
• Carbon-ion radiotherapy for inoperable upper tract ureteral cancer., Mizukami T, Kawamura H, Kubo N, Sato H, Kawahara M, Adachi A, Matsui H, Suzuki K, Saitoh JI, Nakano T, Ohno T., 2023, Asia Pac J Clin Oncol, Apr 23. doi: 10.1111/ajco.13960., Scientific journal
• Changes in Renal Function of Patients With Prostate Cancer: Focus on Androgen Deprivation Therapy., Miyazawa Y, Sekine Y, Arai S, Nomura M, Koike H, Matsui H, Suzuki K., 2022, Cancer Diagn Progn., 2, 6, 686, 690, Scientific journal
• Summary of the clinical practice manual for late-onset hypogonadism, de H, Akehi Y, Fukuhara S, Ohira S, Ogawa S, Kataoka T, Kumagai H, Kobayashi K, Komiya A, Shigehara K, Syuto T, Soh J, Tanabe M, Taniguchi H, Chiba K, Matsushita K, Mitsui Y, Yoneyama T, Shirakawa T, Fujii Y, Kumano H, Ueshiba H, Amano T, Sasaki H, Maeda S, Mizokami A, Suzuki K, Horie S, 2023, Int J Urol, Feb 9. doi: 10.1111/iju.15160., Scientific journal
• Combination therapy with novel androgen recetptor antagonists and statin for castration- resistant prostate cancer, Nakayama H, Sekine Y, Oka D, Miyazawa Y, Arai S, Koike H, Matsui H, Shibata Y, Suzuki K, 2022, Prostate, 82, 3, 314, 322, Doctoral thesis
• Ultrastructural changes in subepithelial capillaries and their surrounding stroma in rat prostate and seminal vesicle after castration, ONO YOSHIHIRO ／ SUZUKI KAZUHIRO ／ YUASA HISAKO ／ KUROKAWA KOHEI ／ FUKABORI YOSHITATSU ／ YAMANAKA HIDETOSHI, Sep. 2003, Tohoku Journal of Experimental Medicine
• Estrogen treatment of prostate cancer increases tyiglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques, USUI SHINICHI ／ SUZUKI KAZUHIRO ／ YAMANAKA HIDETOSHI ／ NAKANO TAKAMITSU ／ NAKAJIMA KATSUYUKI ／ HARA YUKICHI ／ OKAZAKI MITSUYO, Mar. 2002, Clin Chem Acta
• A novel immunosuppressive drug,FTY720,prevents the cancer progerssion indudced by cyclosporine, TANAKA TOSHIYUKI ／ TAKAHARA SHIRO ／ HATORI MOTOAKI ／ SUZUKI KAZUHIRO ／ WANG J-D ／ ICHIMARU NAOTSUGU ／ SUZUKI SEIICHI ／ MOROZUMI KUNIO ／ OKUYAMA AKIHIKO ／ YAMANAKA HIDETOSHI, Jul. 2002, Cancer Letters
• Tumor-associated tissue eosinophilia of penile cancer, ONO YOSHIHIRO ／ OZAWA MASASHI ／ TAMURA YOSHIMI ／ suzuki takanori ／ SUZUKI KAZUHIRO ／ KUROKAWA KOHEI ／ FUKABORI YOSHITATSU ／ YAMANAKA HIDETOSHI, Sep. 2002, Int J Urol
• Incidence of Bladder cancer discovered by urethrocystoscopy at prostate biopsy: extraordinary high incidence of tiny bladder cancer in elderly males., Okazaki H / suzuki takanori / KUROKAWA KOHEI / ITO KAZUTO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, May 2004, Tohoku J Exp Med
• Usefulness of prostate-specific antigen velocity in screening for prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / FUKABORI YOSHITATSU / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Jun. 2002, Int J Urol
• Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, SUZUKI KAZUHIRO / ITO KAZUTO / YAMAMOTO TAKUMI / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / KOIKE HIDEKAZU / MATSUI HIROSHI / ONO YOSHIHIRO / HASUMI MASARU / NAKAZATO HARUKI / OKUGI HIRONOBU / SEKINE YOSHITAKA / OOKI KAZUNARI, Jun. 2002, Int J Cancer
• Prognostic significance of plasma placental growth factor levels in renal cell cancer:An association with clinical characteristics and vascular endothelial growth factor levels, MATSUMOTO KAZUHISA ／ SUZUKI KAZUHIRO ／ KOIKE HIDEKAZU ／ OKAMURA KEIGO ／ TSUCHIYA KIYOTAKA ／ UCHIDA TATSUYA ／ TAKEZAWA YUTAKA ／ kobayashi mikio ／ YAMANAKA HIDETOSHI, 2003, ANTICANCER RESEARCH
• Rapidly progressive malignant epithelioid angiomyolipoma of the kidney, YAMAMOTO TAKUMI / ITO KAZUTO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Jul. 2002, J Urol
• Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population., NAKAZATO HARUKI ／ SUZUKI KAZUHIRO ／ MATSUI HIROSHI ／ OHTAKE NOBUAKI ／ NAKATA SEIJI ／ YAMANAKA HIDETOSHI, 2003, Br J Cancer
• Gene expression profiles of human BPH(II):Optimization of laser-capture microdissection and utilization of cDNA microarray., MATSUI HIROSHI ／ SUZUKI KAZUHIRO ／ HASUMI MASARU ／ KOIKE HIDEKAZU ／ OKUGI HIRONOBU ／ NAKAZATO HARUKI ／ YAMANAKA HIDETOSHI, 2003, Anticancer Research
• Usefulness of PSA screening in outpatients with bladder cancer: Preliminary results, KUROKAWA KOHEI / SUZUKI KAZUHIRO / OKAZAKI HIROSHI / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, May 2002, Int J Urol
• Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR, SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / MATSUI HIROSHI / HASUMI MASARU / ONO YOSHIHIRO / NAKAZATO HARUKI / KOIKE HIDEKAZU / ITO KAZUTO / FUKABORI YOSHITATSU / KUROKAWA KOHEI, Nov. 2001, Anticancer Res
• 前立腺腫瘍マーカーの進歩と問題点：２．前立腺がんスクリーニングにおけるPSA，PSA velocity (PSAV)の使用法, 伊藤 一人 / 鈴木 和浩 / 山中 英寿, May 2001, 14（臨増）: 441-443
• 前立腺集団検診受診者における国際前立腺症状スコアー(I-PSS)の傾向とQOL indexとの関係, 伊藤 一人 / 山本 巧 / 鈴木 和浩 / 山中 英寿, Aug. 2001, 14(8): 868-871
• 前立腺特異抗原値(PSA)が6.1～10.0ng/mlにおける生検陽性率に関係する因子の臨床的検討, 伊藤 一人 / 山本 巧 / 鈴木 和浩 / 山中 英寿, Mar. 2001, 9(1): 66-68
• 前立腺特異抗原(PSA)値別および年齢別の遊離型PSA(fPSA)・総PSA(tPSA)比の基準値設定に関する研究, 山本 巧 / 伊藤 一人 / 鈴木 和浩 / 山中 英寿, Mar. 2001, 9(1): 69-70
• 群馬県における前立腺がん検診の変遷・現況・将来展望, 武智浩之 / 伊藤 一人 / 山本 巧 / 鈴木 和浩, Sep. 2003, 16(9),1005-1010
• Comparative study on the prevalence of clinically detectable prostate cancer in cases with and without bladder cancer, KUROKAWA KOHEI / ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Feb. 2004, Urology
• Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4 ng/ml, OHI MASARU / ITO KAZUTO / SUZUKI KAZUHIRO / YAMAMOTO TAKUMI / YAMANAKA HIDETOSHI, Jan. 2004, Eur Urol
• Androgen-dependent blood flow control and morphological changes of the capillaries in rat prostate, ONO YOSHIHIRO / SUZUKI KAZUHIRO / KASHIWAGI BUNZOU / SHIBATA YASUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, Jan. 2004, Int J Androl
• Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, MATSUMOTO KAZUHISA / SUZUKI KAZUHIRO / KOIKE HIDEKAZU / HASUMI MASARU / MATSUI HIROSHI / OKUGI HIRONOBU / SHIBATA YASUHIRO / ITO KAZUTO / YAMANAKA HIDETOSHI, Sep. 2003, Anticancer Res
• The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer, HASUMI MASARU / SUZUKI KAZUHIRO / MATSUI HIROSHI / YAMAMOTO TAKUMI / ITO KAZUTO / KUROKAWA KOHEI / AOKI JUN / ENDO KEIGO / YAMANAKA HIDETOSHI, Sep. 2003, Anticancer Res
• Association of genetic polymorphisms of Glutathione-S-transpherase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, NAKAZATO HARUKI / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / SUZUKI KAZUHIRO / MATSUI HIROSHI / KOIKE HIDEKAZU / OKUGI HIRONOBU / OHTAKE NOBUAKI / TAKEI TOMOYUKI / NAKATA SEIJI / HASUMI MASARU, May 2003, Anticancer Res
• A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / MATSUI HIROSHI / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / NAKAZATO HARUKI / OKUGI HIRONOBU / KOIKE HIDEKAZU / ONO YOSHIHIRO, Jul. 2003, J Biomed Sci
• 初回ホルモン療法後の再燃における放射線療法の適応　PSAdoubling time(PSADT)による判定は可能か, 黒川 公平 / 伊藤 一人 / 鈴木 和浩 / 深堀 能立 / 秋元 哲夫 / 三橋紀夫 / 山中 英寿, 2001, 14,No.臨時増刊(451-453)
• An evaluation of the Banff 97 classification after kidney transplantation, TANAKA TOSHIYUKI ／ KYO MASAHIRO ／ KOKADO YUKITO ／ TAKAHARA SHIRO ／ HATORI MOTOAKI ／ SUZUKI KAZUHIRO ／ HASUMI MASARU ／ TOKI KIYOHIDE ／ ICHIMARU NAOTSUGU ／ OKUYAMA AKIHIKO ／ YAMANAKA HIDETOSHI, 2003, Transplantation Proceedings
• Hands-free hook for endourological procedures, ONO YOSHIHIRO ／ SUZUKI KAZUHIRO, Oct. 2003, Int J Urol
• Malignant fibrous histiocytoma of the right spermatic cord: a case report., Sekine Y / Saruki K / Morita T / NAKAZATO HARUKI / YOKOO HIDEAKI / Yamanaka H / Ohki K / Okamoto K / Nomura M / Tomita H / Ohtake N / SUZUKI KAZUHIRO / KUROKAWA KOHEI / Mashimo M, 2001, Int J Urol
• Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO / ITO KAZUTO / YAMANAKA HIDETOSHI / NAKAZATO HARUKI / MATSUI HIROSHI / KOIKE HIDEKAZU / OKUGI HIRONOBU / KASHIWAGI BUNZOU / NISHII MASAHIRO / OHTAKE NIBUAKI / NAKATA SEIJI, Oct. 2003, Cancer
• Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, HASUMI MASARU / SUZUKI KAZUHIRO / MATSUI HIROSHI / KOIKE HIDEKAZU / ITO KAZUTO / YAMANAKA HIDETOSHI, Oct. 2003, Cancer Lett
• Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less, ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Sep. 2003, Prostate
• Natural history of PSA increase with and without prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Jul. 2003, Urology
• Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, SUZUKI KAZUHIRO / HATORI MOTOAKI / ITO KAZUTO / YAMANAKA HIDETOSHI / MATSUI HIROSHI / NAKAZATO HARUKI / KOIKE HIDEKAZU / OKUGI HIRONOBU / HASUMI MASARU / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI, Jun. 2003, Cancer Lett
• Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/mL., ITO KAZUTO / YAMAMOTO TAKUMI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Apr. 2003, Urology
• Preliminary results of a monitoring system to confirm the preservation of cavernous nerves, KUROKAWA KOHEI / suzuki takanori / SUZUKI KAZUHIRO / TERADA N / ITO KAZUTO / YAMANAKA HIDETOSHI, Mar. 2003, Int J Urol
• Cumulative probability of PSA increase above 4.0 ng/ml in population based screening for prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Apr. 2004, Int J Cancer
• Association of the genetic polymorphism of the CYP19 intron 4 [TTTA]n repeat with familial prostate cancer risk in a Japanese population., SUZUKI KAZUHIRO / NAKAZATO HARUKI / MATSUI HIROSI / KOIKE HIDEKAZU / OKUGI HIRONOBU / OHTAKE NOBUAKI / NAKATA SEIJI / HASUMI MASARU / YAMANAKA HIDETOSHI, 2003, Anticancer Research
• Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO / ITO KAZUTO / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / MATSUI HIROSHI / ONO YOSHIHIRO / NAKAZATO HARUKI / HASUMI MASARU / KOIKE HIDEKAZU, Nov. 2002, Anticancer Res
• The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with PSA levels of 4.1 to 10.0 ng/ml, ITO KAZUTO / YAMAMOTO TAKUMI / KUROKAWA KOHEI / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Nov. 2002, Cancer
• MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer, HASUMI MASARU / SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, Apr. 2002, Anticancer Res
• Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/ml or less, YAMAMOTO TAKUMI / ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Dec. 2001, Urology
• Intermittent deep coma in a hemodialysis patient with liver cirrhosis:A case report, MATSUMOTO KAZUHISA / HAYASHI MASAMICHI / KOSAKU NOZOMU / YAMAMOTO TAKUMI / HATORI MOTOAKI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / ONO YASUHIRO, 2003, Kitakanto Med J
• 前立腺生検の適応, 鈴木 和浩 / 伊藤 一人 / 山中 英寿, 2004, 58,No.7(455-459)
• Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: is it possible to identify patients likely to have good treatment outcomes?, KUROKAWA KOHEI / ITO KAZUTO / SUZUKI KAZUHIRO / YAMAMOTO TAKUMI / AKIMOTO TETSUO / YAMANAKA HIDETOSHI, Nov. 2002, Jpn J Clin Oncol
• 前立腺癌　男性ホルモン依存性と非依存性, 鈴木 和浩 / 山中 英寿, Jan. 2002, 50,No.1(83-87)
• 酢酸クロルマジノン(プロスタール)を用いた症例, 鈴木 和浩 / 黒川 公平 / 山中 英寿, Mar. 2002, 10,No.3(245-248)
• Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population., SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / MATSUI HIROSHI / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / KOIKE HIDEKAZU / NAKAZATO HARUKI / OKUGI HIRONOBU / HASUMI MASARU, May 2003, Int J Urol
• 進行性前立腺癌におけるFlutamideによる副腎性アンドロゲン抑制効果の臨床的検討, 中里 晴樹 / 鈴木 和浩 / 伊藤 一人 / 深堀 能立 / 黒川 公平 / 山中 英寿, Jan. 2001, 92,No.(6-12）
• Role of androgen on blood flow and capillary structure in rat seminal vesicle, ONO YOSHIHIRO / SUZUKI KAZUHIRO / KASHIWAGI BUNZOU / SHIBATA YASUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, Feb. 2004, Tohoku J Exp Med
• 慢性腎不全に腎盂腫瘍を合併し、血液透析導入、外科手術を行った血友病Ｂの１例, 曲 友弘 / 羽鳥 基明 / 小野芳啓 / 塩野昭彦 / 清水信明 / 黒川 公平 / 深堀 能立 / 鈴木 和浩 / 山中 英寿, Dec. 2003, 36,No.12(1731-1736)
• CAPD導入5年後に陰嚢浮腫、陰茎浮腫を認めた1例, 上井崇智 / 曲 友弘 / 川口拓也 / 羽鳥 基明 / 鈴木 和浩 / 山中 英寿, Mar. 2004, 37,No.3(249-252)
• 網膜多発血栓を合併し、ヘパリン起因性血小板減少症(HIT)が強く疑われた1例, 曲 友弘 / 羽鳥 基明 / 蓮見　勝 / 田中俊之 / 松井　博 / 森田崇弘 / 小野芳啓 / 鈴木 和浩 / 山中 英寿, Jun. 2004, 37,No.6(1437-1442)
• Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer., Shigehito Miyamoto / ITO KAZUTO / KUROKAWA KOHEI / SUZUKI KAZUHIRO / 鈴木慶二 / YAMANAKA HIDETOSHI, Jun. 2006, Int J Urol
• 前立腺疾患のトピックス　前立腺癌家族内発生, 鈴木 和浩 / 大竹伸明 / 中田誠司 / 山中 英寿, Apr. 2003, 57,No.4(310-315)
• 前立腺癌の早期診断と治療をめぐって, 荒井陽一 / 鈴木 和浩 / 頴川　晋, 2004, 22,No.9(88-94)
• 前立腺癌の症状、治療の基礎知識, 鈴木 和浩 / 村椿茂里 / 諸田了子, Oct. 2004, 9,No.10(908-915)
• The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less, ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Feb. 2004, J Urol
• PSAスクリーニング導入後10年間の検診発見前立腺癌症例の臨床病理学的特徴の変化, 山本 巧 / 伊藤 一人 / 武智 浩之 / 河野真意 / 坂西理恵 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2005, 18(8):1000-1002
• 前立腺がん検診暴露率と発見がん症例の臨床的特徴の関係, 武智 浩之 / 伊藤 一人 / 山本 巧 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2005, 18(8): 997-999
• 新しい前立腺がん診断法と将来の方向性について, 伊藤 一人 / 山本 巧 / 鈴木 和浩 / 山中 英寿, 2004, 11: 50-53
• Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia, SHIBATA YASUHIRO / KASHIWAGI BUNZOU / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / ARAI SEIJI, Aug. 2005, Urology
• 前立腺特異抗原(PSA)による前立腺がん検診と精度管理, 山本 巧 / 伊藤 一人 / 武智 浩之 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2004, 11(2): 37-39
• 前立腺癌における新しい画像診断：MR-Spectroscopy(MRS), 鈴木 和浩, 2004, 11,No.2(62-64)
• 前立腺生検法, 鈴木 和浩 / 伊藤 一人, 2005, 63,No.2(253-259)
• 家族性・遺伝性前立腺がん, 鈴木 和浩 / 大竹伸明 / 松井　博 / 中田誠司, Sep. 2004, 17,No.9(971-976)
• Fatal leukemia in interleukin-15 transgenic mice., Fehniger T.A. / SUZUKI KAZUHIRO / VanDeusen J.B. / Cooper M.A. / Freud A.G. / Caligiuri M.A., 2001, Blood Cells, Molecules, and Disease
• BODY MASS INDEX（BMI）の前立腺がん罹患および血清PSA値に与える影響, 山本 巧 / 伊藤 一人 / 武智 浩之 / 鈴木 和浩, Mar. 2006, 14(1): 43-45
• 前立腺がん集団検診における年齢階層別発見がんの臨床病理学的検討―受診年齢上限の設定について―, 山本 巧 / 伊藤 一人 / 武智 浩之 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, Jan. 2003, 10(2):118-122
• 年齢階層別PSAを基準とした前立腺がん検診の展開―前立腺がん集団検診における導入の意義―, 山本 巧 / 黒川 公平 / 伊藤 一人 / 鈴木 和浩 / 山中 英寿, Jan. 2003, 10(2):87-90
• 前立腺がん集団検診における年齢階層別ＰＳＡ基準値の有用性―69歳以下のＰＳＡ基準値引き下げによる効果―, 武智 浩之 / 山本 巧 / 伊藤 一人 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, Jan. 2003, 10(2)：126-129
• 群馬県における前立腺癌の罹患率、臨床病期、組織学的分化度の推移, 中田誠司 / 大竹伸明 / 久保田裕 / 伊藤 一人 / 鈴木 和浩 / 山中 英寿, 2004, 50:165-170
• A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States, Oyama T / Allsbrook WC / Kurokawa K / Matsuda H / SEGAWA ATSUKI / SANO TAKAAKI / SUZUKI KAZUHIRO / Epstein LI, Aug. 2005, Arch Pathol Lab Med
• The evaluation of rat prostate blood flow using a laser speckle flowmetry: a comparative study using the microsphere method in castrated and androgen-replenished rats, SHIBATA YASUHIRO / KASHIWAGI BUNZOU / ONO YOSHIHIRO / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / HONMA SEIJIRO / YAMANAKA HIDETOSHI, Feb. 2004, Urological Research
• 膀胱重量算出ノモグラムを使用した下部尿路閉塞の評価, 曲 友弘 / 深堀 能立 / 鈴木 和浩 / 山中 英寿 / 小倉治之, Jan. 2004, 50,No.1(7-14)
• 前立腺癌検診の効用, 鈴木 和浩 / 山中 英寿, 2004, 53,No.10(2741-2742)
• ガイドラインに基づく腎尿路疾患診療　前立腺癌, 鈴木 和浩 / 羽鳥 基明, 2004, 56,No.5(758-762）
• Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivo., SHIBATA YASUHIRO / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / 本間誠次郎, 2004, Endocrinology
• 生下時より認めていたと思われる小児精巣腫瘍の１例, 上井崇智 / 加藤雄一 / 三木正也 / 鈴木 和浩 / 山中 英寿, Nov. 2002, 15,No.11(1237-1240)
• Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer., KOIKE HIDEKAZU / ITO KAZUTO / OYAMA TETSUNARI / YAMANAKA HIDETOSHI / SUZUKI KAZUHIRO, Apr. 2005, Br J Cancer.
• Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity., AKIMOTO TETSUO / ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / NAKANO TAKASHI, Oct. 2005, Int J Radiat Oncol Biol Phys.
• 本邦における家族性前立腺癌の最新知見, 大竹伸明 / 中田誠司 / 深堀 能立 / 鈴木 和浩 / 山中 英寿, 2002, 60,No.11(469-473)
• 古作クリニックにおけるブラッドアクセスの現状と初回内シャントと2回目内シャントの比較検討, 小野芳啓 / 羽鳥 基明 / 伊藤 一人 / 鈴木 和浩 / 山中 英寿 / 古作　望 / 松本和久 / 林　雅道 / 内田達也 / 竹澤　豊 / 小林 幹男 / 中里 晴樹 / 山本 巧, Oct. 2002, 18,No.10(1377-1381)
• 原発性陰嚢内硬化性脂肪肉芽腫―手術的摘除例と自然消退例, 小野芳啓 / 古作　望 / 矢嶋久徳 / 高橋　修 / 深堀 能立 / 鈴木 和浩 / 山中 英寿 / 真下正道 / 関原哲夫 / 猿木和久 / 松本和久 / 林　雅道, Jul. 2002, 52,No.4(271-277)
• Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: Establishment of a new highly sensitive simultaneous andorgen measurement method, KASHIWAGI BUNZOU / SHIBATA YASUHIRO / ONO YOSHIHIRO / SUZUKI RYOTA / HONMA SEIJIRO / SUZUKI KAZUHIRO, Oct. 2005, Journal of Andrology
• Effect of androgen concentration on seminal vesicle blood flow in rat-establishment of new highly sensitive simultaneous androgen measurement method, KASHIWAGI BUNZOU / SHIBATA YASUHIRO / SUZUKI KAZUHIRO / HONMA SEIJIRO / ONO YOSHIHIRO / YAMANAKA HIDETOSHI, Jun. 2005, Urology
• 未治療進行性前立腺癌における初回LH-RH agonist投与時のflare-up予防：Diethylstilbestrol-Diphosphate, Estramustine Phosphate, Chlormadinone Acetateによる比較検討, 松井　博 / 鈴木 和浩 / 中里 晴樹 / 黒川 公平 / 柴田 康博 / 蓮見　勝 / 伊藤 一人 / 深堀 能立 / 山中 英寿, Oct. 2001, 47,No.10(861-866）
• 多数箇所生検で発見された前立腺癌の前立腺領域別分布, 武智 浩之 / 伊藤 一人 / 山本 巧 / 黒川 公平 / 鈴木 和浩, 2005, 12: 148-150
• 私の行っている縫合と吻合の手技―膀胱･尿道吻合, 黒川 公平 / 鈴木 和浩 / 山中 英寿, Dec. 2002, 56,No.13(1119-1123)
• 集合管癌(Bellini管癌)の一例, 小池 秀和 / 武井智幸 / 大竹伸明 / 真下正道 / 鈴木 和浩 / 山中 英寿, Jul. 2002, 52,No.4(267-270)
• 後腹膜原発性腺外胚細胞腫瘍の一例, 河野真意 / 鈴木光一 / 鈴木 孝憲 / 富田　光 / 岡本亘平 / 松井　博 / 山本 巧 / 中里 晴樹 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, May 2002, 52,No.3(203-206)
• 膀胱平滑筋肉腫の一例, 河野真意 / 松井　博 / 山本 巧 / 小野芳啓 / 深堀 能立 / 黒川 公平 / 鈴木 和浩 / 山中 英寿 / 鈴木慶二, Jul. 2002, 52,No.4(279-282)
• 日本における前立腺がん検診と予後, 鈴木 和浩, 2003, 10,No.2(192-194)
• 男性維持透析患者における前立腺癌のスクリーニング, 羽鳥 基明 / 鈴木 和浩 / 柴田 康博 / 伊藤 一人 / 黒川 公平, 2004, 17, No.12 (1251-1254)
• 膀胱癌と前立腺癌, 羽鳥 基明 / 鈴木 和浩 / 山中英壽, 2004, 62, 増刊号6 (374-377)
• A simple and reliable monitoring system to confirm the preservation of the cavernous nerves, KUROKAWA KOHEI / suzuki takanori / SUZUKI KAZUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, May 2001, Int J Urol
• 群馬大学医学部附属病院における維持透析患者の手術症例の検討, 羽鳥 基明 / 黒川 公平 / 深堀 能立 / 山中 英寿 / 林　雅道 / 塩野昭彦 / 蓮見　勝 / 武井智幸 / 松井　博 / 川口拓也 / 伊藤 一人 / 鈴木 和浩, Nov. 2002, 35,No.11(1447-1451)
• PSA4.1～10ng/mlにおける前立腺生検法の検討　年齢/前立腺体積を考慮に入れた前立腺生検法の有用性, 伊藤 一人 / 山本 巧 / 大井　勝 / 深堀 能立 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, Aug. 2002, 15No.8(934-937)
• NK cell-mediated anti-tumor immune response to human prostate Cancer cell, PC-3 : immunogene therapy using a highly secretable form of interleukin-15 gene transfer., SUZUKI KAZUHIRO / NAKAZATO HARUKI / MATSUI HIROSHI / HASUMI MASARU / SHIBATA YASUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Apr. 2001, Journal of Leucocyte Biology
• Fatal leukemia in inter leukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD 8 T cells, Fehniger, T.A. / Caligiuri M.A. / SUZUKI KAZUHIRO / Ponnappan A. / VanDeusen J.B. / Cooper M.A. / Florea S.M. / Freud A.G. / Robinson M.L. / Durbin J, 2001, J Exp Med
• 前立腺集団検診における年齢階層別PSA基準値の有用性, 山本 巧 / 伊藤 一人 / 大井　勝 / 久保田裕 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2002, 10,No.1(18-19)
• 嫌色素性腎癌の１例, 柏木 文蔵 / 栗田　晋 / 中村敏之 / 加藤宣雄 / 鈴木 和浩 / 山中 英寿, Feb. 2002, 48,No.2(85-87)
• Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population., Hironobu Okugi, Haruki Nakazato, Hiroshi Matsui, Nobuaki Ohtake, Seiji Nakata, Kazuhiro Suzuki, 2006, Cancer Detection and Prevention
• 尿路腫瘍(膀胱、腎盂・尿管癌)外来におけるPSAスクリーニング, 黒川 公平 / 松井　博 / 深堀 能立 / 山中 英寿 / 鈴木 和浩 / 岡崎　浩 / 伊藤 一人 / 塩野昭彦 / 羽鳥 基明 / 蓮見　勝 / 井上雅晴 / 川口拓也, Mar. 2002, 10,No.1(29-30)
• 透析患者の腎尿路系腫瘍　３前立腺癌, 鈴木和浩、羽鳥基明, 2006, 16, 3, 13-15
• A case of emphyematous pyelonephritis in a renal allograft, Seiji Arai, Takeaki Makino, Masaru Hasumi, Yasuhiro Shibata, Motoaki Hatori, Kazuhiro Suzuki, 2006, Transplantation
• 前立腺肥大症治療におけるChlormadinone acetate投与によるPSA測定値への影響（他施設共同研究）, 藤本清秀、舛森直哉、塚本泰司、徳山聡、荒井陽一、谷川俊貴、高橋公太、鈴木和浩、山中英壽、宮永直人、赤座英之、加藤聡彦、石井延久、宮澤克人、鈴木孝治、小野佳成、大島伸一、平尾佳彦、CMA-PSA研究会, 2005, 13, 1, 89-91
• 前立腺癌診療ガイドラインからみた前立腺癌検診, 鈴木和浩, 2006, 55, 11, 2705
• 前立腺癌, 鈴木和浩、羽鳥基明, 2006, 464-468
• Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues., Hironobu Okugi, Hidekazu Koike, Yoshitaka Sekine, Hiroshi Matsui, Kauzhiro Suzuki, 2006, Asia-Pacific Journal of Clinical Oncology
• 前立腺癌の治療Q&A, 鈴木和浩, 2005, 140-153
• 内分泌外科からみた前立腺癌の臨床：前立腺癌の治療法と適応, 鈴木和浩, 2005, 22, 4, 206-216
• 腫瘍マーカー/泌尿器系　PSA(γ-Sm), 鈴木和浩, 2005, 42, 12, 539-541
• 前立腺の病気になりやすい人はいるか, 鈴木和浩、松井博、大竹伸明, 2005, 243
• 腎細胞癌の多発性肺転移症例に対する骨髄非破壊的同種末梢血幹細胞移植, 土岐典子、松島孝文、斉藤泰之、横浜章彦、塚本憲史、唐沢正光、村上博和、鈴木和浩、野島美久 , 2006, 56, 3, 231-235
• Long term follow-up of mass screening for prostate carcinoma in men with initial prostate-specific antigen levels of 4.0ng/ml or less, ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Feb. 2001, Cancer
• Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents Chlormadinone acetate and Finasteride, SHIBATA YASUHIRO / FUKABORI YOSHITATSU / ITO KAZUTO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Jan. 2001, J Urol
• Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome, SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / NAKAZATO HARUKI / HASUMI MASARU / MATSUI HIROSHI / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Jun. 2001, Int J Androl
• Positive effect of prostaglandin on regulation of prostatic blood flow., Kashiwagi B, Shibata Y, Ohki K, Arai S, Honma S, Suzuki K., 2006, Urology
• 機能的解剖を応用した術中勃起神経温存評価の短期結果, 黒川 公平 / 小山大輔 / 山中 英寿 / 鈴木 孝憲 / 鈴木 和浩 / 伊藤 一人 / 小野芳啓 / 深堀 能立 / 武井智幸 / 寺田直樹 / 荒井陽一, Aug. 2002, 15,No.8(928-930)
• Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo., Shibata Y, Kashiwagi B, Arai S, Magari T, Suzuki K, Honma S., 2006, Urology
• Cyclin D1 gene polymorphism and familial prostate cancer : The AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage., KOIKE HIDEKAZU / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / TAKEI TOMOYUKI / NAKATA SEIJI / SATHO T / OHTAKE NOBUAKI, Nov. 2003, Anticancer Research
• Lead time of prostate cancer detected in population-based screening for prostate cancer in Japan., Ito K, Yamamoto T, Miyakubo M, Takechi H, Ohi M, Shibata Y, Suzuki K., Oct. 2007, J Urol , 178, 1258-1264
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., Sekine Y, Ito K, Yamamoto T, Nakazato H, Shibata Y, Hatori M, Suzuki K., 2007
• Editorial Comment, Kazuhiro Suzuki, Feb. 2008, Int J Urol
• Editorial Comment, Kazuhiro Suzuki, Feb. 2008, Int J Urol, 15
• Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells. , Sekine Y, Koike H, Nakano T, Nakajima K, Suzuki K, Aug. 2007, Clin Chim Acta
• 男性型脱毛症薬プロペシア錠（フィナステリド）の前立腺がん検診における内服症例と年齢をマッチさせた非内服症例の血清PSA値の比較, 宮久保真意、伊藤一人、山本巧、武智浩之、大井勝、鈴木和浩, Jan. 2008, 15, 2, 125-127
• 泌尿器悪性腫瘍　最近の診断と治療　増加する前立腺癌　家族性・遺伝性前立腺がん, 鈴木和浩, Mar. 2000, ８４, ３, ３０９－３１４
• EBMに基づいた前立腺癌診療ガイドライン２００６年度版　要約, 守殿貞夫、大島伸一、平尾佳彦、鈴木和浩、荒井陽一、藤元博行、江川晋、赤座英之、原勲、筧善行、樋之津史朗、長谷川友紀、, Mar. 2007, ９８, １－３１
• Pilot study of the optimum hematocrit for patients in the predialysis stage after renal transplantation , Kawaguchi T, Moriyama T, Suzuki K, Hatori M, Tanaka T, Takahara S, Yamanaka H., Jun. 2004, Transplantation Proc
• Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility ot familial prostate cancer in a Japanese population, Tatsuya Hamano, Hiroshi Matsui, Nobuaki Ohtake, Seiji Nakata, Kazuhiro Suzuki, Feb. 2008, Asia-Pacific Journal of Clinical Oncology
• 前立腺癌治療後のPSA再発をいかにとらえるか 放射線療法後のPSA再発に対する治療戦略　When and How+, 鈴木和浩, Apr. 2008, 6, 2, 74-80
• 前立腺癌予見因子としての血清インスリン様成長因子の意義, 山本巧、伊藤一人、武智浩之、大井勝、宮久保真意、鈴木和浩, Mar. 2007, 15, 1, 93-95
• 前立腺癌予防の可能性：脂質, 関根芳岳、小池秀和、鈴木和浩, Dec. 2007, 20, 12, 1525-1529
• 前立腺癌　基礎・臨床研究のアップデート　臨床研究　検診 前立腺癌検診における年齢階層別PSA基準値導入の意義, 大井勝、伊藤一人、山本巧、武智浩之、鈴木和浩, Dec. 2007, 65, 10, 203-206
• 前立腺癌　基礎・臨床研究のアップデート　臨床研究　検診　我が国における前立腺癌検診の現状と展望, 鈴木和浩, Dec. 2007, 65, 10, 187-293
• 前立腺癌　基礎・臨床研究のアップデート　臨床研究　疫学　我が国における家族性前立腺癌の特徴, 大竹伸明、中田誠司、鈴木和浩、深堀能立、山中英壽, Dec. 2007, ６５, １０, 182-186
• 排尿障害の診断と治療, 鈴木和浩, Jul. 2007, 57, 25-27
• 泌尿器科　疼痛対策　進行癌の疼痛対策　前立腺癌, 鈴木和浩、小池秀和, Oct. 2007, ５, ５, ７７－８２
• JUA前立腺癌診療ガイドライン　初版の読みどころと改定に向けての課題　疫学, 鈴木和浩, Jun. 2007, 20, 6, 737-741
• Effects of Aromatase Inhibitor, TZA-2209, on the Prostate of Androstenedione-treated Castrated Dogs : Changes in Prostate Volume and Histopathological Findings, SUZUKI KAZUHIRO / ITO KAZUTO / suzuki takanori / YAMANAKA HIDETOSHI, May 1996, Prostate
• Endocrine Environment of Benign Prostatic Hyperplasia : Prostate Size and Volume are Correlated with Serum Estrogen Concentration, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / suzuki takanori / YAMANAKA HIDETOSHI, Mar. 1995, Scand J Urol Nephrol
• Effects of New Steroidal Antiandrogen, TZP-4238(172-acetoxy-6-chloro-2-oxa-4, 6-pregnadine-3, 20-dione), on Spontaneously Developed Canine Benign Prostatic Hyperplasia, TAKEZAWA YUTAKA / ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, 1995, Prostate
• 群馬県における前立腺集団検診形態の変遷-18年間の総括および現況・問題点-, 伊藤 一人 ／ 山本 巧 ／ 鈴木 和浩 ／ 山中 英寿, 2000, 13/8,997-1001
• Effects of new steroidal aromatase inhibitor, TZA-2237, and/or Chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia, ITO KAZUTO / FUKABORI YOSHITATSU / SHIBATA YASUHIRO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, Oct. 2000, Eur J Endocrinol
• Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, Aug. 2000, Urology
• Correlation of prostate-specific antigen before prostate cancer detection and clinicopathological features : Evaluation of mass screening populations, ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, May 2000, Urology
• Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / suzuki takanori / YAMANAKA HIDETOSHI, 1998, Int Urol Nephrol
• IL-15 costimulates the generalized shuartzman reaction and innate immune IFN-γ production in vivo, SUZUKI KAZUHIRO, 2000, J Immunol
• Differential cytokine and chemokino gene expression by human NK cells following activation with IL-18 or IL-15 combination with IL-12 : Imprication for the innata immune response, SUZUKI KAZUHIRO, 1999, J. Immunol
• Effect of dual inhibition of 5-alpha-reductase and aromatase on spontareously developed canine prostate hypertrophy, SUZUKI KAZUHIRO, 1998, Prostate
• Estimation of canine prostatic volume : Nomesram based on prostatic cubic volume, SUZUKI KAZUHIRO, 1998, 1st Urol Nephrol
• Expression and degredation of rat androgen reoptor following castration testosterone replacement and antiandrogens administration analysis by western blot and immnnohistochemishy, SUZUKI KAZUHIRO, 1997, Tohoku J Ey Med
• Effect of aromotase inhibitor, TZA-2209, on the prostate of androsternedione-treated castrated dogs : chayes in prostate volume and histopathological findings, SUZUKI KAZUHIRO, 1996, Prostate
• Synergistic Effects of Estrogen and Androgen on the Prostate : Effects of Estrogen on Androgen-and Estrogen-receptors, Brd V Uptake, Immunohistochemical Study of AR, and Responses to Antiandrogens, SUZUKI KAZUHIRO / ITO KAZUTO / suzuki takanori / YAMANAKA HIDETOSHI, Mar. 1995, Prostate
• Expression and Degradation of Rat Androgen Receptor Following Castration, testosterone Replacement and Antiandrogens Administration : Analysis by Western Blot and Immunohistochemistry, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / suzuki takanori / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, Nov. 1997, Tohoku J Exp Med
• Changes in the endocrine environment of the human prostate transition zone with aging : Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition, SHIBATA YASUHIRO / ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, Jan. 2000, Prostate
• 照射後の膀胱全摘・尿路変更に伴う腸管トラブル, 鈴木和浩, May 2010, ２３, ５, ７１９
• 前立腺がんと前立腺肥大症の疫学, 鈴木和浩, May 2009, 138, 2, 251
• 前立腺がん検診の有効性　死亡率減少効果について, 鈴木和浩, Dec. 2008, ２１, １２, １５８５
• Epidemiology of prostate cancer and benign prostatic hyperplasia, Kazuhiro Suzuki, Dec. 2009, JMAJ
• Development of an enzyme-linked immunosorbent assay for metallothionein-I and -II in plasma of humans and experimental animals., Nakajima K, Kodaira T, Kato M, Nakazato K, Tokita Y, Kikuchi H, Sekine H, Suzuki K, Nagamine T., May 2010, Clin Chim Acta
• Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells., Abdulah R, Faried A, Kobayashi K, Yamazaki C, Suradji EW, Ito K, Suzuki K, Murakami M, Kuwano H, Koyama H., Nov. 2009, BMC Cancer
• New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry., Arai S, Miyashiro Y, Shibata Y, Kashiwagi B, Tomaru Y, Kobayashi M, Watanabe Y, Honma S, Suzuki K., Jan. 2010, Steroids
• Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer., Okamura K, Koike H, Sekine Y, Matsui H, Suzuki K., Aug. 2009, Cancer Epidemiolo
• Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor., Sekine Y, Koike H, Nakano T, Nakajima K, Takahashi S, Suzuki K., Jul. 2009, Cancer Epidemiol
• The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha1-adrenergic receptor antagonist work well for ureteral stones?, Ohki K, Ohno Y, Suzuki K., Jan. 2010, Int Urol Nephrol
• Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy., Miyakubo M, Ito K, Yamamoto T, Takechi H, Ohi M, Suzuki K., Jun. 2009, Int J Urol
• Induction of type 1 interferon receptor by zinc in U937 cells., Nagamine T, Nakajima K, Takada H, Sekine Y, Suzuki K., Jun. 2009, Cytokine
• Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia., Nagai Y, Hasegawa M, Shinmi K, Kishi C, Tsushima Y, Endo K, Okabe K, Suzuki K, Ishikawa O., Jun. 2008, Acta Derm Venereol
• Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Sekine Y, Furuya Y, Nishii M, Koike H, Matsui H, Suzuki K., Jul. 2008, Biochem Biophys Res Commun.
• Changes in baseline PSA levels in Japanese men from 1988 to 2003., Ohi M, Ito K, Yamamoto T, Miyakubo M, Takechi H, Kubota Y, Suzuki K., Jul. 2008, Urology
• Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds., Yamamoto T, Ito K, Miyakubo M, Takechi H, Suzuki K, Akimoto T, Ishikawa H, Nakano T., Oct. 2008, Urology
• Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease., Hamano T, Matsui H, Sekine Y, Ohtake N, Nakata S, Suzuki K., Aug. 2010, Journal of Urology
• Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer., Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K., Dec. 2008, Urology
• 前立腺と組織内アンドロゲン　ー前立腺癌の診断・治療における応用の可能性, 鈴木和浩、柏木文蔵、新井誠二、柴田康博、本間誠次郎 , Feb. 2009, ８１, ２, ２００
• Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population., Koike H, Nakazato H, Ohtake N, Matsui H, Okugi H, Shibata Y, Nakata S, Yamanaka H, Suzuki K., Apr. 2008, Int Urol Nephrol
• Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan., Takechi H, Ito K, Yamamoto T, Miyakubo M, Ohi M, Suzuki K., Nov. 2008, Urology
• 前立腺癌検診の意義, 鈴木和浩, Nov. 2009, 58, 11, 2351-352
• 進行癌に対する内分泌療法, 鈴木和浩, Apr. 2009, 7, 2, 10-16
• 前立腺疾患：疫学の動向、治療のトレンド、手術のポイント, 鈴木和浩, Nov. 2009, 16, 11, 1064
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related induces in men with total PSA in the 2.0-10.0ng/ml range., 2012, World J Urol
• Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: The relationship between dose-volume histogram parameters and the occurrence rate., 2012, Int J Radiat Oncol Biol Phys
• Serous borderline tumor of the paratestis in a child., 2012, BJUI.org
• Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme., 2012, Prostate Cancer and Prostatic Disease
• Luteinizing horomone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: Implications for the effect of LH on the adrenal glands., 2012, J Androl
• Lower urinary tract symptoms of neurological origin in urological practice., 2012, Clin Auton Res
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., 2012
• Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation., 2012, Biochem Biophys Res Commun
• Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy., 2012, Prostate Cancer and Prostatic Disease
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., 2011, Steroids
• 腎・泌尿器疾患のインフォームドコンセントと治療選択：前立腺疾患, 2010
• ＣＲＰＣの定義と発症メカニズム, 2011
• 去勢抵抗性前立腺がんにおける男性ホルモンの意義, 2011
• 前立腺がんの病態・診断・治療, 2011
• 国内外のガイドラインからみた間歇的内分泌療法の位置付けと現状, 2011
• 我が国における前立腺癌検診の現状と展望, 2011
• 尿路上皮癌に対するＧＣ療法施行時におけるパロノセトロンの効果：グラニセトロンとの比較検討, 2011
• 泌尿器科領域におけるがん検診と超音波の役割, 2011
• 透析療法における様々な疑問に答える ー４透析患者の腎尿路悪性腫瘍-前立腺癌, 2011
• 腎・泌尿器疾患：ＡＬＰおよびＰＳＡの異常高値をきたした64歳の男性ー進行性前立腺癌, 2012
• 進行性・去勢抵抗性前立腺癌に対するホルモン療法の現状と今後の展望ー前立腺癌のアンドロゲン依存性に関するパラダイムシフトー, 2012
• 去勢抵抗性前立腺癌に対するドセタキセルの役割：効果判定とその後の治療選択, 2012
• シロドシンによる排尿障害の治療：Urief Dose-up Study, 2012
• Role of squalene synthase in prostate cancer risk and the biological aggressiveness on human prostate cancer, 2012, Prostate Cancer and Prostatic Disease
• Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., 2011, J Urol
• HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion., 2011, The Prostate
• High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., 2011, The Prostate
• Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010., 2010, Int J Urol
• The investigation of ureteral sympathetic innevation, using semi-serial sections: why dose the alpha1-adrenergic receptor antagonist work well for ureteral stones?, 2010, Int Urol Nephrol
• 泌尿器科領域ＰＳＡスクリーニング検査がもたらすもの, 2010
• "泌尿器科領域におけるトラブルシューティング(第9回) 照射後の膀胱全摘・尿路変更に伴う腸管トラブル", 2010
• 前立腺肥大の術式, 2010
• 臓器部位別の治療戦略　前立腺がん, 2010
• Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist, Miyazawa Y, Kato H, Arai S, Furuya Y, Sekine Y, Nomura M, Koike H, Matsui H, Shibata Y, Ito K, Suzuki K, 2015, Basic and Clinical Andrology

  DOI
• Suicide attempt with an overdose of sunitinib, Arai, Seiji; Matsui, Hiroshi; Ohki, Ryo; Miyazawa, Yoshiyuki; Koike, Hidekazu; Hashita, Tadahiro; Katsuyama, Yoshihiko; Sekine, Yoshitaka; Nomura, Masashi; Shibata, Yasuhiro; Hatori, Motoaki; Ito, Kazuto; Yamamoto, Koujirou; Ohmori, Shigeru; Suzuki, Kazuhiro, Oct. 2014, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

  DOI
• Chlormadinone acetate is effective for hot flush during androgen deprivation therapy, Koike, Hidekazu; Morikawa, Yasuyuki; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013, Prostate International

  DOI
• Androgen receptor coactivator p120 subtype beta is highly expressed in prostate cancer, Muramatasu, Kazumichi; Matsui, Hiroshi; Sekine, Yoshitaka; Koike, Hidekazu; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013, Prostate International

  DOI
• Simple method for preventing inguinal hernias after radical retropubic prostatectomy, Koike, Hidekazu; Matsui, Hiroshi; Morikawa, Yasuyuki; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013, Prostate International

  DOI
• Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues, Arai, S.; Shibata, Y.; Nakamura, Y.; Kashiwagi, B.; Uei, T.; Tomaru, Y.; Miyashiro, Y.; Honma, S.; Hashimoto, K.; Sekine, Y.; Ito, K.; Sasano, H.; Suzuki, K., 2013, ANDROLOGY

  DOI
• A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017, BMC UROLOGY

  DOI
• Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Fujizuka, Yuji; Ito, Kazuto; Oki, Ryo; Suzuki, Rie; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, 2017, INTERNATIONAL JOURNAL OF UROLOGY

  DOI
• Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH

  DOI
• Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Kato, Haruo; Furuya, Yosuke; Koike, Hidekazu; Suzuki, Kazuhiro, 2017, PROSTATE

  DOI
• Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Shibata, Yasuhiro; Kurihara, Sota; Arai, Seiji; Kato, Haruo; Suzuki, Tomomi; Miyazawa, Yoshiyuki; Koike, Hidekazu; Ito, Kazuto; Nakamura, Tetsuya; Suzuki, Kazuhiro, 2017, JOURNAL OF INVESTIGATIVE SURGERY

  DOI
• YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Nitta, Takashi; Koike, Hidekazu; Miyao, Takeshi; Miyazawa, Yoshiyuki; Kato, Haruo; Furuya, Yosuke; Sekine, Yoshitaka; Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH

  DOI
• Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Kato, Haruo; Furuya, Yosuke; Miyazawa, Yoshiyuki; Miyao, Takeshi; Syuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, Nov. 2016, ANTICANCER RESEARCH

  DOI
• Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naive prostate cancer, Miyoshi, Yasuhide; Uemura, Hiroji; Umemoto, Susumu; Sakamaki, Kentaro; Taguri, Masataka; Suzuki, Kazuhiro; Shibata, Yasuhiro; Masumori, Naoya; Ichikawa, Tomohiko; Mizokami, Atsushi; Sugimura, Yoshiki; Nonomura, Norio; Sakai, Hideki; Honma, Seijiro; Harada, Masaoki; Kubota, Yoshinobu, 2016, PROSTATE

  DOI
• Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan, Suzuki, Kazuhiro; Namiki, Mikio; Fujimoto, Tsukasa; Takabayashi, Nobuyoshi; Kudou, Kentarou; Akaza, Hideyuki, Dec. 2015, JAPANESE JOURNAL OF CLINICAL ONCOLOGY

  DOI
• Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Ishikawa, Hitoshi; Katoh, Hiroyuki; Kaminuma, Takuya; Kawamura, Hidemasa; Ito, Kazuto; Matsui, Hiroshi; Hirato, Junko; Shimizu, Nobuaki; Takezawa, Yutaka; Tsuji, Hiroshi; Suzuki, Kazuhiro; Ohno, Tatsuya; Nakano, Takashi, Oct. 2015, ANTICANCER RESEARCH
• Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer, Nozawa, Masahiro; Mukai, Hirofumi; Takahashi, Shunji; Uemura, Hiroji; Kosaka, Takeo; Onozawa, Yusuke; Miyazaki, Jun; Suzuki, Kazuhiro; Okihara, Koji; Arai, Yoichi; Kamba, Tomomi; Kato, Masashi; Nakai, Yasutomo; Furuse, Hiroshi; Kume, Haruki; Ide, Hisamitsu; Kitamura, Hiroshi; Yokomizo, Akira; Kimura, Takahiro; Tomita, Yoshihiko; Ohno, Keiji; Kakehi, Yoshiyuki, Oct. 2015, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY

  DOI
• Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association, Kanayama, Hiro-omi; Fukumori, Tomoharu; Fujimoto, Hiroyuki; Nakanishi, Hiroyuki; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Miki, Tsuneharu; Kamoi, Kazumi; Kubota, Yoshinobu; Takahashi, Satoru; Homma, Yukio; Naito, Seiji, 2015, INTERNATIONAL JOURNAL OF UROLOGY

  DOI
• Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Kato, Haruo; Sekine, Yoshitaka; Furuya, Yosuke; Miyazawa, Yoshiyuki; Koike, Hidekazu; Suzuki, Kazuhiro, 2015, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

  DOI
• Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial, Saad, Fred; Fizazi, Karim; Jinga, Viorel; Efstathiou, Eleni; Fong, Peter C.; Hart, Lowell L.; Jones, Robert; McDermott, Raymond; Wirth, Manfred; Suzuki, Kazuhiro; MacLean, David B.; Wang, Ling; Akaza, Hideyuki; Nelson, Joel; Scher, Howard I.; Dreicer, Robert; Webb, Iain J.; de Wit, Ronald, 2015, LANCET ONCOLOGY

  DOI
• Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Shibata, Yasuhiro; Arai, Seiji; Miyazawa, Yoshiyuki; Shuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Ito, Kazuto; Suzuki, Kazuhiro, 2017, PROSTATE

  DOI
• High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL, Miyoshi, Y.; Uemura, H.; Suzuki, K.; Shibata, Y.; Honma, S.; Harada, M.; Kubota, Y., 2017, ANDROLOGY

  DOI
• A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Suzuki, Kazuhiro; Ozono, Seiichiro; Yamaguchi, Akito; Koike, Hidekazu; Matsui, Hiroshi; Nagata, Masao; Takubo, Takatoshi; Miyashita, Kana; Matsushima, Takafumi; Akaza, Hideyuki, 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY

  DOI
• Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan, Onozawa, Mizuki; Hinotsu, Shiro; Tsukamoto, Taiji; Oya, Mototsugu; Ogawa, Osamu; Kitamura, Tadaichi; Suzuki, Kazuhiro; Naito, Seiji; Namiki, Mikio; Nishimura, Kazuo; Hirao, Yoshihiko; Akaza, Hideyuki, Oct. 2014, JAPANESE JOURNAL OF CLINICAL ONCOLOGY

  DOI
• Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer, Matsuyama, Hideyasu; Shimabukuro, Tomoyuki; Hara, Isao; Kohjimoto, Yasuo; Suzuki, Kazuhiro; Koike, Hidekazu; Uemura, Hirotsugu; Hayashi, Taiji; Ueno, Munehisa; Kodaira, Kiichiro; Tomita, Yoshihiko; Sakurai, Toshihiko; Shimizu, Nobuaki, Oct. 2014, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY

  DOI
• YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Koike, Hidekazu; Nitta, Takashi; Sekine, Yoshitaka; Arai, Seiji; Furuya, Yosuke; Nomura, Masashi; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Oyama, Tetsunari; Suzuki, Kazuhiro, Oct. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

  DOI
• High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients, Miyoshi, Yasuhide; Uemura, Hiroji; Umemoto, Susumu; Sakamaki, Kentaro; Morita, Satoshi; Suzuki, Kazuhiro; Shibata, Yasuhiro; Masumori, Naoya; Ichikawa, Tomohiko; Mizokami, Atsushi; Sugimura, Yoshiki; Nonomura, Norio; Sakai, Hideki; Honma, Seijiro; Harada, Masaoki; Kubota, Yoshinobu, 2014, BMC CANCER

  DOI
• Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Ishizuka, Tamotsu; Hisada, Takeshi; Hatori, Motoaki; Koike, Akio; Hanabuchi, Kikuo; Matsuzaki, Shinichi; Kamide, Yosuke; Utsugi, Mitsuyoshi; Aoki, Haruka; Yoshino, Reiko; Yanagitani, Noriko; Koga, Yasuhiko; Ono, Akihiro; Kaira, Kyoichi; Sunaga, Noriaki; Dobashi, Kunio; Tsuburai, Takahiro; Akiyama, Kazuo; Yamada, Masanobu; Suzuki, Kazuhiro; Mori, Masatomo, 2014, INFLAMMATION RESEARCH

  DOI
• Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association, Miki, Tsuneharu; Kamoi, Kazumi; Fujimoto, Hiroyuki; Kanayama, Hiro-omi; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Naito, Seiji; Fukumori, Tomoharu; Kubota, Yoshinobu; Takahashi, Satoru; Mikami, Kazuya; Homma, Yukio, 2014, INTERNATIONAL JOURNAL OF UROLOGY

  DOI
• Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort, Inamoto, Teruo; Azuma, Haruhito; Hinotsu, Shiro; Tsukamoto, Taiji; Oya, Mototsugu; Ogawa, Osamu; Kitamura, Tadaichi; Kazuhiro, Suzuki; Naito, Seiji; Namiki, Mikio; Nishimura, Kazuo; Hirao, Yoshihiko; Usami, Michiyuki; Murai, Masaru; Akaza, Hideyuki, 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

  DOI
• Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels, Magari, Tomohiro; Shibata, Yasuhiro; Arai, Seiji; Kashiwagi, Bunzo; Suzuki, Keiji; Suzuki, Kazuhiro, 2014, ASIAN JOURNAL OF ANDROLOGY

  DOI
• Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association, Fujimoto, Hiroyuki; Nakanishi, Hiroyuki; Miki, Tsuneharu; Kanayama, Hiro-omi; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Naito, Seiji; Fukumori, Tomoharu; Kubota, Yoshinobu; Takahashi, Satoru; Homma, Yukio; Kamoi, Kazumi, 2014, INTERNATIONAL JOURNAL OF UROLOGY

  DOI
• Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer, Mukai, Hirofumi; Takahashi, Shunji; Nozawa, Masahiro; Onozawa, Yusuke; Miyazaki, Jun; Ohno, Keiji; Suzuki, Kazuhiro, 2014, CANCER CHEMOTHERAPY AND PHARMACOLOGY

  DOI
• Chronic expanding hematoma in the retroperitoneal space: a case report, Syuto, Takahiro; Hatori, Motoaki; Masashi, Nomura; Sekine, Yoshitaka; Suzuki, Kazuhiro, Nov. 2013, BMC UROLOGY

  DOI
• High-Density Lipoprotein and Prostate Cancer: An Overview, Kotani, Kazuhiko; Sekine, Yoshitaka; Ishikawa, Shizukiyo; Ikpot, Imoh Z.; Suzuki, Kazuhiro; Remaley, Alan T., 2013, JOURNAL OF EPIDEMIOLOGY

  DOI
• Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy, Shibata, Y.; Suzuki, K.; Arai, S.; Miyoshi, Y.; Umemoto, S.; Masumori, N.; Kamiya, N.; Ichikawa, T.; Kitagawa, Y.; Mizokami, A.; Sugimura, Y.; Nonomura, N.; Sakai, H.; Honma, S.; Kubota, Y., 2013, ANDROLOGY

  DOI
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Ito, Kazuto; Miyakubo, Mai; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, 2013, WORLD JOURNAL OF UROLOGY

  DOI
• Lower urinary tract symptoms of neurological origin in urological practice, Magari, Tomohiro; Fukabori, Yoshitatsu; Ogura, Haruyuki; Suzuki, Kazuhiro, 2013, CLINICAL AUTONOMIC RESEARCH

  DOI
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation, Magari, Tomohiro; Shibata, Yasuhiro; Arai, Sew; Kashiwagi, Bunzo; Suzuki, Kazuhiro, 2013, SCANDINAVIAN JOURNAL OF UROLOGY

  DOI
• Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial., Hiroji Uemura; Hisashi Matsushima; Kazuki Kobayashi; Hiroya Mizusawa; Hiroaki Nishimatsu; Karim Fizazi; Matthew Smith; Neal Shore; Teuvo Tammela; Ken-Ichi Tabata; Nobuaki Matsubara; Masahiro Iinuma; Hirotsugu Uemura; Mototsugu Oya; Tetsuo Momma; Mutsushi Kawakita; Satoshi Fukasawa; Tadahiro Kobayashi; Iris Kuss; Marie-Aude Le Berre; Amir Snapir; Toni Sarapohja; Kazuhiro Suzuki, 23 Nov. 2020, International journal of clinical oncology, Scientific journal

  DOI
• Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug., Yukie Endo; Aina Oka; Akihito Uehara; Sayaka Toki; Sei-Ichiro Motegi; Osamu Ishikawa; Yoshiyuki Miyazawa; Kazuhiro Suzuki, Oct. 2020, The Journal of dermatology, 47, 10, e359-e360

  DOI
• Cabazitaxel in patients aged ≥80 years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan., Nobuaki Matsubara; Kazuhiro Suzuki; Hirotaka Kazama; Shoko Tsukube; Takeshi Seto; Hideyasu Matsuyama, Sep. 2020, Journal of geriatric oncology, 11, 7, 1067, 1073, Scientific journal

  DOI
• Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial., Kazuto Ito; Mikio Kobayashi; Motokiyo Komiyama; Seiji Naito; Kazuo Nishimura; Junji Yonese; Katsuyoshi Hashine; Shiro Saito; Gaku Arai; Mitsuru Shinohara; Naoya Masumori; Nobuaki Shimizu; Takefumi Satoh; Atsushi Yamauchi; Tatsuo Tochigi; Yutaka Takezawa; Hiroyuki Fujimoto; Akira Yokomizo; Ken-Ichi Kakimoto; Iwao Fukui; Katsuyuki Karasawa; Taiji Tsukamoto; Miwako Nozaki; Masaru Hasumi; Hiromichi Ishiyama; Mikinobu Ohtani; Masaaki Kuwahara; Masaoki Harada; Yasuo Ohashi; Toshihiko Kotake; Tadao Kakizoe; Kazuhiro Suzuki; Hidetoshi Yamanaka, 01 Sep. 2020, Cancer, 126, 17, 3961, 3971, Scientific journal

  DOI
• YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression., Takeshi Miyao; Hidekazu Koike; Yoshitaka Sekine; Akira Ohtsu; Daisuke Oka; Kazuhiro Suzuki, Sep. 2020, Anticancer research, 40, 9, 5091, 5095, Scientific journal

  DOI
• Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m2) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillance study., Hideyasu Matsuyama; Nobuaki Matsubara; Hirotaka Kazama; Takeshi Seto; Shoko Tsukube; Kazuhiro Suzuki, 13 Jul. 2020, BMC cancer, 20, 1, 649, 649, Scientific journal

  DOI
• Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer., Narisa Dewi Maulany Darwis; Takahiro Oike; Hidemasa Kawamura; Masahiro Kawahara; Nobuteru Kubo; Hiro Sato; Yuhei Miyasaka; Hiroyuki Katoh; Hitoshi Ishikawa; Hiroshi Matsui; Yoshiyuki Miyazawa; Kazuto Ito; Kazuhiro Suzuki; Soehartati Gondhowiardjo; Takashi Nakano; Tatsuya Ohno, 04 Mar. 2020, Cancers, 12, 3, Scientific journal

  DOI
• Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702"., Hidemasa Kawamura; Nobuteru Kubo; Hiro Sato; Tatsuji Mizukami; Hiroyuki Katoh; Hitoshi Ishikawa; Tatsuya Ohno; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki; Takashi Nakano, 30 Jan. 2020, BMC cancer, 20, 1, 75, 75, Scientific journal

  DOI
• Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml., Kazuto Ito; Akira Yokomizo; Shoji Tokunaga; Gaku Arai; Mikio Sugimoto; Koichiro Akakura; Hisashi Hasumi; Hideki Sakai; Akiko Ouraji; Ryo Oki; Eiji Kashiwagi; Yoshitomo Kobori; Hiromi Hirama; Hiroki Kitoh; Hiroji Uemura; Tomoaki Hakariya; Kazuhiro Suzuki, Jan. 2020, The Journal of urology, 203, 1, 83, 91, Scientific journal

  DOI
• Quality of life in prostate cancer patients receiving particle radiotherapy: A review of the literature., Hidemasa Kawamura; Nobuteru Kubo; Hiro Sato; Yuhei Miyasaka; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki; Tatsuya Ohno, Jan. 2020, International journal of urology : official journal of the Japanese Urological Association, 27, 1, 24, 29, Scientific journal

  DOI
• Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study., Kazuhiro Suzuki; Nobuaki Matsubara; Hirotaka Kazama; Takeshi Seto; Shoko Tsukube; Hideyasu Matsuyama, 27 Dec. 2019, Japanese journal of clinical oncology, 49, 12, 1157, 1163, Scientific journal

  DOI
• Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening., Kazuto Ito; Ryo Oki; Yoshitaka Sekine; Seiji Arai; Yoshiyuki Miyazawa; Yasuhiro Shibata; Kazuhiro Suzuki; Isao Kurosawa, Oct. 2019, International journal of urology : official journal of the Japanese Urological Association, 26, 10, 956, 970, Scientific journal

  DOI
• Phase I trial of TAK-385 in hormone treatment-naïve Japanese patients with nonmetastatic prostate cancer., Hiroyoshi Suzuki; Hiroji Uemura; Atsushi Mizokami; Narihiko Hayashi; Yasuhide Miyoshi; Satoshi Nagamori; Yutaka Enomoto; Hideyuki Akaza; Takayuki Asato; Tadayuki Kitagawa; Kazuhiro Suzuki, Oct. 2019, Cancer medicine, 8, 13, 5891, 5902, Scientific journal

  DOI
• An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression., Yoshiyuki Miyazawa; Yoshitaka Sekine; Nobuaki Shimizu; Yutaka Takezawa; Toshiyuki Nakamura; Takeshi Miyao; Hiroshi Nakayama; Sota Kurihara; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Sep. 2019, The Prostate, 79, 12, 1462, 1470, Scientific journal

  DOI
• Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study., Kubo N; Kawamura H; Oike T; Sato H; Iwanaga M; Mizukami T; Adachi A; Matsui H; Ito K; Suzuki K; Nakano T, Jul. 2019, In vivo (Athens, Greece), 33, 4, 1235, 1241

  DOI
• Improved Arterial Preservation Achieved by Combined Use of Indocyanine Green Angiography and Doppler Detector During Microsurgical Subinguinal Varicocelectomy., Sota Kurihara; Yasuhiro Shibata; Seiji Arai; Yoshitaka Sekine; Yoshiyuki Miyazawa; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki; Tetsuya Nakamura, 09 May 2019, Journal of investigative surgery : the official journal of the Academy of Surgical Research, 1, 7, Scientific journal

  DOI
• Prevalence and clinical characteristics of overactive bladder in systemic sclerosis., Motegi SI; Sekiguchi A; Sekine Y; Nakayama H; Suzuki K; Ishikawa O, Mar. 2019, Modern rheumatology, 1, 5

  DOI
• Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases., Shunji Takahashi; Seigo Kinuya; Norio Nonomura; Nobuo Shinohara; Kazuhiro Suzuki; Hiroyoshi Suzuki; Katsumasa Nakamura; Takefumi Satoh; Ukihide Tateishi; Toshiyuki Yoneda; Hiroyuki Horikoshi; Tsukasa Igawa; Takao Kamai; Mitsuru Koizumi; Takeo Kosaka; Nobuaki Matsubara; Hideaki Miyake; Atsushi Mizokami; Takashi Mizowaki; Naoki Nakamura; Masahiro Nozawa; Takeo Takahashi; Hiroji Uemura; Motohide Uemura; Akira Yokomizo; Mana Yoshimura; Yoshiyuki Kakehi, Dec. 2018, Oncology and therapy, 6, 2, 157, 171, Scientific journal

  DOI
• Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screening., Ryo Oki; Kazuto Ito; Rie Suzuki; Yuji Fujizuka; Seiji Arai; Yoshiyuki Miyazawa; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 01 Oct. 2018, International journal of cancer, 143, 7, 1611, 1619, Scientific journal

  DOI
• 実践!前立腺がん検診 前立腺がん検診に潜む課題をこのように解決している, 酒井 英樹; 伊藤 一人; 鈴木 和浩; 杉元 幹史; 深貝 隆志, Oct. 2018, 5, 2, 213, 218
• Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching., Mizuki Onozawa; Hideyuki Akaza; Shiro Hinotsu; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Taiji Tsukamoto, Oct. 2018, Cancer medicine, 7, 10, 4893, 4902, Scientific journal

  DOI
• Assessment of antimicrobiral prophylaxis in transperineal prostate biopsy: A single-center retrospective study of 485 cases., Kyoko Baba; Yoshitaka Sekine; Yoshiyuki Miyazawa; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Aug. 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 24, 8, 637, 640, Scientific journal

  DOI
• 前立腺癌診療の最新トピックス, 植村 天受; 鈴木 和浩; 上村 博司; 鈴木 啓悦, May 2018, 1, 1, 07, 15
• Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism., Yoshitaka Sekine; Hiroshi Nakayama; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Seiji Arai; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Mar. 2018, Oncology letters, 15, 3, 3167, 3172, Scientific journal

  DOI
• 【去勢抵抗性前立腺癌(CRPC)と骨転移治療の最前線[第3回]】『基礎』と『臨床』から考える去勢抵抗性前立腺癌(CRPC)の骨マネジメント, 植村 天受; 鈴木 和浩; 上村 博司, Feb. 2018, 36, 2, 85, 94
• 前立腺局所所見に乏しく急速に進行した転移性前立腺癌の1 例, 金山あずさ; 宮尾武士; 小池秀和; 澤田達宏; 馬場恭子; 鈴木智美; 栗原聰太; 中山紘史; 大木亮; 宮澤慶行; 藤塚雄司; 周東孝浩; 宮久保真意; 野村昌史; 関根芳岳; 松井博; 柴田康博; 伊藤一人; 鈴木和浩; 平戸純子; 猿木和久, 2018, 5, 1, 147, 150
• Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2018, IN VIVO, 32, 2, 409, 412

  DOI
• 当院TESE/MESA症例における精子採取予測因子の検討, 北原慈和; 柴田康博; 阿部いおり; 根岸淳江; 茂木美里; 小林未央; 飯塚円香; 中里智子; 満下淳地; 鈴木和浩; 岸裕司, 01 Oct. 2017, 日本生殖医学会雑誌, 62, 4, 404
• 去勢抵抗性前立腺癌(CRPC)の逐次療法を再考する, 鈴木 和浩; 鈴木 啓悦; 小坂 威雄; 土谷 順彦; 三宅 秀明, Sep. 2017, Prostate Journal, 4, 2, 209, 217
• 【去勢抵抗性前立腺癌(CRPC)と骨転移治療の最前線[第1回]】去勢抵抗性前立腺癌(CRPC)における骨転移の治療, 植村 天受; 上村 博司; 鈴木 和浩; 絹谷 清剛, Sep. 2017, 35, 9, 89, 95
• A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Yoshiyuki Miyazawa; Yoshitaka Sekine; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 29 Aug. 2017, BMC Urology, 17, 1, 70, Scientific journal

  DOI
• Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL., Yuji Fujizuka; Kazuto Ito; Ryo Oki; Rie Suzuki; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Aug. 2017, International journal of urology : official journal of the Japanese Urological Association, 24, 8, 602, 609, Scientific journal

  DOI
• Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Yoshiyuki Miyazawa; Yoshitaka Sekine; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Jul. 2017, ANTICANCER RESEARCH, 37, 7, 3667, 3671, Scientific journal

  DOI
• Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Yasuhiro Shibata; Seiji Arai; Yoshiyuki Miyazawa; Takahiro Shuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki, May 2017, PROSTATE, 77, 6, 672, 680, Scientific journal

  DOI
• 日本人前立腺癌家系の生殖細胞系列変異, 松井 博; 早野 崇英; 大竹 伸明; 栗原 聰太; 関根 芳岳; 野村 昌史; 小池 秀和; 柴田 康博; 伊藤 一人; 中岡 博史; 細道 一善; 井ノ上 逸朗; 鈴木 和浩, Apr. 2017, 105回, OP41, 3
• CRPCに対する最新治療戦略, 鈴木 和浩; 植村 天受; 大家 基嗣; 西村 和郎, Apr. 2017, 4, 1, 69, 78
• LH-RHアゴニスト投与後に下垂体卒中を発症した前立腺癌症例の内分泌学的検討, 澤田 達宏; 宮澤 慶行; 金山 あずさ; 周東 孝浩; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩; 堀口 和彦; 山田 正信, Apr. 2017, 日本泌尿器科学会総会, 105回, OP71, 2
• High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL, Y. Miyoshi; H. Uemura; K. Suzuki; Y. Shibata; S. Honma; M. Harada; Y. Kubota, Mar. 2017, ANDROLOGY, 5, 2, 262, 267, Scientific journal

  DOI
• Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells., Yoshiyuki Miyazawa; Yoshitaka Sekine; Haruo Kato; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki, Mar. 2017, The Prostate, 77, 4, 337, 349, Scientific journal

  DOI
• 去勢抵抗性前立腺癌に対するカバジタキセル療法の治療経験, 宮尾 武士; 小池 秀和; 栗原 聡太; 中山 紘史; 大木 亮; 宮澤 慶行; 周東 孝浩; 関根 芳岳; 野村 昌史; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩, 2017, 4, 2, 293, 297
• 重度精神運動発達遅滞を持つ腎移植患者に対し、服薬コンプライアンスの向上に関与した1例, 真下貴子; 飯塚 誠; 関根芳岳; 八島秀明; 阿部正樹; 荒木拓也; 鈴木和浩; 山本康次郎, 2017, 43, 3, 13, 16
• Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Yasuhiro Shibata; Sota Kurihara; Seiji Arai; Haruo Kato; Tomomi Suzuki; Yoshiyuki Miyazawa; Hidekazu Koike; Kazuto Ito; Tetsuya Nakamura; Kazuhiro Suzuki, 2017, JOURNAL OF INVESTIGATIVE SURGERY, 30, 4, 247, 251, Scientific journal

  DOI
• YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Takashi Nitta; Hidekazu Koike; Takeshi Miyao; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Yoshitaka Sekine; Kazuhiro Suzuki, Jan. 2017, ANTICANCER RESEARCH, 37, 1, 75, 80, Scientific journal

  DOI
• 前立腺癌に対するLH-RHアゴニスト投与後に下垂体卒中を認めた1例, 澤田 達宏; 宮澤 慶行; 金山 あずさ; 藤塚 雄司; 周東 孝浩; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩; 堀口 和彦; 山田 正信; 冨田 健介; 秋山 恵里奈; 福間 裕二; 羽鳥 基明; 大竹 伸明; 関原 哲夫, Nov. 2016, The Kitakanto Medical Journal, 66, 4, 309, 309
• Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer., Haruo Kato; Yosuke Furuya; Yoshiyuki Miyazawa; Takeshi Miyao; Takahiro Syuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Nov. 2016, Anticancer research, 36, 11, 6141, 6149, Scientific journal

  DOI
• Asia prostate cancer study (A-CaP Study) launch symposium., Hideyuki Akaza; Yoshihiko Hirao; Choung-Soo Kim; Mototsugu Oya; Seiichiro Ozono; Dingwei Ye; Matthew Cooperberg; Shiro Hinotsu; Ji Youl Lee; Gang Zhu; Mikio Namiki; Shigeo Horie; Byung Ha Chung; Chung-Hsin Chen; Ng Chi Fai; Lukman Hakim; Edmund Chiong; Jason Letran; Rainy Umbas; Kazuhiro Suzuki; Kazuo Nishimura; Teng Aik Ong; Bannakij Lojanapiwat; Tong-Lin Wu; Wun-Jae Kim; Declan Murphy; Osamu Ogawa; Peter Carroll; Seiji Naito; Taiji Tsukamoto, Sep. 2016, Prostate international, 4, 3, 88, 96, Scientific journal

  DOI
• Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins., Yosuke Furuya; Yoshitaka Sekine; Haruo Kato; Yoshiyuki Miyazawa; Hidekazu Koike; Kazuhiro Suzuki, Jun. 2016, Prostate international, 4, 2, 56, 60, Scientific journal

  DOI
• [Perspective of basic research on prostate cancer]., Kazuhiro Suzuki; Hiroshi Matsui, 20 May 2016, Nihon rinsho. Japanese journal of clinical medicine, 74 Suppl 3, 12, 6, Scientific journal
• [Hereditary and familial prostate cancer]., Yoshitatsu Fukabori; Nobuaki Ohtake; Hiroshi Matsui; Kazuhiro Suzuki, 20 May 2016, Nihon rinsho. Japanese journal of clinical medicine, 74 Suppl 3, 47, 51, Scientific journal
• 泌尿器科と合同手術で、より安全に施行しえた左上腹部巨大後腹膜腫瘍の2切除例, 平井 圭太郎; 新木 健一郎; 久保 憲生; 渡辺 亮; 五十嵐 隆通; 塚越 真理子; 石井 範洋; 星野 弘毅; 野村 昌史; 柴田 康博; 伊藤 一人; 鈴木 和浩; 桑野 博行; 調 憲, May 2016, 日本外科系連合学会誌, 41, 3, 533, 533
• Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association., Takuya Koie; Chikara Ohyama; Hiroyuki Fujimoto; Hiroyuki Nishiyama; Jun Miyazaki; Shiro Hinotsu; Eiji Kikuchi; Mizuaki Sakura; Junichi Inokuchi; Tomohiko Hara; Chikara Ohyama; Hiroyuki Nishiyama; Masato Fujisawa; Hirotsugu Uemura; Hiroyuki Fujimoto; Kazuhiro Suzuki; Masatoshi Eto; Isao Hara; Akio Matsubara; Norio Nonomura; Hiroyuki Nakanishi; Takuya Koie; Hiroomi Kanayama; Tsuneharu Miki; Tomoharu Fukumori; Seiji Naito, May 2016, Japanese journal of clinical oncology, 46, 5, 468, 74

  DOI
• SIMVASTATIN INHIBITS THE PROLIFERATION, MIGRATION AND INVASION OF ANDROGEN INDEPENDENT HUMAN PROSTATE CANCER CELLS VIA UP-REGULATION OF ANNEXIN A10, Yoshiyuki Miyazawa; Yoshitaka Sekine; Haruo Kato; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki, Apr. 2016, JOURNAL OF UROLOGY, 195, 4, E674, E674
• LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONIST REDUCE SERUM ADRENAL ANDROGEN LEVELS IN PROSTATE CANCER PATIENTS, Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Takashi Nitta; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Apr. 2016, JOURNAL OF UROLOGY, 195, 4, E675, E676
• ROLE OF ADIPONECTIN IN PROSTATE CANCER RISK AND THE PROLIFERATION OF PROSTATE CANCER., Takashi Nitta; Hidekazu Koike; Hiroshi Mastui; Takeshi Miyao; Sota Kurihara; Yoshiyuki Miyazawa; Haruo Kato; Yoshitaka Sekine; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Apr. 2016, JOURNAL OF UROLOGY, 195, 4, E28, E28
• [Screening for prostate cancer: clinical significance and future perspectives]., Kazuto Ito; Kazuhiro Suzuki, Jan. 2016, Nihon rinsho. Japanese journal of clinical medicine, 74, 1, 72, 8, Scientific journal
• Germline Variants of Prostate Cancer in Japanese Families., Takahide Hayano; Hiroshi Matsui; Hirofumi Nakaoka; Nobuaki Ohtake; Kazuyoshi Hosomichi; Kazuhiro Suzuki; Ituro Inoue, 2016, PloS one, 11, 10, e0164233, Scientific journal

  DOI
• [Heavy ion radiotherapy for prostate cancer -- the role of hormone therapy]., Kazuhiro Suzuki; Hiroshi Matsui; Hidemasa Kawamura; Tatsuya Ohno, Feb. 2015, Gan to kagaku ryoho. Cancer & chemotherapy, 42, 2, 159, 63, Scientific journal
• [II. Radiotherapy for prostate cancer-the role of multi-disciplinary team]., Kazuhiro Suzuki; Hiroshi Matsui; Hidemasa Kawamura; Junko Hirado; Kei Shibuya; Naoko Taniyama; Tomomi Hashimoto; Tatsuaki Kanai; Takashi NAkano; Tatsuya Ohno, Jan. 2015, Gan to kagaku ryoho. Cancer & chemotherapy, 42, 1, 32, 5, Scientific journal
• [Lipid metabolism and castration resistant prostate cancer]., Kazuhiro Suzuki; Yoshitaka Sekine; Hiroshi Matsui, Dec. 2014, Nihon rinsho. Japanese journal of clinical medicine, 72, 12, 2116, 20, Scientific journal
• [Clinical and basic aspects of familial prostate cancer]., Kazuhiro Suzuki; Hiroshi Matsui; Nobuaki Ohtake, Feb. 2013, Gan to kagaku ryoho. Cancer & chemotherapy, 40, 2, 159, 63, Scientific journal
• Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score., Hideyuki Akaza; Shiro Hinotsu; Michiyuki Usami; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Taiji Tsukamoto; Seiji Naito; Mikio Namiki; Yoshihiko Hirao; Masaru Murai, 2013, Prostate international, 1, 2, 81, 8, Scientific journal

  DOI
• [Prostate cancer-the role of docetaxel on castration-resistant prostate cancer: evaluation of efficacy and subsequent treatment]., Kazuhiro Suzuki, Oct. 2012, Gan to kagaku ryoho. Cancer & chemotherapy, 39, 10, 1467, 70, Scientific journal
• [The clinical merit of anti-RANKL antibody denosumab in prostate cancer]., Hideyuki Akaza; Taiji Tsukamoto; Kazuhiro Suzuki; Mikio Namiki; Seiichiro Ozono; Seiji Naitodept, Feb. 2012, Gan to kagaku ryoho. Cancer & chemotherapy, 39, 2, 207, 12, Scientific journal
• Oncological outcomes of the prostate cancer patients registered in 2004: report from the Cancer Registration Committee of the JUA., Hiroyuki Fujimoto; Hiroyuki Nakanishi; Tsuneharu Miki; Yoshinobu Kubota; Satoru Takahashi; Kazuhiro Suzuki; Hiro-omi Kanayama; Kazuya Mikami; Yukio Homma, Dec. 2011, International journal of urology : official journal of the Japanese Urological Association, 18, 12, 876, 81, Scientific journal

  DOI
• High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., Yoshitaka Sekine; David Osei-Hwedieh; Kant Matsuda; Nalini Raghavachari; Delong Liu; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki; Alan T Remaley, 01 Oct. 2011, The Prostate, 71, 14, 1499, 509, Scientific journal

  DOI
• [Characteristics of hereditary and familial prostate cancer in Japan 2011]., Yoshitatsu Fukabori; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Jun. 2011, Nihon rinsho. Japanese journal of clinical medicine, 69 Suppl 5, 197, 202, Scientific journal
• [Prostate cancer screening in Japan: current status and perspective]., Kazuhiro Suzuki, Jun. 2011, Nihon rinsho. Japanese journal of clinical medicine, 69 Suppl 5, 203, 6, Scientific journal
• HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion., Yoshitaka Sekine; Kazuhiro Suzuki; Alan T Remaley, 15 May 2011, The Prostate, 71, 7, 690, 9, Scientific journal

  DOI
• 群馬大学での限局性前立腺癌に対する重粒子線治療・初年次報告, 加藤弘之; 石川仁; 神沼拓也; 石居隆義; 小屋順一; 島田博文; 金井達明; 北田陽子; 大野達也; 中野隆史; 鈴木和浩, May 2011, The Kitakanto Medical Journal, 61, 2, 242, Scientific journal
• Suppressive effects of the antiandrogen agent, chlormadinone acetate and the 5alpha-reductase inhibitor, dutasteride on prostate weight and intraprostatic androgen levels in rats., Hideo Kobayashi; Kotaro Gotanda; Yasuhiro Shibata; Jun-ichi Watanabe; Youichi Nakano; Atsushi Shinbo; Kazuhiro Suzuki, 2011, Arzneimittel-Forschung, 61, 9, 515, 20, Scientific journal

  DOI
• High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism., Yoshitaka Sekine; Steve J Demosky; John A Stonik; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki; Alan T Remaley, Sep. 2010, Molecular cancer research : MCR, 8, 9, 1284, 94, Scientific journal

  DOI
• [Clinical research on prostate cancer detected in Tone central hospital--comparison of survival rates between patients diagnosed with prostate cancer in and outside screening system]., Yoshimi Tamur; Tomoko Koya; Takahiro Morita; Yutaka Kubota; Osamu Takahashi; Isao Fujiduka; Kazuto Ito; Kazuhiro Suzuki, May 2009, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 100, 4, 525, 33, Scientific journal
• 2.前立腺癌ヨウ素125シード永久挿入時の術中・術後治療計画の比較(一般演題I,第38回群馬放射線腫瘍研究会抄録), 工藤,滋弘; 石川,仁; 岡本,雅彦; 江原,威; 吉田,大作; 原島,浩一; 櫻井,英幸; 中野,隆史; 山本,巧; 伊藤,一人; 鈴木,和浩, Aug. 2008, The KITAKANTO medical journal, 58, 3, 341, Scientific journal
• がん予防食品としてのセレン強化ブロッコリースプラウト 前立腺がん細胞による検討(Selenium-enriched broccoli sprouts as an anticancer nutraceutical: study in the human prostate cancer cell lines), アブドゥラ・リズキー; 小林 健司; ファリエド・アハマド; スラジ・エカ; 伊藤 一人; 鈴木 和浩; 村上 正巳; 桑野 博行; 小山 洋, Jun. 2008, Biomedical Research on Trace Elements, 19, 2, 213, 213
• OP-220 ノモグラムランキングによる前立腺がん治療成績の客観的評価システム(前立腺腫瘍/放射線治療1,一般演題口演,第96回日本泌尿器科学会総会), 山本, 巧; 伊藤, 一人; 宮久保, 真意; 武智, 浩之; 大井, 勝; 鈴木, 和浩; 石川, 仁; 中野, 隆史; 秋元, 哲夫, Feb. 2008, The Japanese Journal of Urology, 99, 2, 326, Scientific journal
• 3 前立腺癌ヨウ素125シード永久挿入時の術前・術中治療計画の比較(一般演題I,第37回群馬放射線腫瘍研究会抄録), 工藤,滋弘; 石川,仁; 岡本,雅彦; 江原,威; 吉田,大作; 原島,浩一; 櫻井,英幸; 中野,隆史; 山本,巧; 伊藤,一人; 鈴木,和浩, Feb. 2008, The KITAKANTO medical journal, 58, 1, 104, Scientific journal
• Evidence-based clinical practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition)., Sadao Kamidono; Shinichi Ohshima; Yoshihiko Hirao; Kazuhiro Suzuki; Yoichi Arai; Hiroyuki Fujimoto; Shin Egawa; Hideyuki Akaza; Isao Hara; Shiro Hinotsu; Yoshiyuki Kakehi; Tomonori Hasegawa, Jan. 2008, International journal of urology : official journal of the Japanese Urological Association, 15, 1, 1, 18, Scientific journal

  DOI
• Exploration of target molecules for prostate cancer gene therapy., Kazuhiro Suzuki; Kiminori Nakamura; Kazunori Kato; Hirofumi Hamada; Taiji Tsukamoto, 01 Aug. 2007, The Prostate, 67, 11, 1163, 73, Scientific journal
• [Prostate cancer screening at Tatebayashi City in Gunma prefecture--results of screening with PSA alone between 2003 and 2005]., Toshiyuki Nakamura; Toru Etsunaga; Yasushi Sasaki; Takashi Nitta; Yasunobu Okugi; Hiroshi Okazaki; Nobuo Katou; Takumi Yamamoto; Kazuhiro Suzuki, May 2007, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 98, 4, 619, 28, Scientific journal
• WS2-2 前立腺癌に対する放射線外照射療法 (斜入4門照射) の有害事象 : 直腸出血を中心に(限局性前立腺癌に対する非観血的治療-各治療の有害事象とQOLへの影響を中心に, 第95回日本泌尿器科学会総会), 伊藤, 一人; 秋元, 哲夫; 山本, 巧; 石川, 仁; 中野, 隆史; 鈴木, 和浩, Feb. 2007, The Japanese Journal of Urology, 98, 2, 188, Scientific journal
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., Yoshitaka Sekine; Kazuto Ito; Takumi Yamamoto; Haruki Nakazato; Yasuhiro Shibata; Motoaki Hatori; Kazuhiro Suzuki, 2007, Cancer detection and prevention, 31, 2, 149, 53, Scientific journal
• [Prostate biopsy]., Kazuhiro Suzuki; Kazuto Ito, Feb. 2005, Nihon rinsho. Japanese journal of clinical medicine, 63, 2, 253, 9, Scientific journal
• [Bladder cancer and prostate cancer in hemodialysis patients]., Motoaki Hatori; Kazuhiro Suzuki; Hidetoshi Yamanaka, Jun. 2004, Nihon rinsho. Japanese journal of clinical medicine, 62 Suppl 6, 374, 7, Scientific journal
• [Chronological changes of incidence rates, clinical stages and pathological differentiation of prostate cancer in Gunma Prefecture, Japan]., Seiji Nakata; Nobuaki Ohtake; Yutaka Kubota; Kazuto Ito; Kazuhiro Suzuki; Hidetoshi Yamanaka, Mar. 2004, Hinyokika kiyo. Acta urologica Japonica, 50, 3, 165, 70, Scientific journal
• 前立腺癌に対する外照射併用高線量率組織内照射法の短期効果と急性反応, 斎藤, 淳一; 秋元, 哲夫; 北本, 佳住; 石川, 仁; 桜井, 英幸; 中野, 隆史; 黒川, 公平; 山本, 巧; 鈴木, 和浩; 山中, 英寿, May 2003, The KITAKANTO medical journal, 53, 2, 234, Scientific journal
• リムパーザの登場によりmCRPCの個別化治療はどこまで進んだか, ;;;, Apr. 2022, 9, 1, 1
• 前立腺癌の画像診断の最前線　unmet needsへの現状と展望, ;;;, Apr. 2022, 5, 1, 05
• 【前立腺癌を対象にした最新の基礎研究-トランスレーショナルリサーチによる未来予想図-】前立腺癌における血中・組織ステロイドの代謝と薬剤感受性, ;;;;;;, Apr. 2022, 9, 1, 35
• Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer., Kazama Hirotaka;Kawaguchi Osamu;Seto Takeshi;Suzuki Kazuhiro;Matsuyama Hideyasu;Matsubara Nobuaki;Tajima Yuki;Fukao Taro, Apr. 2022, BMC cancer, 22, 1

  DOI
• リムパーザの登場によりmCRPCの個別化治療はどこまで進んだか, ;;;, Apr. 2022, 9, 1, 1
• 【前立腺癌を対象にした最新の基礎研究-トランスレーショナルリサーチによる未来予想図-】前立腺癌における血中・組織ステロイドの代謝と薬剤感受性, ;;;;;;, Apr. 2022, 9, 1, 35
• Enzalutamide投与前のCRPC患者の血中テストステロン濃度と投与後QOL変化の相関, ;;;;, Apr. 2022, 98, 1, 312
• 前立腺癌の画像診断の最前線　unmet needsへの現状と展望, ;;;, Apr. 2022, 5, 1, 05
• 34年前に全骨盤照射施行後、生体腎移植を施行した1例, ;;;;;;;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 469
• 当院で発生した水道水汚染に対する人工腎臓センターの対応, ;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 516
• 当院で水汚染時に行ったRO膜による透析用水浄化前後の亜硝酸塩濃度の考察, ;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 674
• 本人の強い意思で保存的腎臓療法が行われた一例, ;;;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 775
• 群馬県における前立腺がん検診の有効性評価研究(PROCEED), ;;;;;;, Jul. 2022, 31回, 34
• 【LOH症候群】テストステロン補充療法の副作用, ;, Jul. 2022, 16, 1, 25
• 【泌尿器科領域の遺伝性疾患とゲノム医療の最前線】遺伝性前立腺がん, ;;;;;;;;, Aug. 2022, 16, 2, 149
• タンパク翻訳阻害剤Homoharringtonineの前立腺癌細胞における抗腫瘍効果の検討, ;;;;;, Aug. 2022, 35, 8, 860
• プレシジョンメディシンを目指した前立腺癌診療〜生検、臨床病理、遺伝子検査、リキッドバイオプシー〜　前立腺生検update, ;;;;, Aug. 2022, 35, 8, 909
• 【泌尿器科医が知っておくべき遺伝性・家族性疾患:最近のTopics】家族性前立腺癌, ;;, Oct. 2015, 28, 10, 1631
• Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer, Nakayama, Hiroshi;Sekine, Yoshitaka;Oka, Daisuke;Miyazawa, Yoshiyuki;Arai, Seiji;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2022, PROSTATE, 82, 3, 314, 322

  DOI
• A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS., Miyazawa, Yoshiyuki;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Arai, Seiji;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2022, JOURNAL OF CLINICAL ONCOLOGY, 40, 6

  DOI
• Comparative study of RARP and carbon ion radiotherapy sexual functional changes for prostate cancer using the propensity score matching method., Miyazawa, Yoshiyuki;Oka, Daisuke;Koike, Hidekazu;Kawamura, Hidemasa;Miyasaka, Yuhei;Syuto, Takahiro;Arai, Seiji;Sekine, Yoshitaka;Matsui, Hiroshi;Ohno, Tatsuya;Suzuki, Kazuhiro, 2022, JOURNAL OF CLINICAL ONCOLOGY, 40, 6

  DOI
• Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer, Kazama, Hirotaka;Kawaguchi, Osamu;Seto, Takeshi;Suzuki, Kazuhiro;Matsuyama, Hideyasu;Matsubara, Nobuaki;Tajima, Yuki;Fukao, Taro, 2022, BMC CANCER, 22, 1

  DOI
• Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study, Uemura, Hiroji;Kobayashi, Kazuki;Yokomizo, Akira;Hinotsu, Shiro;Horie, Shigeo;Kakehi, Yoshiyuki;Nonomura, Norio;Ogawa, Osamu;Oya, Mototsugu;Suzuki, Kazuhiro;Saito, Atsushi;Asakawa, Keiko;Uno, Satoshi;Naito, Seiji, 2022, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 27, 10, 1632, 1643

  DOI
• Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells, Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Kato, Mai;Maeno, Yuta;Miyazawa, Yoshiyuki;Fujizuka, Yuji;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2022, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 628, 76, 83

  DOI
• Brefeldin A mediates integrated stress response and in combination with Navitoclax induces apoptosis in prostate cancer cells., Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2022, CANCER RESEARCH, 82, 12
• Brefeldin A mediates integrated stress response and in combination with Navitoclax induces apoptosis in prostate cancer cells, Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2022, CANCER RESEARCH, 82, 12
• A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS, Miyazawa, Yoshiyuki;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Sekine, Yoshitaka;Arai, Seiji;Suzuki, Kazuhiro, 2023, PROSTATE, 83, 8, 759, 764

  DOI
• Summary of the clinical practice manual for late-onset hypogonadism, Ide, Hisamitsu;Akehi, Yuko;Fukuhara, Shinichiro;Ohira, Shin;Ogawa, Sumito;Kataoka, Tomoya;Kumagai, Hiroshi;Kobayashi, Ko;Komiya, Akira;Shigehara, Kazuyoshi;Syuto, Takahiro;Soh, Jintetu;Tanabe, Makito;Taniguchi, Hisanori;Chiba, Koji;Matsushita, Kazuhito;Mitsui, Yozo;Yoneyama, Takahiro;Shirakawa, Tomoya;Fujii, Yasuhisa;Kumano, Hiroaki;Ueshiba, Hajime;Amano, Toshiyasu;Sasaki, Haruaki;Maeda, Seiji;Mizokami, Atsushi;Suzuki, Kazuhiro;Horie, Shigeo, 2023, INTERNATIONAL JOURNAL OF UROLOGY, 30, 5, 422, 430

  DOI
• Carbon-ion radiotherapy for inoperable upper tract ureteral cancer, Mizukami, Tatsuji;Kawamura, Hidemasa;Kubo, Nobuteru;Sato, Hiro;Kawahara, Masahiro;Adachi, Akiko;Matsui, Hiroshi;Suzuki, Kazuhiro;Saitoh, Jun-ichi;Nakano, Takashi;Ohno, Tatsuya, 2023, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

  DOI
• Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report, Ohtsu, Akira;Arai, Seiji;Fujizuka, Yuji;Fukuda, Reon;Hori, Keisuke;Morimura, Yuki;Kawahara, Rintaro;Shiraishi, Takuya;Ogawa, Hiroomi;Miyazawa, Yoshiyuki;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2023, BMC UROLOGY, 23, 1

  DOI
• The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamide, Miyazawa, Yoshiyuki;Hori, Keisuke;Tsuji, Yusuke;Sekine, Yoshitaka;Arai, Seiji;Fujizuka, Yuji;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2023, INTERNATIONAL JOURNAL OF UROLOGY

  DOI
• Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan, Matsuyama, Hideyasu;Matsubara, Nobuaki;Kazama, Hirotaka;Seto, Takeshi;Sunaga, Yoshinori;Suzuki, Kazuhiro, 2023, BMC CANCER, 23, 1

  DOI
• Moving beyond negative campaign for PSA-based screening for prostate cancer, Ito, Kazuto;Sekine, Yoshitaka;Suzuki, Kazuhiro;Kurosawa, Isao, 2023, CANCER SCIENCE, 114, 1536, 1536
• Baseline characteristics may impact treatment duration of cabazitaxel in patients with mCRPC: a subanalysis of data from a post-marketing surveillance, Matsubara, Nobuaki;Matsuyama, Hideyasu;Kazama, Hirotaka;Seto, Takeshi;Sunaga, Yoshinori;Suzuki, Kazuhiro, 2023, JAPANESE JOURNAL OF CLINICAL ONCOLOGY

  DOI
• 去勢抵抗性前立腺癌　基礎と臨床　Intracrinologyからみた前立腺癌のバイオロジー, 鈴木 和浩, Feb. 2016, 31, 24
• Predictive models of long-term survival outcomes following radical cystectomy., Ohtsu Akira;Arai Seiji;Fujizuka Yuji;Miyazawa Yoshiyuki;Nomura Masashi;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Oct. 2023, Cancer medicine, 12, 23

  DOI
• Successful embolization of subcutaneous mesenteric varices within an ileal conduit in a patient with liver cirrhosis., Sakurai Ayaka;Ohtsu Akira;Arai Seiji;Aoki Masanori;Ikeya Miho;Tokue Hiroyuki;Hori Keisuke;Fujizuka Yuji;Sekine Yoshitaka;Koike Hidekazu;Suzuki Kazuhiro, Sep. 2023, IJU case reports, 6, 6

  DOI
• L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity., Rii Junryo;Sakamoto Shinichi;Mizokami Atsushi;Xu Minhui;Fujimoto Ayumi;Saito Shinpei;Koike Hidekazu;Tamura Takaaki;Arai Takayuki;Yamada Yasutaka;Goto Yusuke;Sazuka Tomokazu;Imamura Yusuke;Suzuki Kazuhiro;Kanai Yoshikatsu;Anzai Naohiko;Ichikawa Tomohiko, Jan. 2024, Cancer science, 115, 3

  DOI
• Comparison of sexual function after robot-assisted radical prostatectomy and carbon-ion radiotherapy for Japanese prostate cancer patients using propensity score matching., Miyazawa Yoshiyuki;Koike Hidekazu;Oka Daisuke;Kawamura Hidemasa;Kubo Nobuteru;Miyasaka Yuhei;Onishi Masahiro;Syuto Takahiro;Sekine Yoshitaka;Matsui Hiroshi;Ohno Tatsuya;Suzuki Kazuhiro, Mar. 2024, BMC cancer, 24, 1

  DOI
• Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial., Yokomizo Akira;Koga Hirofumi;Ito Kazuto;Takezawa Yutaka;Komiyama Motokiyo;Nishimura Kazuo;Yonese Junji;Hashine Katsuyoshi;Masumori Naoya;Arai Gaku;Saito Shiro;Shinohara Mitsuru;Shimizu Nobuaki;Yamauchi Atsushi;Satoh Takefumi;Tochigi Tatsuo;Kobayashi Mikio;Fujimoto Hiroyuki;Kakimoto Ken-Ichi;Fukui Iwao;Tsukamoto Taiji;Nozaki Miwako;Karasawa Katsuyuki;Hasumi Masaru;Ohtani Mikinobu;Ishiyama Hiromichi;Kuwahara Masaaki;Harada Masaoki;Ohashi Yasuo;Kotake Toshihiko;Kakizoe Tadao;Suzuki Kazuhiro;Naito Seiji;Yamanaka Hidetoshi; , May 2021, Cancer medicine, 10, 10

  DOI
• A Prospective Study of the Relationship Between Clinical Outcomes After Enzalutamide and Serum Androgen Levels Measured via Liquid Chromatography-tandem Mass Spectrometry in Patients with Castration-resistant Prostate Cancer., Miyazawa Yoshiyuki;Sekine Yoshitaka;Arai Seiji;Nakamura Toshiyuki;Takezawa Yutaka;Shimizu Nobuaki;Matsuo Yasushige;Ogura Haruyuki;Takei Tomoyuki;Suzuki Kazuhiro, Jun. 2021, European urology open science, 29

  DOI
• Carbon ion radiotherapy for prostate cancer with bladder invasion., Miyasaka Yuhei;Kawamura Hidemasa;Sato Hiro;Kubo Nobuteru;Mizukami Tatsuji;Matsui Hiroshi;Miyazawa Yoshiyuki;Ito Kazuto;Nakano Takashi;Suzuki Kazuhiro;Ohno Tatsuya, Aug. 2021, BMC urology, 21, 1

  DOI
• Presepsin as a predictor of septic shock in patients with urinary tract infection., Sekine Yoshitaka;Kotani Kazuhiko;Oka Daisuke;Nakayama Hiroshi;Miyazawa Yoshiyuki;Syuto Takahiro;Arai Seiji;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Murakami Masami;Suzuki Kazuhiro, Oct. 2021, BMC urology, 21, 1

  DOI
• Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer., Sekine Yoshitaka;Nakayama Hiroshi;Miyazawa Yoshiyuki;Arai Seiji;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Oct. 2021, Oncology letters, 22, 6

  DOI
• Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer., Nakayama Hiroshi;Sekine Yoshitaka;Oka Daisuke;Miyazawa Yoshiyuki;Arai Seiji;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, Nov. 2021, The Prostate, 82, 3

  DOI
• Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study., Uemura Hiroji;Kobayashi Kazuki;Yokomizo Akira;Hinotsu Shiro;Horie Shigeo;Kakehi Yoshiyuki;Naito Seiji;Nonomura Norio;Ogawa Osamu;Oya Mototsugu;Suzuki Kazuhiro;Saito Atsushi;Uno Satoshi;Akaza Hideyuki, Aug. 2021, BJUI compass, 3, 1

  DOI
• Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study., Uemura Hiroji;Kobayashi Kazuki;Yokomizo Akira;Hinotsu Shiro;Horie Shigeo;Kakehi Yoshiyuki;Nonomura Norio;Ogawa Osamu;Oya Mototsugu;Suzuki Kazuhiro;Saito Atsushi;Asakawa Keiko;Uno Satoshi;Naito Seiji, Aug. 2022, International journal of clinical oncology, 27, 10

  DOI
• Variants in HOXB13, G132E and F127C, Are Associated With Prostate Cancer Risk in Japanese Men., Kurihara Sota;Matsui Hiroshi;Ohtake Nobuaki;Aoki Masanori;Sekine Yoshitaka;Arai Seiji;Koike Hidekazu;Suzuki Kazuhiro;Miyazawa Yoshiyuki, Sep. 2022, Cancer diagnosis & prognosis, 2, 5

  DOI
• Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells., Ohtsu Akira;Arai Seiji;Sawada Tatsuhiro;Kato Mai;Maeno Yuta;Miyazawa Yoshiyuki;Fujizuka Yuji;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, Aug. 2022, Biochemical and biophysical research communications, 628

  DOI
• Changes in Renal Function of Patients With Prostate Cancer: Focus on Androgen Deprivation Therapy., Miyazawa Yoshiyuki;Sekine Yoshitaka;Arai Seiji;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, Nov. 2022, Cancer diagnosis & prognosis, 2, 6

  DOI
• Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin., Miyazawa Yoshiyuki;Shimizu Takanori;Sekine Yoshitaka;Arai Seiji;Ohtsu Akira;Fujizuka Yuji;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, Oct. 2022, IJU case reports, 6, 1

  DOI
• Summary of the clinical practice manual for late-onset hypogonadism., Ide Hisamitsu;Akehi Yuko;Fukuhara Shinichiro;Ohira Shin;Ogawa Sumito;Kataoka Tomoya;Kumagai Hiroshi;Kobayashi Ko;Komiya Akira;Shigehara Kazuyoshi;Syuto Takahiro;Soh Jintetu;Tanabe Makito;Taniguchi Hisanori;Chiba Koji;Matsushita Kazuhito;Mitsui Yozo;Yoneyama Takahiro;Shirakawa Tomoya;Fujii Yasuhisa;Kumano Hiroaki;Ueshiba Hajime;Amano Toshiyasu;Sasaki Haruaki;Maeda Seiji;Mizokami Atsushi;Suzuki Kazuhiro;Horie Shigeo, Feb. 2023, International journal of urology : official journal of the Japanese Urological Association, 30, 5

  DOI
• A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS., Miyazawa Yoshiyuki;Nakamura Toshiyuki;Takezawa Yutaka;Shimizu Nobuaki;Matsuo Yasushige;Ogura Haruyuki;Takei Tomoyuki;Sekine Yoshitaka;Arai Seiji;Suzuki Kazuhiro, Mar. 2023, The Prostate, 83, 8

  DOI
• Carbon-ion radiotherapy for inoperable upper tract ureteral cancer., Mizukami Tatsuji;Kawamura Hidemasa;Kubo Nobuteru;Sato Hiro;Kawahara Masahiro;Adachi Akiko;Matsui Hiroshi;Suzuki Kazuhiro;Saitoh Jun-Ichi;Nakano Takashi;Ohno Tatsuya, Apr. 2023, Asia-Pacific journal of clinical oncology

  DOI
• Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report., Ohtsu Akira;Arai Seiji;Fujizuka Yuji;Fukuda Reon;Hori Keisuke;Morimura Yuki;Kawahara Rintaro;Shiraishi Takuya;Ogawa Hiroomi;Miyazawa Yoshiyuki;Nomura Masashi;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, May 2023, BMC urology, 23, 1

  DOI
• The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamide., Miyazawa Yoshiyuki;Hori Keisuke;Tsuji Yusuke;Sekine Yoshitaka;Arai Seiji;Fujizuka Yuji;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, May 2023, International journal of urology : official journal of the Japanese Urological Association, 30, 10

  DOI
• Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan., Matsuyama Hideyasu;Matsubara Nobuaki;Kazama Hirotaka;Seto Takeshi;Sunaga Yoshinori;Suzuki Kazuhiro, Jun. 2023, BMC cancer, 23, 1

  DOI
• Blood Concentration of Cabazitaxel in a Patient Whose General Condition Worsened with Concomitant Use of Clarithromycin., Katsumi Shigeaki;Araki Takuya;Yashima Hideaki;Miyazawa Yoshiyuki;Suzuki Kazuhiro;Yamamoto Koujirou, Jul. 2023, Case reports in oncology, 16, 1

  DOI
• Hormonal therapy for localized prostate cancer in Japan: The outcome of J-CaP database, Hinotsu, Shiro;Akaza, Hideyuki;Ogawa, Osamu;Oya, Mototsugu;Kitamura, Tadaichi;Suzuki, Kazuhiro;Tsukamoto, Taiji;Naito, Seiji;Namiki, Mikio;Nishimura, Kazuo;Hirao, Yoshihiko;J-CaP Study Grp, 2012, JOURNAL OF CLINICAL ONCOLOGY, 30, 5
• Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer, Miyamoto, Shigehito;Ito, Kazuto;Kurokawa, Kohei;Suzuki, Kazuhiro;Suzuki, Keiji;Yamanaka, Hidetoshi, 2006, INTERNATIONAL JOURNAL OF UROLOGY, 13, 6, 767, 772
• Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population, Okugi, Hironobu;Nakazato, Haruki;Matsui, Hiroshi;Ohtake, Nobuaki;Nakata, Seiji;Suzuki, Kazuhiro, 2006, CANCER DETECTION AND PREVENTION, 30, 3, 262, 268

  DOI
• Positive effect of prostaglandin on regulation of prostatic blood flow, Kashiwagi, Bunzo;Shibata, Yasuhiro;Ohki, Kazunari;Arai, Seiji;Honma, Seijiro;Suzuki, Kazuhiro, 2006, UROLOGY, 68, 3, 682, 686

  DOI
• Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo, Shibata, Yasuhiro;Kashiwagi, Bunzo;Arai, Seiji;Magari, Tomohiro;Suzuki, Kazuhiro;Honma, Seijiro, 2006, UROLOGY, 68, 5, 1127, 1131

  DOI
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan, Sekine, Yoshitaka;Ito, Kazuto;Yamamoto, Takumi;Nakazato, Haruki;Shibata, Yasuhiro;Hatori, Motoaki;Suzuki, Kazuhiro, 2007, CANCER DETECTION AND PREVENTION, 31, 2, 149, 153
• Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells, Sekine, Yoshitaka;Koike, Hidekazu;Nakano, Takamitsu;Nakajima, Katsuyuki;Suzuki, Kazuhiro, 2007, CLINICA CHIMICA ACTA, 383, 1-2, 78, 84

  DOI
• Lead time of prostate cancer detected in population based screening for prostate cancer in Japan, Ito, Kazuto;Yamamoto, Takumi;Miyakubo, Mai;Takechi, Hiroyuki;Ohi, Masaru;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2007, JOURNAL OF UROLOGY, 178, 4, 1258, 1263
• The Second Joint Meeting of American Urological Association (AUA)/Japanese Urological Association (JUA) International Program on the 102nd Annual Meeting of American Urological Association at Anaheim 2007, Ogan, Kenneth;Kawai, Koji;Gill, Inderbir Singh;Naito, Seiji;Isaacs, Williams B.;Suzuki, Kazuhiro;Kibel, Adam S.;Kakehi, Yoshiyuki;Yoshimura, Naoki;Yokoyama, Osamu;Chancellor, Michael B.;Takahashi, Satoru, 2007, INTERNATIONAL JOURNAL OF UROLOGY, 14, 12, 1116, 1116

  DOI
• Familial prostate cancer in Japan, Suzuki, Kazuhiro, 2007, INTERNATIONAL JOURNAL OF UROLOGY, 14, 12, 1120, 1120
• Evidence-based clinical practice guidelines for prostate cancer (Summary JUA 2006 edition), Kamidono, Sadao;Ohshima, Shinichi;Hirao, Yoshihiko;Suzuki, Kazuhiro;Arai, Yoichi;Fujimoto, Hiroyuki;Egawa, Shin;Akaza, Hideyuki;Hara, Isao;Hinotsu, Shiro;Kakehi, Yoshiyuki;Hasegawa, Tomonori, 2008, INTERNATIONAL JOURNAL OF UROLOGY, 15, 1, 1, 18
• Willingness to pay for mass screening for prostate cancer: A contingent valuation survey - Comment, Suzuki, Kazuhiro, 2008, INTERNATIONAL JOURNAL OF UROLOGY, 15, 1, 105, 105
• Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan - Comment, Suzuki, Kazuhiro, 2008, INTERNATIONAL JOURNAL OF UROLOGY, 15, 2, 161, 161
• Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population, Hamano, Tatsuya;Matsui, Hiroshi;Ohtake, Nobuaki;Nakata, Seiji;Suzuki, Kazuhiro, 2008, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 4, 1, 21, 26

  DOI
• Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor, Sekine, Yoshitaka;Furuya, Yosuke;Nishii, Masahiro;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2008, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 372, 2, 356, 361

  DOI
• Changes in baseline PSA levels in Japanese men from 1988 to 2003, Ohi, Masaru;Ito, Kazuto;Yamamoto, Takumi;Miyakubo, Mai;Takechi, Hiroyuki;Kubota, Yutaka;Suzuki, Kazuhiro, 2008, UROLOGY, 72, 1, 95, 98

  DOI
• Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds, Yamamoto, Takumi;Ito, Kazuto;Miyakubo, Mal;Takechi, Hiroyuki;Suzuki, Kazuhiro;Akimoto, Tetsuo;Ishikawa, Hitoshi;Nakano, Takashi, 2008, UROLOGY, 72, 4, 892, 897

  DOI
• Prostate-Specific Antigen Kinetics in Screen-Detected Prostate Cancer in Japan, Takechi, Hiroyuki;Ito, Kazuto;Yamamoto, Takumi;Miyakubo, Mai;Ohi, Masaru;Suzuki, Kazuhiro, 2008, UROLOGY, 72, 5, 1111, 1115

  DOI
• Nephrogenic Systemic Fibrosis with Multiple Calcification and Osseous Metaplasia, Nagai, Yayoi;Hasegawa, Michiko;Shinmi, Kahori;Kishi, Chikako;Tsushima, Yoshito;Endo, Keigo;Okabe, Kazuhiko;Suzuki, Kazuhiro;Ishikawa, Osamu, 2008, ACTA DERMATO-VENEREOLOGICA, 88, 6, 597, 600

  DOI
• Gene Expression of Survivin and Its Spliced Isoforms Associated With Proliferation and Aggressive Phenotypes of Prostate Cancer, Koike, Hidekazu;Sekine, Yoshitaka;Kamiya, Makoto;Nakazato, Haruki;Suzuki, Kazuhiro, 2008, UROLOGY, 72, 6, 1229, 1233

  DOI
• Proprostate-specific antigen: Its usefulness in the era of multiple-core prostate biopsy, Miyakubo, Mai;Ito, Kazuto;Yamamoto, Takumi;Takechi, Hiroyuki;Ohi, Masaru;Suzuki, Kazuhiro, 2009, INTERNATIONAL JOURNAL OF UROLOGY, 16, 6, 561, 565

  DOI
• Induction of type 1 interferon receptor by zinc in U937 cells, Nagamine, Takeaki;Nakajima, Kastuyuki;Takada, Hisashi;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2009, CYTOKINE, 46, 3, 346, 350

  DOI
• Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor, Sekine, Yoshitaka;Koike, Hidekazu;Nakano, Takamitsu;Nakajima, Katsuyuki;Takahashi, Sadao;Suzuki, Kazuhiro, 2009, CANCER EPIDEMIOLOGY, 33, 1, 16, 23

  DOI
• Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Okamura, Keigo;Koike, Hidekazu;Sekine, Yoshitaka;Matsui, Hiroshi;Suzuki, Kazuhiro, 2009, CANCER EPIDEMIOLOGY, 33, 2, 137, 141

  DOI
• Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells, Abdulah, Rizky;Faried, Ahmad;Kobayashi, Kenji;Yamazaki, Chiho;Suradji, Eka W.;Ito, Kazuto;Suzuki, Kazuhiro;Murakami, Masami;Kuwano, Hiroyuki;Koyama, Hiroshi, 2009, BMC CANCER, 9

  DOI
• New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry, Arai, Seiji;Miyashiro, Yoshimichi;Shibata, Yasuhiro;Kashiwagi, Bunzo;Tomaru, Yukio;Kobayashi, Mikio;Watanabe, Yoko;Honma, Seijiro;Suzuki, Kazuhiro, 2010, STEROIDS, 75, 1, 13, 19

  DOI
• The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the α1-adrenergic receptor antagonist work well for ureteral stones?, Ohki, Kazunari;Ohno, Yosihiro;Suzuki, Kazuhiro, 2010, INTERNATIONAL UROLOGY AND NEPHROLOGY, 42, 1, 113, 117

  DOI
• Association of SNP rs1447295 and Microsatellite Marker DG8S737 With Familial Prostate Cancer and High Grade Disease, Hamano, Tatsuya;Matsui, Hiroshi;Sekine, Yoshitaka;Ohtake, Nobuaki;Nakata, Seiji;Suzuki, Kazuhiro, 2010, JOURNAL OF UROLOGY, 184, 2, 738, 742

  DOI
• High-Density Lipoprotein Induces Proliferation and Migration of Human Prostate Androgen-Independent Cancer Cells by an ABCA1-Dependent Mechanism, Sekine, Yoshitaka;Demosky, Steve J.;Stonik, John A.;Furuya, Yosuke;Koike, Hidekazu;Suzuki, Kazuhiro;Remaley, Alan T., 2010, MOLECULAR CANCER RESEARCH, 8, 9, 1284, 1294

  DOI
• Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010, Naito, Seiji;Kakehi, Yoshiyuki;Okuyama, Akihiko;Imamura, Tomoaki;Yasunaga, Hideo;Akaza, Hideyuki;Hinotsu, Shiro;Arai, Yoichi;Dokiya, Takushi;Egawa, Shin;Suzuki, Kazuhiro;Koga, Hirofumi;Masumori, Naoya;Akakura, Koichiro;Kawashima, Kiyotaka;Okihara, Koji;Ito, Kazuto;Comm Estab Guidelines Screening Pr;Japanese Urological Assoc, 2010, INTERNATIONAL JOURNAL OF UROLOGY, 17, 10, 830, 838

  DOI
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues, Arai, Seiji;Miyashiro, Yoshimichi;Shibata, Yasuhiro;Tomaru, Yukio;Kobayashi, Mikio;Honma, Seijiro;Suzuki, Kazuhiro, 2011, STEROIDS, 76, 3, 301, 308

  DOI
• Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D₃ Induced Cell Growth Inhibition in Prostate Cancer, Koike, Hidekazu;Morikawa, Yasuyuki;Sekine, Yoshitaka;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2011, JOURNAL OF UROLOGY, 185, 4, 1497, 1503

  DOI
• HDL and Sphingosine-1-Phosphate Activate Stat3 in Prostate Cancer DU145 Cells Via ERK1/2 and S1P Receptors, and Promote Cell Migration and Invasion, Sekine, Yoshitaka;Suzuki, Kazuhiro;Remaley, Alan T., 2011, PROSTATE, 71, 7, 690, 699

  DOI
• HDL and Sphingosine-I-Phosphate Activate Stat3 in Prostate Cancer DU145 Cells Via ERK1/2 and SIP Receptors, and Promote Cell Migration and Invasion (vol 71, pg 690, 2011), Sekine, Yoshitaka;Suzuki, Kazuhiro;Remaley, Alan T., 2011, PROSTATE, 71, 13, 1480, 1480

  DOI
• High Fat Diet Reduces the Expression of Glutathione Peroxidase 3 in Mouse Prostate, Sekine, Yoshitaka;Osei-Hwedieh, David;Matsuda, Kant;Raghavachari, Nalini;Liu, Delong;Furuya, Yosuke;Koike, Hidekazu;Suzuki, Kazuhiro;Remaley, Alan T., 2011, PROSTATE, 71, 14, 1499, 1509

  DOI
• Suppressive effects of the antiandrogen agent, chlormadinone acetate and the 5α-reductase inhibitor, dutasteride on prostate weight and intraprostatic androgen levels in rats, Kobayashi, Hideo;Gotanda, Kotaro;Shibata, Yasuhiro;Watanabe, Jun-ichi;Nakano, Youichi;Shinbo, Atsushi;Suzuki, Kazuhiro, 2011, ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 61, 9, 515, 520
• Oncological outcomes of the prostate cancer patients registered in 2004: Report from the Cancer Registration Committee of the JUA, Fujimoto, Hiroyuki;Nakanishi, Hiroyuki;Miki, Tsuneharu;Kubota, Yoshinobu;Takahashi, Satoru;Suzuki, Kazuhiro;Kanayama, Hiro-omi;Mikami, Kazuya;Homma, Yukio, 2011, INTERNATIONAL JOURNAL OF UROLOGY, 18, 12, 876, 881

  DOI
• Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, Morikawa, Yasuyuki;Koike, Hidekazu;Sekine, Yoshitaka;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2012, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 419, 3, 584, 589

  DOI
• Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Nishii, Masahiro;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Oyama, Tetsunari;Suzuki, Kazuhiro, 2012, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238

  DOI
• Lower urinary tract symptoms of neurological origin in urological practice, Magari, Tomohiro;Fukabori, Yoshitatsu;Ogura, Haruyuki;Suzuki, Kazuhiro, 2013, CLINICAL AUTONOMIC RESEARCH, 23, 2, 67, 72

  DOI
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Ito, Kazuto;Miyakubo, Mai;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2013, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311

  DOI
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation, Magari, Tomohiro;Shibata, Yasuhiro;Arai, Sew;Kashiwagi, Bunzo;Suzuki, Kazuhiro, 2013, SCANDINAVIAN JOURNAL OF UROLOGY, 47, 3, 236, 241

  DOI
• High-Density Lipoprotein and Prostate Cancer: An Overview, Kotani, Kazuhiko;Sekine, Yoshitaka;Ishikawa, Shizukiyo;Ikpot, Imoh Z.;Suzuki, Kazuhiro;Remaley, Alan T., 2013, JOURNAL OF EPIDEMIOLOGY, 23, 5, 313, 319

  DOI
• Chronic expanding hematoma in the retroperitoneal space: a case report, Syuto, Takahiro;Hatori, Motoaki;Masashi, Nomura;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2013, BMC UROLOGY, 13

  DOI
• Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer, Mukai, Hirofumi;Takahashi, Shunji;Nozawa, Masahiro;Onozawa, Yusuke;Miyazaki, Jun;Ohno, Keiji;Suzuki, Kazuhiro;TED 11576 Invest, 2014, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 4, 703, 710

  DOI
• Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association, Fujimoto, Hiroyuki;Nakanishi, Hiroyuki;Miki, Tsuneharu;Kanayama, Hiro-omi;Ohyama, Chikara;Suzuki, Kazuhiro;Nishiyama, Hiroyuki;Eto, Masatoshi;Naito, Seiji;Fukumori, Tomoharu;Kubota, Yoshinobu;Takahashi, Satoru;Homma, Yukio;Kamoi, Kazumi, 2014, INTERNATIONAL JOURNAL OF UROLOGY, 21, 5, 527, 534

  DOI
• Phase I clinical study of cabazitaxel plus prednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in a Japanese population., Takahashi, Shunji;Mukai, Hirofumi;Uemura, Hirotsugu;Uemura, Hiroji;Kosaka, Takeo;Nishiyama, Hiroyuki;Suzuki, Kazuhiro;Kakehi, Yoshiyuki;Okihara, Koji;Namiki, Shunichi;Ogawa, Osamu;Kato, Masashi;Nakai, Yasutomo;Ohno, Keiji;TED11576 Investigators, 2014, JOURNAL OF CLINICAL ONCOLOGY, 32, 4
• Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels, Magari, Tomohiro;Shibata, Yasuhiro;Arai, Seiji;Kashiwagi, Bunzo;Suzuki, Keiji;Suzuki, Kazuhiro, 2014, ASIAN JOURNAL OF ANDROLOGY, 16, 3, 457, 460

  DOI
• Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association, Miki, Tsuneharu;Kamoi, Kazumi;Fujimoto, Hiroyuki;Kanayama, Hiro-omi;Ohyama, Chikara;Suzuki, Kazuhiro;Nishiyama, Hiroyuki;Eto, Masatoshi;Naito, Seiji;Fukumori, Tomoharu;Kubota, Yoshinobu;Takahashi, Satoru;Mikami, Kazuya;Homma, Yukio, 2014, INTERNATIONAL JOURNAL OF UROLOGY, 21, 8, S1, S6

  DOI
• Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Ishizuka, Tamotsu;Hisada, Takeshi;Hatori, Motoaki;Koike, Akio;Hanabuchi, Kikuo;Matsuzaki, Shinichi;Kamide, Yosuke;Utsugi, Mitsuyoshi;Aoki, Haruka;Yoshino, Reiko;Yanagitani, Noriko;Koga, Yasuhiko;Ono, Akihiro;Kaira, Kyoichi;Sunaga, Noriaki;Dobashi, Kunio;Tsuburai, Takahiro;Akiyama, Kazuo;Yamada, Masanobu;Suzuki, Kazuhiro;Mori, Masatomo, 2014, INFLAMMATION RESEARCH, 63, 9, 789, 796

  DOI
• YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Koike, Hidekazu;Nitta, Takashi;Sekine, Yoshitaka;Arai, Seiji;Furuya, Yosuke;Nomura, Masashi;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Oyama, Tetsunari;Suzuki, Kazuhiro, 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713

  DOI
• High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients, Miyoshi, Yasuhide;Uemura, Hiroji;Umemoto, Susumu;Sakamaki, Kentaro;Morita, Satoshi;Suzuki, Kazuhiro;Shibata, Yasuhiro;Masumori, Naoya;Ichikawa, Tomohiko;Mizokami, Atsushi;Sugimura, Yoshiki;Nonomura, Norio;Sakai, Hideki;Honma, Seijiro;Harada, Masaoki;Kubota, Yoshinobu, 2014, BMC CANCER, 14

  DOI
• Suicide attempt with an overdose of sunitinib, Arai, Seiji;Matsui, Hiroshi;Ohki, Ryo;Miyazawa, Yoshiyuki;Koike, Hidekazu;Hashita, Tadahiro;Katsuyama, Yoshihiko;Sekine, Yoshitaka;Nomura, Masashi;Shibata, Yasuhiro;Hatori, Motoaki;Ito, Kazuto;Yamamoto, Koujirou;Ohmori, Shigeru;Suzuki, Kazuhiro, 2014, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935

  DOI
• Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer, Matsuyama, Hideyasu;Shimabukuro, Tomoyuki;Hara, Isao;Kohjimoto, Yasuo;Suzuki, Kazuhiro;Koike, Hidekazu;Uemura, Hirotsugu;Hayashi, Taiji;Ueno, Munehisa;Kodaira, Kiichiro;Tomita, Yoshihiko;Sakurai, Toshihiko;Shimizu, Nobuaki, 2014, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 5, 946, 954

  DOI
• Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan, Onozawa, Mizuki;Hinotsu, Shiro;Tsukamoto, Taiji;Oya, Mototsugu;Ogawa, Osamu;Kitamura, Tadaichi;Suzuki, Kazuhiro;Naito, Seiji;Namiki, Mikio;Nishimura, Kazuo;Hirao, Yoshihiko;Akaza, Hideyuki, 2014, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 10, 969, 981

  DOI
• A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Suzuki, Kazuhiro;Ozono, Seiichiro;Yamaguchi, Akito;Koike, Hidekazu;Matsui, Hiroshi;Nagata, Masao;Takubo, Takatoshi;Miyashita, Kana;Matsushima, Takafumi;Akaza, Hideyuki, 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 75, 2, 373, 380

  DOI
• Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial, Saad, Fred;Fizazi, Karim;Jinga, Viorel;Efstathiou, Eleni;Fong, Peter C.;Hart, Lowell L.;Jones, Robert;McDermott, Raymond;Wirth, Manfred;Suzuki, Kazuhiro;MacLean, David B.;Wang, Ling;Akaza, Hideyuki;Nelson, Joel;Scher, Howard I.;Dreicer, Robert;Webb, Iain J.;de Wit, Ronald;ELM-PC 4 Investigators, 2015, LANCET ONCOLOGY, 16, 3, 338, 348

  DOI
• Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Kato, Haruo;Sekine, Yoshitaka;Furuya, Yosuke;Miyazawa, Yoshiyuki;Koike, Hidekazu;Suzuki, Kazuhiro, 2015, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 461, 1, 115, 121

  DOI
• Phase 3, randomized, placebo-controlled trial of orteronel (TAK-700) plus prednisone in patients (pts) with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC) (ELM-PC 4 trial), De Wit, Ronald;Fizazi, Karim;Jinga, Viorel;Efstathiou, Eleni;Fong, Peter C. C.;Wirth, Manfred;Suzuki, Kazuhiro;Moran, Susan;Wang, Ling;Akaza, Hideyuki;Nelson, Joel;Scher, Howard I.;Dreicer, Robert;Borgstein, Niels Geert;Saad, Fred, 2014, JOURNAL OF CLINICAL ONCOLOGY, 32, 15
• Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association, Kanayama, Hiro-omi;Fukumori, Tomoharu;Fujimoto, Hiroyuki;Nakanishi, Hiroyuki;Ohyama, Chikara;Suzuki, Kazuhiro;Nishiyama, Hiroyuki;Eto, Masatoshi;Miki, Tsuneharu;Kamoi, Kazumi;Kubota, Yoshinobu;Takahashi, Satoru;Homma, Yukio;Naito, Seiji, 2015, INTERNATIONAL JOURNAL OF UROLOGY, 22, 9, S1, S7

  DOI
• Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Ishikawa, Hitoshi;Katoh, Hiroyuki;Kaminuma, Takuya;Kawamura, Hidemasa;Ito, Kazuto;Matsui, Hiroshi;Hirato, Junko;Shimizu, Nobuaki;Takezawa, Yutaka;Tsuji, Hiroshi;Suzuki, Kazuhiro;Ohno, Tatsuya;Nakano, Takashi;Gunma Heavy Ion Medical Ctr, 2015, ANTICANCER RESEARCH, 35, 10, 5559, 5566
• Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer, Nozawa, Masahiro;Mukai, Hirofumi;Takahashi, Shunji;Uemura, Hiroji;Kosaka, Takeo;Onozawa, Yusuke;Miyazaki, Jun;Suzuki, Kazuhiro;Okihara, Koji;Arai, Yoichi;Kamba, Tomomi;Kato, Masashi;Nakai, Yasutomo;Furuse, Hiroshi;Kume, Haruki;Ide, Hisamitsu;Kitamura, Hiroshi;Yokomizo, Akira;Kimura, Takahiro;Tomita, Yoshihiko;Ohno, Keiji;Kakehi, Yoshiyuki, 2015, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 5, 1026, 1034

  DOI
• Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan, Suzuki, Kazuhiro;Namiki, Mikio;Fujimoto, Tsukasa;Takabayashi, Nobuyoshi;Kudou, Kentarou;Akaza, Hideyuki, 2015, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45, 12, 1168, 1174

  DOI
• Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naive prostate cancer, Miyoshi, Yasuhide;Uemura, Hiroji;Umemoto, Susumu;Sakamaki, Kentaro;Taguri, Masataka;Suzuki, Kazuhiro;Shibata, Yasuhiro;Masumori, Naoya;Ichikawa, Tomohiko;Mizokami, Atsushi;Sugimura, Yoshiki;Nonomura, Norio;Sakai, Hideki;Honma, Seijiro;Harada, Masaoki;Kubota, Yoshinobu, 2016, PROSTATE, 76, 4, 376, 382

  DOI
• Germline Variants of Prostate Cancer in Japanese Families, Hayano, Takahide;Matsui, Hiroshi;Nakaoka, Hirofumi;Ohtake, Nobuaki;Hosomichi, Kazuyoshi;Suzuki, Kazuhiro;Inoue, Ituro, 2016, PLOS ONE, 11, 10

  DOI
• Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Kato, Haruo;Furuya, Yosuke;Miyazawa, Yoshiyuki;Miyao, Takeshi;Syuto, Takahiro;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2016, ANTICANCER RESEARCH, 36, 11, 6141, 6149

  DOI
• YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Nitta, Takashi;Koike, Hidekazu;Miyao, Takeshi;Miyazawa, Yoshiyuki;Kato, Haruo;Furuya, Yosuke;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH, 37, 1, 75, 80

  DOI
• Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Kato, Haruo;Furuya, Yosuke;Koike, Hidekazu;Suzuki, Kazuhiro, 2017, PROSTATE, 77, 4, 337, 349

  DOI
• Pros and cons of docetaxel used to treat metastatic hormone-sensitive prostate cancer: The cons, Suzuki, Kazuhiro, 2016, ANNALS OF ONCOLOGY, 27
• ARAMIS trial: Efficacy and safety of ODM-201 in men with high-risk nonmetastatic castration-resistant prostate cancer, Suzuki, Kazuhiro;Kuss, Iris;Smith, Matthew R.;Fizazi, Karim, 2016, ANNALS OF ONCOLOGY, 27
• Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Shibata, Yasuhiro;Arai, Seiji;Miyazawa, Yoshiyuki;Shuto, Takahiro;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro, 2017, PROSTATE, 77, 6, 672, 680

  DOI
• Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Shibata, Yasuhiro;Kurihara, Sota;Arai, Seiji;Kato, Haruo;Suzuki, Tomomi;Miyazawa, Yoshiyuki;Koike, Hidekazu;Ito, Kazuto;Nakamura, Tetsuya;Suzuki, Kazuhiro, 2017, JOURNAL OF INVESTIGATIVE SURGERY, 30, 4, 247, 251

  DOI
• A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2017, BMC UROLOGY, 17

  DOI
• Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Fujizuka, Yuji;Ito, Kazuto;Oki, Ryo;Suzuki, Rie;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2017, INTERNATIONAL JOURNAL OF UROLOGY, 24, 8, 602, 609

  DOI
• Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH, 37, 7, 3667, 3671

  DOI
• Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2018, IN VIVO, 32, 2, 409, 412

  DOI
• Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism, Sekine, Yoshitaka;Nakayama, Hiroshi;Miyazawa, Yoshiyuki;Kato, Haruo;Furuya, Yosuke;Arai, Seiji;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2018, ONCOLOGY LETTERS, 15, 3, 3167, 3172

  DOI
• Post marketing surveillance study of cabazitaxel (CBZ) in Japanese patients with castration resistant prostate cancer (CRPC) in real world settings., Matsuyama, Hideyasu;Matsubara, Nobuaki;Taguchi, Tomoyuki;Seto, Takeshi;Suzuki, Kazuhiro, 2018, JOURNAL OF CLINICAL ONCOLOGY, 36, 6
• Assessment of antimicrobiral prophylaxis in transperineal prostate biopsy: A single-center retrospective study of 485 cases, Baba, Kyoko;Sekine, Yoshitaka;Miyazawa, Yoshiyuki;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2018, JOURNAL OF INFECTION AND CHEMOTHERAPY, 24, 8, 637, 640

  DOI
• Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screening, Oki, Ryo;Ito, Kazuto;Suzuki, Rie;Fujizuka, Yuji;Arai, Seiji;Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2018, INTERNATIONAL JOURNAL OF CANCER, 143, 7, 1611, 1619

  DOI
• Clinical Outcomes and Survival Surrogacy Studies of PSA Declines and PSA kinetics Following Enzalutamide in Men with mCRPC, Miyazawa, Yoshiyuki;Miyao, Takeshi;Nakayama, Hiroshi;Kurihara, Sota;Oki, Ryo;Syuto, Takahiro;Sekine, Yoshitaka;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2018, INTERNATIONAL JOURNAL OF UROLOGY, 25, 357, 357
• Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching, Onozawa, Mizuki;Akaza, Hideyuki;Hinotsu, Shiro;Oya, Mototsugu;Ogawa, Osamu;Kitamura, Tadaichi;Suzuki, Kazuhiro;Naito, Seiji;Namiki, Mikio;Nishimura, Kazuo;Hirao, Yoshihiko;Tsukamoto, Taiji, 2018, CANCER MEDICINE, 7, 10, 4893, 4902

  DOI
• Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study, Kubo, Nobuteru;Kawamura, Hidemasa;Oike, Takahiro;Sato, Hiro;Iwanaga, Mototaro;Mizukami, Tatsuji;Adachi, Akiko;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Nakano, Takashi, 2019, IN VIVO, 33, 4, 1235, 1241

  DOI
• An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Shimizu, Nobuaki;Takezawa, Yutaka;Nakamura, Toshiyuki;Miyao, Takeshi;Nakayama, Hiroshi;Kurihara, Sota;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2019, PROSTATE, 79, 12, 1462, 1470

  DOI
• Quality of life in prostate cancer patients receiving particle radiotherapy: A review of the literature, Kawamura, Hidemasa;Kubo, Nobuteru;Sato, Hiro;Miyasaka, Yuhei;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Ohno, Tatsuya, 2020, INTERNATIONAL JOURNAL OF UROLOGY, 27, 1, 24, 29

  DOI
• Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening, Ito, Kazuto;Oki, Ryo;Sekine, Yoshitaka;Arai, Seiji;Miyazawa, Yoshiyuki;Shibata, Yasuhiro;Suzuki, Kazuhiro;Kurosawa, Isao, 2019, INTERNATIONAL JOURNAL OF UROLOGY, 26, 10, 956, 970

  DOI
• Exploratory study of prognostic factors in mCRPC patients who administered enzalutamide focusing on early PSA decline and PSA kinetics at PSA progression: Results of retrospective multicenter study., Miyazawa, Yoshiyuki;Shimizu, Nobuaki;Takezawa, Yutaka;Nakamura, Toshiyuki;Miyao, Takeshi;Nakayama, Hiroshi;Kurihara, Sota;Syuto, Takahiro;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2019, JOURNAL OF CLINICAL ONCOLOGY, 37, 7
• Phase I trial of TAK-385 in hormone treatment-naive Japanese patients with nonmetastatic prostate cancer, Suzuki, Hiroyoshi;Uemura, Hiroji;Mizokami, Atsushi;Hayashi, Narihiko;Miyoshi, Yasuhide;Nagamori, Satoshi;Enomoto, Yutaka;Akaza, Hideyuki;Asato, Takayuki;Kitagawa, Tadayuki;Suzuki, Kazuhiro, 2019, CANCER MEDICINE, 8, 13, 5891, 5902

  DOI
• Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml, Ito, Kazuto;Yokomizo, Akira;Tokunaga, Shoji;Arai, Gaku;Sugimoto, Mikio;Akakura, Koichiro;Hasumi, Hisashi;Sakai, Hideki;Ouraji, Akiko;Oki, Ryo;Kashiwagi, Eiji;Kobori, Yoshitomo;Hirama, Hiromi;Kitoh, Hiroki;Uemura, Hiroji;Hakariya, Tomoaki;Suzuki, Kazuhiro;PROPHET, 2020, JOURNAL OF UROLOGY, 203, 1, 83, 91

  DOI
• Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study, Suzuki, Kazuhiro;Matsubara, Nobuaki;Kazama, Hirotaka;Seto, Takeshi;Tsukube, Shoko;Matsuyama, Hideyasu, 2019, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 49, 12, 1157, 1163

  DOI
• Prevalence and clinical characteristics of overactive bladder in systemic sclerosis, Motegi, Sei-Ichiro;Sekiguchi, Akiko;Sekine, Yoshitaka;Nakayama, Hiroshi;Suzuki, Kazuhiro;Ishikawa, Osamu, 2020, MODERN RHEUMATOLOGY, 30, 2, 327, 331

  DOI
• Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702", Kawamura, Hidemasa;Kubo, Nobuteru;Sato, Hiro;Mizukami, Tatsuji;Katoh, Hiroyuki;Ishikawa, Hitoshi;Ohno, Tatsuya;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Nakano, Takashi;Gunma Univ Heavy Ion Med Ctr, 2020, BMC CANCER, 20, 1

  DOI
• A prospective study of the relationship between clinical outcomes of enzalutamide and serum androgen levels measured by LC-MS/MS in patients with CRPC, Miyazawa, Yoshiyuki;Miyao, Takeshi;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Oka, Daisuke;Arai, Seiji;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2020, JOURNAL OF CLINICAL ONCOLOGY, 38, 6
• Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer, Darwis, Narisa Dewi Maulany;Oike, Takahiro;Kawamura, Hidemasa;Kawahara, Masahiro;Kubo, Nobuteru;Sato, Hiro;Miyasaka, Yuhei;Katoh, Hiroyuki;Ishikawa, Hitoshi;Matsui, Hiroshi;Miyazawa, Yoshiyuki;Ito, Kazuto;Suzuki, Kazuhiro;Gondhowiardjo, Soehartati;Nakano, Takashi;Ohno, Tatsuya, 2020, CANCERS, 12, 3

  DOI
• Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial, Ito, Kazuto;Kobayashi, Mikio;Komiyama, Motokiyo;Naito, Seiji;Nishimura, Kazuo;Yonese, Junji;Hashine, Katsuyoshi;Saito, Shiro;Arai, Gaku;Shinohara, Mitsuru;Masumori, Naoya;Shimizu, Nobuaki;Satoh, Takefumi;Yamauchi, Atsushi;Tochigi, Tatsuo;Takezawa, Yutaka;Fujimoto, Hiroyuki;Yokomizo, Akira;Kakimoto, Ken-Ichi;Fukui, Iwao;Karasawa, Katsuyuki;Tsukamoto, Taiji;Nozaki, Miwako;Hasumi, Masaru;Ishiyama, Hiromichi;Ohtani, Mikinobu;Kuwahara, Masaaki;Harada, Masaoki;Ohashi, Yasuo;Kotake, Toshihiko;Kakizoe, Tadao;Suzuki, Kazuhiro;Yamanaka, Hidetoshi;Natl Res Project Endocrine-Radiati, 2020, CANCER, 126, 17, 3961, 3971

  DOI
• Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug, Endo, Yukie;Oka, Aina;Uehara, Akihito;Toki, Sayaka;Motegi, Sei-ichiro;Ishikawa, Osamu;Miyazawa, Yoshiyuki;Suzuki, Kazuhiro, 2020, JOURNAL OF DERMATOLOGY, 47, 10, E359, E360

  DOI
• Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m²) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillance study, Matsuyama, Hideyasu;Matsubara, Nobuaki;Kazama, Hirotaka;Seto, Takeshi;Tsukube, Shoko;Suzuki, Kazuhiro, 2020, BMC CANCER, 20, 1

  DOI
• YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression, Miyao, Takeshi;Koike, Hidekazu;Sekine, Yoshitaka;Ohtsu, Akira;Oka, Daisuke;Suzuki, Kazuhiro, 2020, ANTICANCER RESEARCH, 40, 9, 5091, 5095

  DOI
• Cabazitaxel in patients aged ≥80 years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan, Matsubara, Nobuaki;Suzuki, Kazuhiro;Kazama, Hirotaka;Tsukube, Shoko;Seto, Takeshi;Matsuyama, Hideyasu, 2020, JOURNAL OF GERIATRIC ONCOLOGY, 11, 7, 1067, 1073

  DOI
• Improved Arterial Preservation Achieved by Combined Use of Indocyanine Green Angiography and Doppler Detector During Microsurgical Subinguinal Varicocelectomy, Kurihara, Sota;Shibata, Yasuhiro;Arai, Seiji;Sekine, Yoshitaka;Miyazawa, Yoshiyuki;Koike, Hidekazu;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Nakamura, Tetsuya, 2020, JOURNAL OF INVESTIGATIVE SURGERY, 33, 10, 941, 947

  DOI
• Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial, Uemura, Hiroji;Matsushima, Hisashi;Kobayashi, Kazuki;Mizusawa, Hiroya;Nishimatsu, Hiroaki;Fizazi, Karim;Smith, Matthew;Shore, Neal;Tammela, Teuvo;Tabata, Ken-ichi;Matsubara, Nobuaki;Iinuma, Masahiro;Uemura, Hirotsugu;Oya, Mototsugu;Momma, Tetsuo;Kawakita, Mutsushi;Fukasawa, Satoshi;Kobayashi, Tadahiro;Kuss, Iris;Le Berre, Marie-Aude;Snapir, Amir;Sarapohja, Toni;Suzuki, Kazuhiro, 2021, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 26, 3, 578, 590

  DOI
• Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese Institute, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Arai, Seiji;Oka, Daisuke;Nakayama, Hiroshi;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2021, IN VIVO, 35, 1, 373, 384

  DOI
• Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors, Saad, Fred;Boegemann, Martin;Suzuki, Kazuhiro;Shore, Neal, 2021, PROSTATE CANCER AND PROSTATIC DISEASES, 24, 2, 323, 334

  DOI
• Mitochondria E3 Ubiquitin Ligase MARCH5 Mediates Stress-Induced and NOXA-Dependent MCL1 Degradation, Arai, Seiji;Ohtsu, Akira;Sawada, Tatsuhiro;Suzuki, Kazuhiro, 2021, CANCER SCIENCE, 112, 329, 329
• MCL1 inhibitor drives prostate cancer cell apoptosis in combination with mitochondria-targeting drugs, Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Suzuki, Kazuhiro, 2021, CANCER SCIENCE, 112, 668, 668
• Antitumor effect of a statin in castration resistant prostate cancer cells, with a focus on autophagy, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Arai, Seiji;Suzuki, Kazuhiro, 2021, CANCER SCIENCE, 112, 845, 845
• Enzalutamide plus androgen deprivation therapy (ADT) versus flutamide plus ADT in men with castration-resistant prostate cancer (CRPC): AFTERCAB, Uemura, Hiroji;Kobayashi, Kazuki;Yokomizo, Akira;Hinotsu, Shiro;Horie, Shigeo;Kakehi, Yoshiyuki;Naito, Seiji;Nonomura, Norio;Ogawa, Osamu;Oya, Mototsugu;Suzuki, Kazuhiro;Saito, Atsushi;Uno, Satoshi;Akaza, Hideyuki, 2021, JOURNAL OF CLINICAL ONCOLOGY, 39, 6

  DOI
• Relationship between changes in serum androgen level measured by LC-MS/MS and therapeutic effect after enzalutamide treatment., Miyazawa, Yoshiyuki;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Arai, Seiji;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2021, JOURNAL OF CLINICAL ONCOLOGY, 39, 6

  DOI
• Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial, Yokomizo, Akira;Koga, Hirofumi;Ito, Kazuto;Takezawa, Yutaka;Komiyama, Motokiyo;Nishimura, Kazuo;Yonese, Junji;Hashine, Katsuyoshi;Masumori, Naoya;Arai, Gaku;Saito, Shiro;Shinohara, Mitsuru;Shimizu, Nobuaki;Yamauchi, Atsushi;Satoh, Takefumi;Tochigi, Tatsuo;Kobayashi, Mikio;Fujimoto, Hiroyuki;Kakimoto, Ken-ichi;Fukui, Iwao;Tsukamoto, Taiji;Nozaki, Miwako;Karasawa, Katsuyuki;Hasumi, Masaru;Ohtani, Mikinobu;Ishiyama, Hiromichi;Kuwahara, Masaaki;Harada, Masaoki;Ohashi, Yasuo;Kotake, Toshihiko;Kakizoe, Tadao;Suzuki, Kazuhiro;Naito, Seiji;Yamanaka, Hidetoshi;Locally Adv Prostate Canc Invest, 2021, CANCER MEDICINE, 10, 10, 3240, 3248

  DOI
• A Prospective Study of the Relationship Between Clinical Outcomes After Enzalutamide and Serum Androgen Levels Measured via Liquid Chromatography-tandem Mass Spectrometry in Patients with Castration-resistant Prostate Cancer, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Arai, Seiji;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Suzuki, Kazuhiro, 2021, EUROPEAN UROLOGY OPEN SCIENCE, 29, 59, 67

  DOI
• Erdafitinib in combination with BCLXL/BCL2 inhibitor induce apoptosis in urothelial carcinoma cells without FGFR mutation., Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Suzuki, Kazuhiro, 2021, CANCER RESEARCH, 81, 13
• Antitumor effect mechanism of statin in PCa cells focusing on autophagy., Miyazawa, Yoshiyuki;Oka, Daisuke;Nakayama, Hiroshi;Sekine, Yoshitaka;Arai, Seiji;Suzuki, Kazuhiro, 2021, CANCER RESEARCH, 81, 13
• Carbon ion radiotherapy for prostate cancer with bladder invasion, Miyasaka, Yuhei;Kawamura, Hidemasa;Sato, Hiro;Kubo, Nobuteru;Mizukami, Tatsuji;Matsui, Hiroshi;Miyazawa, Yoshiyuki;Ito, Kazuto;Nakano, Takashi;Suzuki, Kazuhiro;Ohno, Tatsuya, 2021, BMC UROLOGY, 21, 1

  DOI
• Presepsin as a predictor of septic shock in patients with urinary tract infection, Sekine, Yoshitaka;Kotani, Kazuhiko;Oka, Daisuke;Nakayama, Hiroshi;Miyazawa, Yoshiyuki;Syuto, Takahiro;Arai, Seiji;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Murakami, Masami;Suzuki, Kazuhiro, 2021, BMC UROLOGY, 21, 1

  DOI
• Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer, Sekine, Yoshitaka;Nakayama, Hiroshi;Miyazawa, Yoshiyuki;Arai, Seiji;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2021, ONCOLOGY LETTERS, 22, 6

  DOI
• Protein translation inhibitor homoharringtonine prevents androgen receptor-positive prostate cancer cell growth, Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Suzuki, Kazuhiro, 2022, CANCER SCIENCE, 113, 1731, 1731
• TRANSURETHRAL BALLOON LASER HYPERTHERMIA FOR CHRONIC NON-BACTERIAL PROSTATITIS: A CLINICAL TRIAL, SUZUKI Takanori;KUROKAWA Kohei;SUZUKI Kazuhiro;MATSUMOTO Kazuhisa;YAMANAKA Hidetoshi, Mar. 1995, Int. J. Urol., 2, 1, 29, 32
• Transurethral Balloon Laser Thermotherapy: Effects of a Directionally Shielded Balloon in Canine Prostates, SUZUKI Takanori;KUROKAWA Kohei;SUZUKI Kazuhiro;NAKANO Katsuya;DAIKUZONO Norio;YAMANAKA Hidetoshi, Jan. 1996, Int J Urol, 3, 1, 35, 38
• Clinical Experience of Transurethral Balloon Laser Thermotherapy for the Benign Prostatic Hypertrophy Patients, KUROKAWA Kohei;SUZUKI Takanori;SUZUKI Kazuhiro;MATSUMOTO Kazuhisa;HASHIMOTO Katsuyoshi;ONO Yoshihiro;KUBOTA Yutaka;SAITO Yoshitaka;YAMANAKA Hidetoshi, Jun. 1995, 16, 2, 19, 24
• Application of YAG Laser to Prostaic Diseses : Basic Reserch and Clinical Experience-, KUROKAWA Kohei;SUZUKI Takanori;SUZUKI Kazuhiro;HIGASHI Hiroomi;YAMANAKA Hidetoshi, Mar. 1998, 19, 1, 19, 27
• Tumor-associated tissue eosinophilia of penile cancer, ONO Yoshihiro;OZAWA Masashi;TAMURA Yoshimi;SUZUKI Takanori;SUZUKI Kazuhiro;KUROKAWA Kohei;FUKABORI Yoshitatsu;YAMANAKA Hidetoshi, Feb. 2002, 9, 2, 82, 87
• Androgen dependency and independency of prostate cancer, SUZUKI Kazuhiro;YAMANAKA Hidetoshi, Jan. 2002, 50, 1, 83, 87
• THERMAL DAMAGE TO NORMAL AND HYPERPLASTIC PROSTATES DUE TO TRANSURETHRAL BALLOON LASER THERAPY IN DOGS, SUZUKI Takanori;KUROKAWA Kohei;SUZUKI Kazuhiro;IMAI Kyoichi;YAMANAKA Hidetoshi, Jun. 1994, Int J Urol, 1, 2, 162, 166
• METALLOTHIONEIN IN HUMAN SEMINAL PLASMA, SUZUKI Takanori;SUZUKI Kazuhiro;NAKAJIMA Katsuyuki;OTAKI Noriko;YAMANAKA Hidetoshi, Dec. 1994, Int. J. Urol., 1, 4, 345, 348
• Surgical procedures for chronic dialysis patients at Gunma University Hospital, HATORI Motoaki;HAYASHI Masamichi;SHIONO Akihiko;HASUMI Masaru;TAKEI Tomoyuki;MATSUI Hiroshi;KAWAGUCHI Takuya;ITO Kazuto;SUZUKI Kazuhiro;KUROKAWA Kohei;FUKABORI Yoshitatsu;YAMANAKA Hidetoshi, Oct. 2002, 35, 11, 1447, 1451
• Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population, SUZUKI Kazuhiro;MATSUI Hiroshi;OHTAKE Nobuaki;NAKATA Seiji;TAKEI Tomoyuki;KOIKE Hidekazu;NAKAZATO Haruki;OKUGI Hironobu;HASUMI Masaru;FUKABORI Yoshitatsu;KUROKAWA Kohei;YAMANAKA Hidetoshi, May 2003, 10, 5, 261, 266
• Transurethral Balloon Laser Thermotherapy for Benign Prostatic Hyperplasia, SUZUKI TAKANORI;KUROKAWA KOHEI;SUZUKI KAZUHIRO;HIGASHI HIROOMI;YAMANAKA HIDETOSHI, Oct. 1996, 9, 2, 158, 160
• Ultrastructural Changes in Subepithelial Capillaries and Their Surrounding Stroma in Rat Prostate and Seminal Vesicle after Castration, ONO YOSHIHIRO;SUZUKI KAZUHIRO;YUASA HISAKO;KUROKAWA KOHEI;FUKABORI YOSHITATSU;YAMANAKA HIDETOSHI, Sep. 2003, Tohokn J. Exp. Med., 201, 1, 29, 38
• Genomewide linkage analysis of familial prostate cancer in the Japanese population, MATSUI Hiroshi;SUZUKI Kazuhiro;OHTAKE Nobuaki;NAKATA Seiji;TAKEUCHI Toshiyuki;YAMANAKA Hidetoshi;INOUE Ituro, Jan. 2004, Journal of Human Genetics, 49, 1, 9, 15
• Hands-free hook for endourological procedures, ONO YOSHIHIRO;SUZUKI KAZUHIRO, Oct. 2003, 10, 10, 561, 562
• Role of Androgen on Blood Flow and Capillary Structure in Rat Seminal Vesicles, ONO YOSHIHIRO;SUZUKI KAZUHIRO;KASHIWAGI BUNZO;SHIBATA YASUHIRO;ITO KAZUTO;FUKABORI YOSHITATSU;YAMANAKA HIDETOSHI, Mar. 2004, The Tohoku Journal of Experimental Medicine, 202, 3, 193, 201

  DOI
• A case of hemophilia B complicated with chronic renal failure and renal pelvic tumor., Magari Tomohiro;Hatori Motoaki;Ono Yoshihiro;Shiono Akihiko;Shimizu Nobuaki;Kurokawa Kohei;Fukabori Yoshitatsu;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2003, Nihon Toseki Igakkai Zasshi, 36, 12, 1731, 1736

  DOI
• A simple and reliable monitoring system to confirm the preservation of the cavernous nerves, KUROKAWA KOHEI;SUZUKI TAKANORI;SUZUKI KAZUHIRO;ITO KAZUTO;SHIMIZU NOBUAKI;FUKABORI YOSHITATSU;YAMANAKA HIDETOSHI, May 2001, Int J Urol, 8, 5, 231, 236
• Malignant fibrous histiocytoma of the right spermatic cord : A case report, SEKINE YOSHITAKA;OHKI KAZUNARI;OKAMOTO KOHEI;NOMURA MASASHI;TOMITA HIKARU;OHTAKE NOBUAKI;SUZUKI KAZUHIRO;KUROKAWA KOHEI;MASHIMO MASAMICHI;SARUKI KAZUHISA;MORITA TAKAHIRO;NAKAZATO HARUKI;YOKOO HIDEAKI;YAMANAKA HIDETOSHI, Oct. 2001, 8, 10, 581, 584
• Successful maintenance hemodialysis treatment for a patient with hemophilia A and chronic renal failure, KOIKE Hidekazu;HATORI Motoaki;NITTA Takashi;KASHIWAGI Bunzou;SUZUKI Kazuhiro;YAMANAKA Hidetoshi;UTSUMI Hideki;NOJIMA Yoshihisa, Jan. 2004, 37, 1, 91, 94
• Incidence of Bladder Cancer Discovered by Urethrocystoscopy at Prostate Biopsy : Extraordinary High Incidence of Tiny Bladder Cancer in Elderly Males, OKAZAKI HIROSHI;SUZUKI KOICHI;SUZUKI TAKANORI;KUROKAWA KOHEI;ITO KAZUTO;SUZUKI KAZUHIRO;YAMANAKA HIDETOSHI, May 2004, Tohoku J. Exp. Med., 203, 1, 31, 36
• Scrotal and penile edema developed in a CAPD patient for 5 years, UEI Takatoshi;MAGARI Tomohiro;KAWAGUCHI Takuya;HATORI Motoaki;SUZUKI Kazuhiro;YAMANAKA Hidetoshi, Mar. 2004, 37, 3, 249, 252
• A case with combined multiple retina thrombosis probably due to heparin-induced thrombocytopenia (HIT), MAGARI Tomohiro;HATORI Motoaki;HASUMI Masaru;TANAKA Toshiyuki;MATSUI Hiroshi;MORITA Takahiro;ONO Yoshihiro;SUZUKI Kazuhiro;YAMANAKA Hidetoshi, Jun. 2004, 37, 6, 1437, 1442
• 前立腺肥大症とエストロゲン, ;;, Apr. 1997, 73, 2
• Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer, MIYAMOTO SHIGEHITO;ITO KAZUTO;KUROKAWA KOHEI;SUZUKI KAZUHIRO;SUZUKI KEIJI;YAMANAKA HIDETOSHI, Jun. 2006, 13, 6, 767, 772
• A pediatric case of kidney transplantation in Bartter's syndrome with end-stage renal failure, Sekine Yoshitaka;Hatori Motoaki;Takei Tomoyuki;Kashiwagi Bunzo;Magari Tomohiro;Fukuma Yuji;Nishii Masahiro;Hamano Tatsuya;Yamamoto Takumi;Shibata Yasuhiro;Ito Kazuto;Kurokawa Kohei;Machida Masami;Hayashi Masamichi;Suzuki Kazuhiro, 2007, Nihon Toseki Igakkai Zasshi, 40, 7, 623, 627

  DOI
• The Second Joint Meeting of American Urological Association (AUA)/Japanese Urological Association (JUA) International Program on the 102nd Annual Meeting of American Urological Association at Anaheim 2007, OGAN Kenneth;KAWAI Koji;GILL Inderbir Singh;NAITO Seiji;ISAACS Williams B;SUZUKI Kazuhiro;KIBEL Adam S;KAKEHI Yoshiyuki;YOSHIMURA Naoki;YOKOYAMA Osamu;CHANCELLOR Michael B;TAKAHASHI Satoru, Dec. 2007, 14, 12, 1116, 1123
• The Follow-up Investigations on Men Who Underwent PSA Test in Takasaki Health Maintenance Center, Kurosawa Hospital, Takasaki Between 2002 and 2004, KUMASAKA Fuminari;KONO Mai;UEI Takatoshi;OGURA Haruyuki;KUROSAWA Isao;SHIMADA Kazuko;MATSUMOTO Fusae;ISHII Hidekazu;KASE Yoshiaki;YAMANAKA Hidetoshi;ITO Kazuto;SUZUKI Kazuhiro, Jun. 2005, Official Journal of Japan Society of Ningen Dock, 20, 1, 11, 14

  DOI
• Histological and Immunohistochemical Changes after Transurethral Balloon Laser Hyperthermia in the Canine Prostate, SUZUKI TAKANORI;KUROKAWA KOHEI;SUZUKI KAZUHIRO;MATSUMOTO KAZUHISA;YAMANAKA HIDETOSHI, Sep. 1995, Tohoku J. Exp. Med., 177, 1, 39, 48
• Expression and Degradation of Rat Androgen Receptor Following Castration, Testosterone Replacement and Antiandrogens Administration : Analysis by Western Blot and Immunohistochemistry, SUZUKI KAZUHIRO;ITO KAZUTO;KUROKAWA KOHEI;SUZUKI TAKANORI;SHIMIZU NOBUAKI;FUKABORI YOSHITATSU;HONMA SEIJIRO;YAMANAKA HIDETOSHI, Nov. 1997, The Tohoku Journal of Experimental Medicine, 183, 3, 159, 172

  DOI
• Proprostate-specific antigen : Its usefulness in the era of multiple-core prostate biopsy, MIYAKUBO Mai;ITO Kazuto;YAMAMOTO Takumi;TAKECHI Hiroyuki;OHI Masaru;SUZUKI Kazuhiro, Jun. 2009, 16, 6, 561, 565
• Treatment and its indication of prostate cancer, SUZUKI Kazuhiro, Dec. 2005, 22, 4, 206, 216
• Outline of "Clinical Guidelines for Prostate Cancer - 2006 Edition", SUZUKI Kazuhiro, Mar. 2009, Official Journal of Japan Society of Ningen Dock, 23, 5, 1005, 1020

  DOI
• 生体腎移植後に海馬硬化をきたし内側側頭葉てんかんを発症した1例, ;;;;;;;, Aug. 2004, 24, 241, 243
• Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010, ITO Kazuto;NAITO Seiji;KAKEHI Yoshiyuki;OKUYAMA Akihiko;IMAMURA Tomoaki;YASUNAGA Hideo;AKAZA Hideyuki;HINOTSU Shiro;ARAI Yoichi;DOKIYA Takushi;EGAWA Shin;SUZUKI Kazuhiro;KOGA Hirofumi;MASUMORI Naoya;AKAKURA Koichiro;KAWASHIMA Kiyotaka;OKIHARA Koji, Oct. 2010, Int. J. Urol., 17, 10, 830, 838
• High-Density Lipoprotein and Prostate Cancer: An Overview, Kotani Kazuhiko;Sekine Yoshitaka;Ishikawa Shizukiyo;Ikpot Imoh Z.;Suzuki Kazuhiro;Remaley Alan T., 2013, Journal of Epidemiology, 23, 5, 313, 319

  DOI
• Intermittent Deep Coma in a Hemodialysis Patient with Liver Cirrhosis: A Case Report., Matsumoto Kazuhisa;Hayashi Masamichi;Kosaku Nozomu;Ono Yoshihiro;Yamamoto Takumi;Hatori Motoaki;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2003, The Kitakanto Medical Journal, 53, 1, 55, 57

  DOI
• 5. 生体腎移植後に内側側頭葉てんかんを発症した1例, ;;;;;;;, Feb. 2003, The KITAKANTO medical journal, 53, 1, 80
• 7. FTY720による抗腫瘍効果, ;;;;;;;;;;, Feb. 2003, The KITAKANTO medical journal, 53, 1, 80, 81
• 1. 巨大腎血管筋脂肪腫の破裂により腎摘出術を行った2例(臨床症例1)(第33回日本泌尿器科学会群馬地方会演題抄録), ;;;;;;;, Nov. 2003, The KITAKANTO medical journal, 53, 4, 423
• 11. 急性陰嚢症にて発症した急性リンパ性白血病精巣浸潤の1例(臨床症例2)(第33回日本泌尿器科学会群馬地方会演題抄録), ;;;;;;;;;;, Nov. 2003, The KITAKANTO medical journal, 53, 4, 425
• 13. 古作クリニックにおける前立腺針生検の現状(臨床的研究)(第33回日本泌尿器科学会群馬地方会演題抄録), ;;;;;;;;;;;, Nov. 2003, The KITAKANTO medical journal, 53, 4, 426
• Effects of Aspirin-dialminate on Suppression in the Serum Phosphorus Levels in Patients Treated with Hemodialysis, Ito Kazuto;Kosaku Nozomu;Ono Yoshihiro;Hatori Motoaki;Suzuki Kazuhiro;Fukabori Yoshitatsu;Yamanaka Hidetoshi;Hamano Tatsuya;Matsumoto Kazuhisa;Hayashi Masamichi, 2004, The Kitakanto Medical Journal, 54, 1, 5, 8

  DOI
• 3.石灰化と骨形成を伴った腎細胞癌の1例(臨床症例1)(第34回日本泌尿器科学会群馬地方会演題抄録), ;;;;;, Feb. 2004, The KITAKANTO medical journal, 54, 1, 41
• 12.多系統萎縮症(MSA)における排尿機能の臨床的検討(臨床的研究2)(第34回日本泌尿器科学会群馬地方会演題抄録), ;;;;, Feb. 2004, The KITAKANTO medical journal, 54, 1, 43
• (The 51th Annual Meeting of the Kitakanto Medical Society), 鈴木 和浩, Aug. 2004, The KITAKANTO medical journal, 54, 3
• 3.神経刺激を利用した神経温存後腹膜リンパ節郭清術の経験, ;;;;;;;;, May 2003, The KITAKANTO medical journal, 53, 2, 217
• 7.尿路内視鏡操作用ハンズフリーフック : 小さな工夫, ;;;, May 2003, The KITAKANTO medical journal, 53, 2, 218
• 9.前立腺集団検診受診者における国際前立腺症状スコアー (I・PSS) およびQOL Indexの傾向について, ;;;;;;;;;, May 2003, The KITAKANTO medical journal, 53, 2
• 15.前立腺癌に対する外照射併用高線量率組織内照射法の短期効果と急性反応, ;;;;;;;;;, May 2003, The KITAKANTO medical journal, 53, 2, 234
• Intraarterial Infusion of Lipiodol CDDP Suspension into the Internal Iliac Artery-Pre Clinical Dose Escalation Study Using Canine Model-:Pre Clinical Dose Escalation Study Using Canine Model, Okazaki Hiroshi;Kurokawa Kohei;Suzuki Kazuhiro;Matsumura Yuka;Honda Shigeru;Horiuchi Ryuya;Yamanaka Hidetoshi, 2003, The Kitakanto Medical Journal, 53, 3, 275, 279

  DOI
• Transurethral En Bloc Resection of an Urachal Cyst, Etsunaga Toru;Ono Yoshihiro;Koya Tomoko;Shimizu Nobuaki;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2003, The Kitakanto Medical Journal, 53, 3, 323, 324

  DOI
• 1.腎移植術直後に無尿となった1例(一般演題I)(第21回群馬移植研究会学術講演会), ;;;;;;;;, Aug. 2003, The KITAKANTO medical journal, 53, 3, 331
• 2.小児精巣腫瘍の臨床的検討(第5回群馬小児がん研究会), ;;;;, Aug. 2003, The KITAKANTO medical journal, 53, 3, 347
• The 6th Joint Meeting of Gunma and Tochigi Urological Association, ;;;;;;;;, Nov. 2004, The KITAKANTO medical journal, 54, 4
• ACUTE SCROTUM FROM TESTICULAR INVOLVEMENT IN ACUTE LYMPHOCYTIC LEUKEMIA, Nitta Takashi;Koike Hidekazu;Fukabori Yoshitatsu;Hatori Motoaki;Ono Yoshitaka;Matsui Hiroshi;Suzuki Kazuhiro;Yamanaka Hidetoshi;Shigawa Youko;Kanazawa Takashi;Ogawa Chitose, 2004, The Japanese Journal of Urology, 95, 5, 722, 724

  DOI
• アンチアンドロジェンおよび去勢によるアンドロジェンレセプター蛋白の調節 : ウェスタンブロットによる検討, ;;;;;, 1995, The Japanese Journal of Urology, 86, 3, 428

  DOI
• 去勢ラット前立腺におけるandrogenとestrogenの協調作用 : 第3報 : Estrogen receptor (ER) type I,type IIの役割, ;;;, 1995, The Japanese Journal of Urology, 86, 3

  DOI
• 遮閉レーザーバルーンによる前立腺切除の基礎的検討, ;;;;;;, 1995, The Japanese Journal of Urology, 86, 3, 714

  DOI
• 術中神経血管束電気刺激による陰茎海綿体内圧の変化 : 根治的前立腺全摘除術および膀胱全摘術における検討, ;;;;;;, 2000, The Japanese Journal of Urology, 91, 3, 264

  DOI
• LH-RHアナログによるホルモン療法を主体とした前立腺癌臨床病期C症例の長期経過観察, ;;;;;, 2000, The Japanese Journal of Urology, 91, 3, 272

  DOI
• わが国における家族性前立腺癌について : 第3報, ;;;;;;;;;;;;, 2000, The Japanese Journal of Urology, 91, 3

  DOI
• 前立腺特異抗原値(PSA)が4.1-6.0ng/mlにおける生検陽性率に関係する因子 の臨床的検討, ;;;;;;;, 2000, The Japanese Journal of Urology, 91, 3

  DOI
• ホルモン療法を主体とした臨床病期Bの前立腺癌における治療前予後因子・再発因子に関する検討, ;;;;;, 2000, The Japanese Journal of Urology, 91, 3, 348

  DOI
• 前立腺アポトーシスとホルモン : 第2報 : 去勢後のアポトーシス関連因子の変化とアンドロゲン補充の影響, ;;;;;;, 2000, The Japanese Journal of Urology, 91, 3

  DOI
• 前立腺集団検診における経直腸的超音波検査像に関する検討, ;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 133

  DOI
• 前立腺集団検診受診者における国際前立腺症状スコアー(I-PSS)の傾向およびQOL indexについて, ;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 134

  DOI
• 腎盂尿管癌、膀胱癌の経過観察における高速CTの利点について, ;;;;, 2003, The Japanese Journal of Urology, 94, 2, 162

  DOI
• 家族性前立腺癌におけるhigh-and low-penetrance遺伝子の検討, ;;;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2

  DOI
• 上下腹神経(SHP)あるいは腰内蔵神経の電気刺激は陰茎海綿体内圧(ICP)を上昇させかつ陰茎を萎縮させる。, ;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 177

  DOI
• 腎移植患者の腎機能、QOLに対する貧血管理の関与, ;;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2

  DOI
• 利根中央病院に於ける前立腺癌の臨床的検討, ;;;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2

  DOI
• 精巣胚細胞腫瘍の臨床的検討, ;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 234

  DOI
• 精嚢の血流調節機構とホルモン(第1報) : 去勢およびホルモン補充による精嚢の血流について, ;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2

  DOI
• ICUにおける血清シスタチンCによる腎機能の評価, ;;;, 2003, The Japanese Journal of Urology, 94, 2, 257

  DOI
• わが国における家族性前立腺癌について : 第6報, ;;;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2

  DOI
• 海綿体神経電気刺激時の至適条件の設定 : 雑種犬を用いた検討, ;;;;;, 2003, The Japanese Journal of Urology, 94, 2

  DOI
• 犬内腸骨動脈に対するLipiodol-CDDP-Suspensionの動注実験, ;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2

  DOI
• ヒト前立腺癌細胞における亜鉛代謝に関する基礎的研究 : 第2報, ;;;;;;;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 380

  DOI
• 前立腺の血流調節機構とホルモン(第3報) : Nitric oxide(NO)とvascular endothelial growth factor(VEGF)の関与, ;;;;;;, 2003, The Japanese Journal of Urology, 94, 2, 400

  DOI
• CP11-3 前立腺癌検診の今後の展望(総合企画11「予防医学から見た泌尿器科」), ;;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• S4-5 前立腺癌のスクリーニング(4. 泌尿器癌 : 透析患者における診断と治療), ;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• APP-047 前立腺の血流調節機構とホルモン(第4報) : 前立腺血管内皮細胞の分離培養およびアンドロゲンへの反応(総会賞応募(ポスター)), ;;;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• APP-063 本邦の家族性前立腺癌における全ゲノム罹患同胞対連鎖解析(総会賞応募(ポスター)), ;;;;;;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• APP-069 PSAの基礎値が2.0ng/mlの症例における、将来のPSAの変化と前立腺癌の罹患予測(総会賞応募(ポスター)), ;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• APP-071 PSA検診において発見された前立腺癌のリードタイム(総会賞応募(ポスター)), ;;;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• APP-081 わが国における家族性前立腺癌について : 第7報(総会賞応募(ポスター)), ;;;;;;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• APP-104 精嚢の血流調整機構とホルモン(第3報) : 精嚢血流調節に関与するアンドロゲンの同定とシグナル伝達におけるVEGFの関与(総会賞応募(ポスター)), ;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• OP2-001 神経内科受診前に泌尿器科受診歴のある神経疾患症例の検討(一般演題(口演)), ;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• PP3-088 家族性前立腺癌におけるIGFBP-3プロモーター領域の遺伝子多型(一般演題(ポスター)), ;;;;;;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• PP3-089 家族性前立腺癌におけるHER-2 Ile655Val遺伝子多型(一般演題(ポスター)), ;;;;;;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• PP4-082 前立腺癌治療効果判定におけるMRSの有用性に関する臨床的検討(一般演題(ポスター)), ;;;;;;;;;;;, 2004, The Japanese Journal of Urology, 95, 2

  DOI
• INTERSTITIAL TEMPERATURE MEASUREMENT DURING BALLOON LASERTHERAPY (PROSTALASE™) OF THE CANINE PROSTATE, Kurokawa Kohei;Suzuki Takanori;Suzuki Kazuhiro;Yamanaka Hidetoshi, 1994, The Japanese Journal of Urology, 85, 8, 1243, 1247

  DOI
• AN ANALYSIS OF FAMILIAL PROSTATE CANCER, NAKATA Seiji;MASUDA Hiroshi;SATO Jin;SHIMIZU Nobuaki;SUZUKI Kazuhiro;IMAI Kyoichi;YAMANAKA Hidetoshi;SAITO Koki;NAKAMURA Toshiyuki;KATO Nobuo;TAKAHASHI Osamu;YAJIMA Hisanori;UMEYAMA Tomokazu;SHINOZAKI Tadatoshi;OHTAKE Obuaki;SEKIHARA Tetsuo;SARUKI Kazuhisa;SUZUKI Keiji, Sep. 1995, The Japanese Journal of Urology, 86, 9, 1483, 1487

  DOI
• SUPPRESSIVE EFFECTS OF THE ANTIANDROGEN FLUTAMIDE ON ADRENAL ANDROGENS IN ADVANCED PROSTATE CANCER PATIENTS, Nakazato Haruki;Suzuki Kazuhiro;Ito Kazuto;Fukabori Yoshitatu;Kurokawa Kohei;Yamanaka Hidetoshi, 2001, The Japanese Journal of Urology, 92, 1, 6, 12

  DOI
• ENDOCRINE ENVIRONMENT OF BENIGN PROSTATIC HYPERPLASIA:Relationships of Sex Steroid Hormone Levels with Age and the Size of the Prostate, Suzuki Kazuhiro;Inaba Shigeki;Takeuchi Hiroyuki;Takezawa Yutaka;Fukabori Yoshitatsu;Suzuki Takanori;Imai Kyoichi;Yamanaka Hidetoshi;Honma Seijiro, 1992, The Japanese Journal of Urology, 83, 5, 664, 671

  DOI
• ホルモン不応前立腺癌に対するFosfestrol投与の検討, ;;;;;;;, 1996, The Japanese Journal of Urology, 87, 2, 291

  DOI
• 免疫組織化学によるラット前立腺アンドロジェンレセプターの検討, ;;;;, 1996, The Japanese Journal of Urology, 87, 2, 579

  DOI
• 前立腺体積の変化と近位尿道コンプライアンスの関係, ;;;;;, 1996, The Japanese Journal of Urology, 87, 2, 580

  DOI
• Transurethral balloon laser enhanced thermotherapy(TUBAL-ET)の基礎的検討, ;;;;;;, 1996, The Japanese Journal of Urology, 87, 2, 601

  DOI
• 仮性動脈瘤を形成し動静脈シャントを併発した腎血管筋脂肪腫の一例, ;;;;;;;;;;, 1996, The Japanese Journal of Urology, 87, 2, 625

  DOI
• 前立腺肥大症に対する酢酸クロルマジノン長期投与の検討, ;;;;;;;, 1997, The Japanese Journal of Urology, 88, 2, 188

  DOI
• 前立腺肥大症におけるEstrogenの役割(第4報) : 実験的・自然発症イヌBPHにおけるアロマターゼ阻害剤の効果, ;;;;;;;;, 1997, The Japanese Journal of Urology, 88, 2

  DOI
• 選択的深陰茎動脈閉塞術により改善したHigh flow priapismの一例, ;;;;;;;;, 1997, The Japanese Journal of Urology, 88, 2, 334

  DOI
• 前立腺癌ホルモン療法中の PSA 倍加時間, ;;;;;;;;;, 1998, The Japanese Journal of Urology, 89, 2, 144

  DOI
• 精巣腫瘍58例の臨床的検討 : 第86回日本泌尿器科学会総会, ;;;;;;;, 1998, The Japanese Journal of Urology, 89, 2, 362

  DOI
• PSA 2.1-4.0ng/mlの前立腺生検適応におけるPSA density(PSAD)の有用性, ;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 169

  DOI
• 前立腺癌におけるMR Spectoroscopyの有用性に関する臨床的検討, ;;;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 173

  DOI
• 浸潤性膀胱腫瘍に対するする超選択的動注化学療法及び塞栓術の試み, ;;;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 259

  DOI
• PSA 4〜10ng/mlにおけるPSA velocity(PSAV)の使用法・問題点, ;;;;;;, 2001, The Japanese Journal of Urology, 92, 2

  DOI
• わが国における家族性前立腺癌について : 第4報, ;;;;;;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2

  DOI
• 前立腺癌臨床病期D症例の長期経過観察, ;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 282

  DOI
• 勃起神経温存を神経電気刺激にて確認した症例の中期成績, ;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2

  DOI
• 進行性胚細胞腫瘍における大量化学療法の臨床的検討, ;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2

  DOI
• 電顕的定量的評価によると幼弱例より成熟例において去勢によるラット前立腺微細毛細血管の縮小変化が著明である, ;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 320

  DOI
• DNA microarrayによる前立腺癌細胞のexpression profileの検討, ;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 368

  DOI
• 分泌型IL-15遺伝子導入によるimmunogene-therapy : ヒト前立腺癌細胞株PC-3移植ヌードマウスモデルによる検討, ;;;;, 2001, The Japanese Journal of Urology, 92, 2, 369

  DOI
• 未治療前立腺癌症例に対するLH-RH agonist投与時のflare up予防効果;diethylstilbestrol diphosphate,Estracyt,chlotmadinone acetateによる比較検討, ;;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 390

  DOI
• 左水腎症を呈した馬蹄腎に対する峡部離断術および腎固定術, ;;;;;;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2, 434

  DOI
• 腹腔鏡下前立腺全摘術における神経温存 : 術中電気刺激による陰茎海綿体神経の同定, ;;;;;;;, 2001, The Japanese Journal of Urology, 92, 2

  DOI
• 再燃前立腺癌に対する免疫療法・細胞療法, ;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 機能的解剖を応用した勃起神経同定における簡便な陰茎内圧変化の測定 : 尿道内バルン・カテーテルによる圧導出, ;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 腎移植後高脂血症に対するフェノフィブラートの有効性と安全性の検討, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• PSA4.0ng/ml以下の症例におけるDRE(直腸診)・TRUS(経直腸的超音波検査)の有用性, ;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 217

  DOI
• 抗アンドロゲン剤およびα遮断剤のラット前立腺血流に対する作用, ;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 機能的解剖を応用した骨盤神経膀胱枝温存の評価 : 予報, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 246

  DOI
• 男性維持透析患者における血清PSAによる前立腺癌スクリーニング, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 男性維持透析患者の血清PSA測定による前立腺癌スクリーニング : 初診時PSA4.0ng/ml以下症例のPSA値の変動について, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 前立腺癌におけるゲノタイプ : アンドロゲンレセプターおよびPSAプロモーターの遺伝子多型, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 前立腺癌におけるゲノタイプ : Vitamine D レセプターの遺伝子多型, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 前立腺癌におけるゲノタイプ : Glutathione-S transferase 遺伝子多型, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 前立腺癌におけるゲノタイプ : 5αreductase type II,CYP-17およびUDP-グルクロノシルウリジルトランスフェラーゼの遺伝子多型, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 腎腫瘍に対する自己血輸血, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 膀胱腫瘍外来におけるPSAスクリーニング, ;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 324

  DOI
• 浸潤性膀胱癌に対する超選択的動注化学療法十塞栓術の短期的効果, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 326

  DOI
• Diethylstilbestrol diphosphateによるヒト前立腺癌細胞の遺伝子発現プロフィールの変化, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 330

  DOI
• 前立腺全摘除術(開放式)に対する自己血輸血, ;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• わが国における家族性前立腺癌について : 第5報, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 前立腺肥大症組織における遺伝子発現プロフィール, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 347

  DOI
• 前立腺の血流調節機構とホルモン(第2報) : アンドロゲンとエストロゲンの協調作用, ;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• 精巣腫瘍治療後の不妊症に対する精巣内精子採取術(TESE)の経験, ;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 352

  DOI
• FTY720による癌進行抑制効果, ;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2

  DOI
• ヒト前立腺癌細胞における亜鉛代謝に関する基礎的研究 : 第1報, ;;;;;;;;;;;;, 2002, The Japanese Journal of Urology, 93, 2, 383

  DOI
• レーザーキャプチャーマイクロダイセクションと核酸の解析, ;;, Jul. 2002, 2002, 127, 135
• 超音波凝固切開装置を用いた鏡視下無阻血腎部分切除術(第93回日本泌尿器科学会総会), ;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• 膀胱癌治療後経過観察中に見いだされた小肺病変に対する積極的治療(第93回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• 尿管の神経支配について(第93回日本泌尿器科学会総会), ;;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• 市町村の前立腺がん検診受診率隔差による発見癌症例の臨床的特徴への影響(第93回日本泌尿器科学会総会), ;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• 年齢・前立腺体積に応じた多数カ所生検法で発見された前立腺癌の前立腺領域別分布(第93回日本泌尿器科学会総会), ;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• 前立腺の血流調節機構とホルモン (第6報) : 前立腺血流調節における adrenomedullin の関与(第93回日本泌尿器科学会総会), ;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• PSA検診導入後10年間で検診発見前立腺癌症例の臨床病理学的特徴に変化がおこったか?(第93回日本泌尿器科学会総会), ;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• 前立腺癌検診における年齢階層別PSA基準値導入の成果(第93回日本泌尿器科学会総会), ;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• わが国における家族性前立腺癌について : 第8報(第93回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• 前立腺癌におけるIGFBP-3プロモーター領域の Hypermethylation に関する検討(第93回日本泌尿器科学会総会), ;;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• 前立腺の血流調節機構とホルモン (第5報) : 前立腺血流調節のシグナル伝達における Prostaglandin の関与(第93回日本泌尿器科学会総会), ;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• 内分泌間歇療法におけるQOL : 局所進行前立腺がんに対する内分泌放射線併用療法に対する無作為化比較試験における検討(第93回日本泌尿器科学会総会), ;;;;;;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• パーキンソン病における排尿障害の検討 : 多系統萎縮症との比較(第93回日本泌尿器科学会総会), ;;;, 2005, The Japanese Journal of Urology, 96, 2

  DOI
• 10. 平成16年度群馬県前立腺がん検診の結果と今後の取り組み（第40回日本泌尿器科学会群馬地方会演題抄録）, ;;;;;;;, Feb. 2006, The Kitakanto medical journal, 56, 1, 47, 47
• Nonmyeloablative Allogenic Peripheral Blood Stem Cell Transplantation for Lung Metastases of Renal Cell Carcinoma, Doki Noriko;Matsushima Takafumi;Saito Yasuyuki;Yokohama Akihiko;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu;Suzuki Kazuhiro;Nojima Yoshihisa, 2006, The Kitakanto Medical Journal, 56, 3, 231, 235

  DOI
• W1-1 家族性前立腺癌の遺伝子解析(ワークショップ1「前立腺癌の発症・進行の規定因子-遺伝子から生活・環境因子まで-」,第94回日本泌尿器科学会総会), ;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• PD:座長のことば(パネルディスカッション「日本における前立腺癌検診の現状と展望」,第94回日本泌尿器科学会総会), ;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• AVP-012 経会陰的前立腺多部位生検 : 特に標本作成上の工夫について(総会賞応募ビデオ,第94回日本泌尿器科学会総会), ;;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• OP-094 年齢・前立腺体積に応じた前立腺多数カ所生検法の有用性(一般演題口演,第94回日本泌尿器科学会総会), ;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• OP-178 前立腺がん検診研究班対照研究 : 群馬県伊勢崎市における3年間の検診結果(一般演題口演,第94回日本泌尿器科学会総会), ;;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• OP-180 前立腺癌スクリーニングにおける年齢階層別PSA基準値の有用性(一般演題口演,第94回日本泌尿器科学会総会), ;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• OP-269 神経内科的診断確定前に泌尿器科受診歴のある神経疾患症例の検討(一般演題口演,第94回日本泌尿器科学会総会), ;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• OP-283 前立腺癌に対するIr-192を用いた高線量率(HDR) brachytherapyの治療成績(一般演題口演,第94回日本泌尿器科学会総会), ;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• MP-187 腎移植後リンパ嚢胞治療に難渋した1例(一般演題ポスター,第94回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• MP-316 前立腺全摘除術の手術成績(一般演題ポスター,第94回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• MP-396 前立腺がん検診受診者における年齢別PSA値別Positive Predictive Value (PPV)の検討(一般演題ポスター,第94回日本泌尿器科学会総会), ;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• MP-437 わが国における家族性前立腺癌について : 第9報(一般演題ポスター,第94回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• MP-457 当院での前立腺癌密封小線源永久挿入治療の初期経験(一般演題ポスター,第94回日本泌尿器科学会総会), ;;;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• MP-468 Sequential MAB療法の治療経験(一般演題ポスター,第94回日本泌尿器科学会総会), ;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• MP-500 レムナントリポ蛋白による前立腺癌細胞増殖効果の検討(一般演題ポスター,第94回日本泌尿器科学会総会), ;;;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• MP-506 前立腺癌におけるsurvivinの発現とsiRNA導入による抗腫瘍効果(一般演題ポスター,第94回日本泌尿器科学会総会), ;;;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• MP-540 前立腺血流調節機構におけるProstaglandin E2とVascular Endothelial Growth Factorの役割についての検討 : 前立腺血流調節におけるシグナル伝達経路の解明(一般演題ポスター,第94回日本泌尿器科学会総会), ;;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• MP-542 実験的ラット前立腺肥大モデルにおけるphellinus linteus抽出物の影響(一般演題ポスター,第94回日本泌尿器科学会総会), ;;;, 2006, The Japanese Journal of Urology, 97, 2

  DOI
• Examination of Cadaveric Renal Transplantation at Gunma University Hospital during 20-year Period, Hatori Motoaki;Hayashi Masamichi;Machida Masami;Sekihara Tetsuo;Matsuo Yasuharu;Hasumi Masaru;Tanaka Toshiyuki;Sekine Yositake;Arai Seiji;Nakazato Haruki;Shibata Yasuhiro;Yamamoto Takumi;Magari Tomohiro;Koike Hidekazu;Ito Kazuto;Kawaguchi Takuya;Kato Yuichi;Yamanaka Hidetoshi;Suzuki Kazuhiro, 2007, The Kitakanto Medical Journal, 57, 2, 165, 168

  DOI
• 1. 頻尿を主訴とした成人女性の傍尿道嚢腫の1例（第45回日本泌尿器科学会群馬地方会演題抄録）, ;;;;;;;;;;;;;;, May 2007, The Kitakanto medical journal, 57, 2, 201, 201
• PROSTATE CANCER SCREENING AT TATEBAYASHI CITY IN GUNMA PREFECTURE : RESULTS OF SCREENING WITH PSA ALONE BETWEEN 2003 AND 2005, NAKAMURA Toshiyuki;ETSUNAGA Toru;SASAKI Yasushi;NITTA Takashi;OKUGI Yasunobu;OKAZAKI Hiroshi;KATOU Nobuo;YAMAMOTO Takumi;SUZUKI Kazuhiro, May 2007, The Japanese Journal of Urology, 98, 4, 619, 628

  DOI
• SS8 座長のことば(前立腺再燃癌の機序, 第95回日本泌尿器科学会総会), ;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• SS8-4 骨転移の一機序と治療戦略(前立腺再燃癌の機序, 第95回日本泌尿器科学会総会), ;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• WS2-2 前立腺癌に対する放射線外照射療法 (斜入4門照射) の有害事象 : 直腸出血を中心に(限局性前立腺癌に対する非観血的治療-各治療の有害事象とQOLへの影響を中心に, 第95回日本泌尿器科学会総会), ;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• APP-034 アンドロゲン測定による前立腺癌検査法の開発 (第2報) : LC-MS/MSによる前立腺癌および肥大症の前立腺組織中アンドロゲン濃度分布 (予備的検討)(第95回日本泌尿器科学会総会), ;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• OP-027 前立腺多数カ所生検における経直腸的超音波検査 (TRUS) 所見の意義(第95回日本泌尿器科学会総会), ;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• OP-028 前立腺癌スクリーニングにおける年齢階層別PSA基準値の有用性(第95回日本泌尿器科学会総会), ;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• OP-304 局所進行前立腺癌に対する内分泌・待機放射線療法の長期治療成績(第95回日本泌尿器科学会総会), ;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• OP-358 群馬大学医学部附属病院における間歇式バルーン使用症例の臨床的検討 : CIC導入早期の使用症例を中心に(第95回日本泌尿器科学会総会), ;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• PP-100 緊急処置を要した、腎良性疾患の3例(第95回日本泌尿器科学会総会), ;;;;;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• PP-300 LDL受容体発現とリポ蛋白による前立腺癌細胞増殖との関与(第95回日本泌尿器科学会総会), ;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• PP-313 日本人の家族性および遺伝性前立腺癌における Macrophage Scavenger Receptor 1 (MSR1) の遺伝子多型の検討(第95回日本泌尿器科学会総会), ;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• PP-321 アンドロゲン感受性前立腺癌細胞における低酸素刺激下の細胞増殖と5αリダクターゼの発現に関する検討(第95回日本泌尿器科学会総会), ;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• PP-326 前立腺癌における survivin spliced isoforms の発現(第95回日本泌尿器科学会総会), ;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• PP-380 LH-RH agonist による hot flush に対する酢酸クロルマジノンの有用性(第95回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• PP-464 精巣胚細胞腫瘍の臨床的検討(第95回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2, 512

  DOI
• PP-604 群馬県における前立腺がん検診の14年間の集計 : 年度別、PSA値別、スクリーニング方法及び検診受診回数別の臨床病期(第95回日本泌尿器科学会総会), ;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• PP-611 わが国における家族性前立腺癌について-第10報-(第95回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• PP-642 アンドロゲン測定による前立腺癌検査の検討 (第3報) : 針生検組織中のアンドロゲン測定の検討(第95回日本泌尿器科学会総会), ;;;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• PP-643 アンドロゲン測定による前立腺癌検査法の開発 (第1報) : LC-MS/MSによる前立腺針生検組織中 Testosterone, DHTの同時定量法の確立(第95回日本泌尿器科学会総会), ;;;;;;;, 2007, The Japanese Journal of Urology, 98, 2

  DOI
• Examination of Living Donor Renal Transplantation in Gunma University Hospital in a 20-year Period, Hatori Motoaki;Hayashi Masamichi;Machida Masami;Sekihara Tetsuo;Matsuo Yasuharu;Hasumi Masaru;Tanaka Toshiyuki;Sekine Yositake;Arai Seiji;Nakazato Haruki;Shibata Yasuhiro;Yamamoto Takumi;Magari Tomohiro;Koike Hidekazu;Ito Kazuto;Kawaguchi Takuya;Kato Yuichi;Yamanaka Hidetoshi;Suzuki Kazuhiro, 2007, The Kitakanto Medical Journal, 57, 3, 225, 230

  DOI
• 13. 2006年度群馬県前立腺がん検診の結果と2007年度の実施状況（第46回日本泌尿器科学会群馬地方会演題抄録）, ;;;;;;;, Nov. 2007, The Kitakanto medical journal, 57, 4, 328, 328
• S2 座長のことば(日本の前立腺がん検診を考える,第96回日本泌尿器科学会総会), ;, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• PD3-1 年齢と前立腺体積を考慮に入れた前立腺多数カ所生検 : 群馬大学における生検コンセプト・有用性・生検部位別癌開性率・生検陰性後の対応(至適前立腺生検とは?,第96回日本泌尿器科学会総会), ;;, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• WS1-3-3 The Usefulness of [-5,-7] Pro/ Free PSA Ratio in the Era Undergoing Multiple-core Biopsies for Men with PSA Levels between 4 and 10 ng/ml(Prostate Cancer), Miyakubo Mai;Ito Kazuto;Takechi Hiroyuki;Yamamoto Takumi;Ohi Masaru;Suzuki Kazuhiro, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• CS3-4 PSA低値で発見された前立腺癌(前立腺癌,第96回日本泌尿器科学会総会), ;;;;;;;;;;;, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• AVP-010 リアルタイム経直腸前立腺超音波(TRUS)モニター下ホルミウムレーザー前立腺核出術(HoLEP)(前立腺・その他,総会賞応募ビデオ,第96回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• OP-007 前立腺癌スクリーニングにおける年齢階層別PSA基準値の有用性(前立腺腫瘍/診断・マーカー2,一般演題口演,第96回日本泌尿器科学会総会), ;;;;;;, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• OP-205 コハク酸ソリフェナシンのOABに対する治療効果 : 前治療あり症例に対するVASを用いたQOL評価(尿失禁,一般演題口演,第96回日本泌尿器科学会総会), ;;;;;, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• OP-220 ノモグラムランキングによる前立腺がん治療成績の客観的評価システム(前立腺腫瘍/放射線治療1,一般演題口演,第96回日本泌尿器科学会総会), ;;;;;;;;, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• PP-009 スタチン投与における前立腺癌細胞増殖抑制とLDL受容体発現との関与(前立腺腫瘍/基礎1,一般演題ポスター,第96回日本泌尿器科学会総会), ;;;;;, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• PP-055 前立腺癌における腫瘍悪性度の予見因子としてのPSA関連マーカーの有用性 : PSAグレーゾーンにおける多数カ所生検症例を対象にした検討結果(前立腺腫瘍/診断・マーカー4,一般演題ポスター,第96回日本泌尿器科学会総会), ;;;;;, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• PP-081 わが国における家族性前立腺癌について-第11報-(前立腺腫瘍/診断・マーカー6,一般演題ポスター,第96回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2008, The Japanese Journal of Urology, 99, 2

  DOI
• PP-108 ホルモン抵抗性前立腺癌に対するドセタキセル療法の検討(前立腺腫瘍/薬物療法3,一般演題ポスター,第96回日本泌尿器科学会総会), ;;;;;;;;;;, 2008, The Japanese Journal of Urology, 99, 2, 404

  DOI
• Echo Free Space in Morrison's Pouch in a Patient with Traumatic Bladder Rupture: A Case Report:A Case Report, Takahashi Yuga;Iino Yuichi;Ogino Takashi;Hagiwara Shuichi;Isaka Akira;Nameki Taro;Kagoshima Kaie;Yamada Takuro;Ito Kazuto;Suzuki Kazuhiro, 2008, The Kitakanto Medical Journal, 58, 2, 217, 219

  DOI
• Gene Expression Profiles of Prostate Cancer Cell Lines, LNCaP, PC-3 and DU-145, Assessed by cDNA Microarray, Okamura Keigo;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, 2008, The Kitakanto Medical Journal, 58, 4, 363, 369

  DOI
• CLINICAL RESEARCH OF PROSTATE CANCER DETECTED IN TONE CENTRAL HOSPITAL : COMPARISON OF SURVIVAL RATES BETWEEN PATIENTS DIAGNOSED WITH PROSTATE CANCER IN AND OUTSIDE SCREENING SYSTEM, TAMURA Yoshimi;KOYA Tomoko;MORITA Takahiro;KUBOTA Yutaka;TAKAHASHI Osamu;FUJIDUKA Isao;ITO Kazuto;SUZUKI Kazuhiro, May 2009, The Japanese Journal of Urology, 100, 4, 525, 533

  DOI
• APP-095-AM 夜間頻尿を主とした下部尿路症状の改善には、塩酸タムスロシンの服用時間は影響するか? : IPSS、排尿日誌を用いた朝、夜投与の無作為化比較試験(総会賞応募ポスター,第97回日本泌尿器科学会総会), ;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• OP-108 前立腺がん検診研究班(田中班)の対照研究 : 群馬セクションにおける初期結果(前立腺腫瘍/診断・マーカー2,一般演題口演,第97回日本泌尿器科学会総会), ;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• PP-069 家族性前立腺癌におけるFDFT1遺伝子多型の検討(前立腺/基礎1,一般演題ポスター,第97回日本泌尿器科学会総会), ;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• PP-071 液体クロマトグラフ・タンデム質量分析計(LC-MS/MS)による前立腺癌組織中副腎性アンドロゲンの定量(前立腺/基礎1,一般演題ポスター,第97回日本泌尿器科学会総会), ;;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• PP-090 骨転移を有する内分泌抵抗性前立腺癌患者における骨関連事象の実態(前立腺/基礎3,一般演題ポスター,第97回日本泌尿器科学会総会), ;;;;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• PP-607 わが国における家族性前立腺癌について : 第12報(前立腺腫瘍/診断・マーカー2,一般演題ポスター,第97回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• PP-100 腎癌におけるメバロン経路の関与(腎腫瘍/基礎1,一般演題ポスター,第97回日本泌尿器科学会総会), ;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• PP-427 再燃前立腺癌に対するドセタキセル療法の検討(前立腺腫瘍/薬物療法1,一般演題ポスター,第97回日本泌尿器科学会総会), ;;;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• PP-128 シロドシンによる排尿障害の治療 : Urief Dose-Up and QOL Study(前立腺肥大症/薬物療法・診断1,一般演題ポスター,第97回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• APP-058-PM 利根中央病院における前立腺癌症例の臨床的検討 : PSAスクリーニング受診歴の有無による生存率の比較(総会賞応募ポスター,第97回日本泌尿器科学会総会), ;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• AVP-016 経尿道的ホルミウムレーザー前立腺核出術(HoLEP)施行時の剥離法の検討 : より迅速・安全な手術をめざして(総会賞応募ビデオ,第97回日本泌尿器科学会総会), ;;;;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• PP-068 日本人前立腺癌における疾患関連遺伝子座8q24の検討 : 第2報(前立腺/基礎1,一般演題ポスター,第97回日本泌尿器科学会総会), ;;;;;;, 2009, The Japanese Journal of Urology, 100, 2

  DOI
• SY12 司会のことば(低リスク前立腺がん : 診断と治療,シンポジウム12,第98回日本泌尿器科学会総会), ;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• OP-111 Japanese Prospective cohort Study of Screening for Prostate Cancer(JPSPC) : 群馬セクションにおける2008年度までの研究結果(前立腺腫瘍/診断・マーカー1,一般演題口演,第98回日本泌尿器科学会総会), ;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• OP-170 下大静脈腫瘍血栓を伴う腎細胞癌症例の臨床的検討(腎腫瘍/手術1,一般演題口演,第98回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• OP-283 夜間多尿を合併した前立腺肥大症に対する塩酸タムスロシンの効果 : 非多尿群との比較検討(BPH/薬物療法1,一般演題口演,第98回日本泌尿器科学会総会), ;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• OP-292 酢酸クロルマジノンによる前立腺肥大症患者の血中PSA値に与える影響(BPH/薬物療法2,一般演題口演,第98回日本泌尿器科学会総会), ;;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• PP-004 家族性前立腺癌責任遺伝子の候 : farnesyl-diphosphate farnesyltransferase 1 (FDFT1)遺伝子多型と機能解析についての検討(発表・討論,一般演題ポスター,第98回日本泌尿器科学総会), ;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• PP-005 わが国における家族性前立腺癌について-第13報-(発表・討論,一般演題ポスター,第98回日本泌尿器科学総会), ;;;;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• PP-006 前立腺癌における活性型ビタミンD3 (1α, 25 (OH) 2D3)の効果とsurvivinの関与(発表・討論,一般演題ポスター,第98回日本泌尿器科学総会), ;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• PP-177 組織内アンドロゲン濃度による前立腺癌再燃予測(発表・討論,一般演題ポスター,第98回日本泌尿器科学会総会), ;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• PP-192 再燃前立腺癌に対するドセタキセル療法の検討(発表・討論,一般演題ポスター,第98回日本泌尿器科学会総会), ;;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• PP-343 最近10年間の群馬大学泌尿器科における腎癌手術成績(発表・討論,一般演題ポスター,第98回日本泌尿器科学会総会), ;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• PP-348 群馬大学医学部附属病院泌尿器科における腎臓摘出術の変遷 : 1999年～2009年5月までの11年間の統計(発表・討論,一般演題ポスター,第98回日本泌尿器科学会総会), ;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• PP-468 液体クロマトグラフィー・タンデム質量分析計による前立腺組織内エストラジオール定量法(発表・討論,第98回日本泌尿器科学会総会), ;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2

  DOI
• PP-586 右腎コレステリン肉芽腫の1例(発表・討論,一般演題ポスター,第98回日本泌尿器科学総会), ;;;;;;;;;;, 2010, The Japanese Journal of Urology, 101, 2, 515

  DOI
• ガイドラインと取り扱い規約のあり方 (教育ワークショップ2010), ;;;;;, Nov. 2010, 101, -, S59, 70
• スキル7 座長のメッセージ(手術に必要な基礎知識Part2,スキルアップ企画7,第99回日本泌尿器科学会総会), 鈴木 和浩, 2011, The Japanese Journal of Urology, 102, 2, 235

  DOI
• APP-035 ABCA1を介したHDLによる前立腺癌増殖機構の解明(総会賞応募ポスター,第99回日本泌尿器科学会総会), ;;;;, 2011, The Japanese Journal of Urology, 102, 2, 310

  DOI
• OP-026 Japanese Prospective Cohort Study of Screening for Prostate Cancer(JPSPC) : 群馬セクションにおける2009年度までの研究結果(前立腺腫瘍/診断・マーカー1,一般演題口演,第99回日本泌尿器科学会総会), ;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 345

  DOI
• PP-014 腎原発ユーイング肉腫の1例(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 405

  DOI
• PP-018 腎mucinous tubular and spindle cell carcinomaの一例(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 405

  DOI
• PP-024 腎摘除術および腎部分切除術後におけるクレアチニン値の検討(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 406

  DOI
• PP-055 両側精巣腫瘍の臨床的検討(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 412

  DOI
• PP-081 経尿道的ホルミウムレーザー前立腺核出術(HoLEP)習得における術中経直腸的前立腺超音波(TRUS)操作経験の有用性(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 416

  DOI
• PP-208 わが国における家族性前立腺癌について-第14報-(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 438

  DOI
• PP-354 気腫性膀胱炎の2例(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 462

  DOI
• PP-415 当院における進行性腎細胞癌に対するSunitinibの使用経験(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 473

  DOI
• PP-465 膀胱原発骨肉腫の一例(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 481

  DOI
• PP-486 アンドロゲンが膀胱血流と機能に及ぼす影響 : 膀胱と血管の組織学的検討も含めて(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;, 2011, The Japanese Journal of Urology, 102, 2, 484

  DOI
• PP-552 再燃前立腺癌に対するドセタキセル療法の検討(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 496

  DOI
• PP-751 群馬大学附属病院泌尿器科における若年性腎腫瘍の臨床的検討(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 529

  DOI
• PP-809 前立腺癌と脂肪組織(第一報) : ヒト脂肪組織内性ステロイドホルモン代謝の検討(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会), ;;;;;;, 2011, The Japanese Journal of Urology, 102, 2, 539

  DOI
• CHOLESTEROL GRANULOMA OF THE KIDNEY: A CASE REPORT, Okamoto Kohei;Hatori Motoaki;Tomita Kensuke;Yokoyama Yoshinari;Makino Takeaki;Hirono Masanori;Muramatsu Kazumichi;Arai Seiji;Morikawa Yasuyuki;Miyakubo Mai;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, 2011, The Japanese Journal of Urology, 102, 3, 586, 590

  DOI
• Hypertonicity-induced transmitter release at Drosophila neuromuscular junctions is partly mediated by integrins and cAMP/protein kinase A., Suzuki Kazuhiro;Grinnell Alan D;Kidokoro Yoshiaki, The Journal of physiology, 538, Pt 1

  DOI
• Clinical study on 78 cases of testicular tumor, Suzuki, Kazuhiro;Ozawa, Masashi;Nakazato, Haruki;Kurokawa, Kohei;Hayashi, Masamichi;Jinbo, Susumu;Kobayashi, Mikio;Suzuki, Takanori;Imai, Kyoichi;Yamanaka, Hidetoshi, Mar. 1995, Hinyokika Kiyo, 41, 3, 197, 203
• Carboplatin-based combination chemotherapy for testicular cancer: relationship among administration dose of carboplatin, renal function and myelosuppression, Suzuki, Kazuhiro;Matsumoto, Kazuhisa;Hashimoto, Katsuyoshi;Kurokawa, Kohei;Jinbo, Susumu;Suzuki, Takanori;Imai, Kyoichi;Yamanaka, Hidetoshi;Kawashima, Kiyotaka;Takahashi, Hirotomo, Oct. 1995, Hinyokika Kiyo, 41, 10, 775, 780
• Serial changes in proximal urethral function after transurethral balloon laser hyperthermia of the prostate (TUBAL-H) in a canine model, KUROKAWA, Kohei;SUZUKI, Takanori;SUZUKI, Kazuhiro;FUKABORI, Yoshitatsu;IMAI, Kyoichi;YAMANAKA, Hidetoshi, Sep. 1996, Hinyokika Kiyo, 42, 9, 655, 661
• Effects of Gosha-Jinki-Gan on the function of the urinary bladder in anesthetized dogs, SUZUKI, Takanori;KUROKAWA, Kohei;SUZUKI, Kazuhiro;HIGASHI, Hiroomi;OHMA, Chikako;IMAI, Kyoichi;YAMANAKA, Hidetoshi, Dec. 1996, Hinyokika Kiyo, 42, 12, 951, 955
• Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography, Suzuki, Kazuhiro;Ichinose, Yoshio;Hashimoto, Katsuyoshi;Matsumoto, Kazuhisa;Suzuki, Takanori;Imai, Kyoichi;Yamanaka, Hidetoshi, May 1990, Hinyokika Kiyo, 36, 5, 557, 560
• Preliminary report on the effect of etoposide or etoposide and CDDP on recurrent prostate cancer, Suzuki, Kazuhiro;Nakamura, Toshiyuki;Kato, Nobuo;Kurita, Makoto;Nakazawa, Yasuo;Suzuki, Takanori;Imai, Kyoichi;Yamanaka, Hidetoshi, Nov. 1991, Hinyokika Kiyo, 37, 11, 1499, 1503
• Age-related changes in the size and shape of the prostate observed by transrectal ultrasonography, Kurokawa, Kohei;Suzuki, Takanori;Ohtake, Nobuaki;Itoh, Kazuto;Ichinose, Yoshio;Kurihara, Jun;Suzuki, Kazuhiro;Shiono, Akihiko;Mashimo, Tooru;Machida, Masami;Fukabori, Yoshitatsu;Hayashi, Masamichi;Kumasaka, Fuminari;Imai, Kyoichi;Yamanaka, Hidetoshi, Sep. 1993, Hinyokika Kiyo, 39, 9, 813, 817
• Tumor-associated tissue eosinophilia of penile cancer., Ono Yoshihiro;Ozawa Masashi;Tamura Yoshimi;Suzuki Takanori;Suzuki Kazuhiro;Kurokawa Kohei;Fukabori Yoshitatsu;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 9, 2

  DOI
• Rapidly progressive malignant epithelioid angiomyolipoma of the kidney., Yamamoto Takumi;Ito Kazuto;Suzuki Kazuhiro;Yamanaka Hidetosi;Ebihara Kazunori;Sasaki Atsushi, The Journal of urology, 168, 1
• Usefulness of PSA screening in outpatients with bladder cancer: preliminary results., Kurokawa Kohei;Suzuki Kazuhiro;Okazaki Hiroshi;Ito Kazuto;Shiono Akihiko;Fukabori Yoshitastu;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 9, 5

  DOI
• Usefulness of prostate-specific antigen velocity in screening for prostate cancer., Ito Kazuto;Yamamoto Takumi;Ohi Masaru;Kubota Yutaka;Fukabori Yoshitatsu;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 9, 6

  DOI
• Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3., Suzuki Kazuhiro;Koike Hidekazu;Matsui Hiroshi;Ono Yoshihiro;Hasumi Masaru;Nakazato Haruki;Okugi Hironobu;Sekine Yoshitaka;Oki Kazuya;Ito Kazuto;Yamamoto Takumi;Fukabori Yoshitatsu;Kurokawa Kohei;Yamanaka Hidetoshi, International journal of cancer, 99, 6

  DOI
• MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer., Hasumi Masaru;Suzuki Kazuhiro;Oya Nariyuki;Ito Kazuto;Kurokawa Kohei;Fukabori Yoshitatsu;Yamanaka Hidetoshi, Anticancer research, 22, 2B
• A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine., Tanaka Toshiyuki;Takahara Shiro;Hatori Motoaki;Suzuki Kazuhiro;Wang Jing;Ichimaru Naotsugu;Suzuki Seiichi;Morozumi Kunio;Okuyama Akihiko;Yamanaka Hidetoshi, Cancer letters, 181, 2

  DOI
• In vivo gene transfer of hepatocyte growth factor to skeletal muscle prevents changes in rat kidneys after 5/6 nephrectomy., Tanaka Toshiyuki;Ichimaru Naotsugu;Takahara Shiro;Yazawa Koji;Hatori Motoaki;Suzuki Kazuhiro;Isaka Yoshitaka;Moriyama Toshiki;Imai Enyu;Azuma Haruhito;Nakamura Toshikazu;Okuyama Akihiko;Yamanaka Hidetoshi, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2, 9

  DOI
• The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL., Ito Kazuto;Ohi Masaru;Yamamoto Takumi;Miyamoto Shigeto;Kurokawa Kohei;Fukabori Yoshitatsu;Suzuki Kazuhiro;Yamanaka Hidetoshi, Cancer, 95, 10

  DOI
• Biphasic modulation of synaptic transmission by hypertonicity at the embryonic Drosophila neuromuscular junction., Suzuki Kazuhiro;Okamoto Tomonori;Kidokoro Yoshiaki, The Journal of physiology, 545, 1

  DOI
• Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: is it possible to identify patients likely to have good treatment outcomes?, Kurokawa Kohei;Ito Kazuto;Suzuki Kazuhiro;Ono Yoshihiro;Yamamoto Takumi;Akimoto Tetsuo;Yamanaka Hidetoshi, Japanese journal of clinical oncology, 32, 11

  DOI
• Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population., Suzuki Kazuhiro;Ohtake Nobuaki;Nakata Seiji;Takei Tomoyuki;Matsui Hiroshi;Ono Yoshihiro;Nakazato Haruki;Hasumi Masaru;Koike Hidekazu;Ito Kazuto;Fukabori Yoshitatsu;Kurokawa Kohei;Yamanaka Hidetoshi, Anticancer research, 22, 6B
• [Treatment strategy for locally advanced prostate cancer]., Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, Gan to kagaku ryoho. Cancer & chemotherapy, 30, 1
• Preliminary results of a monitoring system to confirm the preservation of cavernous nerves., Kurokawa Kohei;Suzuki Takanori;SuzukI Kazuhiro;Terada Naoki;Ito Kazuto;Yoshikawa Daisuke;Arai Yoichi;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 10, 3

  DOI
• Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/mL., Ito Kazuto;Yamamoto Takumi;Ohi Masaru;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, Urology, 61, 4

  DOI
• Gene expression profiles of human BPH (II): Optimization of laser-capture microdissection and utilization of cDNA microarray., Matsui Hiroshi;Suzuki Kazuhiro;Hasumi Masaru;Koike Hidekazu;Okugi Hironobu;Nakazato Haruki;Yamanaka Hidetoshi, Anticancer research, 23, 1A
• Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population., Suzuki Kazuhiro;Matsui Hiroshi;Ohtake Nobuaki;Nakata Seiji;Takei Tomoyuki;Koike Hidekazu;Nakazato Haruki;Okugi Hironobu;Hasumi Masaru;Fukabori Yoshitatsu;Kurokawa Kohei;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 10, 5

  DOI
• Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study., Suzuki Kazuhiro;Matsui Hiroshi;Nakazato Haruki;Koike Hidekazu;Okugi Hironobu;Hasumi Masaru;Ohtake Nobuaki;Nakata Seiji;Takei Tomoyuki;Hatori Motoaki;Ito Kazuto;Yamanaka Hidetoshi, Cancer letters, 195, 2

  DOI
• A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese., Suzuki Kazuhiro;Matsui Hiroshi;Ohtake Nobuaki;Nakata Seiji;Takei Tomoyuki;Nakazato Haruki;Okugi Hironobu;Koike Hidekazu;Ono Yoshihiro;Ito Kazuto;Kurokawa Kohei;Yamanaka Hidetoshi, Journal of biomedical science, 10, 4

  DOI
• Natural history of PSA increase with and without prostate cancer., Ito Kazuto;Yamamoto Takumi;Ohi Masaru;Takechi Hiroyuki;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, Urology, 62, 1

  DOI
• Presynaptic impairment of synaptic transmission in Drosophila embryos lacking Gs(alpha)., Hou Dongmei;Suzuki Kazuhiro;Wolfgang William J;Clay Catherine;Forte Michael;Kidokoro Yoshiaki, The Journal of neuroscience : the official journal of the Society for Neuroscience, 23, 13

  DOI
• Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less., Ito Kazuto;Yamamoto Takumi;Ohi Masaru;Takechi Hiroyuki;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, The Prostate, 57, 1

  DOI
• Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population., Nakazato Haruki;Suzuki Kazuhiro;Matsui Hiroshi;Koike Hidekazu;Okugi Hironobu;Ohtake Nobuaki;Takei Tomoyuki;Nakata Seiji;Hasumi Masaru;Ito Kazuto;Kurokawa Kohei;Yamanaka Hidetoshi, Anticancer research, 23, 3C
• Examination of Laparoscopic Nephrectomy for Renal Cancer in Elderly Patients, Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Hatori Motoaki;Ito Kazuto;Kobayashi Mikio;Suzuki Kazuhiro, 2009, The Kitakanto Medical Journal, 59, 4, 333, 336

  DOI
• Sunitinib Induced Immune Thrombocytopenia, Matsumoto Kumiko;Handa Hiroshi;Yuzuriha Akinori;Toyama Kohtarou;Mitsui Takeki;Hashimoto Yoko;Koiso Hiromi;Saitoh Takayuki;Uchiumi Hideki;Murakami Hirokazu;Matsui Hiroshi;Suzuki Kazuhiro;Tsukamoto Norifumi;Nojima Yoshihisa, 2011, The Kitakanto Medical Journal, 61, 2, 175, 177

  DOI
• Clinical Statistics on the Gunma University Hospital Department of Urology. Statistics of New Outpatients in 1999., Sasaki Yasushi;Kurokawa Kohei;Okamoto Kohei;Oki Kazunari;Sekine Yoshitaka;Tomita Hikaru;Nomura Masashi;Inoue Masaharu;Oi Masaru;Kawaguchi Takuya;Matsui Hiroshi;Hasumi Masaru;Ito Kazuto;Hatori Motoaki;Otake Nobuaki;Shiono Akihiko;Suzuki Kazuhiro;Fukabori Yoshitatsu;Yamanaka Hidetoshi, 2001, The Kitakanto Medical Journal, 51, 2, 113, 117

  DOI
• A Cace of Extragonadal Germ Cell Tumor in the Retroperitoneal Space., Kono Mai;Tomita Hikaru;Okamoto Kouhei;Matsui Hiroshi;Yamamoto Takumi;Nakazato Haruki;Kurokawa Kouhei;Suzuki Kazuhiro;Yamanaka Hidetoshi;Suzuki Kouichi;Suzuki Takanori, 2002, The Kitakanto Medical Journal, 52, 3, 203, 206

  DOI
• A Case of Bellini Duct Carcinoma., Koike Hidekazu;Takei Tomoyuki;Ohtake Nobuaki;Masimo Masamichi;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2002, The Kitakanto Medical Journal, 52, 4, 267, 270

  DOI
• Primary Scrotal Sclerosing Lipogranuloma: Surgical Therapy and Conservative Therapy.:Surgical Therapy and Conservative Therapy, Ono Yoshihiro;Kosaku Nozomu;Yajima Hisanori;Takahashi Osamu;Fukabori Yoshitatsu;Suzuki Kazuhiro;Yamanaka Hidetoshi;Mashimo Masamichi;Sekihara Tetsuo;Saruki Kazuhisa;Matsumoto Kazuhisa;Hayashi Masamichi, 2002, The Kitakanto Medical Journal, 52, 4, 271, 277

  DOI
• A Case of Vesical Leiomyosarcoma., Kono Mai;Matsui Hiroshi;Yamamoto Takumi;Ono Yoshihiro;Fukabori Yoshitatsu;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi;Suzuki Keiji, 2002, The Kitakanto Medical Journal, 52, 4, 279, 282

  DOI
• Immunohistochemical study of metallothionein in human testicular tumors., Suzuki Takanori;Suzuki Kazuhiro;Ohma Chikako;Jinbo Susumu;Suzuki Keiji;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 2, 67, 72

  DOI
• Ultrastructural changes in benign prostatic hyperplasia induced by transurethral balloon laser thermotherapy., Suzuki Takanori;Kurokawa Kohei;Suzuki Kazuhiro;Hayashi Masamichi;Suzuki Keiji;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 3, 159, 161

  DOI
• Testicular epidermoid cyst with calcified capsule: A case report., Suzuki Kazuhiro;Ono Yoshihiro;Tokunaga Takashi;Tsuji Hiroaki;Kurokawa Kohei;Suzuki Takanori;Suzuki Keiji;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 3, 171, 172

  DOI
• Evaluation of Lower Urinary Tract Symptoms of Outpatients with Prostatic Disease: The Relationship among UFM, TRUS, and IPSS and QOL Score.:THE RELATIONSHIP AMONG UFM, TRUS, AND IPSS AND QOL SCORE, Suzuki Kazuhiro;Totsuka Yoshihiro;Matsumoto Kazuhisa;Ono Yoshihiro;Tsuji Hiroaki;Kurokawa Kohei;Suzuki Takanori;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 5, 305, 309

  DOI
• Synchonous Double Primary Cancers Consisting of Bladder and Prostatic Cances: A Case Report., Suzuki Kazuhiro;Totsuka Yoshihiro;Matsumoto Kazuhisa;Tsuji Hiroaki;Ono Yoshihiro;Kurokawa Kohei;Suzuki Takanori;Suzuki Keiji;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 5, 335, 337

  DOI
• Limitation of Conventional Cisplatin-Based Combination Chemotherapy for Disseminated Germ Cell Tumor: Implication for Introduction of Aggressive Treatment as an Initial Chemotherapy.:IMPLICATION FOR INTRODUCTION OF AGGRESSIVE TREATMENT AS AN INITIAL CHEMONTHERAPY, Suzuki Kazuhiro;Kurokawa Kohei;Hayashi Masamichi;Suzuki Tananori;Yamanaka Hidetoshi;Nakazato Haruki;Masuda Hiroshi;Shinya Hiroyuki;Shibata Yasuhiro;Nakano Katsuya;Kubota Yutaka;Shimizu Nobuaki;Fukabori Yoshitatsu, 1997, The Kitakanto Medical Journal, 47, 6, 421, 424

  DOI
• Endoscopic Demonstration of Obstructive Mechanism in the Prostatic Urethral Polyp., Suzuki Kazuhiro;Matsumoto Kazuhisa;Ono Yoshihiro;Kurokawa Kohei;Suzuki Takanori;Suzuki Keiji;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 6, 433, 434

  DOI
• Marked Prostate Volume Decrease Attained by Transurethral Balloon Laser Thermotherapy in a Patient with Benign Prostatic Hypertrophy: a Case Report., Kurokawa Kohei;Suzuki Takanori;Suzuki Kazuhiro;Nakano Katsuya;Kubota Yutaka;Ono Yoshihiro;Fukabori Yoshitatsu;Yamanaka Hidetoshi, 1997, The Kitakanto Medical Journal, 47, 6, 439, 442

  DOI
• Benign Prostatic Hypertrophy and Estrogen., 鈴木 和浩, 1998, The Kitakanto Medical Journal, 48, 1, 69, 71

  DOI
• Clinical Statistics of the Department of Urology of Gunma University Hospital: Statistics on New Outpatients in 1996., Koike Hidekazu;Kurokawa Kohei;Sasaki Yasushi;Masuda Hiroshi;Nakazato Haruki;Shinya Hiroyuki;Shibata Yasuhiro;Nakano Katsuya;Kubota Yutaka;Suzuki Kazuhiro;Shimizu Nobuaki;Fukabori Yoshitatsu;Hayasi Masamichi;Yamanaka Hidetoshi, 1998, The Kitakanto Medical Journal, 48, 3, 197, 201

  DOI
• Effects of Hachimi-Jio-Gan on the function of the urinary bladder in anesthetized dogs., Suzuki Takanori;Okazaki Hiroshi;Suzuki Kouichi;Kurokawa Kohei;Higashi Hiroomi;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2000, The Kitakanto Medical Journal, 50, 1, 15, 19

  DOI
• Clinical Study on 77 Cases of Testicular Tumor., Nakazato Haruki;Suzuki Kazuhiro;Ito Kazuto;Hatori Motoaki;Shiono Akihiko;Shimizu Nobuaki;Fukabori Yoshitatu;Kurokawa Kohei;Suzuki Takanori;Jinbo Susumu;Yamanaka Hidetoshi, 2000, The Kitakanto Medical Journal, 50, 3, 259, 266

  DOI
• Effects of antiandrogen TZP-4238 on the prostatic androgen receptor and prostatic androgen in rat, Honma Seijiro;Suzuki Kazuhiro;Takezawa Yutaka;Minato Kouichi;Fukabori Yoshitatsu;Yamanaka Hidetoshi, 1994, Folia Endocrinologica Japonica, 70, 8, 925, 940

  DOI
• Clinical Outcomes of Microscopic Subinguinal Varicocelectomy for Male Infertility and Scrotal Pain Patients, Shibata Yasuhiro;Ohyama Yusuke;Arai Seiji;Suzuki Kazuhiro, 2014, The Kitakanto Medical Journal, 64, 1, 31, 35

  DOI
• Histological and Immunohistochemical Changes after Transurethral Balloon Laser Hyperthermia in the Canine Prostate., SUZUKI TAKANORI;KUROKAWA KOHEI;SUZUKI KAZUHIRO;MATSUMOTO KAZUHISA;YAMANAKA HIDETOSHI, 1995, The Tohoku Journal of Experimental Medicine, 177, 1, 39, 48

  DOI
• Experimental Research of Transurethral Balloon Laser Therapy for Prostatic Diseases., ;;;, 1994, Thermal Medicine(Japanese Journal of Hyperthermic Oncology), 10, 2, 121, 125

  DOI
• ULTRASONIC LOCALIZATION OF NORMAL MALE RAT PROSTATE AND URINARY BLADDER, SUZUKI TAKANORI;TAKEZAWA YUTAKA;SUZUKI KAZUHIRO;TAMURA YOSHIMI;OKABE KAZUHIKO;YUASA HISAKO;OHMA CHIKAKO;YAMANAKA HIDETOSHI;HAMATAKI TOSHINOBU, 1991, The KITAKANTO Medical Journal, 41, 2, 321, 325

  DOI
• CLINICAL EXPERIENCE WITH EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY USING DORNIER MFL 5000 FOR UPPER URINARY TRACT CALCULI, KUROKAWA KOHEI;TAKEZAWA YUTAKA;SUZUKI TAKANORI;SUZUKI KAZUHIRO;;TAMURA YOSHIMI;KURITA MAKOTO;HAYASHI MASAMICHI;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1995, The KITAKANTO Medical Journal, 45, 5, 401, 406

  DOI
• SURGICAL APPROACH TO PATIENTS WITH PROGRESSED-STAGE TESTICULAR CANCER : CLINICAL STUDY OF ONE-STAGE OPERATION FOR RESIDUAL MASSES IN RETROPERITONEAL, THORACIC AND CERVICAL AREAS, SUZUKI KAZUHIRO;MATSUMOTO KAZUHISA;KUROKAWA KOHEI;SUZUKI TAKANORI;YOSHIDA ICHIRO;OHTAKI AKIO;ISHIKAWA SUSUMU;YOKOE TAKAO;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1995, The KITAKANTO Medical Journal, 45, 6, 529, 535

  DOI
• CLINICAL STUDY OF TESTICULAR AND PARA-TESTICULAR NON-GERM CELL TUMORS, SUZUKI KAZUHIRO;TAMURA YOSHIMI;KUROKAWA KOHEI;JINBO SUSUMU;SUZUKI TAKANORI;IMAI KYOICHI;SUZUKI KEIJI;YAMANAKA HIDETOSHI, 1995, The KITAKANTO Medical Journal, 45, 6, 537, 541

  DOI
• EXTRAGONADAL GERM CELL TUMOR SUCCESSFULLY TREATED BY HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE MARROW TRANSPLANTATION : A CASE REPORT, SUZUKI KAZUHIRO;TAKEZAWA YUTAKA;;KUROKAWA KOHEI;JINBO SUSUMU;KURAYASHIKI RYUJI;SUZUKI TAKANORI;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1995, The KITAKANTO Medical Journal, 45, 6, 579, 582

  DOI
• TRANSURETHRAL BALLOON LASER HYPERTHERMIA FOR CHRONIC NON-BACTERIAL PROSTATITIS : LONG-TERM FOLLOW-UP RESULTS, SUZUKI TAKANORI;KUROKAWA KOHEI;SUZUKI KAZUHIRO;OKAMURA KEIGO;OHTAKE NOBUAKI;YOSHIDA TADASHI;KURITA SUSUMU;OKAZAKI HIROSHI;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 1, 11, 15

  DOI
• LITHOTRIPSY OF THE BL ADDER STONE, KUROKAWA KOHEI;SUZUKI TAKANORI;SUZUKI KAZUHIRO;KURITA MAKOTO;NAKANO KATSUYA;HATORI MOTOAKI;ITO KAZUTO;KURITA SUSUMU;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 1, 23, 27

  DOI
• SURGICAL APPROACH TO THE RETROCRUAL SPACE IN RETROPERITONEAL LYMPHNODE DISSECTION : ANATOMICAL STUDY, SUZUKI KAZUHIRO;KURITA SUSUMU;KUROKAWA KOHEI;SUZUKI TAKANORI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 1, 29, 35

  DOI
• MECHANISMS OF TISSUE DAMAGE IN BENIGN PROSTATIC HYPERPLASIA AFTER TRANSURETHRAL BALLOON LASER THERMOTHERAPY, SUZUKI TAKANORI;KUROKAWA KOHEI;HIGASHI HIROOMI;SUZUKI KAZUHIRO;FUKABORI YOSHITATSU;IMAI KYOICHI;SUZUKI KEIJI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 2, 147, 154

  DOI
• QUALITY OF LIFE AFTER RADICAL PROSTATECTOMY, KUROKAWA KOHEI;SUZUKI TAKANORI;SUZUKI KAZUHIRO;OKAZAKI HIROSHI;ONO YOSHIHIRO;SHIONO AKIHIKO;TAKEZAWA YUTAKA;HAYASHI MASAMICHI;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 4, 301, 307

  DOI
• TRANSURETHRAL BALLOON LASER-ENHANCED THERMOTHERAPY USING ULTRAFINE CARBON PARTICLES:TEMPERATURE DISTRIBUTION IN A PHANTOM, SUZUKI TAKANORI;KUROKAWA KOHEI;HIGASHI HIROOMI;SUZUKI KAZUHIRO;DAIKUZONO NORIO;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 5, 359, 364

  DOI
• A CASE OF POSTOPERATIVE MRSA PNEUMONIA : MYELOSUPPRESSION AFTER CHEMOTHERAPY FOR TESTICULAR CANCER AS A WORSENING FACTOR, SUZUKI KAZUHIRO;YOSHIDA ICHIRO;YOSHIDA TADASHI;KURITA SUSUMU;KUROKAWA KOHEI;SUZUKI TAKANORI;IMAI KYOICHI;YAMANAKA HIDETOSHI, 1996, The KITAKANTO Medical Journal, 46, 5, 393, 396

  DOI
• Successful maintenance hemodialysis treatment for a patient with hemophilia A and chronic renal failure, Koike Hidekazu;Hatori Motoaki;Nitta Takashi;Kashiwagi Bunzou;Suzuki Kazuhiro;Yamanaka Hidetoshi;Utsumi Hideki;Nojima Yoshihisa, 2004, Nihon Toseki Igakkai Zasshi, 37, 1, 91, 94

  DOI
• Scrotal and penile edema developed in a CAPD patient for 5 years, Uei Takatoshi;Magari Tomohiro;Kawaguchi Takuya;Hatori Motoaki;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2004, Nihon Toseki Igakkai Zasshi, 37, 3, 249, 252

  DOI
• Surgical procedures for chronic dialysis patients at Gunma University Hospital., Hatori Motoaki;Hayashi Masamichi;Shiono Akihiko;Hasumi Masaru;Takei Tomoyuki;Matsui Hiroshi;Kawaguchi Takuya;Ito Kazuto;Suzuki Kazuhiro;Kurokawa Kohei;Fukabori Yoshitatsu;Yamanaka Hidetoshi, 2002, Nihon Toseki Igakkai Zasshi, 35, 11, 1447, 1451

  DOI
• A case with combined multiple retina thrombosis probably due to heparin-induced thrombocytopenia (HIT), Magari Tomohiro;Hatori Motoaki;Hasumi Masaru;Tanaka Toshiyuki;Matsui Hiroshi;Morita Takahiro;Ono Yoshihiro;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2004, Nihon Toseki Igakkai Zasshi, 37, 6, 1437, 1442

  DOI
• Ultrastructural Changes in Subepithelial Capillaries and Their Surrounding Stroma in Rat Prostateand Seminal Vesicle after Castration, Ono Yoshihiro;Suzuki Kazuhiro;Yuasa Hisako;Kurokawa Kohei;Fukabori Yoshitatsu;Yamanaka Hidetoshi, 2003, The Tohoku Journal of Experimental Medicine, 201, 1, 29, 38

  DOI
• Incidence of Bladder Cancer Discovered by Urethrocystoscopy at Prostate Biopsy: Extraordinary High Incidence of Tiny Bladder Cancer in Elderly Males, Okazaki Hiroshi;Suzuki Koichi;Suzuki Takanori;Kurokawa Kohei;Ito Kazuto;Suzuki Kazuhiro;Yamanaka Hidetoshi, 2004, The Tohoku Journal of Experimental Medicine, 203, 1, 31, 36

  DOI
• Contrast enhancement of ATN-4T on PC-3 prostate cancer for magnetic resonance imaging, Suzuki Takanori;Kurokawa Kohei;Suzuki Kazuhiro;Tomiyoshi Katsumi;Sakata Isao;Nakajima Susumu;Endo Keigo;Yamanaka Hidetoshi, 1995, Nippon Laser Igakkaishi, 16, Supplement, 363, 364

  DOI
• Application of YAG Laser to Prostaic Diseses, KUROKAWA Kohei;SUZUKI Takanori;SUZUKI Kazuhiro;HIGASHI Hiroomi;YAMANAKA Hidetoshi, 1998, Nippon Laser Igakkaishi, 19, 1, 19, 27

  DOI
• Interstitial temperature measurement during balloon laserthermia (PROSTALASE^TM) of the canine prostate, Kurokawa Kohei;Suzuki Takanori;Suzuki Kazuhiro;Yamanaka Hidetoshi, 1993, Nippon Laser Igakkaishi, 14, Supplement, 341, 342

  DOI
• Basic and clinical studies of transurethral balloon laser therapy for prostate diseases, Suzuki Takanori;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, 1994, Nippon Laser Igakkaishi, 15, Supplement, 285, 286

  DOI
• Clinical Experience of Transurethral Balloon Laser Thermotherapy for the Benign Prostatic Hypertrophy Patients, KUROKAWA Kohei;SUZUKI Takanori;SUZUKI Kazuhiro;MATSUMOTO Kazuhisa;HASHIMOTO Katsuyoshi;ONO Yoshihiro;KUBOTA Yutaka;SAITO Yoshitaka;YAMANAKA Hidetoshi, 1995, Nippon Laser Igakkaishi, 16, 2, 19, 24

  DOI
• Basic study of the difference between Nd: YAG pulsed and continuous wave lasers on thermotherapy for the prostate gland, Suzuki Takanori;Kurokawa Kohei;Suzuki Kazuhiro;Higashi Hiroomi;Yamanaka Hidetoshi, 1996, Nippon Laser Igakkaishi, 17, Supplement, 327, 330

  DOI
• SQUAMOUS CELL CARCINOMA WITH CLOACAL EXSTROPHY: A CASE REPORT, Ohtsu Akira;Miyao Takeshi;Koike Hidekazu;Baba Kyoko;Aoki Masanori;Kurihara Sota;Miyazawa Yoshiyuki;Kato Haruo;Shuto Takahiro;Arai Seiji;Furuya Yosuke;Nitta Takashi;Nomura Masashi;Sekine Yoshitaka;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro;Makiguchi Takaya;Morita Hiroki;Kosaku Nozomu;Matsumoto Kazuhisa;Tomita Hikaru;Yamamoto Takumi;Hayashi Masamichi, 2015, The Japanese Journal of Urology, 106, 4, 274, 279

  DOI
• EFFICACY OF MICROSURGICAL SUBINGUINAL VARICOCELECTOMY USING INDOCYANINE GREEN FLUORESCENCE ANGIOGRAPHY: A PILOT STUDY, Shibata Yasuhiro;Kurihara Sota;Arai Seiji;Miyazawa Yoshiyuki;Kato Haruo;Koike Hidekazu;Ito Kazuto;Nakamura Tetsuya;Suzuki Kazuhiro, 2015, The Japanese Journal of Urology, 106, 4, 293, 298

  DOI
• A CASE OF GROWING TERATOMA SYNDROME, Baba Kyoko;Sekine Yoshitaka;Kurihara Sota;Koike Hidekazu;Matsui Hiroshi;Nakazato Haruki;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro;Nishii Masahiro;Mashimo Toru;Okamura Keigo;Hirato Junko, 2016, The Japanese Journal of Urology, 107, 2, 115, 120

  DOI
• Clinicopathological Features and Outcomes of Prostate Cancer Patients Detected using Ningen Dock (annual health check-up) System and Population-based Screening in Rural Area of Japan, Tamura Yoshimi;Ohki Kazunari;Nishii Masahiro;Ohtuka Yasuhiro;Miyakubo Mai;Nomura Masashi;Ito Kazuto;Suzuki Keiji;Suzuki Kazuhiro, 2014, Ningen Dock International, 2, 1, 27, 34

  DOI
• Clinical Characteristics of Hereditary and Familial Prostate Cancer in Japan, Ohtake Nobuaki;Nakata Seiji;Suzuki Kazuhiro;Yamanaka Hidetoshi;Suzuki Keiji;Fukabori Yoshitatsu, 2011, JOURNAL OF FAMILIAL TUMORS, 11, 1, 5, 10

  DOI
• Initial Outcome of Robot-Assisted Radical Prostatectomy, Koike Hidekazu;Sekine Yoshitaka;Miyao Takeshi;Nomura Masashi;Matsui Hiroshi;Syuutou Takahiro;Kurihara Sota;Nakayama Hiroshi;Miyazawa Yoshiyuki;Shibata Yasuhiro;Suzuki Kazuhiro;Okauchi Kenzo;Hattori Kazunori;Okegawa Takatsugu, May 2020, The Kitakanto Medical Journal, 70, 2, 83, 94

  DOI
• Microscopic Review on the Curability and Invasiveness of Heavy Ion Radiotherapy in a Patient with Locally Advanced High-grade Prostate Cancer without Biochemical Recurrence:, Kurokawa Kohei;Takatama Masamitsu;Fukuda Toshio;Suzuki Keiji;Kawamura Masahide;Ohno Tatsuya;Matsui Hiroshi;Ito Kazuto;Suzuki Kazuhiro, Feb. 2021, The Kitakanto Medical Journal, 71, 1, 47, 52

  DOI
• Analysis of the factors affecting the results of arteriovenous fistula surgery, Oka Daisuke;Sekine Yoshitaka;Ohtsu Akira;Aoki Masanori;Hayashi Takuma;Baba Kyoko;Nakayama Hiroshi;Kurihara Sota;Miyao Takeshi;Ohki Ryo;Miyazawa Yoshiyuki;Shibata Yasuhiro;Suzuki Kazuhiro, 2021, Nihon Toseki Igakkai Zasshi, 54, 3, 155, 158

  DOI
• Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population., Suzuki Kazuhiro;Nakazato Haruki;Matsui Hiroshi;Koike Hidekazu;Okugi Hironobu;Kashiwagi Bunzo;Nishii Masahiro;Ohtake Nobuaki;Nakata Seiji;Ito Kazuto;Yamanaka Hidetoshi, Cancer, 98, 7

  DOI
• Hands-free hook for endourological procedures., Ono Yoshihiro;Suzuki Kazuhiro, International journal of urology : official journal of the Japanese Urological Association, 10, 10

  DOI
• The evaluation of rat prostate blood flow using a laser speckle flowmetry: a comparative study using the microsphere method in castrated and androgen-replenished rats., Shibata Yasuhiro;Kashiwagi Bunzo;Ono Yoshihiro;Fukabori Yoshitatsu;Suzuki Kazuhiro;Honma Seijiro;Yamanaka Hidetoshi, Oct. 2003, Urological research, 32, 1

  DOI
• Correlation between the Banff 97 classification of renal allograft biopsies and clinical outcome., Tanaka Toshiyuki;Kyo Masahiro;Kokado Yukito;Takahara Shiro;Hatori Motoaki;Suzuki Kazuhiro;Hasumi Masaru;Toki Kiyohide;Ichimaru Naotsugu;Yazawa Koji;Hanafusa Toru;Namba Yukiomi;Oka Kazumasa;Moriyama Toshiki;Imai Enyu;Okuyama Akihiko;Yamanaka Hidetoshi, Oct. 2003, Transplant international : official journal of the European Society for Organ Transplantation, 17, 2

  DOI
• Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues., Hasumi Masaru;Suzuki Kazuhiro;Matsui Hiroshi;Koike Hidekazu;Ito Kazuto;Yamanaka Hidetoshi, Cancer letters, 200, 2

  DOI
• Ultrastructural changes in subepithelial capillaries and their surrounding stroma in rat prostate and seminal vesicle after castration., Ono Yoshihiro;Suzuki Kazuhiro;Yuasa Hisako;Kurokawa Kohei;Fukabori Yoshitatsu;Yamanaka Hidetoshi, The Tohoku journal of experimental medicine, 201, 1

  DOI
• Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate., Shibata Yasuhiro;Ono Yoshihiro;Kashiwagi Bunzo;Suzuki Kazuhiro;Fukabori Yoshitatsu;Honma Seijiro;Yamanaka Hidetoshi, Urology, 62, 5

  DOI
• Genomewide linkage analysis of familial prostate cancer in the Japanese population., Matsui Hiroshi;Suzuki Kazuhiro;Ohtake Nobuaki;Nakata Seiji;Takeuchi Toshiyuki;Yamanaka Hidetoshi;Inoue Ituro, Dec. 2003, Journal of human genetics, 49, 1

  DOI
• The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer., Hasumi Masaru;Suzuki Kazuhiro;Taketomi Ayako;Matsui Hiroshi;Yamamoto Takumi;Ito Kazuto;Kurokawa Kohei;Aoki Jun;Endo Keigo;Yamanaka Hidetoshi, Anticancer research, 23, 5b
• Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia., Matsumoto Kazuhisa;Suzuki Kazuhiro;Koike Hidekazu;Hasumi Masaru;Matsui Hiroshi;Okugi Hironobu;Shibata Yasuhiro;Ito Kazuto;Yamanaka Hidetoshi, Anticancer research, 23, 5A
• Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4ng/ml., Ohi Masaru;Ito Kazuto;Suzuki Kazuhiro;Yamamoto Takumi;Yamanaka Hidetoshi, European urology, 45, 1

  DOI
• The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less., Ito Kazuto;Yamamoto Takumi;Suzuki Kazuhiro;Kurokawa Kohei;Yamanaka Hidetoshi, The Journal of urology, 171, 2 Pt 1

  DOI
• Androgen-dependent blood flow control and morphological changes of the capillaries in rat prostate., Ono Yoshihiro;Suzuki Kazuhiro;Kashiwagi Bunzo;Shibata Yasuhiro;Ito Kazuto;Fukabori Yoshitatsu;Yamanaka Hidetoshi, International journal of andrology, 27, 1

  DOI
• Cumulative probability of PSA increase above 4.0 NG/ML in population-based screening for prostate cancer., Ito Kazuto;Yamamoto Takumi;Ohi Masaru;Takechi Hiroyuki;Kurokawa Kohei;Suzuki Kazuhiro;Yamanaka Hidetoshi, International journal of cancer, 109, 3

  DOI
• Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer., Kurokawa Kohei;Ito Kazuto;Yamamoto Takumi;Takechi Hiroyuki;Miyamoto Shigeto;Suzuki Kazuhiro;Yamanaka Hidetoshi, Urology, 63, 2

  DOI
• Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population., Suzuki Kazuhiro;Nakazato Haruki;Matsui Hiroshi;Koike Hidekazu;Okugi Hironobu;Ohtake Nobuaki;Takei Tomoyuki;Nakata Seiji;Hasumi Masaru;Yamanaka Hidetoshi, Anticancer research, 23, 6D
• Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage., Koike Hidekazu;Suzuki Kazuhiro;Satoh Tetsuo;Ohtake Nobuaki;Takei Tomoyuki;Nakata Seiji;Yamanaka Hidetoshi, Anticancer research, 23, 6D
• Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels., Matsumoto Kazuhisa;Suzuki Kazuhiro;Koike Hidekazu;Okamura Keigo;Tsuchiya Kiyotaka;Uchida Tatsuya;Takezawa Yutaka;Kobayashi Mikio;Yamanaka Hidetoshi, Anticancer research, 23, 6D
• [The evaluation of bladder outlet obstruction using the bladder weight calculation nomogram]., Magari Tomohiro;Fukabori Yoshitatsu;Suzuki Kazuhiro;Yamanaka Hidetoshi;Ogura Haruyuki, Hinyokika kiyo. Acta urologica Japonica, 50, 1
• Role of androgen on blood flow and capillary structure in rat seminal vesicles., Ono Yoshihiro;Suzuki Kazuhiro;Kashiwagi Bunzo;Shibata Yasuhiro;Ito Kazuto;Fukabori Yoshitatsu;Yamanaka Hidetoshi, The Tohoku journal of experimental medicine, 202, 3

  DOI
• Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivo., Shibata Yasuhiro;Kashiwagi Bunzo;Arai Seiji;Fukabori Yoshitatsu;Suzuki Kazuhiro;Honma Seijiro;Yamanaka Hidetoshi, Jul. 2004, Endocrinology, 145, 10

  DOI
• [Bladder cancer and prostate cancer in hemodialysis patients]., Hatori Motoaki;Suzuki Kazuhiro;Yamanaka Hidetoshi, Nihon rinsho. Japanese journal of clinical medicine, 62 Suppl 6
• [Acute scrotum from testicular involvement in acute lymphocytic leukemia: a case report]., Nitta Takashi;Koike Hidekazu;Fukabori Yoshitatsu;Hatori Motoaki;Ono Yoshitaka;Matsui Hiroshi;Suzuki Kazuhiro;Yamanaka Hidetoshi;Shigawa Youko;Kanazawa Takashi;Ogawa Chitose, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 95, 5

  DOI
• [Prostate biopsy]., Suzuki Kazuhiro;Ito Kazuto, Nihon rinsho. Japanese journal of clinical medicine, 63, 2
• Effect of androgen concentration on seminal vesicle blood flow in rats-establishment of new highly sensitive simultaneous androgen measurement method., Kashiwagi Bunzo;Shibata Yasuhiro;Ono Yoshihiro;Suzuki Kazuhiro;Honma Seijiro;Yamanaka Hidetoshi, Urology, 66, 1

  DOI
• External Ca2+ dependency of synaptic transmission in drosophila synaptotagmin I mutants., Okamoto Tomonori;Tamura Takuya;Suzuki Kazuhiro;Kidokoro Yoshiaki, Journal of neurophysiology, 94, 2

  DOI
• Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: establishment of a new highly sensitive simultaneous androgen measurement method., Kashiwagi Bunzo;Shibata Yasuhiro;Ono Yoshihiro;Suzuki Ryota;Honma Seijiro;Suzuki Kazuhiro, Journal of andrology, 26, 5

  DOI
• Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia., Shibata Yasuhiro;Kashiwagi Bunzo;Arai Seiji;Fukabori Yoshitatsu;Suzuki Kazuhiro, Urology, 66, 2

  DOI
• Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity., Akimoto Tetsuo;Ito Kazuto;Saitoh Jun-ichi;Noda Shin-ei;Harashima Koichi;Sakurai Hideyuki;Nakayama Yuko;Yamamoto Takumi;Suzuki Kazuhiro;Nakano Takashi;Niibe Hideo, International journal of radiation oncology, biology, physics, 63, 2

  DOI
• Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer., Miyamoto Shigehito;Ito Kazuto;Kurokawa Kohei;Suzuki Kazuhiro;Suzuki Keiji;Yamanaka Hidetoshi, International journal of urology : official journal of the Japanese Urological Association, 13, 6

  DOI
• Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population., Okugi Hironobu;Nakazato Haruki;Matsui Hiroshi;Ohtake Nobuaki;Nakata Seiji;Suzuki Kazuhiro, Jul. 2006, Cancer detection and prevention, 30, 3

  DOI
• Positive effect of prostaglandin on regulation of prostatic blood flow., Kashiwagi Bunzo;Shibata Yasuhiro;Ohki Kazunari;Arai Seiji;Honma Seijiro;Suzuki Kazuhiro, Urology, 68, 3

  DOI
• Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo., Shibata Yasuhiro;Kashiwagi Bunzo;Arai Seiji;Magari Tomohiro;Suzuki Kazuhiro;Honma Seijiro, Urology, 68, 5

  DOI
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., Sekine Yoshitaka;Ito Kazuto;Yamamoto Takumi;Nakazato Haruki;Shibata Yasuhiro;Hatori Motoaki;Suzuki Kazuhiro, Apr. 2007, Cancer detection and prevention, 31, 2

  DOI
• Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells., Sekine Yoshitaka;Koike Hidekazu;Nakano Takamitsu;Nakajima Katsuyuki;Suzuki Kazuhiro, Apr. 2007, Clinica chimica acta; international journal of clinical chemistry, 383, 1-2

  DOI
• Lead time of prostate cancer detected in population based screening for prostate cancer in Japan., Ito Kazuto;Yamamoto Takumi;Miyakubo Mai;Takechi Hiroyuki;Ohi Masaru;Shibata Yasuhiro;Suzuki Kazuhiro, Aug. 2007, The Journal of urology, 178, 4 Pt 1

  DOI
• Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer., Koike Hidekazu;Sekine Yoshitaka;Kamiya Makoto;Nakazato Haruki;Suzuki Kazuhiro, Mar. 2008, Urology, 72, 6

  DOI
• Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan., Takechi Hiroyuki;Ito Kazuto;Yamamoto Takumi;Miyakubo Mai;Ohi Masaru;Suzuki Kazuhiro, Mar. 2008, Urology, 72, 5

  DOI
• Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds., Yamamoto Takumi;Ito Kazuto;Miyakubo Mai;Takechi Hiroyuki;Suzuki Kazuhiro;Akimoto Tetsuo;Ishikawa Hitoshi;Nakano Takashi, Apr. 2008, Urology, 72, 4

  DOI
• Changes in baseline PSA levels in Japanese men from 1988 to 2003., Ohi Masaru;Ito Kazuto;Yamamoto Takumi;Miyakubo Mai;Takechi Hiroyuki;Kubota Yutaka;Suzuki Kazuhiro, May 2008, Urology, 72, 1

  DOI
• Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Sekine Yoshitaka;Furuya Yosuke;Nishii Masahiro;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, May 2008, Biochemical and biophysical research communications, 372, 2

  DOI
• Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia., Nagai Yayoi;Hasegawa Michiko;Shinmi Kahori;Kishi Chikako;Tsushima Yoshito;Endo Keigo;Okabe Kazuhiko;Suzuki Kazuhiro;Ishikawa Osamu, Acta dermato-venereologica, 88, 6

  DOI
• Induction of type 1 interferon receptor by zinc in U937 cells., Nagamine Takeaki;Nakajima Kastuyuki;Takada Hisashi;Sekine Yoshitaka;Suzuki Kazuhiro, Apr. 2009, Cytokine, 46, 3

  DOI
• Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy., Miyakubo Mai;Ito Kazuto;Yamamoto Takumi;Takechi Hiroyuki;Ohi Masaru;Suzuki Kazuhiro, May 2009, International journal of urology : official journal of the Japanese Urological Association, 16, 6

  DOI
• The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha1-adrenergic receptor antagonist work well for ureteral stones?, Ohki Kazunari;Ohno Yosihiro;Suzuki Kazuhiro, Jun. 2009, International urology and nephrology, 42, 1

  DOI
• Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor., Sekine Yoshitaka;Koike Hidekazu;Nakano Takamitsu;Nakajima Katsuyuki;Takahashi Sadao;Suzuki Kazuhiro, May 2009, Cancer epidemiology, 33, 1

  DOI
• Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer., Okamura Keigo;Koike Hidekazu;Sekine Yoshitaka;Matsui Hiroshi;Suzuki Kazuhiro, Cancer epidemiology, 33, 2

  DOI
• New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry., Arai Seiji;Miyashiro Yoshimichi;Shibata Yasuhiro;Kashiwagi Bunzo;Tomaru Yukio;Kobayashi Mikio;Watanabe Yoko;Honma Seijiro;Suzuki Kazuhiro, Sep. 2009, Steroids, 75, 1

  DOI
• Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells., Abdulah Rizky;Faried Ahmad;Kobayashi Kenji;Yamazaki Chiho;Suradji Eka W;Ito Kazuto;Suzuki Kazuhiro;Murakami Masami;Kuwano Hiroyuki;Koyama Hiroshi, Nov. 2009, BMC cancer, 9

  DOI
• 【前立腺がん治療におけるGnRHアンタゴニストへの期待】ゴナックスの特徴　内分泌動態, 鈴木 和浩, Oct. 2015, 11, 5, 10
• ロボット手術　前立腺全摘(膀胱尿道吻合), ;;;;;;, Nov. 2015, 28, 3, 146
• 固い腎周囲脂肪により腫瘍同定が困難であった腎腫瘍の1例, ;;;;;;;;;, Nov. 2015, 28, 3, 186
• 腎細胞癌(T2a)との鑑別困難な腹腔鏡下左腎摘除術を施行した腎オンコサイトーマの1例, ;;;;;;;, Nov. 2015, 28, 3, 227
• 泌尿器疾患におけるBone Management　Bone Scan Index(BSI)による骨転移の評価, ;;, Oct. 2015, 2, 2, 241
• 精索静脈瘤に対する術中インドシアニングリーン蛍光血管造影下顕微鏡下低位結紮術の有用性　予備的検討, ;;;;;;;;, Oct. 2015, 106, 4, 293
• 【前立腺癌-基礎・臨床研究の最新知見-】最新の臨床研究　前立腺癌検診の意義と課題, ;, Jan. 2016, 74, 1, 72
• 完全鏡視下腎部分切除術への安全な移行に関する検討, ;;;;, Dec. 2015, 20, 7, OS304
• 尿膜管癌・腹膜播種症例に対して施行した集学的治療の経験, ;;;;;;;;;;;;;;;;;;;;;, Nov. 2015, 65, 4, 311
• 巨大多発嚢胞腎に発生した腎細胞癌に対する手術療法の経験, ;;;;;;;;;;;;;;;;;;;;;, Nov. 2015, 65, 4, 311
• 契機なく発症し腎周囲に広範な血腫を形成した腎出血の一例, ;;;;;;;;;;;;;;;;;;, Nov. 2015, 65, 4, 312
• 去勢抵抗性前立腺癌に対しドセタキセル療法57コースを施行し、終了後2年間の無増悪生存期間を得ることができた1例, ;;;;;;;;;;;;;;;;;;, Nov. 2015, 65, 4, 313
• 画像上腎膿瘍と診断された肺癌腎転移の一例, ;;;;;;;;;;;;;;;;;;, Nov. 2015, 65, 4, 313
• 【新前立腺癌学-最新の基礎研究と診断・治療-】前立腺癌基礎研究の課題と展望, ;, May 2016, 74, 増刊3 新前立腺癌学, 12
• 当科における去勢抵抗性前立腺癌に対するカバジタキセル療法の初期治療経験, ;;;;;;;;;;;, May 2016, 29, 臨増, 893
• 前立腺における小細胞腺癌に対しIP(塩酸イリノテカン+シスプラチン)療法を行った2例, ;;;;;;;;;;;;, May 2016, 29, 臨増, 929
• Growing teratoma syndromeの1例, ;;;;;;;;;;;;, Apr. 2016, 107, 2, 115
• 左大腿人工血管留置術直後にDICを発症した一例, ;;;;;;;;;;;;;;;;;;;, May 2016, 49, Suppl.1, 719
• 生体腎移植後長期無症状であったシャント瘤が原因と思われた橈骨動脈血流障害の一例, ;;;;;;;;;;;;;;;;;;, May 2016, 49, Suppl.1, 761
• 前立腺癌と脂質・糖代謝　IGF1受容体を介した増殖メカニズム, ;;;;;;;;, Aug. 2016, 29, 8, 1219
• 泌尿器科と合同手術で、より安全に施行しえた左上腹部巨大後腹膜腫瘍の2切除例, ;;;;;;;;;;;;;, May 2016, 41, 3, 533
• 【基礎研究から臨床への架け橋】家族性前立腺癌の遺伝子解析と臨床応用の可能性, ;;;;;, Apr. 2016, 3, 1, 53
• 前立腺癌におけるBone Health　Denosumab療法の意義, ;, Apr. 2016, 3, 1, 61
• 28年間の日本人男性のベースラインPSA値の変化, ;;;, Sep. 2016, 24, 1, 98
• 【前立腺癌　がん・合併症・有害事象での薬物治療戦略を総まとめ】新たに登場した医薬品のノウハウとピットフォール　デガレリクス, 鈴木 和浩, Oct. 2016, 67, 11, 3027
• 【前立腺がん診療】前立腺がん内分泌療法の進歩, 鈴木 和浩, Nov. 2016, 145, 8, 1631
• 【最新遺伝医学研究と遺伝カウンセリング(シリーズ1)　最新遺伝性腫瘍・家族性腫瘍研究と遺伝カウンセリング】(第2章)遺伝性腫瘍研究・診療各論　遺伝性前立腺がん, 鈴木 和浩, Aug. 2016, 別冊, 最新遺伝性腫瘍・家族性腫瘍研究と遺伝カウンセリング, 197
• 顕微鏡下低位結紮術におけるICG蛍光血管造影の有用性の検討, ;;;;;;, Oct. 2016, 61, 4, 457
• 骨転移のあるCRPCに対する治療戦略, ;;;, Oct. 2016, 3, 2, 195
• 脂質・糖代謝による前立腺癌進展機構, ;;;;;;, Nov. 2016, 5, 4, 165
• 副腎皮質癌の一例, ;;;;;;;;;;;;;;;;;;, Aug. 2016, 66, 3, 228
• 生体腎移植後長期無症状であったシャント瘤が原因と思われた橈骨動脈血流障害の一例, ;;;;;;;;;;;;;;;;;;;, Aug. 2016, 66, 3, 228
• 前立腺癌における骨マネージメント, 鈴木 和浩, Aug. 2016, 31, 2, 125
• 【脂質代謝と腎泌尿器疾患】前立腺がんと脂質代謝, ;;, Dec. 2016, 4, 6, 559
• 尿閉を契機に診断に至った前立腺肉腫の一例, ;;;;;;;;;;;;, Apr. 2016, 104回, PP1
• 初診時にDICを併発していた進行性前立腺癌に対しLHRH-antagonistでの治療導入が有効であった1例, ;;;;;;;;;;;;, Apr. 2016, 104回, PP1
• 群馬大学医学部附属病院におけるHoLEP症例の臨床的検討, ;;;;;;;;;;;;, Apr. 2016, 104回, PP1
• 褐色細胞腫との鑑別が困難であった副腎皮質癌の1例, ;;;;;;;;;;;;, Apr. 2016, 104回, PP2
• 出血性膀胱炎を契機とした気腫性膀胱炎から膀胱破裂に至り、治療に難渋した1例, ;;;;;;;;;;;;, Apr. 2016, 104回, PP2
• 去勢抵抗性前立腺癌に対するエンザルタミド投与症例の臨床的検討　80mg導入による有害事象マネジメントと短期成績, ;;;;;;;;;;;;, Apr. 2016, 104回, OP
• LHRH-agonistを投与した前立腺癌患者のCTIBLの検討, ;;;;;;;;;;;;, Apr. 2016, 104回, OP
• ADTを誘因とする前立腺癌患者のCTIBLに対するデノスマブ投与の検討, ;;;;;;;;;;;;, Apr. 2016, 104回, OP
• Annexin A10を介したスタチンによる去勢抵抗性前立腺癌進展制御機構の解明, ;;;;;;;;;;;;, Apr. 2016, 104回, PP3
• RALP術前における腹腔内癒着の予測, ;;;;;;, Apr. 2016, 104回, PP3
• 前立腺癌に対するTomoTherapyによる寡分割強度変調放射線治療の長期成績, ;;;;;;;;;;;;, Apr. 2016, 104回, OP
• わが国における家族性前立腺癌について(第19報), ;;;;;;;;;;;;;, Apr. 2016, 104回, OP
• 手術不能原発性尿管癌に対する重粒子線治療の初期経験, ;;;;;;;;;;;;, Apr. 2016, 104回, PP3
• CBDCA+VP-16療法が間質性肺炎合併の前立腺神経内分泌癌の転移巣に奏功した一例, ;;;;;;;;;;;;, Apr. 2016, 104回, PP3
• 実践マニュアル　GnRHアンタゴニスト製剤デガレリクスの注射方法と局所副作用対策, 鈴木 和浩, Feb. 2017, 24, 1, 29
• 前立腺　放射線治療　前立腺癌に対する重粒子線治療の初期経験(前向き観察研究GUNMA0702), ;;;;;;;;;;;;;;, Oct. 2016, 54回, WS23
• 前立腺　生検と初期診断　前立腺癌に対する放射線治療前の便潜血検査の有用性の検討, ;;;;;;;;;;;;;;, Oct. 2016, 54回, WS25
• 泌尿器　泌尿器がん治療の進歩　手術不能原発性尿管癌に対する重粒子線治療の初期経験, ;;;;;;;;;;;;;, Oct. 2016, 54回, WS63
• 前立腺　前立腺がんのホルモン療法　前立腺癌に対するLHRHantagonistが副腎性アンドロゲン分泌に与える影響についての検討, ;;;;;;;;;, Oct. 2016, 54回, WS67
• 進行腎癌に対してスニチニブ投与後に腹腔鏡下腎摘除術を施行した一例, ;;;;;;;;;;;;, Oct. 2016, 54回, P44
• 28年間の日本人男性のベースラインPSA値の変化, ;;;, Oct. 2016, 54回, P51
• proPSA関連インデックスは前立腺癌の生物学的悪性度を予測可能か?, ;;;;, Oct. 2016, 54回, P54
• リュープロライドからゴセレリンに変更後、下垂体-性腺系ホルモン分泌が回復し、PSA上昇を認めた前立腺癌の3例, ;;;;;;;;;;;;, May 2017, 30, 臨増, 904
• 前立腺癌に対するアンドロゲン除去療法と腎機能の関係, ;;;;;;;;;;;;, May 2017, 30, 臨増, 904
• 当院における去勢抵抗性前立腺癌に対するカバジタキセルの治療成績, ;;;;;;;;;;;;, May 2017, 30, 臨増, 904
• 筋層非浸潤性膀胱癌に対して施行したBCG/エピルビシン交互膀胱内注入療法の検討, ;;;;;, May 2017, 30, 臨増, 911
• 28年間の日本人男性のベースラインPSA値の変化, ;;;, May 2017, 30, 臨増, 914
• エベロリムスを導入した結節性硬化症に伴う腎血管筋脂肪腫の2例, ;;;;;;;;;;;, May 2017, 30, 臨増, 923
• 前立腺癌に対するLH-RHアゴニスト投与後に下垂体卒中を認めた1例, ;;;;;;;;;;;;;;;;;;;, Nov. 2016, 66, 4, 309
• 【高齢者に対する腎泌尿器疾患のマネージメント】高齢者における前立腺がんの管理, 鈴木 和浩, Mar. 2017, 5, 3, 268
• 前立腺癌におけるBone Health　Denosumab療法の意義, ;, Apr. 2017, 4, 1, 59
• CRPCに対する最新治療戦略, ;;;, Apr. 2017, 4, 1, 69
• 再発・去勢抵抗性前立腺癌をマネジメントする　新ガイドラインを活かした治療, ;, Apr. 2017, 4, 1, 83
• 有馬症候群による慢性腎不全患者に二次献腎移植を施行した1例, ;;;;;;;;;;;;;;;;;;;, May 2017, 50, Suppl.1, 705
• 腎芽腫にて腎摘出術後26年目に対側腎に腎癌が発生し透析導入となった1例, ;;;;;;;;;;;;;;;;;;, May 2017, 50, Suppl.1, 708
• 腹腔鏡下腎部分切除術を施行した傍糸球体細胞腫の2例, ;;;;;;;;;;;;;;;;, Feb. 2017, 67, 1, 71
• 局所所見を認めなかった転移性前立腺癌の一例, ;;;;;;;;;;;;;;, Feb. 2017, 67, 1, 71
• 前立腺癌に対する重粒子線治療　16回照射の成績と12回照射新プロトコールの紹介, ;;;;, Feb. 2017, 67, 1, 73
• 尿管結石におけるタダラフィルの排石促進効果の臨床的検討, ;;;;;;;;;;;;;;;;;, Feb. 2017, 67, 1, 73
• 当院における腎腫瘍に対する経皮的凍結療法の初期治療成績, ;;;;;, Apr. 2017, 32, Suppl., 181
• 前立腺がん検診受診者における低用量フィナステリド内服のPSA値への影響, ;;;, Aug. 2017, 25, 1, 86
• Body mass index(BMI)の血清PSA値、PSA動態への影響, ;;;;;;;;;;, Apr. 2017, 105回, OP23
• 去勢抵抗性前立腺癌患者を対象とした本邦におけるカバジタキセル使用成績調査(全例調査)報告, ;;;;;, Apr. 2017, 105回, OP39
• アンドロゲン除去療法下前立腺癌患者に対するデノスマブの投与が骨質に与える影響についての検討, ;;;;;;;;;;;;, Apr. 2017, 105回, OP40
• 去勢抵抗性前立腺癌におけるAR-V7とARとの発現比の検討, ;;;;;;;;, Apr. 2017, 105回, OP41
• 日本人前立腺癌家系の生殖細胞系列変異, ;;;;;;;;;;;;, Apr. 2017, 105回, OP41
• スタチン耐性腎癌細胞において、YM155によるsurvivinの抑制は、スタチンの抗腫瘍効果を回復させる, ;;;;;;;, Apr. 2017, 105回, OP48
• LH-RHアゴニスト投与後に下垂体卒中を発症した前立腺癌症例の内分泌学的検討, ;;;;;;;;;;;;, Apr. 2017, 105回, OP71
• 前立腺癌に前立腺原発MALTリンパ腫を合併した1例, ;;;;;;;;;;;;, Apr. 2017, 105回, OP71
• 腎腫瘍に対する腎部分切除後における腎機能の推移及び腎体積に関する検討, ;;;;;;;;;;, Apr. 2017, 105回, PP10
• 群馬大学医学部附属病院におけるICG使用低位結紮術の臨床的検討の追加報告, ;;;;;;;;;;;;, Apr. 2017, 105回, PP57
• 前立腺がん検診受診者における低用量フィナステリド内服のPSA値への影響, ;;;, Apr. 2017, 105回, PP86
• 去勢抵抗性前立腺癌(CRPC)の逐次療法を再考する, ;;;;, Sep. 2017, 4, 2, 209
• 去勢抵抗性前立腺癌に対するカバジタキセル療法の治療経験, ;;;;;;;;;;;;, Sep. 2017, 4, 2, 293
• 当院TESE/MESA症例における精子採取予測因子の検討, ;;;;;;;;;;, Oct. 2017, 62, 4, 404
• 前立腺癌におけるBone Health, 鈴木 和浩, Aug. 2017, 32, 2, 181
• 有害事象の観察を外来化学療法センターと統一した電子パス作成, ;;;;;;;;, Nov. 2017, 19, 4, 518
• 【去勢抵抗性前立腺癌(CRPC)と骨転移治療の最前線[第2回]】去勢抵抗性前立腺癌(CRPC)における骨転移の診断と治療, ;;;, Nov. 2017, 35, 11, 112
• 抗アンドロゲン剤および5α還元酵素阻害剤投与による前立腺組織内ホルモン構成への影響, ;;;;;;;;;;, Jan. 2017, 92, 3, 796
• ADT下前立腺癌患者へのデノスマブ投与が骨質マーカーに与える影響についての検討, ;;;;;;;;;;;;;;, Oct. 2017, 55回, P65
• アンドロゲン除去療法の継続期間が前立腺癌患者の腎機能に与える影響についての検討, ;;;;;;;;;;;;;;, Oct. 2017, 55回, P65
• 当院におけるロボット支援腹腔鏡下腎部分切除術(RAPN)の初期経験, ;;;;;;;;;, Nov. 2017, 30, 3, 189
• 大きな前立腺肥大症に対する一塊核出法ホルミウムレーザー前立腺核出術の検討, ;;;;;;;;;, Nov. 2017, 30, 3, 211
• 腎腫瘍に対する腎部分切除術前後における腎機能の推移と腎体積に関する検討, ;;;;;;;;, Nov. 2017, 30, 3, 254
• 当院におけるロボット支援腹腔鏡下前立腺全摘(RALP)術の短期成績, ;;;;;;;;;, Nov. 2017, 30, 3, 261
• アンドロゲン除去療法下前立腺癌患者に対するデノスマブの投与が骨質マーカーに与える影響についての検討, ;;;;;;;;, Dec. 2017, 93, 3, 755
• 前立腺癌患者に対するLHRHアンタゴニスト投与が副腎性アンドロゲン分泌に与える影響についての検討, ;;;;;;;;, Dec. 2017, 93, 3, 761
• 【新薬展望2018】(第III部)治療における最近の新薬の位置付け<薬効別>〜新薬の広場〜　膀胱癌・前立腺癌治療薬, ;, Feb. 2018, 54, 増刊, 563
• 前立腺局所所見に乏しく急速に進行した転移性前立腺癌の1例, ;;;;;;;;;;;;;;;;;;;;, Apr. 2018, 5, 1, 147
• 有馬症候群に対して献腎移植を施行した1例, ;;;;;;;;, Aug. 2017, 52, 総会臨時, 493
• アンドロゲン除去療法の継続期間が前立腺癌患者の腎機能に与える影響についての検討, ;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 822
• 当院における進行性腎癌に対するニボルマブの初期投与経験, ;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 837
• 前立腺がん検診におけるPSA値の季節性変動について, ;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 841
• 当院における治療抵抗性前立腺癌に対するカバジタキセルの使用成績, ;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 842
• 難治性の出血性膀胱炎に対して膀胱全摘、回腸導管造設術を施行した1例, ;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 850
• 群馬大学における前立腺癌に対する重粒子線治療の治療経験, ;;;;;;;;;;;, Jun. 2018, 31, 臨増, 850
• 当院における骨転移を有する去勢抵抗性前立腺癌に対するRa-223の初期使用経験, ;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 851
• CRPCに対するアビラテロン導入後に急性骨髄性白血病の発症を認めた1例, ;;;;;;;;;;;;, Jun. 2018, 31, 臨増, 852
• 両側気腫性腎盂腎炎に対して両側腎摘除術を施行し血液透析導入となった1例, ;;;;;;;;;;;;;;;;;, May 2018, 51, Suppl.1, 558
• Goodpasture症候群で透析導入となった患者に対して生体腎移植を施行した1例, ;;;;;;;;, May 2018, 51, Suppl.1, 744
• 水中毒に起因する横紋筋融解症を発症した腎移植後の一例, ;;;;;;;;;;;;;;;;;;;, May 2018, 51, Suppl.1, 799
• フルニエ壊疽に伴う敗血症性ショックに対しデブリドマン、CHDF、PMX-DHP、sepXirisの併用により救命できた1例, ;;;;;;;;;;;;;;;;;, May 2018, 51, Suppl.1, 865
• 遠隔転移を有する前立腺癌の局所に対する症状の緩和・予防目的の放射線治療, ;;;;;;;;;;, Jun. 2018, 13, Suppl., S382
• 当院における低リスク限局性前立腺癌症例についての検討, ;;;;;;;;;, Sep. 2018, 26, 1, 86
• 去勢抵抗性前立腺癌における放射線抵抗性機序の検討, ;;;;;;;;;, Apr. 2018, 106回, OP
• 限局性前立腺癌で放射線治療を受けた患者における意思決定と健康関連QOLの検討, ;;;;;;;;;;;;, Apr. 2018, 106回, OP
• 群馬大学における結節性硬化症に伴う腎血管筋脂肪腫に対するエベロリムスの治療経験及び診療連携について, ;;;;;;;;;;;;, Apr. 2018, 106回, OP
• 去勢抵抗性前立腺癌患者を対象としたカバジタキセルの安全性および有効性の検討　市販後使用成績調査の結果, ;;;;, Apr. 2018, 106回, OP
• 群馬大学における高リスク前立腺癌に対する重粒子線治療, ;;;;;;;;;;;;, Apr. 2018, 106回, PP1
• 前立腺癌に対する短期ホルモン療法併用重粒子線治療後のPSA値変化, ;;;;;;;;;;;;, Apr. 2018, 106回, PP1
• 25年間の日本人男性のPSA基礎値の変化, ;;;;;;;;;;;;, Apr. 2018, 106回, PP2
• 左腎尿管全摘後の術後乳糜漏に対して、リピオドール造影にて治癒した1例, ;;;;;;;;;;;;, Apr. 2018, 106回, PP2
• 酢酸クロルマジノンおよびデュタステリド短期投与によるPSA、ホルモンの変化, ;;;;;;;;;;;;, Apr. 2018, 106回, PP2
• 経会陰的前立腺生検における予防的抗菌薬投与に関する後ろ向き検討, ;;;;;;;;;, Apr. 2018, 106回, PP2
• 群馬大学医学部附属病院におけるロボット支援腹腔鏡下前立腺全摘(RALP)術の短期成績, ;;;;;;;;;;;;, Apr. 2018, 106回, PP3
• 尿管結石排石促進治療におけるタダラフィルの有用性, ;;;;;;;;;;;;, Apr. 2018, 106回, PP3
• ロボット支援腹腔鏡下前立腺全摘術に伴うリンパ節郭清により発見されたMALTリンパ腫の1例, ;;;;;;;;;;;, Apr. 2018, 106回, PP3
• 群馬大学医学部附属病院泌尿器科における男性不妊症に対する精索静脈瘤に対する顕微鏡下低位結紮術の有用性検討　調査表による妊孕能に関する効果解析, ;;;, Aug. 2018, 63, 3, 394
• アンドロゲン除去療法が前立腺癌患者の骨密度に与える影響についての検討, ;;;;;;;;;, Aug. 2018, 33, 2, 228
• 【悪性腫瘍と骨・カルシウム代謝】前立腺がん骨転移の病態と治療　オーバービュー, ;, Oct. 2018, 28, 11, 1441
• 両側気腫性腎盂腎炎の一例, ;;;;;;;;;;;;;;;;;;, Nov. 2017, 67, 4, 375
• 膀胱粘膜下腫瘍と鑑別が困難であった尿膜管遺残の一例, ;;;;;;;;;;;;;;;;;;, Nov. 2017, 67, 4, 375
• 当院におけるロボット支援腹腔鏡下腎部分切除術(RAPN)の初期経験, ;;;;;;;;;;;;;;;;;;;, Nov. 2017, 67, 4, 376
• 前立腺がん検診研究班　研究進捗状況報告　平成28年度伊勢崎コホートの検診結果, ;;;;;;;;, Aug. 2018, 31, 8, 1247
• 献腎移植後にニューモシスチス肺炎を発症した1例, ;;;;;;;;;;;;;;;;;;, May 2018, 68, 2, 134
• 重複尿道の一例, ;;;;;;;;;;;;;;;;;;, May 2018, 68, 2, 134
• 前立腺生検における周術期予防的抗菌薬投与に関する検討, ;;;;;;;;;, May 2018, 68, 2, 135
• 【泌尿器科医のためのゲノム腫瘍学入門-時代に取り残されるな】遺伝性前立腺腫瘍, ;;, Oct. 2018, 72, 11, 902
• 前立腺癌の画像診断最前線, ;;;, Nov. 2018, 1, 2, 75
• 【泌尿器がん】前立腺がん　前立腺がん骨転移の治療　ラジウム223・骨修飾薬投与のタイミング, ;;, Jan. 2019, 23, 1, 31
• 前立腺癌におけるBone Health, ;;, Oct. 2018, 5, 2, 195
• 実践!前立腺がん検診　前立腺がん検診に潜む課題をこのように解決している, ;;;;, Oct. 2018, 5, 2, 213
• 【泌尿器科癌　争論!クロスファイア2019】Oligomets前立腺癌に対する一次治療　全身治療, ;;, Feb. 2019, 32, 2, 131
• 当院におけるレシピエント移植コーディネーターによる看護専門外来開設の現状と今後の課題, ;;;;;, Sep. 2018, 53, 総会臨時, 361
• 両側気腫性腎炎に対し経皮的ドレナージ術を施行した一例, ;;;;;;;;;;;;;;;;;;;;;;, Mar. 2019, 32, 3, 302
• 当院におけるロボット支援腹腔鏡下腎部分切除術(レトロアプローチ)の検討, ;;;;;;;;;;;;;;;;;, Mar. 2019, 32, 3, 303
• CRPCに対するエンザルタミド治療早期、増悪時のPSA動態に着目した予後予測因子の検討, ;;;;;;;;;;;;;;, Oct. 2018, 56回, P43
• Joubert症候群による慢性腎不全患者に献腎移植を施行した一例, ;;;;;;;;;, Feb. 2019, 52回, 236
• 献腎移植時に同側腎摘を行ったADPKDの1例　ADPKD腎移植症例の検討, ;;;;;;;;;, Feb. 2019, 52回, 259
• 献腎移植におけるレシピエントの受容プロセスと看護支援, ;;;;;, Feb. 2019, 52回, 270
• 【これ一冊でパーフェクト!!泌尿器科薬物療法】前立腺癌　併用療法, ;;, Apr. 2019, 32, 特別号, 126
• 前立腺癌骨転移の診断と治療効果判定、治療戦略UPDATE　骨転移診断、治療効果判定、治療法選択におけるBSI(Bone Scan Index)の有用性, ;;, Apr. 2019, 6, 1, 65
• CRPCに対するタキサンの話題Update　進行前立腺がんの今後の治療戦略, ;;, Apr. 2019, 6, 1, 83
• 群馬大学医学部附属病院泌尿器科における低リスク限局性前立腺癌症例についての検討, ;;;;;;;;;;, Apr. 2019, 6, 1, 148
• ARAMIS試験　非転移性去勢抵抗性前立腺癌(nmCRPC)におけるダロルタミド(DARO)の有効性及び安全性の検討, ;;;;;;;;;;;;;;;;, Apr. 2019, 107回, LBE1
• 前立腺癌薬物治療のパラダイムシフト　mCRPCに対する薬物療法のパラダイムシフト　ARAT薬剤を中心に, ;;, Apr. 2019, 107回, SY11
• DNA修復遺伝子群を介したスタチンとPARP阻害剤の併用による去勢抵抗性前立腺癌細胞増殖抑制効果の解明, ;;;;;;;;;, Apr. 2019, 107回, AOP
• 前立腺癌に対する重粒子線治療の前向き観察研究, ;;;;;;;;, Apr. 2019, 107回, OP
• LHRH antagonist投与下の前立腺癌患者における血中副腎アンドロゲン濃度の変化と下部尿路症状の相関についての検討, ;;;;;;;;;;;;, Apr. 2019, 107回, OP
• カバジタキセル抵抗性前立腺癌細胞株に対するSurvivin抑制による効果, ;;;;;;;;;;;;, Apr. 2019, 107回, PP1
• 妊娠13週でAML破裂を来した一例, ;;;;;;;;;;;;, Apr. 2019, 107回, PP1
• 自己血管内シャント開存率へ影響を与える因子の解析, ;;;;;;;;;;;;, Apr. 2019, 107回, PP1
• 当院における低リスク限局性前立腺癌治療についての検討, ;;;;;;;;;;;;, Apr. 2019, 107回, PP2
• 群馬大学医学部附属病院で診断、加療した去勢感受性転移性前立腺癌237例における予後予測因子の検討, ;;;;;;;;;;;;, Apr. 2019, 107回, PP3
• 遺伝性前立腺がん, ;;;, May 2019, 9, 5, 512
• ホルモン依存性癌の新展開　進行性前立腺癌薬物治療のupdate, ;;, Apr. 2019, 95, 1, 195
• 内分泌内科医と共有する前立腺癌の内分泌療法の最新情報, ;;, Apr. 2019, 95, 1, 290
• LHRH antagonist投与下の前立腺癌患者における血中副腎アンドロゲン濃度の変化と下部尿路症状の相関についての検討, ;;;;;, Apr. 2019, 95, 1, 372
• リポタンパク受容体を介した、リポタンパクによる前立腺癌細胞増殖機構の解明, ;;;;;, Apr. 2019, 95, 1, 470
• 血液透析患者に認めた転移性腎細胞癌に対するNivolumabの投与経験, ;;;;;;;;;;;;;;, May 2019, 52, Suppl.1, 607
• 自己血管内シャント開存率へ影響を与える因子の解析, ;;;;;;, May 2019, 52, Suppl.1, 694
• ハイリスク前立腺がん:最新の治療法の使い分け　群馬大学における高リスク前立腺癌に対する重粒子線治療, ;;;;;;;;;;;, Jun. 2019, 32, 臨増, 631
• 当院における進行性腎癌に対するニボルマブの使用経験, ;;;;;;;;;;;, Jun. 2019, 32, 臨増, 738
• CRPCに対するエンザルタミド治療早期、増悪時のPSA動態に着目した予後予測因子の検討, ;;;;;;;;;;;;, Jun. 2019, 32, 臨増, 758
• 当院におけるRALPの短期成績　安全性、PSA再発、腹圧性尿失禁を中心に, ;;;;;;;;;;;;, Jun. 2019, 32, 臨増, 759
• 前立腺癌に対する重粒子線治療後の排尿機能に関する検討, ;;;;;;;;;;;, Jun. 2019, 32, 臨増, 766
• スタチンによる前立腺癌3次予防効果の可能性, ;;;;;;;;, Jul. 2019, 28回, 52
• Androgen Deprivation Therapy継続期間が前立腺癌患者の腎機能に与える影響についての検討, ;;;;;;;;;;, Jul. 2019, 28回, 53
• 交通外傷後、広範囲に被膜下血腫を認めた外傷腎による献腎移植の1例, ;;;;;;;;;, Sep. 2019, 54, 総会臨時, 294
• 出血性膀胱炎の経過中に膀胱穿孔を来した一例, ;;;;;;;;;;;;;;;;;;, May 2019, 69, 2, 174
• 前立腺がん検診研究班　研究進捗状況報告　2017年度伊勢崎コホートの検診結果, ;;;;;;;;;, Aug. 2019, 32, 8, 1095
• 泌尿器科領域におけるトラブルシューティング(第108回)　術後合併症でのトラブルシューティング　術後難治性乳糜瘻に対しリピオドールによるリンパ管造影が奏功した1例, ;;;, Dec. 2019, 32, 12, 1515
• 当院における精索静脈瘤顕微鏡下低位結紮術による妊孕能改善効果の検討　術後調査表による解析, ;;;, Oct. 2019, 64, 4, 383
• 膀胱癌症例の術前因子に着目したTURBTパスのバリアンス分析, ;;;;;;;;;, Dec. 2019, 21, 4, 409
• ゲムシタビン+カルボプラチン療法クリニカルパス作成と運用方法, ;;;;;, Dec. 2019, 21, 4, 445
• 腹腔鏡下・後腹膜鏡下腎臓摘出術クリニカルパスのバリアンス分析, ;;;;;;, Dec. 2019, 21, 4, 459
• 全身性強皮症患者における過活動膀胱の有病率と臨床的特徴の検討, ;;;;;;;;;, Sep. 2019, 30, 1, 241
• 前立腺癌患者におけるLHRH antagonist投与下の血中副腎アンドロゲン濃度の変化と下部尿路症状の相関についての検討, ;;;;;;;;;, Sep. 2019, 30, 1, 308
• 前立腺癌に対する重粒子線治療が排尿機能に与える影響について, ;;;;;;;;;;, Sep. 2019, 30, 1, 314
• CRPCに対するEnzalutamideの効果と血中アンドロゲン濃度の関連についての前向き研究, ;;;;;;;;;;;;;;, Oct. 2019, 57回, O36
• 尿路上皮癌に対するペムブロリズマブの初期治療経験, ;;;;;;;;;;;;, Oct. 2019, 57回, P98
• 群馬大学における前立腺癌に対する重粒子線治療, ;;;;;;;;;;;;;;, Oct. 2019, 57回, P107
• Oligomets前立腺癌に対する局所放射線療法とアンドロゲン除去療法の併用治療経験, ;;;;;;;;;;;;;;, Oct. 2019, 57回, P108
• 全身性強皮症患者における過活動膀胱の合併について, ;;;;;, Aug. 2019, 69, 3, 292
• 抗アポトーシス蛋白阻害剤併用による前立腺癌新規治療法の開発(Combination therapies with BH3 mimetic drugs for prostate cancer), ;;, Sep. 2019, 78回, P
• 尿路と交通した腎嚢胞からの尿の流出に苦慮した生体腎移植の1例, ;;;;;;;;;, Feb. 2020, 53回, 249
• レシピエントの自己管理獲得に向けた看護支援, ;;;;;, Feb. 2020, 53回, 288
• スタチンによる前立腺癌3次予防効果の可能性, ;;;;;;;;, Mar. 2020, 28, 1, 57
• 血液透析患者に認めた転移性腎細胞癌に対するNivolumabの投与経験, ;;;;;;;;;;;;;;;;;, Nov. 2019, 69, 4, 349
• ペムブロリズマブによる尿路上皮癌多発転移の加療中にPseudo-Progressionを認めた1例, ;;;;;;;;;;;;;;;;;, Nov. 2019, 69, 4, 350
• 尿管結石排石促進におけるタダラフィルの有用性および展望, ;;;;;;;;;;;;;;;;;, Nov. 2019, 69, 4, 351
• 【泌尿器科診療の最新スタンダード-平成の常識は令和の非常識】腫瘍　部位別　転移性ホルモン感受性前立腺癌, ;;;, Apr. 2020, 74, 4, 073
• 傍糸球体細胞腫2例の臨床・病理学的検討, ;;;;;, Apr. 2020, 37, 2, 136
• 【全国自治体(市区町村)による前立腺がんPSA検診に対する根拠の薄い批判;泌尿器科専門医不在の周回遅れの根拠のない批判を斬る】前立腺がん検診の重要性　前立腺がん検診ガイドライン(2018年版)から, 鈴木 和浩, Apr. 2020, 33, 4, 338
• 【前立腺癌治療の合併症・副作用マネージメント】ホルモン療法　ホットフラッシュに対する対応, ;, Apr. 2020, 7, 1, 55
• 抗アンドロゲン剤とスタチンの併用による去勢抵抗性前立腺癌細胞増殖抑制効果の解明, ;;;;;;;;;;;;, Dec. 2020, 108回, 856
• 尿路上皮癌におけるペムブロリズマブの初期治療経験, ;;;;;;;;;;;, Dec. 2020, 108回, 1838
• 当院における進行性腎癌に対する免疫療法について, ;;;;;;;;;;;;;, Jun. 2021, 34, 臨増, 791
• 当院における転移性尿路上皮癌に対するPembrolizmab使用経験とpseudo progressionを呈した症例の検討, ;;;;;;;;;;;;;;;;;;;;, May 2021, 71, 2, 161
• 当院におけるRALP後の尿禁制回復に関与する因子の検討, ;;;;;;;;, Nov. 2018, 32回, P
• 当院におけるロボット支援腹腔鏡下腎部分切除術の検討, ;;;;;;;, Nov. 2018, 32回, P
• 腹腔鏡下に摘出した後腹膜原発Castleman病の1例, ;;;;;;;;, Nov. 2018, 32回, P
• 日高病院でのPNL、ECIRS導入期5年間における治療効果と安全性の検討, ;;;;;;;;;, Nov. 2018, 32回, P
• 当院で施行したロボット支援腎部分切除術における固着脂肪とMAP scoreについての検討, ;;;;;;;;;, Nov. 2019, 33回, P
• 片側同時性腎腫瘍に対して一期的にロボット支援腹腔鏡下腎部分切除術を施行した1例, ;;;;;;;;;, Nov. 2019, 33回, P
• COVID-19感染症拡大後の群馬大学関連病院における泌尿器科疾患及び手術数の変化, ;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 232
• COVID-19感染症拡大後の群馬大学関連病院における泌尿器科疾患及び手術数の変化, ;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 259
• 群馬大学における光力学的診断を併用した経尿道的膀胱腫瘍切除術(PDD-TURBT)の初期経験, ;;;;;;;;;;;;;;;;;;;;;;, Aug. 2022, 72, 3, 296
• 腎・泌尿器疾患診療における尿沈渣検査の重要性, ;, May 2023, 72回, np540
• 再発を繰り返す小児尖圭コンジローマの1例, ;;;;;;, Jun. 2023, 32, 2, 274
• 【どうする! 前立腺癌-多彩な治療薬をどう上手く使うか】nmCRPCの薬物治療　ダロルタミド, 鈴木 和浩, Oct. 2023, 77, 11, 888
• 術前MRIが有用だった陰茎折症の一例, ;;;;;;;;;;;;;;;;;;;;;, Nov. 2022, 72, 4, 424
• 当院で発生した水道水汚染に対する人工腎臓センターの対応, ;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 859
• シスプラチン奏功歴のあるBRCA2変異陽性前立腺神経内分泌癌症例にオラパリブを投与した1例, ;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 863
• 群馬大学における高リスク前立腺癌に対する重粒子線治療, ;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 863
• 骨転移を伴う進行性腎細胞癌に対してニボルマブ・カボザンチニブ併用療法が奏功した一例, ;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 876
• 当院におけるRTCによる看護専門外来の現状と今後の課題　新体制に伴う業務拡大に向けて, ;;;;, Sep. 2023, 58, 総会臨時, 326
• 前立腺癌の診断の進歩, ;;, Oct. 2023, 10, 2, 95
• 前立腺癌治療におけるデガレリクスの役割を再考する　心血管系リスクを考慮した治療の選択, 鈴木 和浩, Oct. 2023, 10, 2, 189
• 妊娠により心不全の増悪を認めた血液透析患者の2例, ;;;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 179
• 回腸導管ストーマからの出血で腸間膜静脈塞栓術を行った一例, ;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 179
• 膀胱全摘・回腸導管造設後の残存尿道に発生した小細胞癌の1例, ;;;;;;;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 181
• 群馬大学根治的膀胱全摘除術データベースを用いた術後予後予測モデルの確立, ;;;;;;;;;;, May 2023, 73, 2, 181
• 前立腺癌　診断から治療まで　最近のトピックスを含めて, 鈴木 和浩, Jul. 2023, 44, 2, 21
• 群馬県前立腺がん検診に対するCOVID19感染症の影響, ;;;;;;;;;, Jul. 2023, 32回, 35
• 群馬大学膀胱全摘除術データベースを用いた膀胱全出除術後予後予測モデルの確立, ;;;;;;;;;;, Jul. 2023, 32回, 42
• 神経線維腫症I型に発症した膀胱非悪性腫瘍の1例, ;;;;;;;;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 97
• 金属リングによる陰茎絞扼症を歯科口腔外科と連携し解除した一例, ;;;;;;;;;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 97
• 両側気腫性腎盂腎炎の一例, ;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 98
• 当院におけるMD-TESE(顕微鏡下精巣内精子回収術)導入について, ;;;;;;, Feb. 2023, 73, 1, 99
• 前立腺癌診断マーカーとしての[-2]proPSA関連インデックスの有用性の検討(Availability of [-2]proPSA related indices in a diagnosis of prostate cancer), ;;;;;;;;;;;;, Apr. 2023, 110回, AOP04
• ロボット鏡視下腎部分切除術における腎周囲固着脂肪と血中内、組織内性ホルモン濃度の関係(前向き観察研究)(The relationship between adherent perinephric fat and sex hormone levels in serum and fat tissue of patients treated by RAPN; prospective study), ;;;;;;;;;;;;, Apr. 2023, 110回, OP15
• 非転移性去勢抵抗性前立腺癌の重粒子線治療の後向き解析(Retrospective analysis of carbon ion radiotherapy for nonmetastatic castration-resistant prostate cancer), ;;;;;;;;;;;;, Apr. 2023, 110回, OP49
• 去勢抵抗性前立腺癌患者における新規マーカー[-2]proPSAのバイオロジーと有用性の検討(Biology and usefulness of [-2]proPSA as a prognostic marker in CRPC patients), ;;;;;;;;;;;;, Apr. 2023, 110回, OP70
• 群馬大学におけるエンフォルツマブベドチンの初期使用経験(Initial experience of Enfortumab Vedtin at Gunma University Hospital), ;;;;;;;;;;;;, Apr. 2023, 110回, PP21
• 膀胱憩室切除術後に発生した後腹膜尿路上皮癌の一例(Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report), ;;;;;;;;;;;;, Apr. 2023, 110回, PP26
• 放射線照射後に生体腎移植を行なった2例(Two cases of living renal transplantation after radiation therapy), ;;;;;;;;;;;;, Apr. 2023, 110回, PP36
• COVID-19感染により初期診断および治療が遅れた2症例(Two cases of delayed initial diagnosis and treatment due to COVID-19 infection), ;;;;;;;;;;;;, Apr. 2023, 110回, PP70
• 尿路上皮癌に対するFGFR阻害薬の耐性獲得後の新規治療薬の検討(Investigation of new therapeutic agents for FGFR inhibitor resistant urothelial cancer), ;;;;;;;, Sep. 2023, 82回, 1065
• 3ヶ所の病変を同時にRAPN施行したBirt-Hogg-Dube症候群疑いの一例, ;;;;;;;;;, Nov. 2023, 37回, P
• 腎移植後に発生したEBV陽性皮膚粘膜潰瘍(EBVMCU)の1例, ;;;;;;;;, Feb. 2024, 57回, 237
• コルヒチンによる炎症コントロール下でロボット支援左腎腫瘍切除術を施行し得た家族性地中海熱の一例, ;;;;;;;;;;;, Feb. 2021, 17, 臨増1, 168
• 前立腺癌診断における、[-2]proPSA関連インデックスとPI-RADSとの比較, ;;;;;;;;;;;;, Oct. 2023, 61回, O9
• 進行性腎細胞癌に対してアベルマブ・アキシチニブ併用療法施行した2症例, ;;;;;;;;;;;;;;;, Oct. 2023, 61回, P4
• エンフォルツマブ・ベドチンの群馬大学の初期使用経験からみた有害事象について, ;;;;;;;;;;;;;;, Oct. 2023, 61回, P24
• 回腸導管に生じた静脈瘤出血に対して画像下治療をおこなった肝硬変患者の一例, ;;;;;;;;;;, Oct. 2023, 61回, P26
• 膀胱憩室術後、後腹膜に発生した尿路上皮がんの一例, ;;;;;;;;, Oct. 2023, 61回, P26
• 群馬大学重粒子線医学センターにおける高リスク前立腺癌に対する重粒子線治療, ;;;;;;;;;;;;, Oct. 2023, 61回, P27
• ロボット支援根治的前立腺全摘術後の満足度に影響を及ぼす性機能の検討, ;;;;;;;;;;, Oct. 2023, 61回, P28
• 【Urological Pharmacotherapy　これ一冊でパーフェクト!!　泌尿器科薬物療法2024】前立腺癌　三剤併用療法　ADT+ドセタキセル+ダロルタミド, ;;, Apr. 2024, 37, 特別号, 137
• 前立腺癌治療の進歩, ;;, Apr. 2024, 11, 1, 1
• mCSPC薬物治療のup to date　Upfront治療時代のARASENSレジメンの意義と患者像, ;;;, Apr. 2024, 37, 4, 279
• 群馬県前立腺がん検診30年間における初回検診受診者の検討, ;;;;;;, Jul. 2024, 33回, 40
• 腎移植後EBウイルス持続感染中の透析患者に発生した平滑筋腫瘍の1例, ;;;;;;;;;;;;;;;;;;;, May 2024, 57, Suppl.1, 742
• 免疫抑制剤減量と放射線治療にて軽快した腎移植後EBV陽性皮膚粘膜潰瘍(EBV-positive mucocutaneous ulcer:EBVMCU)の1例, ;;;;;;;;;, May 2024, 57, Suppl.1, 742
• 根治切除不能な筋層浸潤性膀胱癌に対し,放射線治療を施行した一例, ;;;;;;;;;;;;;;;;;;, May 2024, 57, Suppl.1, 859
• シスプラチン・エトポシド療法を導入した遠隔転移を有する膀胱小細胞癌の2例, ;;;;;;;;;;;;;;;;;;;;;;;, Jun. 2024, 37, 6, 554
• 陰茎がんと鑑別を要した1期梅毒の1例, ;;;;;;;;;;;;;;;;;;;;;, Jun. 2024, 37, 6, 554
• ロボット支援根治的前立腺全摘術後の満足度に影響を及ぼす性機能の検討, ;;;;;;;;;;, Aug. 2023, 73, 3, 199
• 救急搬送で入院した非がん疾患の地域高齢者のアドバンスケアプランニング状況, ;;;;;;;, Aug. 2023, 73, 3, 246
• Round Table Discussion『前立腺癌診療ガイドライン2023年版』検診パート　改訂ポイントと今後の展望, ;;;, Apr. 2024, 7, 1, 05
• 群馬県前立腺がん検診・診療に対するCOVID19感染症の影響, ;;;;;;;;;;;;;, Jun. 2024, 37, 臨増, 728
• ニボルマブ・イピリムマブ併用療法が奏功した集合管癌の一例, ;;;;;;;;;;;;, Jun. 2024, 37, 臨増, 757
• BCG膀胱注入療法後に発症した結核性直腸周囲膿瘍の1例, ;;;;;;;;;;;;;;, Jun. 2024, 37, 臨増, 766
• 腎盂癌との鑑別が困難であったマントル細胞リンパ腫再発の1例, ;;;;;;;;;;;;;;, Jun. 2024, 37, 臨増, 768
• 尿道憩室が疑われた男性の1例, ;;;;;;;;;;;;;;, Jun. 2024, 37, 臨増, 773
• ロボット支援下根治的前立腺全摘術後の満足度に影響を及ぼす性機能の検討, ;;;;;;;;;;;;;;, Aug. 2024, 39, 2, 211
• 紹介された前立腺癌患者の院内合同カンファレンスによるT因子の再評価, ;;;;;;;, Aug. 2024, 37, 8, 924
• 補助診断マーカーprostate health index(phi)の前立腺癌診断における有用性, ;, Sep. 2024, 32, 1, 87
• 用手的な陰茎根部の絞扼が出血点の特定に有効であった陰茎折症の一例, ;;;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 318
• 陰嚢腫脹を主訴に来院した小児ネフローゼ症候群の1例, ;;;;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 318
• 群馬大学関連病院における,COVID-19感染拡大前後での泌尿器科悪性腫瘍及び手術数の変化, ;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 320
• TMB-high膀胱小細胞癌にペムブロリズマブ療法を行った一例(A case of TMB-high small cell carcinoma of the bladder treated with pembrolizumab), ;;;, Sep. 2024, 83回, P
• 前立腺癌放射線治療・ホルモン療法の進歩, ;;, Oct. 2024, 11, 2, 103
• 前立腺癌診断における"phiファーストアプローチ"による不要な前立腺生検の回避, ;;;;;;;;;;;;, Oct. 2024, 62回, O21
• 前立腺癌に対する重粒子線治療16回照射の長期治療成績, ;;;;;;;, Oct. 2024, 62回, O24
• 傾向スコアマッチング法を用いたRARPと重粒子線治療後の性機能QOLスコア比較研究, ;;;;;;;;;;;, Oct. 2024, 62回, O24
• 化学療法が奏効した腫瘍遺伝子変異最高スコア膀胱小細胞癌に免疫療法を施行した一例, ;;;;;;;;;;;;;;, Oct. 2024, 62回, P7
• 【透析医療とリスク管理】災害時・平時の透析液用の水確保, ;;, Nov. 2024, 34, 4, 8
• Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease., Hamano Tatsuya;Matsui Hiroshi;Sekine Yoshitaka;Ohtake Nobuaki;Nakata Seiji;Suzuki Kazuhiro, Jun. 2010, The Journal of urology, 184, 2

  DOI
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., Arai Seiji;Miyashiro Yoshimichi;Shibata Yasuhiro;Tomaru Yukio;Kobayashi Mikio;Honma Seijiro;Suzuki Kazuhiro, Dec. 2010, Steroids, 76, 3

  DOI
• Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., Koike Hidekazu;Morikawa Yasuyuki;Sekine Yoshitaka;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, Feb. 2011, The Journal of urology, 185, 4

  DOI
• High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., Sekine Yoshitaka;Osei-Hwedieh David;Matsuda Kant;Raghavachari Nalini;Liu Delong;Furuya Yosuke;Koike Hidekazu;Suzuki Kazuhiro;Remaley Alan T, Mar. 2011, The Prostate, 71, 14

  DOI
• Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate., Okamoto Masahiko;Ishikawa Hitoshi;Ebara Takeshi;Kato Hiroyuki;Tamaki Tomoaki;Akimoto Tetsuo;Ito Kazuto;Miyakubo Mai;Yamamoto Takumi;Suzuki Kazuhiro;Takahashi Takeo;Nakano Takashi, May 2011, International journal of radiation oncology, biology, physics, 82, 2

  DOI
• [Cholesterol granuloma of the kidney: a case report]., Okamoto Kohei;Hatori Motoaki;Tomita Kensuke;Yokoyama Yoshinari;Makino Takeaki;Hirono Masanori;Muramatsu Kazumichi;Arai Seiji;Morikawa Yasuyuki;Miyakubo Mai;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 102, 3

  DOI
• [Prostate cancer screening in Japan: current status and perspective]., Suzuki Kazuhiro, Nihon rinsho. Japanese journal of clinical medicine, 69 Suppl 5
• Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation., Morikawa Yasuyuki;Koike Hidekazu;Sekine Yoshitaka;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Feb. 2012, Biochemical and biophysical research communications, 419, 3

  DOI
• Luteinizing hormone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: implications for the effect of LH on the adrenal glands., Nishii Masahiro;Nomura Masashi;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Oyama Tetsunari;Suzuki Kazuhiro, Apr. 2012, Journal of andrology, 33, 6

  DOI
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range., Ito Kazuto;Miyakubo Mai;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, Aug. 2012, World journal of urology, 31, 2

  DOI
• [Prostate cancer-the role of docetaxel on castration-resistant prostate cancer: evaluation of efficacy and subsequent treatment]., Suzuki Kazuhiro, Gan to kagaku ryoho. Cancer & chemotherapy, 39, 10
• [Septic shock following flexible transurethral lithotripsy showing favourable response after multidisciplinary treatment mainly composed of recombinant thrombomodulin : a case report]., Kato Haruo;Shibata Yasuhiro;Suzuki Tomomi;Ito Kazuto;Suzuki Kazuhiro, Hinyokika kiyo. Acta urologica Japonica, 58, 9
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., Magari Tomohiro;Shibata Yasuhiro;Arai Seiji;Kashiwagi Bunzo;Suzuki Kazuhiro, Nov. 2012, Scandinavian journal of urology, 47, 3

  DOI
• [Clinical and basic aspects of familial prostate cancer]., Suzuki Kazuhiro;Matsui Hiroshi;Ohtake Nobuaki, Gan to kagaku ryoho. Cancer & chemotherapy, 40, 2
• Androgen receptor coactivator p120 subtype β is highly expressed in prostate cancer., Muramatsu Kazumichi;Matsui Hiroshi;Sekine Yoshitaka;Koike Hidekazu;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Feb. 2013, Prostate international, 1, 1

  DOI
• Simple method for preventing inguinal hernias after radical retropubic prostatectomy., Koike Hidekazu;Matsui Hiroshi;Morikawa Yasuyuki;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Jun. 2013, Prostate international, 1, 2

  DOI
• Chlormadinone acetate is effective for hot flush during androgen deprivation therapy., Koike Hidekazu;Morikawa Yasuyuki;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Sep. 2013, Prostate international, 1, 3

  DOI
• Chronic expanding hematoma in the retroperitoneal space: a case report., Syuto Takahiro;Hatori Motoaki;Masashi Nomura;Sekine Yoshitaka;Suzuki Kazuhiro, Nov. 2013, BMC urology, 13

  DOI
• Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels., Magari Tomohiro;Shibata Yasuhiro;Arai Seiji;Kashiwagi Bunzo;Suzuki Keiji;Suzuki Kazuhiro, Asian journal of andrology, 16, 3

  DOI
• Suicide attempt with an overdose of sunitinib., Arai Seiji;Matsui Hiroshi;Ohki Ryo;Miyazawa Yoshiyuki;Koike Hidekazu;Hashita Tadahiro;Katsuyama Yoshihiko;Sekine Yoshitaka;Nomura Masashi;Shibata Yasuhiro;Hatori Motoaki;Ito Kazuto;Yamamoto Koujirou;Ohmori Shigeru;Suzuki Kazuhiro, British journal of clinical pharmacology, 78, 4

  DOI
• YM155 reverses rapamycin resistance in renal cancer by decreasing survivin., Koike Hidekazu;Nitta Takashi;Sekine Yoshitaka;Arai Seiji;Furuya Yosuke;Nomura Masashi;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Oyama Tetsunari;Suzuki Kazuhiro, Jun. 2014, Journal of cancer research and clinical oncology, 140, 10

  DOI
• Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma., Ishizuka Tamotsu;Hisada Takeshi;Hatori Motoaki;Koike Akio;Hanabuchi Kikuo;Matsuzaki Shinichi;Kamide Yosuke;Utsugi Mitsuyoshi;Aoki Haruka;Yoshino Reiko;Yanagitani Noriko;Koga Yasuhiko;Ono Akihiro;Kaira Kyoichi;Sunaga Noriaki;Dobashi Kunio;Tsuburai Takahiro;Akiyama Kazuo;Yamada Masanobu;Suzuki Kazuhiro;Mori Masatomo, Jul. 2014, Inflammation research : official journal of the European Histamine Research Society ... [et al.], 63, 9

  DOI
• Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan., Onozawa Mizuki;Hinotsu Shiro;Tsukamoto Taiji;Oya Mototsugu;Ogawa Osamu;Kitamura Tadaichi;Suzuki Kazuhiro;Naito Seiji;Namiki Mikio;Nishimura Kazuo;Hirao Yoshihiko;Akaza Hideyuki, Aug. 2014, Japanese journal of clinical oncology, 44, 10

  DOI
• A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer., Suzuki Kazuhiro;Ozono Seiichiro;Yamaguchi Akito;Koike Hidekazu;Matsui Hiroshi;Nagata Masao;Takubo Takatoshi;Miyashita Kana;Matsushima Takafumi;Akaza Hideyuki, Dec. 2014, Cancer chemotherapy and pharmacology, 75, 2

  DOI
• Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial., Saad Fred;Fizazi Karim;Jinga Viorel;Efstathiou Eleni;Fong Peter C;Hart Lowell L;Jones Robert;McDermott Raymond;Wirth Manfred;Suzuki Kazuhiro;MacLean David B;Wang Ling;Akaza Hideyuki;Nelson Joel;Scher Howard I;Dreicer Robert;Webb Iain J;de Wit Ronald; , Feb. 2015, The Lancet. Oncology, 16, 3

  DOI
• [Heavy ion radiotherapy for prostate cancer -- the role of hormone therapy]., Suzuki Kazuhiro;Matsui Hiroshi;Kawamura Hidemasa;Ohno Tatsuya, Gan to kagaku ryoho. Cancer & chemotherapy, 42, 2
• Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer., Nozawa Masahiro;Mukai Hirofumi;Takahashi Shunji;Uemura Hiroji;Kosaka Takeo;Onozawa Yusuke;Miyazaki Jun;Suzuki Kazuhiro;Okihara Koji;Arai Yoichi;Kamba Tomomi;Kato Masashi;Nakai Yasutomo;Furuse Hiroshi;Kume Haruki;Ide Hisamitsu;Kitamura Hiroshi;Yokomizo Akira;Kimura Takahiro;Tomita Yoshihiko;Ohno Keiji;Kakehi Yoshiyuki, Mar. 2015, International journal of clinical oncology, 20, 5

  DOI
• Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor., Kato Haruo;Sekine Yoshitaka;Furuya Yosuke;Miyazawa Yoshiyuki;Koike Hidekazu;Suzuki Kazuhiro, Apr. 2015, Biochemical and biophysical research communications, 461, 1

  DOI
• [II. Radiotherapy for prostate cancer-the role of multi-disciplinary team]., Suzuki Kazuhiro;Matsui Hiroshi;Kawamura Hidemasa;Hirado Junko;Shibuya Kei;Taniyama Naoko;Hashimoto Tomomi;Kanai Tatsuaki;NAkano Takashi;Ohno Tatsuya, Gan to kagaku ryoho. Cancer & chemotherapy, 42, 1
• Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist., Miyazawa Yoshiyuki;Kato Haruo;Arai Seiji;Furuya Yosuke;Sekine Yoshitaka;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Jul. 2015, Basic and clinical andrology, 25

  DOI
• Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association., Kanayama Hiro-Omi;Fukumori Tomoharu;Fujimoto Hiroyuki;Nakanishi Hiroyuki;Ohyama Chikara;Suzuki Kazuhiro;Nishiyama Hiroyuki;Eto Masatoshi;Miki Tsuneharu;Kamoi Kazumi;Kubota Yoshinobu;Takahashi Satoru;Homma Yukio;Naito Seiji, International journal of urology : official journal of the Japanese Urological Association, 22, 9

  DOI
• Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life., Ishikawa Hitoshi;Katoh Hiroyuki;Kaminuma Takuya;Kawamura Hidemasa;Ito Kazuto;Matsui Hiroshi;Hirato Junko;Shimizu Nobuaki;Takezawa Yutaka;Tsuji Hiroshi;Suzuki Kazuhiro;Ohno Tatsuya;Nakano Takashi; , Anticancer research, 35, 10
• Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan., Suzuki Kazuhiro;Namiki Mikio;Fujimoto Tsukasa;Takabayashi Nobuyoshi;Kudou Kentarou;Akaza Hideyuki, Oct. 2015, Japanese journal of clinical oncology, 45, 12

  DOI
• Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer., Miyoshi Yasuhide;Uemura Hiroji;Umemoto Susumu;Sakamaki Kentaro;Taguri Masataka;Suzuki Kazuhiro;Shibata Yasuhiro;Masumori Naoya;Ichikawa Tomohiko;Mizokami Atsushi;Sugimura Yoshiki;Nonomura Norio;Sakai Hideki;Honma Seijiro;Harada Masaoki;Kubota Yoshinobu, Nov. 2015, The Prostate, 76, 4

  DOI
• Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins., Furuya Yosuke;Sekine Yoshitaka;Kato Haruo;Miyazawa Yoshiyuki;Koike Hidekazu;Suzuki Kazuhiro, Mar. 2016, Prostate international, 4, 2

  DOI
• Asia prostate cancer study (A-CaP Study) launch symposium., Akaza Hideyuki;Hirao Yoshihiko;Kim Choung-Soo;Oya Mototsugu;Ozono Seiichiro;Ye Dingwei;Cooperberg Matthew;Hinotsu Shiro;Lee Ji Youl;Zhu Gang;Namiki Mikio;Horie Shigeo;Chung Byung Ha;Chen Chung-Hsin;Fai Ng Chi;Hakim Lukman;Chiong Edmund;Letran Jason;Umbas Rainy;Suzuki Kazuhiro;Nishimura Kazuo;Ong Teng Aik;Lojanapiwat Bannakij;Wu Tong-Lin;Kim Wun-Jae;Murphy Declan;Ogawa Osamu;Carroll Peter;Naito Seiji;Tsukamoto Taiji, Mar. 2016, Prostate international, 4, 3

  DOI
• Germline Variants of Prostate Cancer in Japanese Families., Hayano Takahide;Matsui Hiroshi;Nakaoka Hirofumi;Ohtake Nobuaki;Hosomichi Kazuyoshi;Suzuki Kazuhiro;Inoue Ituro, Oct. 2016, PloS one, 11, 10

  DOI
• Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy., Shibata Yasuhiro;Kurihara Sota;Arai Seiji;Kato Haruo;Suzuki Tomomi;Miyazawa Yoshiyuki;Koike Hidekazu;Ito Kazuto;Nakamura Tetsuya;Suzuki Kazuhiro, Oct. 2016, Journal of investigative surgery : the official journal of the Academy of Surgical Research, 30, 4

  DOI
• Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer., Kato Haruo;Furuya Yosuke;Miyazawa Yoshiyuki;Miyao Takeshi;Syuto Takahiro;Nomura Masashi;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Anticancer research, 36, 11

  DOI
• Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells., Miyazawa Yoshiyuki;Sekine Yoshitaka;Kato Haruo;Furuya Yosuke;Koike Hidekazu;Suzuki Kazuhiro, Nov. 2016, The Prostate, 77, 4

  DOI
• YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin., Nitta Takashi;Koike Hidekazu;Miyao Takeshi;Miyazawa Yoshiyuki;Kato Haruo;Furuya Yosuke;Sekine Yoshitaka;Suzuki Kazuhiro, Anticancer research, 37, 1

  DOI
• Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content., Shibata Yasuhiro;Arai Seiji;Miyazawa Yoshiyuki;Shuto Takahiro;Nomura Masashi;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Ito Kazuto;Suzuki Kazuhiro, Feb. 2017, The Prostate, 77, 6

  DOI
• Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels., Okamoto Kohei;Sekine Yositaka;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Apr. 2015, Basic and clinical andrology, 25

  DOI
• [A CASE OF GROWING TERATOMA SYNDROME]., Baba Kyoko;Sekine Yoshitaka;Kurihara Sota;Koike Hidekazu;Matsui Hiroshi;Nakazato Haruki;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro;Nishii Masahiro;Mashimo Toru;Okamura Keigo;Hirato Junko, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 107, 2

  DOI
• Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL., Fujizuka Yuji;Ito Kazuto;Oki Ryo;Suzuki Rie;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, May 2017, International journal of urology : official journal of the Japanese Urological Association, 24, 8

  DOI
• Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab., Miyazawa Yoshiyuki;Sekine Yoshitaka;Syuto Takahiro;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Anticancer research, 37, 7

  DOI
• A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients., Miyazawa Yoshiyuki;Sekine Yoshitaka;Syuto Takahiro;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Aug. 2017, BMC urology, 17, 1

  DOI
• Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism., Sekine Yoshitaka;Nakayama Hiroshi;Miyazawa Yoshiyuki;Kato Haruo;Furuya Yosuke;Arai Seiji;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Dec. 2017, Oncology letters, 15, 3

  DOI
• Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer., Miyazawa Yoshiyuki;Sekine Yoshitaka;Syuto Takahiro;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, In vivo (Athens, Greece), 32, 2

  DOI
• Assessment of antimicrobiral prophylaxis in transperineal prostate biopsy: A single-center retrospective study of 485 cases., Baba Kyoko;Sekine Yoshitaka;Miyazawa Yoshiyuki;Syuto Takahiro;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 24, 8

  DOI
• Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screening., Oki Ryo;Ito Kazuto;Suzuki Rie;Fujizuka Yuji;Arai Seiji;Miyazawa Yoshiyuki;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, May 2018, International journal of cancer, 143, 7

  DOI
• Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching., Onozawa Mizuki;Akaza Hideyuki;Hinotsu Shiro;Oya Mototsugu;Ogawa Osamu;Kitamura Tadaichi;Suzuki Kazuhiro;Naito Seiji;Namiki Mikio;Nishimura Kazuo;Hirao Yoshihiko;Tsukamoto Taiji, Aug. 2018, Cancer medicine, 7, 10

  DOI
• [Bone and calcium metabolism associated with malignancy. Bone metastasis of prostate cancer:overview of clinical features and treatments.]., Suzuki Kazuhiro;Miyazawa Yoshiyuki, Clinical calcium, 28, 11
• Prevalence and clinical characteristics of overactive bladder in systemic sclerosis., Motegi Sei-Ichiro;Sekiguchi Akiko;Sekine Yoshitaka;Nakayama Hiroshi;Suzuki Kazuhiro;Ishikawa Osamu, Apr. 2019, Modern rheumatology, 30, 2

  DOI
• Improved Arterial Preservation Achieved by Combined Use of Indocyanine Green Angiography and Doppler Detector During Microsurgical Subinguinal Varicocelectomy., Kurihara Sota;Shibata Yasuhiro;Arai Seiji;Sekine Yoshitaka;Miyazawa Yoshiyuki;Koike Hidekazu;Matsui Hiroshi;Ito Kazuto;Suzuki Kazuhiro;Nakamura Tetsuya, May 2019, Journal of investigative surgery : the official journal of the Academy of Surgical Research, 33, 10

  DOI
• Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening., Ito Kazuto;Oki Ryo;Sekine Yoshitaka;Arai Seiji;Miyazawa Yoshiyuki;Shibata Yasuhiro;Suzuki Kazuhiro;Kurosawa Isao, Jun. 2019, International journal of urology : official journal of the Japanese Urological Association, 26, 10

  DOI
• Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study., Kubo Nobuteru;Kawamura Hidemasa;Oike Takahiro;Sato Hiro;Iwanaga Mototaro;Mizukami Tatsuji;Adachi Akiko;Matsui Hiroshi;Ito Kazuto;Suzuki Kazuhiro;Nakano Takashi, In vivo (Athens, Greece), 33, 4

  DOI
• An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression., Miyazawa Yoshiyuki;Sekine Yoshitaka;Shimizu Nobuaki;Takezawa Yutaka;Nakamura Toshiyuki;Miyao Takeshi;Nakayama Hiroshi;Kurihara Sota;Syuto Takahiro;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, Jul. 2019, The Prostate, 79, 12

  DOI
• Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study., Suzuki Kazuhiro;Matsubara Nobuaki;Kazama Hirotaka;Seto Takeshi;Tsukube Shoko;Matsuyama Hideyasu, Japanese journal of clinical oncology, 49, 12

  DOI
• Phase I trial of TAK-385 in hormone treatment-naïve Japanese patients with nonmetastatic prostate cancer., Suzuki Hiroyoshi;Uemura Hiroji;Mizokami Atsushi;Hayashi Narihiko;Miyoshi Yasuhide;Nagamori Satoshi;Enomoto Yutaka;Akaza Hideyuki;Asato Takayuki;Kitagawa Tadayuki;Suzuki Kazuhiro, Aug. 2019, Cancer medicine, 8, 13

  DOI
• Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml., Ito Kazuto;Yokomizo Akira;Tokunaga Shoji;Arai Gaku;Sugimoto Mikio;Akakura Koichiro;Hasumi Hisashi;Sakai Hideki;Ouraji Akiko;Oki Ryo;Kashiwagi Eiji;Kobori Yoshitomo;Hirama Hiromi;Kitoh Hiroki;Uemura Hiroji;Hakariya Tomoaki;Suzuki Kazuhiro; , Aug. 2019, The Journal of urology, 203, 1

  DOI
• Quality of life in prostate cancer patients receiving particle radiotherapy: A review of the literature., Kawamura Hidemasa;Kubo Nobuteru;Sato Hiro;Miyasaka Yuhei;Matsui Hiroshi;Ito Kazuto;Suzuki Kazuhiro;Ohno Tatsuya, Sep. 2019, International journal of urology : official journal of the Japanese Urological Association, 27, 1

  DOI
• Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702"., Kawamura Hidemasa;Kubo Nobuteru;Sato Hiro;Mizukami Tatsuji;Katoh Hiroyuki;Ishikawa Hitoshi;Ohno Tatsuya;Matsui Hiroshi;Ito Kazuto;Suzuki Kazuhiro;Nakano Takashi; , Jan. 2020, BMC cancer, 20, 1

  DOI
• Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer., Darwis Narisa Dewi Maulany;Oike Takahiro;Kawamura Hidemasa;Kawahara Masahiro;Kubo Nobuteru;Sato Hiro;Miyasaka Yuhei;Katoh Hiroyuki;Ishikawa Hitoshi;Matsui Hiroshi;Miyazawa Yoshiyuki;Ito Kazuto;Suzuki Kazuhiro;Gondhowiardjo Soehartati;Nakano Takashi;Ohno Tatsuya, Mar. 2020, Cancers, 12, 3

  DOI
• Cabazitaxel in patients aged ≥80 years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan., Matsubara Nobuaki;Suzuki Kazuhiro;Kazama Hirotaka;Tsukube Shoko;Seto Takeshi;Matsuyama Hideyasu, Mar. 2020, Journal of geriatric oncology, 11, 7

  DOI
• Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial., Ito Kazuto;Kobayashi Mikio;Komiyama Motokiyo;Naito Seiji;Nishimura Kazuo;Yonese Junji;Hashine Katsuyoshi;Saito Shiro;Arai Gaku;Shinohara Mitsuru;Masumori Naoya;Shimizu Nobuaki;Satoh Takefumi;Yamauchi Atsushi;Tochigi Tatsuo;Takezawa Yutaka;Fujimoto Hiroyuki;Yokomizo Akira;Kakimoto Ken-Ichi;Fukui Iwao;Karasawa Katsuyuki;Tsukamoto Taiji;Nozaki Miwako;Hasumi Masaru;Ishiyama Hiromichi;Ohtani Mikinobu;Kuwahara Masaaki;Harada Masaoki;Ohashi Yasuo;Kotake Toshihiko;Kakizoe Tadao;Suzuki Kazuhiro;Yamanaka Hidetoshi; , Jun. 2020, Cancer, 126, 17

  DOI
• Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m2) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillance study., Matsuyama Hideyasu;Matsubara Nobuaki;Kazama Hirotaka;Seto Takeshi;Tsukube Shoko;Suzuki Kazuhiro, Jul. 2020, BMC cancer, 20, 1

  DOI
• Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug., Endo Yukie;Oka Aina;Uehara Akihito;Toki Sayaka;Motegi Sei-Ichiro;Ishikawa Osamu;Miyazawa Yoshiyuki;Suzuki Kazuhiro, Jul. 2020, The Journal of dermatology, 47, 10

  DOI
• Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases., Takahashi Shunji;Kinuya Seigo;Nonomura Norio;Shinohara Nobuo;Suzuki Kazuhiro;Suzuki Hiroyoshi;Nakamura Katsumasa;Satoh Takefumi;Tateishi Ukihide;Yoneda Toshiyuki;Horikoshi Hiroyuki;Igawa Tsukasa;Kamai Takao;Koizumi Mitsuru;Kosaka Takeo;Matsubara Nobuaki;Miyake Hideaki;Mizokami Atsushi;Mizowaki Takashi;Nakamura Naoki;Nozawa Masahiro;Takahashi Takeo;Uemura Hiroji;Uemura Motohide;Yokomizo Akira;Yoshimura Mana;Kakehi Yoshiyuki, Dec. 2018, Oncology and therapy, 6, 2

  DOI
• YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression., Miyao Takeshi;Koike Hidekazu;Sekine Yoshitaka;Ohtsu Akira;Oka Daisuke;Suzuki Kazuhiro, Anticancer research, 40, 9

  DOI
• Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial., Uemura Hiroji;Matsushima Hisashi;Kobayashi Kazuki;Mizusawa Hiroya;Nishimatsu Hiroaki;Fizazi Karim;Smith Matthew;Shore Neal;Tammela Teuvo;Tabata Ken-Ichi;Matsubara Nobuaki;Iinuma Masahiro;Uemura Hirotsugu;Oya Mototsugu;Momma Tetsuo;Kawakita Mutsushi;Fukasawa Satoshi;Kobayashi Tadahiro;Kuss Iris;Le Berre Marie-Aude;Snapir Amir;Sarapohja Toni;Suzuki Kazuhiro, Nov. 2020, International journal of clinical oncology, 26, 3

  DOI
• Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese Institute., Miyazawa Yoshiyuki;Sekine Yoshitaka;Arai Seiji;Oka Daisuke;Nakayama Hiroshi;Syuto Takahiro;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, In vivo (Athens, Greece), 35, 1

  DOI
• [Ⅱ.Development of Anti-Neoplastic Agents for Prostate Cancer-Recent Trend and Perspectives]., Suzuki Kazuhiro;Miyazawa Yoshiyuki, Gan to kagaku ryoho. Cancer & chemotherapy, 48, 1
• Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors., Saad Fred;Bögemann Martin;Suzuki Kazuhiro;Shore Neal, Feb. 2021, Prostate cancer and prostatic diseases, 24, 2

  DOI
• Understanding Treatment Strategies and Preferences in Nonmetastatic Castration-Resistant Prostate Cancer From the Japanese Physician Perspective., Suzuki Kazuhiro;Grillo Vince;Chen Yirong;Singh Shikha;Ledesma Dianne Athene, JCO global oncology, 7

  DOI
• Baseline characteristics may impact treatment duration of cabazitaxel in patients with mCRPC: a subanalysis of data from a post-marketing surveillance., Matsubara Nobuaki;Matsuyama Hideyasu;Kazama Hirotaka;Seto Takeshi;Sunaga Yoshinori;Suzuki Kazuhiro, Japanese journal of clinical oncology, 54, 1

  DOI
• Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells., Miyazawa Yoshiyuki;Sekine Yoshitaka;Oka Daisuke;Nakazawa Shun;Tsuji Yusuke;Nakayama Hiroshi;Suzuki Kazuhiro, Anticancer research, 43, 12

  DOI
• Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells via Inhibition of RAD51 Expression., Oka Daisuke;Sekine Yoshitaka;Tsuji Yusuke;Nakayama Hiroshi;Miyazawa Yoshiyuki;Arai Seiji;Koike Hidekazu;Suzuki Kazuhiro, Anticancer research, 44, 1

  DOI
• A case of anterior urethral polyp after transurethral resection of prostate, ;;;;;, Nov. 2002, 56, 12, 1089, 1091

  DOI
• Septic Shock Following Flexible Transurethral Lithotripsy Showing Favourable Response after Multidisciplinary Treatment Mainly Composed of Recombinant Thrombomodulin : A Case Report, Kato, Haruo;Shibata, Yasuhiro;Suzuki, Tomomi;Ito, Kazuto;Suzuki, Kazuhiro, Sep. 2012, Hinyokika Kiyo, 58, 9, 499, 502
• 症例 慢性骨髄性白血病に伴う持続勃起症, ;;;;;, Jun. 2014, 68, 7, 523, 526

  DOI
• Endocrine therapy for prostate cancer:history and perspective, ;, Apr. 2015, 69, 5, 330, 333

  DOI
• A CASE OF GROWING TERATOMA SYNDROME, Baba Kyoko;Sekine Yoshitaka;Kurihara Sota;Koike Hidekazu;Matsui Hiroshi;Nakazato Haruki;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro;Nishii Masahiro;Mashimo Toru;Okamura Keigo;Hirato Junko, 2016, The Japanese Journal of Urology, 107, 2, 115, 120

  DOI
• 特集 泌尿器科医のためのゲノム腫瘍学入門─時代に取り残されるな 遺伝性前立腺腫瘍, ;;, Oct. 2018, 72, 11, 902, 905

  DOI
• Usefulness of PSA screening in outpatients with bladder cancer : Preliminary results, KUROKAWA Kohei;SUZUKI Kazuhiro;OKAZAKI Hiroshi;ITO Kazuto;SHIONO Akihiko;FUKABORI Yoshitastu;YAMANAKA Hidetoshi, May 2002, Int. J. Urol., 9, 5, 237, 240
• Usefulness of prostate-specific antigen velocity in screening for prostate cancer, ITO Kazuto;YAMAMOTO Takumi;OHI Masaru;KUBOTA Yutaka;FUKABORI Yoshitatsu;KUROKAWA Kohei;SUZUKI Kazuhiro;YAMANAKA Hidetoshi, Jun. 2002, Int. J. Urol., 9, 6, 316, 321
• Autopsy findings of patients with urological neoplasms, ONO Yoshihiro;OZAWA Masashi;SUZUKI Koichi;OKAZAKI Hiroshi;TAMURA Yoshimi;SUZUKI Takanori;SUZUKI Kazuhiro;OGAWA Akira;SUGIHARA Shiro, Oct. 2002, Int J Clin Oncol., 7, 5, 301, 305
• Preliminary results of a monitoring system to confirm the preservation of cavernous nerves, KUROKAWA KOHEI;SUZUKI TAKANORI;SUZUKI KAZUHIRO;TERADA NAOKI;ITO KAZUTO;YOSHIKAWA DAISUKE;ARAI YOICHI;YAMANAKA HIDETOSHI, Mar. 2003, 10, 3, 136, 140
• 群馬大学医学部附属病院におけるロボット支援腹腔鏡下前立腺全摘(RALP)術の短期成績, ;;;;;;;;;;;;;, May 2020, 70, 2, 83
• 開放性腎生検後、広範な後腹膜気腫を認めた1例, ;;;;;;;;;;;;, May 2020, 70, 2, 163
• ニボルマブ・イピリムマブ併用療法後に生じた肝障害の一例, ;;;;;;;;;;;, May 2020, 70, 2, 168
• 当院におけるロボット支援腎部分切除術(RAPN)の検討, ;;;;;;;;;;;, Jun. 2020, 33, 臨増, 899
• 進行性腎細胞癌に対するイピリムマブ・ニボルマブ併用療法の初期経験, ;;;;;;;;;;;;, Jun. 2020, 33, 臨増, 910
• 化学療法(CDDP+VP-16)が著効した前立腺神経内分泌癌の一例, ;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 226
• 診断に苦慮した前立腺孤立性線維性腫瘍の一例, ;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 226
• 腎盂腫瘍との鑑別を要した後腹膜原発悪性リンパ腫の1例, ;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231
• 絨毛癌症候群を考慮しmodified PE療法を施行した一例, ;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231
• 精巣腫瘍化学療法後にテストステロン負荷試験を施行した一例, ;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231
• COVID-19感染症拡大後の群馬大学関連病院における泌尿器科疾患及び手術数の変化, ;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 232
• ロボット支援腹腔鏡下前立腺全摘術(RALP)後3年間における満足度に影響を及ぼす勃起機能の検討, ;;;;;;;;;;;;;, Aug. 2021, 71, 3, 232
• BRCA遺伝子検査と前立腺癌, 鈴木 和浩, Aug. 2021, 71, 3, 233
• COVID-19感染症拡大後の群馬大学関連病院における泌尿器科疾患及び手術数の変化, ;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 259
• 献腎移植の希望と現実, ;;;;;;;, Feb. 2022, 55回, 186
• 34年前に全骨盤照射施行後、生体腎移植を施行した1例, ;;;;;;;;, Feb. 2022, 55回, 300
• 持続勃起症に対して緊急で亀頭シャント術を施行した一例, ;;;;;;;;;;;;;;;;;;;;;;, Feb. 2022, 72, 1, 119
• 群馬大学医学部附属病院泌尿器科における生体腎移植100例の治療成績, ;;;;;;;;;, Feb. 2022, 72, 1, 121
• 当院におけるRALP後の尿禁制回復に関与する因子の検討, ;;;;;;;;, Nov. 2018, 32回, P
• 当院におけるロボット支援腹腔鏡下腎部分切除術の検討, ;;;;;;;, Nov. 2018, 32回, P
• 腹腔鏡下に摘出した後腹膜原発Castleman病の1例, ;;;;;;;;, Nov. 2018, 32回, P
• 日高病院でのPNL、ECIRS導入期5年間における治療効果と安全性の検討, ;;;;;;;;;, Nov. 2018, 32回, P
• 当院で施行したロボット支援腎部分切除術における固着脂肪とMAP scoreについての検討, ;;;;;;;;;, Nov. 2019, 33回, P
• 片側同時性腎腫瘍に対して一期的にロボット支援腹腔鏡下腎部分切除術を施行した1例, ;;;;;;;;;, Nov. 2019, 33回, P
• 当院で施行したロボット支援腎部分切除術の検討, ;;;;;;;;;, Nov. 2020, 34回, P
• 絨毛癌に伴うhCG著明高値により甲状腺中毒症を発症した1症例, ;;;;;;;;;;;;;;, Mar. 2022, 97, 5, 1149
• シスプラチン耐性膀胱癌に対する豆乳、チーズおよびビタミンCを混合したオリジナルこんにゃくゼリーの抗腫瘍効果と補完効果, ;;;, Mar. 2022, 19, 1, 15
• 術前MRIが有用だった陰茎折症の一例, ;;;;;;;;;;;;;;;;;;;;;, Nov. 2022, 72, 4, 424
• 神経線維腫症I型に発症した膀胱非悪性腫瘍の1例, ;;;;;;;;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 97
• 金属リングによる陰茎絞扼症を歯科口腔外科と連携し解除した一例, ;;;;;;;;;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 97
• 両側気腫性腎盂腎炎の一例, ;;;;;;;;;;;;;;, Feb. 2023, 73, 1, 98
• 当院におけるMD-TESE(顕微鏡下精巣内精子回収術)導入について, ;;;;;;, Feb. 2023, 73, 1, 99
• 妊娠により心不全の増悪を認めた血液透析患者の2例, ;;;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 179
• 回腸導管ストーマからの出血で腸間膜静脈塞栓術を行った一例, ;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 179
• 膀胱全摘・回腸導管造設後の残存尿道に発生した小細胞癌の1例, ;;;;;;;;;;;;;;;;;;;;;;;;;;;, May 2023, 73, 2, 181
• 群馬大学根治的膀胱全摘除術データベースを用いた術後予後予測モデルの確立, ;;;;;;;;;;, May 2023, 73, 2, 181
• 前立腺がんの早期発見と新しい治療, 鈴木 和浩, May 2022, 5回, 40
• 腎・泌尿器疾患診療における尿沈渣検査の重要性, ;, May 2023, 72回, np540
• Wilms腫瘍に対する全腹部照射から40年後に生体腎移植を行った一例, ;;;;;;;;;;;;, May 2023, 56, Suppl.1, 699
• 妊娠経過中に慢性心不全の急性増悪を認めた血液透析患者の1例, ;;;;;;;;;;;;;;;;;;;, May 2023, 56, Suppl.1, 763
• 前立腺癌診断マーカーとしての[-2]proPSA関連インデックスの有用性の検討(Availability of [-2]proPSA related indices in a diagnosis of prostate cancer), ;;;;;;;;;;;;, Apr. 2023, 110回, AOP04
• ロボット鏡視下腎部分切除術における腎周囲固着脂肪と血中内、組織内性ホルモン濃度の関係(前向き観察研究)(The relationship between adherent perinephric fat and sex hormone levels in serum and fat tissue of patients treated by RAPN; prospective study), ;;;;;;;;;;;;, Apr. 2023, 110回, OP15
• 非転移性去勢抵抗性前立腺癌の重粒子線治療の後向き解析(Retrospective analysis of carbon ion radiotherapy for nonmetastatic castration-resistant prostate cancer), ;;;;;;;;;;;;, Apr. 2023, 110回, OP49
• 去勢抵抗性前立腺癌患者における新規マーカー[-2]proPSAのバイオロジーと有用性の検討(Biology and usefulness of [-2]proPSA as a prognostic marker in CRPC patients), ;;;;;;;;;;;;, Apr. 2023, 110回, OP70
• 群馬大学におけるエンフォルツマブベドチンの初期使用経験(Initial experience of Enfortumab Vedtin at Gunma University Hospital), ;;;;;;;;;;;;, Apr. 2023, 110回, PP21
• 膀胱憩室切除術後に発生した後腹膜尿路上皮癌の一例(Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report), ;;;;;;;;;;;;, Apr. 2023, 110回, PP26
• 放射線照射後に生体腎移植を行なった2例(Two cases of living renal transplantation after radiation therapy), ;;;;;;;;;;;;, Apr. 2023, 110回, PP36
• COVID-19感染により初期診断および治療が遅れた2症例(Two cases of delayed initial diagnosis and treatment due to COVID-19 infection), ;;;;;;;;;;;;, Apr. 2023, 110回, PP70
• 再発を繰り返す小児尖圭コンジローマの1例, ;;;;;;, Jun. 2023, 32, 2, 274
• 前立腺癌　診断から治療まで　最近のトピックスを含めて, 鈴木 和浩, Jul. 2023, 44, 2, 21
• ロボット支援根治的前立腺全摘術後の満足度に影響を及ぼす性機能の検討, ;;;;;;;;;;, Aug. 2023, 73, 3, 199
• 救急搬送程入院した非がん疾患の地域高齢者のアドバンスケアプランニング状況, ;;;;;;;, Aug. 2023, 73, 3, 246
• 当院で発生した水道水汚染に対する人工腎臓センターの対応, ;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 859
• シスプラチン奏功歴のあるBRCA2変異陽性前立腺神経内分泌癌症例にオラパリブを投与した1例, ;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 863
• 群馬大学における高リスク前立腺癌に対する重粒子線治療, ;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 863
• 骨転移を伴う進行性腎細胞癌に対してニボルマブ・カボザンチニブ併用療法が奏功した一例, ;;;;;;;;;;;;;;, Aug. 2023, 36, 臨増, 876
• 当院におけるRTCによる看護専門外来の現状と今後の課題　新体制に伴う業務拡大に向けて, ;;;;, Sep. 2023, 58, 総会臨時, 326
• 【どうする! 前立腺癌-多彩な治療薬をどう上手く使うか】nmCRPCの薬物治療　ダロルタミド, 鈴木 和浩, Oct. 2023, 77, 11, 888
• 前立腺癌診断における、[-2]proPSA関連インデックスとPI-RADSとの比較, ;;;;;;;;;;;;, Oct. 2023, 61回, O9
• 進行性腎細胞癌に対してアベルマブ・アキシチニブ併用療法施行した2症例, ;;;;;;;;;;;;;;;, Oct. 2023, 61回, P4
• エンフォルツマブ・ベドチンの群馬大学の初期使用経験からみた有害事象について, ;;;;;;;;;;;;;;, Oct. 2023, 61回, P24
• 回腸導管に生じた静脈瘤出血に対して画像下治療をおこなった肝硬変患者の一例, ;;;;;;;;;;, Oct. 2023, 61回, P26
• 膀胱憩室術後、後腹膜に発生した尿路上皮がんの一例, ;;;;;;;;, Oct. 2023, 61回, P26
• 群馬大学重粒子線医学センターにおける高リスク前立腺癌に対する重粒子線治療, ;;;;;;;;;;;;, Oct. 2023, 61回, P27
• ロボット支援根治的前立腺全摘術後の満足度に影響を及ぼす性機能の検討, ;;;;;;;;;;, Oct. 2023, 61回, P28
• 尿路上皮癌に対するFGFR阻害薬の耐性獲得後の新規治療薬の検討(Investigation of new therapeutic agents for FGFR inhibitor resistant urothelial cancer), ;;;;;;;, Sep. 2023, 82回, 1065
• 用手的な陰茎根部の絞扼が出血点の特定に有効であった陰茎折症の一例, ;;;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 318
• 陰嚢腫脹を主訴に来院した小児ネフローゼ症候群の1例, ;;;;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 318
• 群馬大学関連病院における,COVID-19感染拡大前後での泌尿器科悪性腫瘍及び手術数の変化, ;;;;;;;;;;;;;;;;;;;, Nov. 2023, 73, 4, 320
• 群馬県前立腺がん検診に対するCOVID19感染症の影響, ;;;;;;;;;, Jul. 2023, 32回, 35
• 群馬大学膀胱全摘除術データベースを用いた膀胱全出除術後予後予測モデルの確立, ;;;;;;;;;;, Jul. 2023, 32回, 42
• 3ヶ所の病変を同時にRAPN施行したBirt-Hogg-Dube症候群疑いの一例, ;;;;;;;;;, Nov. 2023, 37回, P
• コルヒチンによる炎症コントロール下でロボット支援左腎腫瘍切除術を施行し得た家族性地中海熱の一例, ;;;;;;;;;;;, Feb. 2021, 17, 臨増1, 168
• 腎移植後に発生したEBV陽性皮膚粘膜潰瘍(EBVMCU)の1例, ;;;;;;;;, Feb. 2024, 57回, 237
• 前立腺癌治療の進歩, ;;, Apr. 2024, 11, 1, 1
• 腎移植後EBウイルス持続感染中の透析患者に発生した平滑筋腫瘍の1例, ;;;;;;;;;;;;;;;;;;;, May 2024, 57, Suppl.1, 742
• 免疫抑制剤減量と放射線治療にて軽快した腎移植後EBV陽性皮膚粘膜潰瘍(EBV-positive mucocutaneous ulcer:EBVMCU)の1例, ;;;;;;;;;, May 2024, 57, Suppl.1, 742
• 根治切除不能な筋層浸潤性膀胱癌に対し,放射線治療を施行した一例, ;;;;;;;;;;;;;;;;;;, May 2024, 57, Suppl.1, 859
• mCSPC薬物治療のup to date　Upfront治療時代のARASENSレジメンの意義と患者像, ;;;, Apr. 2024, 37, 4, 279
• Round Table Discussion『前立腺癌診療ガイドライン2023年版』検診パート　改訂ポイントと今後の展望, ;;;, Apr. 2024, 7, 1, 05
• シスプラチン・エトポシド療法を導入した遠隔転移を有する膀胱小細胞癌の2例, ;;;;;;;;;;;;;;;;;;;;;;;, May 2024, 74, 2, 183
• 陰茎がんと鑑別を要した1期梅毒の1例, ;;;;;;;;;;;;;;;;;;;;;, May 2024, 74, 2, 184
• 群馬県前立腺がん検診30年間における初回検診受診者の検討, ;;;;;;, Jul. 2024, 33回, 40
• シスプラチン・エトポシド療法を導入した遠隔転移を有する膀胱小細胞癌の2例, ;;;;;;;;;;;;;;;;;;;;;;;, Jun. 2024, 37, 6, 554
• 陰茎がんと鑑別を要した1期梅毒の1例, ;;;;;;;;;;;;;;;;;;;;;, Jun. 2024, 37, 6, 554
• 群馬県前立腺がん検診・診療に対するCOVID19感染症の影響, ;;;;;;;;;;;;;, Jun. 2024, 37, 臨増, 728
• ニボルマブ・イピリムマブ併用療法が奏功した集合管癌の一例, ;;;;;;;;;;;;, Jun. 2024, 37, 臨増, 757
• BCG膀胱注入療法後に発症した結核性直腸周囲膿瘍の1例, ;;;;;;;;;;;;;;, Jun. 2024, 37, 臨増, 766
• 腎盂癌との鑑別が困難であったマントル細胞リンパ腫再発の1例, ;;;;;;;;;;;;;;, Jun. 2024, 37, 臨増, 768
• 尿道憩室が疑われた男性の1例, ;;;;;;;;;;;;;;, Jun. 2024, 37, 臨増, 773
• ロボット支援下根治的前立腺全摘術後の満足度に影響を及ぼす性機能の検討, ;;;;;;;;;;;;;;, Aug. 2024, 39, 2, 211
• 紹介された前立腺癌患者の院内合同カンファレンスによるT因子の再評価, ;;;;;;;, Aug. 2024, 37, 8, 924
• 補助診断マーカーprostate health index(phi)の前立腺癌診断における有用性, ;, Sep. 2024, 32, 1, 87
• TMB-high膀胱小細胞癌にペムブロリズマブ療法を行った一例(A case of TMB-high small cell carcinoma of the bladder treated with pembrolizumab), ;;;, Sep. 2024, 83回, P
• 前立腺癌診断における"phiファーストアプローチ"による不要な前立腺生検の回避, ;;;;;;;;;;;;, Oct. 2024, 62回, O21
• 前立腺癌に対する重粒子線治療16回照射の長期治療成績, ;;;;;;;, Oct. 2024, 62回, O24
• 傾向スコアマッチング法を用いたRARPと重粒子線治療後の性機能QOLスコア比較研究, ;;;;;;;;;;;, Oct. 2024, 62回, O24
• 化学療法が奏効した腫瘍遺伝子変異最高スコア膀胱小細胞癌に免疫療法を施行した一例, ;;;;;;;;;;;;;;, Oct. 2024, 62回, P7
• 前立腺癌放射線治療・ホルモン療法の進歩, ;;, Oct. 2024, 11, 2, 103
• 【透析医療とリスク管理】災害時・平時の透析液用の水確保, ;;, Nov. 2024, 34, 4, 8
• 非がん疾患の症状により入所施設から救急搬送後に入院となった高齢者のアドバンス・ケア・プランニングの実施状況, ;;;;;;;, Mar. 2024, 44, 29
• 当院における妊孕性温存治療の現状　妊孕性温存治療の啓発活動と受診後のフォローアップの重要性について, ;;;;;;;;;;, Feb. 2025, 8, 1, 94
• 当院におけるロボット支援腹腔鏡下副腎摘除術の初期経験, ;;;;;;;;;, Nov. 2024, 38回, P14
• ロボット支援根治的前立腺全摘術後の満足度に影響を及ぼす性機能の検討, ;;;;;;;;;;, Aug. 2024, 74, 3, 227
• 入所施設から救急搬送された入院高齢者のアドバンス・ケア・プランニングの実施状況　非がん疾患による症状のケース分析, ;;;;;;;, Aug. 2024, 74, 3, 233
• 機械学習のクラスター解析を用いた尿細胞診検体の細胞像と筋層浸潤の有無の関係性の解析, ;;;;;;;, Aug. 2024, 74, 3, 242
• 経尿道的膀胱異物除去術後に敗血症性ショック・膀胱タンポナーデになり膀胱高位切開を施行した1例, ;;;;;;;;;;;;;;;;;;;;, Nov. 2024, 74, 4, 318
• 回腸導管造設後47年経過して発症した導管狭窄の一例, ;;;;;;;;;;;;;;;;;;;;, Nov. 2024, 74, 4, 318
• 尿管ステント定期交換患者に認めた内腸骨動脈尿管瘻の一例, ;;;;;;;;;;;;;;;;;;, Feb. 2025, 75, 1, 83
• 診断に苦慮した前立腺孤立性線維性腫瘍の一例, ;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 226
• 腎盂腫瘍との鑑別を要した後腹膜原発悪性リンパ腫の1例, ;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231
• 絨毛癌症候群を考慮しmodified PE療法を施行した一例, ;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231
• 精巣腫瘍化学療法後にテストステロン負荷試験を施行した一例, ;;;;;;;;;;;;;;;;;;;;;;, Aug. 2021, 71, 3, 231
• ロボット支援腹腔鏡下前立腺全摘術(RALP)後3年間における満足度に影響を及ぼす勃起機能の検討, ;;;;;;;;;;;;;, Aug. 2021, 71, 3, 232
• BRCA遺伝子検査と前立腺癌, 鈴木 和浩, Aug. 2021, 71, 3, 233
• 【LOH症候群】テストステロン補充療法の副作用, ;, Jul. 2022, 16, 1, 25
• 絨毛癌に伴うhCG著明高値により甲状腺中毒症を発症した1症例, ;;;;;;;;;;;;;;, Mar. 2022, 97, 5, 1149
• Enzalutamide投与前のCRPC患者の血中テストステロン濃度と投与後QOL変化の相関, ;;;;, Apr. 2022, 98, 1, 312
• 34年前に全骨盤照射施行後、生体腎移植を施行した1例, ;;;;;;;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 469
• 当院で発生した水道水汚染に対する人工腎臓センターの対応, ;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 516
• 当院で水汚染時に行ったRO膜による透析用水浄化前後の亜硝酸塩濃度の考察, ;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 674
• 本人の強い意思で保存的腎臓療法が行われた一例, ;;;;;;;;;;;;;;;, May 2022, 55, Suppl.1, 775
• 【泌尿器科領域の遺伝性疾患とゲノム医療の最前線】遺伝性前立腺がん, ;;;;;;;;, Aug. 2022, 16, 2, 149
• タンパク翻訳阻害剤Homoharringtonineの前立腺癌細胞における抗腫瘍効果の検討, ;;;;;, Aug. 2022, 35, 8, 860
• プレシジョンメディシンを目指した前立腺癌診療～生検、臨床病理、遺伝子検査、リキッドバイオプシー～　前立腺生検update, ;;;;, Aug. 2022, 35, 8, 909
• 群馬県における前立腺がん検診の有効性評価研究(PROCEED), ;;;;;;, Jul. 2022, 31回, 34
• 前立腺癌の診断と治療の進歩　早期発見と長期予後を考慮した治療選択, ;;;, Oct. 2022, 9, 2, 125
• 【新規前立腺癌マーカーproPSA:開発から保険収載までの道程】9.エキスパートが考えるプロステートヘルスインデックス(phi)を組み入れたあたらしい前立腺癌診断フローシート(3)群馬大学医学部附属病院泌尿器科における前立腺癌診断フローシート, ;;;;;;;;, Oct. 2022, 9, 2, 191
• Upfront治療時代のエビデンスに基づく前立腺がん治療戦略とは, ;;, Oct. 2022, 9, 2, 211
• 新規前立腺がん診断バイオマーカーphiへの期待, ;;;, Oct. 2022, 9, 2, 221
• 【限局性前立腺癌診療バイブル-このへんでキッチリと前立腺癌診療の"あたりまえ"を整理しよう!】ホルモン治療　限局性前立腺癌に対する一次ホルモン療法(PADT)の意義と適応, ;, Oct. 2022, 76, 11, 810
• 臨床検査アップデート　前立腺癌診断におけるプロステートヘルスインデックス(phi)測定の意義について, ;, Sep. 2022, 68, 9, 395
• 99mTc-MAG3腎シンチグラフィーは腫瘍性尿管閉塞ドレナージの腎機能改善を予測する, ;;;;;;;;;;;;;;, Oct. 2022, 60回, O4
• 群馬大学における前立腺癌に対する重粒子線治療, ;;;;;;;;;;;;;, Oct. 2022, 60回, O38
• ホルモン非依存性前立腺癌細胞株における、スタチン併用によるX線治療効果への影響, ;;;;;;;, Oct. 2022, 60回, O73
• 当院における進行性腎癌に対するペムブロリズマブ・レンバチニブ併用療法の初期経験, ;;;;;;;;;;;;;;, Oct. 2022, 60回, P28
• 去勢抵抗性前立腺癌患者における新規マーカー[-2]proPSAのバイオロジーと有用性の検討, ;;;;;;;;;;;;;;, Oct. 2022, 60回, P49
• 異なる転機を辿った自己導尿患者に発生した浸潤性膀胱癌, ;;;;;;;;;;;;;;, Oct. 2022, 60回, P51
• シスプラチン耐性膀胱癌に対するオリジナルこんにゃくゼリーの抗腫瘍効果と補完効果, ;;;, Oct. 2022, 60回, P53
• 群馬大学医学部附属病院泌尿器科における生体腎移植生着率に影響を与える因子の検討, ;;;;;;;, Oct. 2022, 57, 総会臨時, 394
• 持続勃起症に対して緊急で亀頭シャント術を施行した一例, ;;;;;;;;;;;;;;;;;;;;;;, Feb. 2022, 72, 1, 119
• 群馬大学医学部附属病院泌尿器科における生体腎移植100例の治療成績, ;;;;;;;;;, Feb. 2022, 72, 1, 121
• ロボット鏡視下腎部分切除術における腎固着脂肪と血中、脂肪組織内性ホルモンとの関連, ;;;;;;;;;, Nov. 2022, 36回, AP
• 卵巣腫瘍に対する全骨盤照射34年後に生体腎移植を施行した1例, ;;;;;;;;;;;;;;;;;;;, Jan. 2023, 56, 1, 19
• 血尿による膀胱タンポナーデを来した右腎動静脈奇形, ;;;;;;;;;;;;;;;;;;;;;, Aug. 2022, 72, 3, 295
• 自己導尿中に発症した浸潤性膀胱癌の2例, ;;;;;;;;;;;;;;;;;;;;;;, Aug. 2022, 72, 3, 295
• 【臨床前立腺癌学-基礎・臨床の最新知見-】治療　薬物療法　古典的薬物療法　LHRHアンタゴニストによるアンドロゲン除去療法, ;, Jun. 2023, 81, 増刊6 臨床前立腺癌学, 348
• 前立腺がんの早期発見と新しい治療, 鈴木 和浩, May 2022, 5回, 40
• Wilms腫瘍に対する全腹部照射から40年後に生体腎移植を行った一例, ;;;;;;;;;;;;, May 2023, 56, Suppl.1, 699
• 妊娠経過中に慢性心不全の急性増悪を認めた血液透析患者の1例, ;;;;;;;;;;;;;;;;;;;, May 2023, 56, Suppl.1, 763

MISC

• Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds., Takumi Yamamoto; Kazuto Ito; Mai Miyakubo; Hiroyuki Takechi; Kazuhiro Suzuki; Tetsuo Akimoto; Hitoshi Ishikawa; Takashi Nakano, Oct. 2008, Urology, 72, 4, 892, 7

  DOI
• Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds, Takumi Yamamoto; Kazuto Ito; Mal Miyakubo; Hiroyuki Takechi; Kazuhiro Suzuki; Tetsuo Akimoto; Hitoshi Ishikawa; Takashi Nakano, Oct. 2008, UROLOGY, 72, 4, 892, 897

  DOI
• Nephrogenic Systemic Fibrosis with Multiple Calcification and Osseous Metaplasia, Yayoi Nagai; Michiko Hasegawa; Kahori Shinmi; Chikako Kishi; Yoshito Tsushima; Keigo Endo; Kazuhiko Okabe; Kazuhiro Suzuki; Osamu Ishikawa, 2008, ACTA DERMATO-VENEREOLOGICA, 88, 6, 597, 600

  DOI
• Nephrogenic Systemic Fibrosis with Multiple Calcification and Osseous Metaplasia, Yayoi Nagai; Michiko Hasegawa; Kahori Shinmi; Chikako Kishi; Yoshito Tsushima; Keigo Endo; Kazuhiko Okabe; Kazuhiro Suzuki; Osamu Ishikawa, 2008, ACTA DERMATO-VENEREOLOGICA, 88, 6, 597, 600

  DOI
• Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan., Hiroyuki Takechi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Masaru Ohi; Kazuhiro Suzuki, Nov. 2008, Urology, 72, 5, 1111, 5

  DOI
• Prostate-Specific Antigen Kinetics in Screen-Detected Prostate Cancer in Japan, Hiroyuki Takechi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Masaru Ohi; Kazuhiro Suzuki, Nov. 2008, UROLOGY, 72, 5, 1111, 1115

  DOI
• Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer., Hidekazu Koike; Yoshitaka Sekine; Makoto Kamiya; Haruki Nakazato; Kazuhiro Suzuki, Dec. 2008, Urology, 72, 6, 1229, 33

  DOI
• Gene Expression of Survivin and Its Spliced Isoforms Associated With Proliferation and Aggressive Phenotypes of Prostate Cancer, Hidekazu Koike; Yoshitaka Sekine; Makoto Kamiya; Haruki Nakazato; Kazuhiro Suzuki, Dec. 2008, UROLOGY, 72, 6, 1229, 1233

  DOI
• Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population, Tatsuya Hamano; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Mar. 2008, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 4, 1, 21, 26

  DOI
• Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population, Tatsuya Hamano; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Mar. 2008, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 4, 1, 21, 26

  DOI
• Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Yoshitaka Sekine; Yosuke Furuya; Masahiro Nishii; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, 25 Jul. 2008, Biochemical and biophysical research communications, 372, 2, 356, 61

  DOI
• Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population, Hidekazu Koike; Haruki Nakazato; Nobuaki Ohtake; Hiroshi Matsui; Hironobu Okugi; Yasuhiro Shibata; Seiji Nakata; Hidetoshi Yamanaka; Kazuhiro Suzuki, Dec. 2008, INTERNATIONAL UROLOGY AND NEPHROLOGY, 40, 4, 947, 951

  DOI
• Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population., Hidekazu Koike; Haruki Nakazato; Nobuaki Ohtake; Hiroshi Matsui; Hironobu Okugi; Yasuhiro Shibata; Seiji Nakata; Hidetoshi Yamanaka; Kazuhiro Suzuki, 2008, International urology and nephrology, 40, 4, 947, 51

  DOI
• Changes in baseline PSA levels in Japanese men from 1988 to 2003., Masaru Ohi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Hiroyuki Takechi; Yutaka Kubota; Kazuhiro Suzuki, Jul. 2008, Urology, 72, 1, 95, 8

  DOI
• Changes in baseline PSA levels in Japanese men from 1988 to 2003, Masaru Ohi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Hiroyuki Takechi; Yutaka Kubota; Kazuhiro Suzuki, Jul. 2008, UROLOGY, 72, 1, 95, 98

  DOI
• Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor., Haruo Kato; Yoshitaka Sekine; Yosuke Furuya; Yoshiyuki Miyazawa; Hidekazu Koike; Kazuhiro Suzuki, 22 May 2015, Biochemical and biophysical research communications, 461, 1, 115, 21

  DOI
• Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial., Fred Saad; Karim Fizazi; Viorel Jinga; Eleni Efstathiou; Peter C Fong; Lowell L Hart; Robert Jones; Raymond McDermott; Manfred Wirth; Kazuhiro Suzuki; David B MacLean; Ling Wang; Hideyuki Akaza; Joel Nelson; Howard I Scher; Robert Dreicer; Iain J Webb; Ronald de Wit, Mar. 2015, The Lancet. Oncology, 16, 3, 338, 48

  DOI
• Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association, Hiro-omi Kanayama; Tomoharu Fukumori; Hiroyuki Fujimoto; Hiroyuki Nakanishi; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Tsuneharu Miki; Kazumi Kamoi; Yoshinobu Kubota; Satoru Takahashi; Yukio Homma; Seiji Naito, Sep. 2015, INTERNATIONAL JOURNAL OF UROLOGY, 22, 9, S1, S7

  DOI
• A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer., Kazuhiro Suzuki; Seiichiro Ozono; Akito Yamaguchi; Hidekazu Koike; Hiroshi Matsui; Masao Nagata; Takatoshi Takubo; Kana Miyashita; Takafumi Matsushima; Hideyuki Akaza, Feb. 2015, Cancer chemotherapy and pharmacology, 75, 2, 373, 80

  DOI
• Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Hitoshi Ishikawa; Hiroyuki Katoh; Takuya Kaminuma; Hidemasa Kawamura; Kazuto Ito; Hiroshi Matsui; Junko Hirato; Nobuaki Shimizu; Yutaka Takezawa; Hiroshi Tsuji; Kazuhiro Suzuki; Tatsuya Ohno; Takashi Nakano, Oct. 2015, ANTICANCER RESEARCH, 35, 10, 5559, 5566
• Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan., Kazuhiro Suzuki; Mikio Namiki; Tsukasa Fujimoto; Nobuyoshi Takabayashi; Kentarou Kudou; Hideyuki Akaza, Dec. 2015, Japanese journal of clinical oncology, 45, 12, 1168, 74

  DOI
• Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer, Masahiro Nozawa; Hirofumi Mukai; Shunji Takahashi; Hiroji Uemura; Takeo Kosaka; Yusuke Onozawa; Jun Miyazaki; Kazuhiro Suzuki; Koji Okihara; Yoichi Arai; Tomomi Kamba; Masashi Kato; Yasutomo Nakai; Hiroshi Furuse; Haruki Kume; Hisamitsu Ide; Hiroshi Kitamura; Akira Yokomizo; Takahiro Kimura; Yoshihiko Tomita; Keiji Ohno; Yoshiyuki Kakehi, Oct. 2015, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 5, 1026, 1034

  DOI
• Induction of type 1 interferon receptor by zinc in U937 cells, Takeaki Nagamine; Kastuyuki Nakajima; Hisashi Takada; Yoshitaka Sekine; Kazuhiro Suzuki, Jun. 2009, CYTOKINE, 46, 3, 346, 350

  DOI
• Induction of type 1 interferon receptor by zinc in U937 cells, Takeaki Nagamine; Kastuyuki Nakajima; Hisashi Takada; Yoshitaka Sekine; Kazuhiro Suzuki, Jun. 2009, CYTOKINE, 46, 3, 346, 350

  DOI
• Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells, Rizky Abdulah; Ahmad Faried; Kenji Kobayashi; Chiho Yamazaki; Eka W. Suradji; Kazuto Ito; Kazuhiro Suzuki; Masami Murakami; Hiroyuki Kuwano; Hiroshi Koyama, Nov. 2009, BMC CANCER, 9, Nov30, 414

  DOI
• Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells., Rizky Abdulah; Ahmad Faried; Kenji Kobayashi; Chiho Yamazaki; Eka W Suradji; Kazuto Ito; Kazuhiro Suzuki; Masami Murakami; Hiroyuki Kuwano; Hiroshi Koyama, 30 Nov. 2009, BMC cancer, 9, Nov30, 414, 414

  DOI
• Proprostate-specific antigen: Its usefulness in the era of multiple-core prostate biopsy, Mai Miyakubo; Kazuto Ito; Takumi Yamamoto; Hiroyuki Takechi; Masaru Ohi; Kazuhiro Suzuki, Jun. 2009, INTERNATIONAL JOURNAL OF UROLOGY, 16, 6, 561, 565

  DOI
• Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy., Mai Miyakubo; Kazuto Ito; Takumi Yamamoto; Hiroyuki Takechi; Masaru Ohi; Kazuhiro Suzuki, Jun. 2009, International journal of urology : official journal of the Japanese Urological Association, 16, 6, 561, 5

  DOI
• Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor, Yoshitaka Sekine; Hidekazu Koike; Takamitsu Nakano; Katsuyuki Nakajima; Sadao Takahashi; Kazuhiro Suzuki, Jul. 2009, CANCER EPIDEMIOLOGY, 33, 1, 16, 23

  DOI
• Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor., Yoshitaka Sekine; Hidekazu Koike; Takamitsu Nakano; Katsuyuki Nakajima; Sadao Takahashi; Kazuhiro Suzuki, Jul. 2009, Cancer epidemiology, 33, 1, 16, 23

  DOI
• Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy, Y. Shibata; K. Suzuki; S. Arai; Y. Miyoshi; S. Umemoto; N. Masumori; N. Kamiya; T. Ichikawa; Y. Kitagawa; A. Mizokami; Y. Sugimura; N. Nonomura; H. Sakai; S. Honma; Y. Kubota, May 2013, ANDROLOGY, 1, 3, 505, 511

  DOI
• Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy, Y. Shibata; K. Suzuki; S. Arai; Y. Miyoshi; S. Umemoto; N. Masumori; N. Kamiya; T. Ichikawa; Y. Kitagawa; A. Mizokami; Y. Sugimura; N. Nonomura; H. Sakai; S. Honma; Y. Kubota, May 2013, ANDROLOGY, 1, 3, 505, 511

  DOI
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Kazuto Ito; Mai Miyakubo; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2013, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311

  DOI
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Kazuto Ito; Mai Miyakubo; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2013, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311

  DOI
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., Tomohiro Magari; Yasuhiro Shibata; Seiji Arai; Bunzo Kashiwagi; Kazuhiro Suzuki, Jun. 2013, Scandinavian journal of urology, 47, 3, 236, 41

  DOI
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation, Tomohiro Magari; Yasuhiro Shibata; Sew Arai; Bunzo Kashiwagi; Kazuhiro Suzuki, 2013, SCANDINAVIAN JOURNAL OF UROLOGY, 47, 3, 236, 241

  DOI
• Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues, S. Arai; Y. Shibata; Y. Nakamura; B. Kashiwagi; T. Uei; Y. Tomaru; Y. Miyashiro; S. Honma; K. Hashimoto; Y. Sekine; K. Ito; H. Sasano; K. Suzuki, Jan. 2013, ANDROLOGY, 1, 1, 169, 174

  DOI
• Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues, S. Arai; Y. Shibata; Y. Nakamura; B. Kashiwagi; T. Uei; Y. Tomaru; Y. Miyashiro; S. Honma; K. Hashimoto; Y. Sekine; K. Ito; H. Sasano; K. Suzuki, Jan. 2013, ANDROLOGY, 1, 1, 169, 174

  DOI
• Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010, Seiji Naito; Yoshiyuki Kakehi; Akihiko Okuyama; Tomoaki Imamura; Hideo Yasunaga; Hideyuki Akaza; Shiro Hinotsu; Yoichi Arai; Takushi Dokiya; Shin Egawa; Kazuhiro Suzuki; Hirofumi Koga; Naoya Masumori; Koichiro Akakura; Kiyotaka Kawashima; Koji Okihara; Kazuto Ito, Oct. 2010, INTERNATIONAL JOURNAL OF UROLOGY, 17, 10, 830, 838

  DOI
• Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010, Seiji Naito; Yoshiyuki Kakehi; Akihiko Okuyama; Tomoaki Imamura; Hideo Yasunaga; Hideyuki Akaza; Shiro Hinotsu; Yoichi Arai; Takushi Dokiya; Shin Egawa; Kazuhiro Suzuki; Hirofumi Koga; Naoya Masumori; Koichiro Akakura; Kiyotaka Kawashima; Koji Okihara; Kazuto Ito, Oct. 2010, INTERNATIONAL JOURNAL OF UROLOGY, 17, 10, 830, 838

  DOI
• The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha 1-adrenergic receptor antagonist work well for ureteral stones?, Kazunari Ohki; Yosihiro Ohno; Kazuhiro Suzuki, Mar. 2010, INTERNATIONAL UROLOGY AND NEPHROLOGY, 42, 1, 113, 117

  DOI
• The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha 1-adrenergic receptor antagonist work well for ureteral stones?, Kazunari Ohki; Yosihiro Ohno; Kazuhiro Suzuki, Mar. 2010, INTERNATIONAL UROLOGY AND NEPHROLOGY, 42, 1, 113, 117

  DOI
• The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha 1-adrenergic receptor antagonist work well for ureteral stones?, Kazunari Ohki; Yosihiro Ohno; Kazuhiro Suzuki, Mar. 2010, INTERNATIONAL UROLOGY AND NEPHROLOGY, 42, 1, 113, 117

  DOI
• New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry., Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Bunzo Kashiwagi; Yukio Tomaru; Mikio Kobayashi; Yoko Watanabe; Seijiro Honma; Kazuhiro Suzuki, Jan. 2010, Steroids, 75, 1, 13, 9

  DOI
• New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry, Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Bunzo Kashiwagi; Yukio Tomaru; Mikio Kobayashi; Yoko Watanabe; Seijiro Honma; Kazuhiro Suzuki, Jan. 2010, STEROIDS, 75, 1, 13, 19

  DOI
• Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease., Tatsuya Hamano; Hiroshi Matsui; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Aug. 2010, The Journal of urology, 184, 2, 738, 42

  DOI
• Association of SNP rs1447295 and Microsatellite Marker DG8S737 With Familial Prostate Cancer and High Grade Disease, Tatsuya Hamano; Hiroshi Matsui; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Aug. 2010, JOURNAL OF UROLOGY, 184, 2, 738, 742

  DOI
• Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo., Yasuhiro Shibata; Bunzo Kashiwagi; Seiji Arai; Tomohiro Magari; Kazuhiro Suzuki; Seijiro Honma, Nov. 2006, Urology, 68, 5, 1127, 31

  DOI
• Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo, Yasuhiro Shibata; Bunzo Kashiwagi; Seiji Arai; Tomohiro Magari; Kazuhiro Suzuki; Seijiro Honma, Nov. 2006, UROLOGY, 68, 5, 1127, 1131

  DOI
• Positive effect of prostaglandin on regulation of prostatic blood flow, Bunzo Kashiwagi; Yasuhiro Shibata; Kazunari Ohki; Seiji Arai; Seijiro Honma; Kazuhiro Suzuki, Sep. 2006, UROLOGY, 68, 3, 682, 686

  DOI
• Positive effect of prostaglandin on regulation of prostatic blood flow., Bunzo Kashiwagi; Yasuhiro Shibata; Kazunari Ohki; Seiji Arai; Seijiro Honma; Kazuhiro Suzuki, Sep. 2006, Urology, 68, 3, 682, 6

  DOI
• A case of emphysematous pyelonephritis in a renal allograft, S Arai; T Makino; H Okugi; M Hasumi; Y Shibata; M Hatori; K Suzuki, Jan. 2006, TRANSPLANTATION, 81, 2, 296, 297, Report scientific journal

  DOI
• A case of emphysematous pyelonephritis in a renal allograft, S Arai; T Makino; H Okugi; M Hasumi; Y Shibata; M Hatori; K Suzuki, Jan. 2006, TRANSPLANTATION, 81, 2, 296, 297, Report scientific journal

  DOI
• Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population., Hironobu Okugi; Haruki Nakazato; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2006, Cancer detection and prevention, 30, 3, 262, 8

  DOI
• Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population, Hironobu Okugi; Haruki Nakazato; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2006, CANCER DETECTION AND PREVENTION, 30, 3, 262, 268

  DOI
• Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells, Yoshitaka Sekine; Hidekazu Koike; Takamitsu Nakano; Katsuyuki Nakajima; Kazuhiro Suzuki, Aug. 2007, CLINICA CHIMICA ACTA, 383, 1-2, 78, 84

  DOI
• Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells., Yoshitaka Sekine; Hidekazu Koike; Takamitsu Nakano; Katsuyuki Nakajima; Kazuhiro Suzuki, Aug. 2007, Clinica chimica acta; international journal of clinical chemistry, 383, 1-2, 78, 84

  DOI
• Effects of a new steroidal antiandrogen, TZP-4238(17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3,20-dione), on spontaneously developed canine benign prostatic hyperplasia, Y Takezawa; K Ito; K Suzuki; Y Fukabori; H Yamanaka; S Honma; M Mieda; N Hamataki; M Kushitani, Dec. 1995, PROSTATE, 27, 6, 321, 328
• Effects of a new steroidal antiandrogen, TZP-4238(17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3,20-dione), on spontaneously developed canine benign prostatic hyperplasia, Y Takezawa; K Ito; K Suzuki; Y Fukabori; H Yamanaka; S Honma; M Mieda; N Hamataki; M Kushitani, Dec. 1995, PROSTATE, 27, 6, 321, 328
• Effect of androgen concentration on seminal vesicle blood flow in rats - Establishment of new highly sensitive simultaneous androgen measurement method, B Kashiwagi; Y Shibata; Y Ono; K Suzuki; S Honma; H Yamanaka, Jul. 2005, UROLOGY, 66, 1, 218, 223

  DOI
• Effect of androgen concentration on seminal vesicle blood flow in rats - Establishment of new highly sensitive simultaneous androgen measurement method, B Kashiwagi; Y Shibata; Y Ono; K Suzuki; S Honma; H Yamanaka, Jul. 2005, UROLOGY, 66, 1, 218, 223

  DOI
• Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer, H Koike; K Ito; Y Takezawa; T Oyama; H Yamanaka; K Suzuki, Apr. 2005, BRITISH JOURNAL OF CANCER, 92, 8, 1538, 1544

  DOI
• Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer, H Koike; K Ito; Y Takezawa; T Oyama; H Yamanaka; K Suzuki, Apr. 2005, BRITISH JOURNAL OF CANCER, 92, 8, 1538, 1544

  DOI
• Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: Establishment of a new highly sensitive simultaneous androgen measurement method, B Kashiwagi; Y Shibata; Y Ono; R Suzuki; S Honma; K Suzuki, Sep. 2005, JOURNAL OF ANDROLOGY, 26, 5, 586, 591

  DOI
• Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: Establishment of a new highly sensitive simultaneous androgen measurement method, B Kashiwagi; Y Shibata; Y Ono; R Suzuki; S Honma; K Suzuki, Sep. 2005, JOURNAL OF ANDROLOGY, 26, 5, 586, 591

  DOI
• Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia., Yasuhiro Shibata; Bunzo Kashiwagi; Seiji Arai; Yoshitatsu Fukabori; Kazuhiro Suzuki, Aug. 2005, Urology, 66, 2, 455, 60

  DOI
• A comparison of interobserver reproducibility of gleason grading of prostatic carcinoma in Japan and the United States, T Oyama; WC Allsbrook; K Kurokawa; H Matsuda; A Segawa; T Sano; K Suzuki; JI Epstein, Aug. 2005, ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 129, 8, 1004, 1010
• A comparison of interobserver reproducibility of gleason grading of prostatic carcinoma in Japan and the United States, T Oyama; WC Allsbrook; K Kurokawa; H Matsuda; A Segawa; T Sano; K Suzuki; JI Epstein, Aug. 2005, ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 129, 8, 1004, 1010
• Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy, S. Miyamoto; K. Ito; M. Miyakubo; R. Suzuki; T. Yamamoto; K. Suzuki; K. Suzuki; H. Yamanaka, Mar. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 1, 75, 86

  DOI
• Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy, S. Miyamoto; K. Ito; M. Miyakubo; R. Suzuki; T. Yamamoto; K. Suzuki; K. Suzuki; H. Yamanaka, Mar. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 1, 75, 86

  DOI
• Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Masahiro Nishii; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, Nov. 2012, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238

  DOI
• Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Masahiro Nishii; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, Nov. 2012, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238

  DOI
• Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme, M. Nomura; K. Ito; M. Miyakubo; Y. Sekine; Y. Tamura; N. Shimizu; S. Aoki; K. Suzuki, Jun. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 2, 202, 209

  DOI
• Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme, M. Nomura; K. Ito; M. Miyakubo; Y. Sekine; Y. Tamura; N. Shimizu; S. Aoki; K. Suzuki, Jun. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 2, 202, 209

  DOI
• Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer, Y. Fukuma; H. Matsui; H. Koike; Y. Sekine; I. Shechter; N. Ohtake; S. Nakata; K. Ito; K. Suzuki, Dec. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 4, 339, 345

  DOI
• Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer, Y. Fukuma; H. Matsui; H. Koike; Y. Sekine; I. Shechter; N. Ohtake; S. Nakata; K. Ito; K. Suzuki, Dec. 2012, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 4, 339, 345

  DOI
• Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation., Yasuyuki Morikawa; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 16 Mar. 2012, Biochemical and biophysical research communications, 419, 3, 584, 9

  DOI
• Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, K Suzuki; H Koike; H Matsui; Y Ono; M Hasumi; H Nakazato; H Okugi; Y Sekine; K Oki; K Ito; T Yamamoto; Y Fukabori; K Kurokawa; H Yamanaka, Jun. 2002, INTERNATIONAL JOURNAL OF CANCER, 99, 6, 846, 852

  DOI
• Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, K Suzuki; H Koike; H Matsui; Y Ono; M Hasumi; H Nakazato; H Okugi; Y Sekine; K Oki; K Ito; T Yamamoto; Y Fukabori; K Kurokawa; H Yamanaka, Jun. 2002, INTERNATIONAL JOURNAL OF CANCER, 99, 6, 846, 852

  DOI
• The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL, K Ito; M Ohi; T Yamamoto; S Miyamoto; K Kurokawa; Y Fukabori; K Suzuki; H Yamanaka, Nov. 2002, CANCER, 95, 10, 2112, 2119

  DOI
• The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL, K Ito; M Ohi; T Yamamoto; S Miyamoto; K Kurokawa; Y Fukabori; K Suzuki; H Yamanaka, Nov. 2002, CANCER, 95, 10, 2112, 2119

  DOI
• Possibility of re-screening intervals of morethan one year in men with PSA levels of 4.0 ng/ml or less, K Ito; T Yamamoto; M Ohi; H Takechi; K Kurokawa; K Suzuki; H Yamanaka, Sep. 2003, PROSTATE, 57, 1, 8, 13

  DOI
• Possibility of re-screening intervals of morethan one year in men with PSA levels of 4.0 ng/ml or less, K Ito; T Yamamoto; M Ohi; H Takechi; K Kurokawa; K Suzuki; H Yamanaka, Sep. 2003, PROSTATE, 57, 1, 8, 13

  DOI
• Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, M Hasumi; K Suzuki; H Matsui; H Koike; K Ito; H Yamanaka, Oct. 2003, CANCER LETTERS, 200, 2, 187, 195

  DOI
• Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/ml, K Ito; T Yamamoto; M Ohi; K Kurokawa; K Suzuki; H Yamanaka, Apr. 2003, UROLOGY, 61, 4, 760, 764

  DOI
• Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/ml, K Ito; T Yamamoto; M Ohi; K Kurokawa; K Suzuki; H Yamanaka, Apr. 2003, UROLOGY, 61, 4, 760, 764

  DOI
• An evaluation of the Banff 97 classification after kidney transplantation, T Tanaka; M Kyo; Y Kokado; S Takahara; M Hatori; K Suzuki; M Hasumi; K Toki; N Ichimaru; A Okuyama; H Yamanaka, Mar. 2003, TRANSPLANTATION PROCEEDINGS, 35, 2, 860, 861

  DOI
• An evaluation of the Banff 97 classification after kidney transplantation, T Tanaka; M Kyo; Y Kokado; S Takahara; M Hatori; K Suzuki; M Hasumi; K Toki; N Ichimaru; A Okuyama; H Yamanaka, Mar. 2003, TRANSPLANTATION PROCEEDINGS, 35, 2, 860, 861

  DOI
• Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population, H Nakazato; K Suzuki; H Matsui; N Ohtake; S Nakata; H Yamanaka, Aug. 2003, BRITISH JOURNAL OF CANCER, 89, 4, 691, 696

  DOI
• Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population, H Nakazato; K Suzuki; H Matsui; N Ohtake; S Nakata; H Yamanaka, Aug. 2003, BRITISH JOURNAL OF CANCER, 89, 4, 691, 696

  DOI
• Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, K Suzuki; H Matsui; H Nakazato; H Koike; H Okugi; M Hasumi; N Ohtake; S Nakata; T Takei; M Hatori; K Ito; H Yamanaka, Jun. 2003, CANCER LETTERS, 195, 2, 177, 183

  DOI
• Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, K Suzuki; H Matsui; H Nakazato; H Koike; H Okugi; M Hasumi; N Ohtake; S Nakata; T Takei; M Hatori; K Ito; H Yamanaka, Jun. 2003, CANCER LETTERS, 195, 2, 177, 183

  DOI
• A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, K Suzuki; H Matsui; N Ohtake; S Nakata; T Takei; H Nakazato; H Okugi; H Koike; Y Ono; K Ito; K Kurokawa; H Yamanaka, Jul. 2003, JOURNAL OF BIOMEDICAL SCIENCE, 10, 4, 430, 435

  DOI
• A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, K Suzuki; H Matsui; N Ohtake; S Nakata; T Takei; H Nakazato; H Okugi; H Koike; Y Ono; K Ito; K Kurokawa; H Yamanaka, Jul. 2003, JOURNAL OF BIOMEDICAL SCIENCE, 10, 4, 430, 435

  DOI
• Natural history of PSA increase with and without prostate cancer, K Ito; T Yamamato; M Ohi; H Takeuchi; K Kurokawa; K Suzuki; H Yamanaka, Jul. 2003, UROLOGY, 62, 1, 64, 69

  DOI
• Natural history of PSA increase with and without prostate cancer, K Ito; T Yamamato; M Ohi; H Takeuchi; K Kurokawa; K Suzuki; H Yamanaka, Jul. 2003, UROLOGY, 62, 1, 64, 69

  DOI
• Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population, K Suzuki; H Nakazato; H Matsui; H Koike; H Okugi; B Kashiwagi; M Nishii; N Ohtake; S Nakata; K Ito; H Yamanaka, Oct. 2003, CANCER, 98, 7, 1411, 1416

  DOI
• Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population, K Suzuki; H Nakazato; H Matsui; H Koike; H Okugi; B Kashiwagi; M Nishii; N Ohtake; S Nakata; K Ito; H Yamanaka, Oct. 2003, CANCER, 98, 7, 1411, 1416

  DOI
• Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivo., Yasuhiro Shibata; Bunzo Kashiwagi; Seiji Arai; Yoshitatsu Fukabori; Kazuhiro Suzuki; Seijiro Honma; Hidetoshi Yamanaka, Oct. 2004, Endocrinology, 145, 10, 4507, 12

  DOI
• Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivo, Y Shibata; B Kashiwagi; S Arai; Y Fukabori; K Suzuki; S Honma; H Yamanaka, Oct. 2004, ENDOCRINOLOGY, 145, 10, 4507, 4512

  DOI
• The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less, K Ito; T Yamamoto; K Suzuki; K Kurokawa; H Yamanaka, Feb. 2004, JOURNAL OF UROLOGY, 171, 2, 656, 660

  DOI
• The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less, K Ito; T Yamamoto; K Suzuki; K Kurokawa; H Yamanaka, Feb. 2004, JOURNAL OF UROLOGY, 171, 2, 656, 660

  DOI
• Cumulative probability of PSA increase above 4.0 NG/ML in population-based screening for prostate cancer., Kazuto Ito; Takumi Yamamoto; Masaru Ohi; Hiroyuki Takechi; Kohei Kurokawa; Kazuhiro Suzuki; Hidetoshi Yamanaka, 10 Apr. 2004, International journal of cancer, 109, 3, 455, 60

  DOI
• Cumulative probability of PSA increase above 4.0 NG/ML in population-based screening for prostate cancer, K Ito; T Yamamoto; M Ohi; H Takechi; K Kurokawa; K Suzuki; H Yamanaka, Apr. 2004, INTERNATIONAL JOURNAL OF CANCER, 109, 3, 455, 460

  DOI
• Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4 ng/ml, M Ohi; K Ito; K Suzuki; T Yamamoto; H Yamanaka, Jan. 2004, EUROPEAN UROLOGY, 45, 1, 92, 97

  DOI
• Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4 ng/ml, M Ohi; K Ito; K Suzuki; T Yamamoto; H Yamanaka, Jan. 2004, EUROPEAN UROLOGY, 45, 1, 92, 97

  DOI
• The evaluation of rat prostate blood flow using a laser speckle flowmetry: a comparative study using the microsphere method in castrated and androgen-replenished rats, Y Shibata; B Kashiwagi; Y Ono; Y Fukabori; K Suzuki; S Honma; H Yamanaka, Feb. 2004, UROLOGICAL RESEARCH, 32, 1, 44, 48

  DOI
• The evaluation of rat prostate blood flow using a laser speckle flowmetry: a comparative study using the microsphere method in castrated and androgen-replenished rats, Y Shibata; B Kashiwagi; Y Ono; Y Fukabori; K Suzuki; S Honma; H Yamanaka, Feb. 2004, UROLOGICAL RESEARCH, 32, 1, 44, 48

  DOI
• Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer, K Kurokawa; K Ito; T Yamamoto; H Takechi; S Miyamoto; K Suzuki; H Yamanaka, Feb. 2004, UROLOGY, 63, 2, 268, 272

  DOI
• Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer., Kohei Kurokawa; Kazuto Ito; Takumi Yamamoto; Hiroyuki Takechi; Shigeto Miyamoto; Kazuhiro Suzuki; Hidetoshi Yamanaka, Feb. 2004, Urology, 63, 2, 268, 72

  DOI
• Pilot study of the optimum hematocrit for patients in the predialysis stage after renal transplantation, T Kawaguchi; T Moriyama; K Suzuki; M Hatori; T Tanaka; S Takahara; H Yamanaka, Jun. 2004, TRANSPLANTATION PROCEEDINGS, 36, 5, 1293, 1296

  DOI
• Pilot study of the optimum hematocrit for patients in the predialysis stage after renal transplantation, T Kawaguchi; T Moriyama; K Suzuki; M Hatori; T Tanaka; S Takahara; H Yamanaka, Jun. 2004, TRANSPLANTATION PROCEEDINGS, 36, 5, 1293, 1296

  DOI
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues, Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Yukio Tomaru; Mikio Kobayashi; Seijiro Honma; Kazuhiro Suzuki, Feb. 2011, STEROIDS, 76, 3, 301, 308

  DOI
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Yukio Tomaru; Mikio Kobayashi; Seijiro Honma; Kazuhiro Suzuki, Feb. 2011, Steroids, 76, 3, 301, 8

  DOI
• Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., Hidekazu Koike; Yasuyuki Morikawa; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2011, The Journal of urology, 185, 4, 1497, 503

  DOI
• Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D-3 Induced Cell Growth Inhibition in Prostate Cancer, Hidekazu Koike; Yasuyuki Morikawa; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, 1497, 1503

  DOI
• Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels, Tomohiro Magari; Yasuhiro Shibata; Seiji Arai; Bunzo Kashiwagi; Keiji Suzuki; Kazuhiro Suzuki, May 2014, ASIAN JOURNAL OF ANDROLOGY, 16, 3, 457, 460

  DOI
• Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels, Tomohiro Magari; Yasuhiro Shibata; Seiji Arai; Bunzo Kashiwagi; Keiji Suzuki; Kazuhiro Suzuki, May 2014, ASIAN JOURNAL OF ANDROLOGY, 16, 3, 457, 460

  DOI
• Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association, Hiroyuki Fujimoto; Hiroyuki Nakanishi; Tsuneharu Miki; Hiro-omi Kanayama; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Seiji Naito; Tomoharu Fukumori; Yoshinobu Kubota; Satoru Takahashi; Yukio Homma; Kazumi Kamoi, May 2014, INTERNATIONAL JOURNAL OF UROLOGY, 21, 5, 527, 534

  DOI
• Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association, Hiroyuki Fujimoto; Hiroyuki Nakanishi; Tsuneharu Miki; Hiro-omi Kanayama; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Seiji Naito; Tomoharu Fukumori; Yoshinobu Kubota; Satoru Takahashi; Yukio Homma; Kazumi Kamoi, May 2014, INTERNATIONAL JOURNAL OF UROLOGY, 21, 5, 527, 534

  DOI
• Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Tamotsu Ishizuka; Takeshi Hisada; Motoaki Hatori; Akio Koike; Kikuo Hanabuchi; Shinichi Matsuzaki; Yosuke Kamide; Mitsuyoshi Utsugi; Haruka Aoki; Reiko Yoshino; Noriko Yanagitani; Yasuhiko Koga; Akihiro Ono; Kyoichi Kaira; Noriaki Sunaga; Kunio Dobashi; Takahiro Tsuburai; Kazuo Akiyama; Masanobu Yamada; Kazuhiro Suzuki; Masatomo Mori, Sep. 2014, INFLAMMATION RESEARCH, 63, 9, 789, 796

  DOI
• Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Tamotsu Ishizuka; Takeshi Hisada; Motoaki Hatori; Akio Koike; Kikuo Hanabuchi; Shinichi Matsuzaki; Yosuke Kamide; Mitsuyoshi Utsugi; Haruka Aoki; Reiko Yoshino; Noriko Yanagitani; Yasuhiko Koga; Akihiro Ono; Kyoichi Kaira; Noriaki Sunaga; Kunio Dobashi; Takahiro Tsuburai; Kazuo Akiyama; Masanobu Yamada; Kazuhiro Suzuki; Masatomo Mori, Sep. 2014, INFLAMMATION RESEARCH, 63, 9, 789, 796

  DOI
• Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association, Tsuneharu Miki; Kazumi Kamoi; Hiroyuki Fujimoto; Hiro-omi Kanayama; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Seiji Naito; Tomoharu Fukumori; Yoshinobu Kubota; Satoru Takahashi; Kazuya Mikami; Yukio Homma, Aug. 2014, INTERNATIONAL JOURNAL OF UROLOGY, 21, 8, S1, S6

  DOI
• Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association, Tsuneharu Miki; Kazumi Kamoi; Hiroyuki Fujimoto; Hiro-omi Kanayama; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Seiji Naito; Tomoharu Fukumori; Yoshinobu Kubota; Satoru Takahashi; Kazuya Mikami; Yukio Homma, Aug. 2014, INTERNATIONAL JOURNAL OF UROLOGY, 21, 8, S1, S6

  DOI
• Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort, Teruo Inamoto; Haruhito Azuma; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Suzuki Kazuhiro; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Michiyuki Usami; Masaru Murai; Hideyuki Akaza, Jul. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 7, 1197, 1204

  DOI
• Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort., Teruo Inamoto; Haruhito Azuma; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Suzuki Kazuhiro; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Michiyuki Usami; Masaru Murai; Hideyuki Akaza, Jul. 2014, Journal of cancer research and clinical oncology, 140, 7, 1197, 204

  DOI
• Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan., Mizuki Onozawa; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Hideyuki Akaza, Oct. 2014, Japanese journal of clinical oncology, 44, 10, 969, 81

  DOI
• Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan, Mizuki Onozawa; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Hideyuki Akaza, Oct. 2014, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 10, 969, 981

  DOI
• YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Seiji Arai; Yosuke Furuya; Masashi Nomura; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, Oct. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713

  DOI
• YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Seiji Arai; Yosuke Furuya; Masashi Nomura; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, Oct. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713

  DOI
• Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer., Hirofumi Mukai; Shunji Takahashi; Masahiro Nozawa; Yusuke Onozawa; Jun Miyazaki; Keiji Ohno; Kazuhiro Suzuki, Apr. 2014, Cancer chemotherapy and pharmacology, 73, 4, 703, 10

  DOI
• Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer, Hirofumi Mukai; Shunji Takahashi; Masahiro Nozawa; Yusuke Onozawa; Jun Miyazaki; Keiji Ohno; Kazuhiro Suzuki, Apr. 2014, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 4, 703, 710

  DOI
• Suicide attempt with an overdose of sunitinib, Seiji Arai; Hiroshi Matsui; Ryo Ohki; Yoshiyuki Miyazawa; Hidekazu Koike; Tadahiro Hashita; Yoshihiko Katsuyama; Yoshitaka Sekine; Masashi Nomura; Yasuhiro Shibata; Motoaki Hatori; Kazuto Ito; Koujirou Yamamoto; Shigeru Ohmori; Kazuhiro Suzuki, Oct. 2014, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935, Report scientific journal

  DOI
• Suicide attempt with an overdose of sunitinib, Seiji Arai; Hiroshi Matsui; Ryo Ohki; Yoshiyuki Miyazawa; Hidekazu Koike; Tadahiro Hashita; Yoshihiko Katsuyama; Yoshitaka Sekine; Masashi Nomura; Yasuhiro Shibata; Motoaki Hatori; Kazuto Ito; Koujirou Yamamoto; Shigeru Ohmori; Kazuhiro Suzuki, Oct. 2014, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935, Report scientific journal

  DOI
• Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer., Hideyasu Matsuyama; Tomoyuki Shimabukuro; Isao Hara; Yasuo Kohjimoto; Kazuhiro Suzuki; Hidekazu Koike; Hirotsugu Uemura; Taiji Hayashi; Munehisa Ueno; Kiichiro Kodaira; Yoshihiko Tomita; Toshihiko Sakurai; Nobuaki Shimizu, Oct. 2014, International journal of clinical oncology, 19, 5, 946, 54

  DOI
• Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer., Hideyasu Matsuyama; Tomoyuki Shimabukuro; Isao Hara; Yasuo Kohjimoto; Kazuhiro Suzuki; Hidekazu Koike; Hirotsugu Uemura; Taiji Hayashi; Munehisa Ueno; Kiichiro Kodaira; Yoshihiko Tomita; Toshihiko Sakurai; Nobuaki Shimizu, Oct. 2014, International journal of clinical oncology, 19, 5, 946, 54

  DOI
• High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients., Yasuhide Miyoshi; Hiroji Uemura; Susumu Umemoto; Kentaro Sakamaki; Satoshi Morita; Kazuhiro Suzuki; Yasuhiro Shibata; Naoya Masumori; Tomohiko Ichikawa; Atsushi Mizokami; Yoshiki Sugimura; Norio Nonomura; Hideki Sakai; Seijiro Honma; Masaoki Harada; Yoshinobu Kubota, 26 Sep. 2014, BMC cancer, 14, 717, 717

  DOI
• High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients., Yasuhide Miyoshi; Hiroji Uemura; Susumu Umemoto; Kentaro Sakamaki; Satoshi Morita; Kazuhiro Suzuki; Yasuhiro Shibata; Naoya Masumori; Tomohiko Ichikawa; Atsushi Mizokami; Yoshiki Sugimura; Norio Nonomura; Hideki Sakai; Seijiro Honma; Masaoki Harada; Yoshinobu Kubota, 26 Sep. 2014, BMC cancer, 14, 717, 717

  DOI
• Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer., Yasuhide Miyoshi; Hiroji Uemura; Susumu Umemoto; Kentaro Sakamaki; Masataka Taguri; Kazuhiro Suzuki; Yasuhiro Shibata; Naoya Masumori; Tomohiko Ichikawa; Atsushi Mizokami; Yoshiki Sugimura; Norio Nonomura; Hideki Sakai; Seijiro Honma; Masaoki Harada; Yoshinobu Kubota, Mar. 2016, The Prostate, 76, 4, 376, 82

  DOI
• Development of an enzyme-linked immunosorbent assay for metallothionein-I and -II in plasma of humans and experimental animals, Katsuyuki Nakajima; Tsukasa Kodaira; Mihoko Kato; Kyoumi Nakazato; Yoshiharu Tokita; Hiroki Kikuchi; Hiromi Sekine; Keiji Suzuki; Takeaki Nagamine, 2010, Clinica Chimica Acta, 411, 9-10, 758, 761

  DOI
• Development of an enzyme-linked immunosorbent assay for metallothionein-I and -II in plasma of humans and experimental animals, Katsuyuki Nakajima; Tsukasa Kodaira; Mihoko Kato; Kyoumi Nakazato; Yoshiharu Tokita; Hiroki Kikuchi; Hiromi Sekine; Keiji Suzuki; Takeaki Nagamine, 2010, Clinica Chimica Acta, 411, 9-10, 758, 761

  DOI
• Association of the genetic polymorphism of the CYP19 intron 4 [TTTA](n) repeat with familial prostate cancer risk in a Japanese population, K Suzuki; H Nakazato; H Matsui; H Koike; H Okugi; N Ohtake; T Takei; S Nakata; M Hasumi; H Yamanaka, Nov. 2003, ANTICANCER RESEARCH, 23, 6D, 4941, 4946
• Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population, K Suzuki; H Matsui; N Ohtake; S Nakata; T Takei; H Koike; H Nakazato; H Okugi; M Hasumi; Y Fukabori; K Kurokawa; H Yamanaka, May 2003, INTERNATIONAL JOURNAL OF UROLOGY, 10, 5, 261, 266

  DOI
• Administration of extract of the mushroom phellinus linteus induces prostate enlargement with an increase in the stromal component in experimentally developed rat benign prostatic hyperplasia, Y Shibata; B Kashiwagi; S Arai; K Suzuki, Apr. 2005, JOURNAL OF UROLOGY, 173, 4, 387, 387, Summary international conference

  DOI
• 日本における前立腺がん検診と予後, 鈴木 和浩, 2003, 10,No.2(192-194)
• Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques, S Usui; K Suzuki; H Yamanaka; T Nakano; K Nakajima; Y Hara; M Okazaki, Mar. 2002, CLINICA CHIMICA ACTA, 317, 1-2, 133, 143

  DOI
• A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine, T Tanaka; S Takahara; M Hatori; K Suzuki; JD Wang; N Ichimaru; S Suzuki; K Morozumi; A Okuyama; H Yamanaka, Jul. 2002, CANCER LETTERS, 181, 2, 165, 171

  DOI
• Tumor-associated tissue eosinophilia of penile cancer, Y Ono; M Ozawa; Y Tamura; T Suzuki; K Suzuki; K Kurokawa; Y Fukabori; H Yamanaka, Feb. 2002, INTERNATIONAL JOURNAL OF UROLOGY, 9, 2, 82, 87

  DOI
• 膀胱重量算出ノモグラムを使用した下部尿路閉塞の評価, 曲 友弘; 深堀 能立; 鈴木 和浩; 山中 英寿; 小倉治之, 2004, 50,No.1(7-14)
• 男性維持透析患者における前立腺癌のスクリーニング, 羽鳥 基明; 鈴木 和浩; 柴田 康博; 伊藤 一人; 黒川 公平, 2004, 17, No.12 (1251-1254)
• Prognostic significance of plasma placental growth factor levels in renal cell cancer: An association with clinical characteristics and vascular endothelial growth factor levels, K Matsumoto; K Suzuki; H Koike; K Okamura; K Tsuchiya; T Uchida; Y Takezawa; M Kobayashi; H Yamanaka, Nov. 2003, ANTICANCER RESEARCH, 23, 6D, 4953, 4958
• Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, K Matsumoto; K Suzuki; H Koike; M Hasumi; H Matsui; H Okugi; Y Shibata; K Ito; H Yamanaka, Sep. 2003, ANTICANCER RESEARCH, 23, 5A, 3767, 3773
• Androgen-dependent blood flow control and morphological changes of the capillaries in rat prostate, Y Ono; K Suzuki; B Kashiwagi; Y Shibata; K Ito; Y Fukabori; H Yamanaka, Feb. 2004, INTERNATIONAL JOURNAL OF ANDROLOGY, 27, 1, 50, 56

  DOI
• 未治療進行性前立腺癌における初回LH-RH agonist投与時のflare-up予防：Diethylstilbestrol-Diphosphate, Estramustine Phosphate, Chlormadinone Acetateによる比較検討, 松井 博; 鈴木 和浩; 中里 晴樹; 黒川 公平; 柴田 康博; 蓮見 勝; 伊藤 一人; 深堀 能立; 山中 英寿, 2001, 47,No.10(861-866)
• Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity., Tetsuo Akimoto; Kazuto Ito; Jun-ichi Saitoh; Shin-ei Noda; Koichi Harashima; Hideyuki Sakurai; Yuko Nakayama; Takumi Yamamoto; Kazuhiro Suzuki; Takashi Nakano; Hideo Niibe, 01 Oct. 2005, International journal of radiation oncology, biology, physics, 63, 2, 463, 71

  DOI
• Intermittent deep coma in a hemodialysis patient with liver cirrhosis: A case report, Kazuhisa Matsumoto; Masamichi Hayashi; Nozomu Kosaku; Yoshihiro Ono; Takumi Yamamoto; Motoaki Hatori; Kazuhiro Suzuki; Hidetoshi Yamanaka, 2003, Kitakanto Medical Journal, 53, 1, 55, 57

  DOI
• 前立腺生検の適応, 鈴木 和浩; 伊藤 一人; 山中 英寿, 2004, 58,No.7(455-459)

  DOI
• Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8(+) T cells, TA Fehniger; K Suzuki; A Ponnappan; JB VanDeusen; MA Cooper; SM Florea; AG Freud; ML Robinson; J Durbin; MA Caligiuri, Jan. 2001, JOURNAL OF EXPERIMENTAL MEDICINE, 193, 2, 219, 231

  DOI
• 膀胱癌と前立腺癌, 羽鳥 基明; 鈴木 和浩; 山中英壽, 2004, 62, 増刊号6 (374-377)
• 前立腺疾患のトピックス 前立腺癌家族内発生, 鈴木 和浩; 大竹伸明; 中田誠司; 山中 英寿, 2003, 57,No.4(310-315)

  DOI
• 前立腺癌における新しい画像診断：MR-Spectroscopy(MRS), 鈴木 和浩, 2004, 11,No.2(62-64)
• 前立腺癌検診の効用, 鈴木 和浩; 山中 英寿, 2004, 53,No.10(2741-2742)
• ガイドラインに基づく腎尿路疾患診療 前立腺癌, 鈴木 和浩; 羽鳥 基明, 2004, 56,No.5(758-762)
• 家族性・遺伝性前立腺がん, 鈴木 和浩; 大竹伸明; 松井 博; 中田誠司, 2004, 17,No.9(971-976)
• 前立腺癌の症状、治療の基礎知識, 鈴木 和浩; 村椿茂里; 諸田了子, 2004, 9,No.10(908-915)
• 進行性前立腺癌におけるFlutamideによる副腎性アンドロゲン抑制効果の臨床的検討, 中里 晴樹; 鈴木 和浩; 伊藤 一人; 深堀 能立; 黒川 公平; 山中 英寿, 2001, 92,No.(6-12)

  DOI
• Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer, S Miyamoto; K Ito; K Kurokawa; K Suzuki; K Suzuki; H Yamanaka, Jun. 2006, INTERNATIONAL JOURNAL OF UROLOGY, 13, 6, 767, 772

  DOI
• 前立腺生検法, 鈴木 和浩; 伊藤 一人, 2005, 63,No.2(253-259)
• Fatal leukemia in interleukin-15 transgenic mice, TA Fehniger; K Suzuki; JB VanDeusen; MA Cooper; AG Freud; MA Caligiuri, Jan. 2001, BLOOD CELLS MOLECULES AND DISEASES, 27, 1, 223, 230

  DOI
• 酢酸クロルマジノン(プロスタール)を用いた症例, 鈴木 和浩; 黒川 公平; 山中 英寿, 2002, 10,No.3(245-248)
• 初回ホルモン療法後の再燃における放射線療法の適応 PSAdoubling time(PSADT)による判定は可能か, 黒川 公平; 伊藤 一人; 鈴木 和浩; 深堀 能立; 秋元 哲夫; 三橋紀夫; 山中 英寿, 2001, 14,No.臨時増刊(451-453)
• CAPD導入5年後に陰嚢浮腫、陰茎浮腫を認めた1例, 上井崇智; 曲 友弘; 川口拓也; 羽鳥 基明; 鈴木 和浩; 山中 英寿, 2004, 37,No.3(249-252)

  DOI
• 網膜多発血栓を合併し、ヘパリン起因性血小板減少症(HIT)が強く疑われた1例, 曲 友弘; 羽鳥 基明; 蓮見 勝; 田中俊之; 松井 博; 森田崇弘; 小野芳啓; 鈴木 和浩; 山中 英寿, 2004, 37,No.6(1437-1442)

  DOI
• BODY MASS INDEX（BMI）の前立腺がん罹患および血清PSA値に与える影響, 山本 巧; 伊藤 一人; 武智 浩之; 鈴木 和浩, 2006, 14(1): 43-45
• 前立腺がん集団検診における年齢階層別発見がんの臨床病理学的検討―受診年齢上限の設定について―, 山本 巧; 伊藤 一人; 武智 浩之; 黒川 公平; 鈴木 和浩; 山中 英寿, 2003, 10(2):118-122
• 年齢階層別PSAを基準とした前立腺がん検診の展開―前立腺がん集団検診における導入の意義―, 山本 巧; 黒川 公平; 伊藤 一人; 鈴木 和浩; 山中 英寿, 2003, 10(2):87-90
• 前立腺がん集団検診における年齢階層別ＰＳＡ基準値の有用性―69歳以下のＰＳＡ基準値引き下げによる効果―, 武智 浩之; 山本 巧; 伊藤 一人; 黒川 公平; 鈴木 和浩; 山中 英寿, 2003, 10(2):126-129
• Hands-free hook for endourological procedures, Y Ono; K Suzuki, Oct. 2003, INTERNATIONAL JOURNAL OF UROLOGY, 10, 10, 561, 562

  DOI
• 群馬県における前立腺癌の罹患率、臨床病期、組織学的分化度の推移, 中田誠司; 大竹伸明; 久保田裕; 伊藤 一人; 鈴木 和浩; 山中 英寿, 2004, 50:165-170
• Role of androgen on blood flow and capillary structure in rat seminal vesicles, Y Ono; K Suzuki; B Kashiwagi; Y Shibata; K Ito; Y Fukabori; H Yamanaka, Mar. 2004, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 202, 3, 193, 201

  DOI
• 本邦における家族性前立腺癌の最新知見, 大竹伸明; 中田誠司; 深堀 能立; 鈴木 和浩; 山中 英寿, 2002, 60,No.11(469-473)
• 古作クリニックにおけるブラッドアクセスの現状と初回内シャントと2回目内シャントの比較検討, 小野芳啓; 羽鳥 基明; 伊藤 一人; 鈴木 和浩; 山中 英寿; 古作 望; 松本和久; 林 雅道; 内田達也; 竹澤 豊; 小林 幹男; 中里 晴樹; 山本 巧, 2002, 18,No.10(1377-1381)
• 原発性陰嚢内硬化性脂肪肉芽腫―手術的摘除例と自然消退例, 小野芳啓; 古作 望; 矢嶋久徳; 高橋 修; 深堀 能立; 鈴木 和浩; 山中 英寿; 真下正道; 関原哲夫; 猿木和久; 松本和久; 林 雅道, 2002, 52,No.4(271-277)

  DOI
• 機能的解剖を応用した術中勃起神経温存評価の短期結果, 黒川 公平; 小山大輔; 山中 英寿; 鈴木 孝憲; 鈴木 和浩; 伊藤 一人; 小野芳啓; 深堀 能立; 武井智幸; 寺田直樹; 荒井陽一, 2002, 15,No.8(928-930)
• 尿路腫瘍(膀胱、腎盂・尿管癌)外来におけるPSAスクリーニング, 黒川 公平; 松井 博; 深堀 能立; 山中 英寿; 鈴木 和浩; 岡崎 浩; 伊藤 一人; 塩野昭彦; 羽鳥 基明; 蓮見 勝; 井上雅晴; 川口拓也, 2002, 10,No.1(29-30)
• 集合管癌(Bellini管癌)の一例, 小池 秀和; 武井智幸; 大竹伸明; 真下正道; 鈴木 和浩; 山中 英寿, 2002, 52,No.4(267-270)

  DOI
• Preliminary results of a monitoring system to confirm the preservation of cavernous nerves, K Kurokawa; T Suzuki; K Suzuki; N Terada; K Ito; D Yoshikawa; Y Arai; H Yamanaka, Mar. 2003, INTERNATIONAL JOURNAL OF UROLOGY, 10, 3, 136, 140

  DOI
• Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: Is it possible to identify patients likely to have good treatment outcomes?, K Kurokawa; K Ito; K Suzuki; Y Ono; T Yamamoto; T Akimoto; H Yamanaka, Nov. 2002, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 32, 11, 466, 471

  DOI
• Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, K Suzuki; N Ohtake; S Nakata; T Takei; H Matsui; Y Ono; H Nakazato; M Hasumi; H Koike; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, Nov. 2002, ANTICANCER RESEARCH, 22, 6B, 3507, 3511
• MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer, M Hasumi; K Suzuki; N Oya; K Ito; K Kurokawa; Y Fukabori; H Yamanaka, Mar. 2002, ANTICANCER RESEARCH, 22, 2B, 1205, 1208
• 私の行っている縫合と吻合の手技―膀胱･尿道吻合, 黒川 公平; 鈴木 和浩; 山中 英寿, 2002, 56,No.13(1119-1123)

  DOI
• Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage, H Koike; K Suzuki; T Satoh; N Ohtake; T Takei; S Nakata; H Yamanaka, Nov. 2003, ANTICANCER RESEARCH, 23, 6D, 4947, 4951
• 慢性腎不全に腎盂腫瘍を合併し、血液透析導入、外科手術を行った血友病Ｂの１例, 曲 友弘; 羽鳥 基明; 小野芳啓; 塩野昭彦; 清水信明; 黒川 公平; 深堀 能立; 鈴木 和浩; 山中 英寿, 2003, 36,No.12(1731-1736)

  DOI
• 後腹膜原発性腺外胚細胞腫瘍の一例, 河野真意; 鈴木光一; 鈴木 孝憲; 富田 光; 岡本亘平; 松井 博; 山本 巧; 中里 晴樹; 黒川 公平; 鈴木 和浩; 山中 英寿, 2002, 52,No.3(203-206)
• 前立腺特異抗原(PSA)による前立腺がん検診と精度管理, 山本 巧; 伊藤 一人; 武智 浩之; 黒川 公平; 鈴木 和浩; 山中 英寿, 2004, 11(2): 37-39
• PSA4.1～10ng/mlにおける前立腺生検法の検討 年齢/前立腺体積を考慮に入れた前立腺生検法の有用性, 伊藤 一人; 山本 巧; 大井 勝; 深堀 能立; 黒川 公平; 鈴木 和浩; 山中 英寿, 2002, 15No.8(934-937)
• 膀胱平滑筋肉腫の一例, 河野真意; 松井 博; 山本 巧; 小野芳啓; 深堀 能立; 黒川 公平; 鈴木 和浩; 山中 英寿; 鈴木慶二, 2002, 52,No.4(279-282)

  DOI
• Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/mL or less, K Ito; Y Kubota; T Yamamoto; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, Feb. 2001, CANCER, 91, 4, 744, 751

  DOI
• Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride, Y Shibata; Y Fukabori; K Ito; K Suzuki; H Yamanaka, Jan. 2001, JOURNAL OF UROLOGY, 165, 1, 289, 293
• Gene expression profiles of human BPH (II): Optimization of laser-capture microdissection and utilization of cDNA microarray, H Matsui; K Suzuki; M Hasumi; H Koike; H Okugi; H Nakazato; H Yamanaka, Jan. 2003, ANTICANCER RESEARCH, 23, 1A, 195, 200
• 生下時より認めていたと思われる小児精巣腫瘍の１例, 上井崇智; 加藤雄一; 三木正也; 鈴木 和浩; 山中 英寿, 2002, 15,No.11(1237-1240)
• Rapidly progressive malignant epithelioid angiomyolipoma of the kidney, T Yamamoto; K Ito; K Suzuki; H Yamanaka; K Ebihara; A Sasaki, Jul. 2002, JOURNAL OF UROLOGY, 168, 1, 190, 191, Others
• Usefulness of PSA screening in outpatients with bladder cancer: Preliminary results, K Kurokawa; K Suzuki; H Okazaki; K Ito; A Shiono; Y Fukabori; H Yamanaka, May 2002, INTERNATIONAL JOURNAL OF UROLOGY, 9, 5, 237, 240

  DOI
• Gene expression profiles in human BPH: Utilization of laser-capture microdissection and quantitative real-time PCR, K Suzuki; H Matsui; M Hasumi; Y Ono; H Nakazato; H Koike; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, Nov. 2001, ANTICANCER RESEARCH, 21, 6A, 3861, 3864
• Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/mL or less, T Yamamoto; K Ito; M Ohi; Y Kubota; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, Dec. 2001, UROLOGY, 58, 6, 994, 998

  DOI
• 透析患者の腎尿路系腫瘍 ３前立腺癌, 鈴木和浩; 羽鳥基明, 2006, 16, 3, 13, 15
• 前立腺肥大症治療におけるChlormadinone acetate投与によるPSA測定値への影響（他施設共同研究）, 藤本清秀; 舛森直哉; 塚本泰司; 徳山聡; 荒井陽一; 谷川俊貴; 高橋公太; 鈴木和浩; 山中英壽; 宮永直人; 赤座英之; 加藤聡彦; 石井延久; 宮澤克人; 鈴木孝治; 小野佳成; 大島伸一; 平尾佳彦; CMA-PSA研究会, 2005, 13, 1, 89, 91
• 前立腺癌診療ガイドラインからみた前立腺癌検診, 鈴木和浩, 2006, 55, 11, 2705
• 前立腺癌, 鈴木和浩; 羽鳥基明, 2006, 464, 468
• Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues, Hironobu Okugi; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, Sep. 2006, Asia-Pacific Journal of Clinical Oncology, 2, 3, 144, 149

  DOI
• 前立腺の病気になりやすい人はいるか, 鈴木和浩; 松井博; 大竹伸明, 2005, 243
• Ultrastructural changes in subepithelial capillaries and their surrounding stroma in rat prostate and seminal vesicle after castration, Y Ono; K Suzuki; H Yuasa; K Kurokawa; Y Fukabori; H Yamanaka, Sep. 2003, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 201, 1, 29, 38

  DOI
• Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, H Nakazato; K Suzuki; H Matsui; H Koike; H Okugi; N Ohtake; T Takei; S Nakata; M Hasumi; K Ito; K Kurokawa; H Yamanaka, May 2003, ANTICANCER RESEARCH, 23, 3C, 2897, 2902
• The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer, M Hasumi; K Suzuki; A Taketomi; H Matsui; T Yamamoto; K Ito; K Kurokawa; J Aoki; K Endo; H Yamanaka, Sep. 2003, ANTICANCER RESEARCH, 23, 5B, 4223, 4227
• NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer, K Suzuki; H Nakazato; H Matsui; M Hasumi; Y Shibata; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, Apr. 2001, JOURNAL OF LEUKOCYTE BIOLOGY, 69, 4, 531, 537
• 新しい前立腺がん診断法と将来の方向性について, 伊藤 一人; 山本 巧; 鈴木 和浩; 山中 英寿, 2004, 11: 50-53
• 群馬大学医学部附属病院における維持透析患者の手術症例の検討, 羽鳥 基明; 黒川 公平; 深堀 能立; 山中 英寿; 林 雅道; 塩野昭彦; 蓮見 勝; 武井智幸; 松井 博; 川口拓也; 伊藤 一人; 鈴木 和浩, 2002, 35,No.11(1447-1451)

  DOI
• 嫌色素性腎癌の１例, 柏木 文蔵; 栗田 晋; 中村敏之; 加藤宣雄; 鈴木 和浩; 山中 英寿, 2002, 48,No.2(85-87)
• Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome, K Suzuki; Y Fukabori; H Nakazato; M Hasumi; H Matsui; K Ito; K Kurokawa; H Yamanaka, Jun. 2001, INTERNATIONAL JOURNAL OF ANDROLOGY, 24, 3, 183, 188

  DOI
• A simple and reliable monitoring system to confirm the preservation of the cavernous nerves, K Kurokawa; T Suzuki; K Suzuki; K Ito; N Shimizu; Y Fukabori; H Yamanaka, May 2001, INTERNATIONAL JOURNAL OF UROLOGY, 8, 5, 231, 236

  DOI
• Usefulness of prostate-specific antigen velocity in screening for prostate cancer, K Ito; T Yamamoto; M Ohi; Y Kubota; Y Fukabori; K Kurokawa; K Suzuki; H Yamanaka, Jun. 2002, INTERNATIONAL JOURNAL OF UROLOGY, 9, 6, 316, 321

  DOI
• 内分泌外科からみた前立腺癌の臨床：前立腺癌の治療法と適応, 鈴木和浩, 2005, 22, 4, 206, 216
• 腫瘍マーカー/泌尿器系 PSA(γ-Sm), 鈴木和浩, 2005, 42, 12, 539, 541
• Nonmyeloablative allogenic peripheral blood stem cell transplantation for lung metastases of renal cell carcinoma, Noriko Doki; Takafumi Matsushima; Yasuyuki Saito; Akihiko Yokohama; Norifumi Tsukamoto; Masamitsu Karasawa; Hirokazu Murakami; Kazuhiro Suzuki; Yoshihisa Nojima, Aug. 2006, Kitakanto Medical Journal, 56, 3, 231, 235

  DOI
• 前立腺腫瘍マーカーの進歩と問題点：２．前立腺がんスクリーニングにおけるPSA，PSA velocity (PSAV)の使用法, 伊藤 一人; 鈴木 和浩; 山中 英寿, 2001, 14(臨増): 441-443
• 前立腺集団検診受診者における国際前立腺症状スコアー(I-PSS)の傾向とQOL indexとの関係, 伊藤 一人; 山本 巧; 鈴木 和浩; 山中 英寿, 2001, 14(8): 868-871
• 前立腺特異抗原値(PSA)が6.1～10.0ng/mlにおける生検陽性率に関係する因子の臨床的検討, 伊藤 一人; 山本 巧; 鈴木 和浩; 山中 英寿, 2001, 9(1): 66-68
• 前立腺特異抗原(PSA)値別および年齢別の遊離型PSA(fPSA)・総PSA(tPSA)比の基準値設定に関する研究, 山本 巧; 伊藤 一人; 鈴木 和浩; 山中 英寿, 2001, 9(1): 69-70
• 群馬県における前立腺がん検診の変遷・現況・将来展望, 武智浩之; 伊藤 一人; 山本 巧; 鈴木 和浩, 2003, 16(9),1005-1010
• 前立腺集団検診における年齢階層別PSA基準値の有用性, 山本 巧; 伊藤 一人; 大井 勝; 久保田裕; 黒川 公平; 鈴木 和浩; 山中 英寿, 2002, 10,No.1(18-19)
• Malignant fibrous histiocytoma of the right spermatic cord: A case report, Y Sekine; K Ohki; K Okamoto; M Nomura; H Tomita; N Ohtake; K Suzuki; K Kurokawa; M Mashimo; K Saruki; T Morita; H Nakazato; H Yokoo; H Yamanaka, Oct. 2001, INTERNATIONAL JOURNAL OF UROLOGY, 8, 10, 581, 584

  DOI
• 前立腺癌の早期診断と治療をめぐって, 荒井陽一; 鈴木 和浩; 頴川 晋, 2004, 22,No.9(88-94)
• 男性型脱毛症薬プロペシア錠（フィナステリド）の前立腺がん検診における内服症例と年齢をマッチさせた非内服症例の血清PSA値の比較, 宮久保真意; 伊藤一人; 山本巧; 武智浩之; 大井勝; 鈴木和浩, 2008, 15, 2, 125, 127
• 前立腺癌の治療Q&A, 鈴木和浩, 2005, 140, 153
• 前立腺癌治療後のPSA再発をいかにとらえるか 放射線療法後のPSA再発に対する治療戦略 When and How+, 鈴木和浩, 2008, 6, 2, 74, 80
• 前立腺癌予見因子としての血清インスリン様成長因子の意義, 山本巧; 伊藤一人; 武智浩之; 大井勝; 宮久保真意; 鈴木和浩, 2007, 15, 1, 93, 95
• 前立腺癌予防の可能性：脂質, 関根芳岳; 小池秀和; 鈴木和浩, 2007, 20, 12, 1525, 1529
• 前立腺癌 基礎・臨床研究のアップデート 臨床研究 検診 前立腺癌検診における年齢階層別PSA基準値導入の意義, 大井勝; 伊藤一人; 山本巧; 武智浩之; 鈴木和浩, 2007, 65, 10, 203, 206
• 前立腺癌 基礎・臨床研究のアップデート 臨床研究 検診 我が国における前立腺癌検診の現状と展望, 鈴木和浩, 2007, 65, 10, 187, 293
• 前立腺癌 基礎・臨床研究のアップデート 臨床研究 疫学 我が国における家族性前立腺癌の特徴, 大竹伸明; 中田誠司; 鈴木和浩; 深堀能立; 山中英壽, 2007, 65, 10, 182, 186
• 排尿障害の診断と治療, 鈴木和浩, 2007, 57, 25, 27
• 前立腺癌 男性ホルモン依存性と非依存性, 鈴木 和浩; 山中 英寿, 2002, 50,No.1(83-87)
• 泌尿器科 疼痛対策 進行癌の疼痛対策 前立腺癌, 鈴木和浩; 小池秀和, 2007, 5, 5, 77, 82
• 多数箇所生検で発見された前立腺癌の前立腺領域別分布, 武智 浩之; 伊藤 一人; 山本 巧; 黒川 公平; 鈴木 和浩, 2005, 12: 148-150
• PSAスクリーニング導入後10年間の検診発見前立腺癌症例の臨床病理学的特徴の変化, 山本 巧; 伊藤 一人; 武智 浩之; 河野真意; 坂西理恵; 黒川 公平; 鈴木 和浩; 山中 英寿, 2005, 18(8):1000-1002
• 前立腺がん検診暴露率と発見がん症例の臨床的特徴の関係, 武智 浩之; 伊藤 一人; 山本 巧; 黒川 公平; 鈴木 和浩; 山中 英寿, 2005, 18(8): 997-999
• 群馬県における前立腺集団検診形態の変遷-18年間の総括および現況・問題点-, 伊藤 一人; 山本 巧; 鈴木 和浩; 山中 英寿, 2000, 13/8,997-1001
• Incidence of bladder cancer discovered by urethrocystoscopy at prostate biopsy: Extraordinary high incidence of tiny bladder cancer in elderly males, H Okazaki; K Suzuki; T Suzuki; K Kurokawa; K Ito; K Suzuki; H Yamanaka, May 2004, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 203, 1, 31, 36

  DOI
• JUA前立腺癌診療ガイドライン 初版の読みどころと改定に向けての課題 疫学, 鈴木和浩, 2007, 20, 6, 737, 741
• 泌尿器悪性腫瘍 最近の診断と治療 増加する前立腺癌 家族性・遺伝性前立腺がん, 鈴木和浩, 2000, 84, 3, 309, 314
• EBMに基づいた前立腺癌診療ガイドライン２００６年度版 要約, 守殿貞夫; 大島伸一; 平尾佳彦; 鈴木和浩; 荒井陽一; 藤元博行; 江川晋; 赤座英之; 原勲; 筧善行; 樋之津史朗; 長谷川友紀, 2007, 98, 1, 31
• Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia, K Ito; Y Fukabori; Y Shibata; K Suzuki; M Mieda; K Gotanda; S Honma; H Yamanaka, Oct. 2000, EUROPEAN JOURNAL OF ENDOCRINOLOGY, 143, 4, 543, 554
• Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: Evaluation of mass screening populations, K Ito; Y Kubota; K Suzuki; N Shimizu; Y Fukabori; K Kurokawa; K Imai; H Yamanaka, May 2000, UROLOGY, 55, 5, 705, 709
• Changes in the endocrine environment of the human prostate transition zone with aging: Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition, Y Shibata; K Ito; K Suzuki; K Nakano; Y Fukabori; R Suzuki; Y Kawabe; S Honma; H Yamanaka, Jan. 2000, PROSTATE, 42, 1, 45, 55

  DOI
• Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, K. Suzuki; K. Ito; H. Okazaki; Y. Ono; K. Kurokawa; T. Suzuki; H. Yamanaka, 1998, International Urology and Nephrology, 30, 6, 725, 730

  DOI
• Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: Analysis by Western blot and immunohistochemistry, K Suzuki; K Ito; K Kurokawa; T Suzuki; N Shimizu; Y Fukabori; S Honma; H Yamanaka, Nov. 1997, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 183, 3, 159, 172

  DOI
• Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: Changes in prostate volume and histopathological findings, K Suzuki; K Ito; Y Tamura; T Suzuki; S Honma; H Yamanaka, May 1996, PROSTATE, 28, 5, 328, 337

  DOI
• Editorial Comment, Kazuhiro Suzuki, 2008, 2, 15, 161

  DOI
• Editorial Comment, Kazuhiro Suzuki, 2008, 15

  DOI
• Lead time of prostate cancer detected in population based screening for prostate cancer in Japan - Comment, Ernesto Lopez-Corona; Maxwell Meng, Oct. 2007, JOURNAL OF UROLOGY, 178, 4, 1263, 1264, Others

  DOI
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan, Yoshitaka Sekine; Kazuto Ito; Takumi Yamamoto; Haruki Nakazato; Yasuhiro Shibata; Motoaki Hatori; Kazuhiro Suzuki, Apr. 2007, JOURNAL OF UROLOGY, 177, 4, 536, 537, Summary international conference

  DOI
• Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response, TA Fehniger; MH Shah; MJ Turner; JB VanDeusen; SP Whitman; MA Cooper; K Suzuki; M Wechser; F Goodsaid; MA Caligiuri, Apr. 1999, JOURNAL OF IMMUNOLOGY, 162, 8, 4511, 4520
• Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: Analysis by Western blot and immunohistochemistry, K Suzuki; K Ito; K Kurokawa; T Suzuki; N Shimizu; Y Fukabori; S Honma; H Yamanaka, Nov. 1997, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 183, 3, 159, 172

  DOI
• Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: Changes in prostate volume and histopathological findings, K Suzuki; K Ito; Y Tamura; T Suzuki; S Honma; H Yamanaka, May 1996, PROSTATE, 28, 5, 328, 337

  DOI
• Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-gamma production in vivo, TA Fehniger; HX Yu; MA Cooper; K Suzuki; MH Shah; MA Caligiuri, Feb. 2000, JOURNAL OF IMMUNOLOGY, 164, 4, 1643, 1647
• Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, K. Suzuki; K. Ito; H. Okazaki; Y. Ono; K. Kurokawa; T. Suzuki; H. Yamanaka, 1998, International Urology and Nephrology, 30, 6, 725, 730

  DOI
• Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer, K Ito; T Yamamoto; Y Kubota; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, Aug. 2000, UROLOGY, 56, 2, 278, 282

  DOI
• ENDOCRINE ENVIRONMENT OF BENIGN PROSTATIC HYPERPLASIA - PROSTATE SIZE AND VOLUME ARE CORRELATED WITH SERUM ESTROGEN CONCENTRATION, K SUZUKI; K ITO; Y ICHINOSE; K KUROKAWA; T SUZUKI; K IMAI; H YAMANAKA; S HONMA, Mar. 1995, SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 29, 1, 65, 68
• SYNERGISTIC EFFECTS OF ESTROGEN AND ANDROGEN ON THE PROSTATE - EFFECTS OF ESTROGEN ON ANDROGEN-RECEPTORS AND ESTROGEN-RECEPTORS, BRDU UPTAKE, IMMUNOHISTOCHEMICAL STUDY OF AR, AND RESPONSES TO ANTIANDROGENS, K SUZUKI; K ITO; T SUZUKI; S HONMA; H YAMANAKA, Mar. 1995, PROSTATE, 26, 3, 151, 163
• 前立腺疾患：疫学の動向、治療のトレンド、手術のポイント, 鈴木和浩, 2009, 16, 11, 1064
• Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Keigo Okamura; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, Aug. 2009, Cancer Epidemiology, 33, 2, 137, 141

  DOI
• 前立腺癌検診の意義, 鈴木和浩, 2009, 58, 11, 2351, 352
• 進行癌に対する内分泌療法, 鈴木和浩, 2009, 7, 2, 10, 16
• 照射後の膀胱全摘・尿路変更に伴う腸管トラブル, 鈴木和浩, 2010, 23, 5, 719
• 前立腺がんと前立腺肥大症の疫学, 鈴木和浩, 2009, 138, 2, 251
• 前立腺がん検診の有効性 死亡率減少効果について, 鈴木和浩, 2008, 21, 12, 1585
• Epidemiology of prostate cancer and benign prostatic hyperplasia, Kazuhiro Suzuki, 2009, 52, 6, 478
• Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy, K Suzuki; H Okazaki; Y Ono; K Kurokawa; T Suzuki; E Onuma; H Takanashi; Y Mamiya; H Yamanaka, Oct. 1998, PROSTATE, 37, 2, 70, 76

  DOI
• 前立腺と組織内アンドロゲン ー前立腺癌の診断・治療における応用の可能性, 鈴木和浩; 柏木文蔵; 新井誠二; 柴田康博; 本間誠次郎, 2009, 81, 2, 200
• 去勢抵抗性前立腺がんにおける男性ホルモンの意義, 2011
• 前立腺がんの病態・診断・治療, 2011
• 国内外のガイドラインからみた間歇的内分泌療法の位置付けと現状, 2011
• 我が国における前立腺癌検診の現状と展望, 2011
• 尿路上皮癌に対するＧＣ療法施行時におけるパロノセトロンの効果：グラニセトロンとの比較検討, 2011
• 泌尿器科領域におけるがん検診と超音波の役割, 2011
• 透析療法における様々な疑問に答える ー４透析患者の腎尿路悪性腫瘍-前立腺癌, 2011
• 腎・泌尿器疾患：ＡＬＰおよびＰＳＡの異常高値をきたした64歳の男性ー進行性前立腺癌, 2012
• 進行性・去勢抵抗性前立腺癌に対するホルモン療法の現状と今後の展望ー前立腺癌のアンドロゲン依存性に関するパラダイムシフトー, 2012
• 去勢抵抗性前立腺癌に対するドセタキセルの役割：効果判定とその後の治療選択, 2012
• シロドシンによる排尿障害の治療：Urief Dose-up Study, 2012
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range., Kazuto Ito; Mai Miyakubo; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2013, World journal of urology, 31, 2, 305, 11

  DOI
• Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: The relationship between dose-volume histogram parameters and the occurrence rate, Masahiko Okamoto; Hitoshi Ishikawa; Takeshi Ebara; Hiroyuki Kato; Tomoaki Tamaki; Tetsuo Akimoto; Kazuto Ito; Mai Miyakubo; Takumi Yamamoto; Kazuhiro Suzuki; Takeo Takahashi; Takashi Nakano, 01 Feb. 2012, International Journal of Radiation Oncology Biology Physics, 82, 2, e211, e217

  DOI
• Serous borderline tumor of the paratestis in a child., 2012
• Lower urinary tract symptoms of neurological origin in urological practice., 2012

  DOI
• THE INFLUENCE OF CASTRATION ON BLADDER BLOOD FLOW AND FUNCTION DURING RAPID PHASE OF ANDROGEN DEPRIVATION, T. Magari; Y. Shibata; S. Arai; B. Kashiwagi; K. Suzuki, 2010, NEUROUROLOGY AND URODYNAMICS, 29, 6, 912, 914, Summary international conference
• Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, Yasuyuki Morikawa; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 16 Mar. 2012, Biochemical and Biophysical Research Communications, 419, 3, 584, 589

  DOI
• HDL and Sphingosine-I-Phosphate Activate Stat3 in Prostate Cancer DU145 Cells Via ERK1/2 and SIP Receptors, and Promote Cell Migration and Invasion (vol 71, pg 690, 2011), Yoshitaka Sekine; Kazuhiro Suzuki; Alan T. Remaley, Sep. 2011, PROSTATE, 71, 13, 1480, 1480, Others

  DOI
• HIGH FAT DIET REDUCES THE EXPRESSION OF GLUTATHIONE PEROXIDASE 3 IN MOUSE PROSTATE, Yoshitaka Sekine; Yosuke Furuya; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki; Alan Remaley, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, E293, E294, Summary international conference

  DOI
• 泌尿器科領域ＰＳＡスクリーニング検査がもたらすもの, 2010
• "泌尿器科領域におけるトラブルシューティング(第9回) 照射後の膀胱全摘・尿路変更に伴う腸管トラブル", 2010
• 前立腺肥大の術式, 2010
• 臓器部位別の治療戦略 前立腺がん, 2010
• Chronic expanding hematoma in the retroperitoneal space: A case report, Takahiro Syuto; Motoaki Hatori; Nomura Masashi; Yoshitaka Sekine; Kazuhiro Suzuki, 18 Nov. 2013, BMC Urology, 13, 60

  DOI
• Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist, Yoshiyuki Miyazawa; Haruo Kato; Seiji Arai; Yosuke Furuya; Yoshitaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 03 Jul. 2015, Basic and Clinical Andrology, 25, 1, 7

  DOI
• Chlormadinone acetate is effective for hot flush during androgen deprivation therapy, Koike, Hidekazu; Morikawa, Yasuyuki; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013, 1, 3, 113, 116

  DOI
• Simple method for preventing inguinal hernias after radical retropubic prostatectomy, Koike, Hidekazu; Matsui, Hiroshi; Morikawa, Yasuyuki; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013, 1, 2, 76, 80

  DOI
• 腎・泌尿器疾患のインフォームドコンセントと治療選択：前立腺疾患, 2010
• ＣＲＰＣの定義と発症メカニズム, 2011
• High-density lipoprotein and prostate cancer: An overview, Kazuhiko Kotani; Yoshitaka Sekine; Shizukiyo Ishikawa; Imoh Z. Ikpot; Kazuhiro Suzuki; Alan T. Remaley, 2013, Journal of Epidemiology, 23, 5, 313, 319

  DOI
• Lower urinary tract symptoms of neurological origin in urological practice, Tomohiro Magari; Yoshitatsu Fukabori; Haruyuki Ogura; Kazuhiro Suzuki, Apr. 2013, Clinical Autonomic Research, 23, 2, 67, 72

  DOI
• Androgen receptor coactivator p120 subtype β is highly expressed in prostate cancer., Kazumichi Muramatsu; Hiroshi Matsui; Yoshitaka Sekine; Hidekazu Koike; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2013, Prostate international, 1, 1, 10, 5

  DOI
• Association of the genetic polymorphism of the CYP19 intron 4 [TTTA](n) repeat with familial prostate cancer risk in a Japanese population, K Suzuki; H Nakazato; H Matsui; H Koike; H Okugi; N Ohtake; T Takei; S Nakata; M Hasumi; H Yamanaka, Nov. 2003, ANTICANCER RESEARCH, 23, 6D, 4941, 4946
• Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population, K Suzuki; H Matsui; N Ohtake; S Nakata; T Takei; H Koike; H Nakazato; H Okugi; M Hasumi; Y Fukabori; K Kurokawa; H Yamanaka, May 2003, INTERNATIONAL JOURNAL OF UROLOGY, 10, 5, 261, 266

  DOI
• Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques, S Usui; K Suzuki; H Yamanaka; T Nakano; K Nakajima; Y Hara; M Okazaki, Mar. 2002, CLINICA CHIMICA ACTA, 317, 1-2, 133, 143

  DOI
• A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine, T Tanaka; S Takahara; M Hatori; K Suzuki; JD Wang; N Ichimaru; S Suzuki; K Morozumi; A Okuyama; H Yamanaka, Jul. 2002, CANCER LETTERS, 181, 2, 165, 171

  DOI
• Tumor-associated tissue eosinophilia of penile cancer, Y Ono; M Ozawa; Y Tamura; T Suzuki; K Suzuki; K Kurokawa; Y Fukabori; H Yamanaka, Feb. 2002, INTERNATIONAL JOURNAL OF UROLOGY, 9, 2, 82, 87

  DOI
• Prognostic significance of plasma placental growth factor levels in renal cell cancer: An association with clinical characteristics and vascular endothelial growth factor levels, K Matsumoto; K Suzuki; H Koike; K Okamura; K Tsuchiya; T Uchida; Y Takezawa; M Kobayashi; H Yamanaka, Nov. 2003, ANTICANCER RESEARCH, 23, 6D, 4953, 4958
• Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, K Matsumoto; K Suzuki; H Koike; M Hasumi; H Matsui; H Okugi; Y Shibata; K Ito; H Yamanaka, Sep. 2003, ANTICANCER RESEARCH, 23, 5A, 3767, 3773
• Androgen-dependent blood flow control and morphological changes of the capillaries in rat prostate, Y Ono; K Suzuki; B Kashiwagi; Y Shibata; K Ito; Y Fukabori; H Yamanaka, Feb. 2004, INTERNATIONAL JOURNAL OF ANDROLOGY, 27, 1, 50, 56

  DOI
• Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity, T Akimoto; K Ito; J Saitoh; S Noda; K Harashima; H Sakurai; Y Nakayama; T Yamamoto; K Suzuki; T Nakano; H Niibe, Oct. 2005, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 63, 2, 463, 471

  DOI
• Intermittent deep coma in a hemodialysis patient with liver cirrhosis: A case report, Kazuhisa Matsumoto; Masamichi Hayashi; Nozomu Kosaku; Yoshihiro Ono; Takumi Yamamoto; Motoaki Hatori; Kazuhiro Suzuki; Hidetoshi Yamanaka, 2003, Kitakanto Medical Journal, 53, 1, 55, 57

  DOI
• Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8(+) T cells, TA Fehniger; K Suzuki; A Ponnappan; JB VanDeusen; MA Cooper; SM Florea; AG Freud; ML Robinson; J Durbin; MA Caligiuri, Jan. 2001, JOURNAL OF EXPERIMENTAL MEDICINE, 193, 2, 219, 231

  DOI
• Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer., Shigehito Miyamoto; Kazuto Ito; Kohei Kurokawa; Kazuhiro Suzuki; Keiji Suzuki; Hidetoshi Yamanaka, Jun. 2006, International journal of urology : official journal of the Japanese Urological Association, 13, 6, 767, 72

  DOI
• Fatal leukemia in interleukin-15 transgenic mice, TA Fehniger; K Suzuki; JB VanDeusen; MA Cooper; AG Freud; MA Caligiuri, Jan. 2001, BLOOD CELLS MOLECULES AND DISEASES, 27, 1, 223, 230

  DOI
• Hands-free hook for endourological procedures, Y Ono; K Suzuki, Oct. 2003, INTERNATIONAL JOURNAL OF UROLOGY, 10, 10, 561, 562

  DOI
• Role of androgen on blood flow and capillary structure in rat seminal vesicles, Y Ono; K Suzuki; B Kashiwagi; Y Shibata; K Ito; Y Fukabori; H Yamanaka, Mar. 2004, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 202, 3, 193, 201

  DOI
• Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, Masaru Hasumi; Kazuhiro Suzuki; Hiroshi Matsui; Hidekazu Koike; Kazuto Ito; Hidetoshi Yamanaka, 28 Oct. 2003, Cancer Letters, 200, 2, 187, 195

  DOI
• Preliminary results of a monitoring system to confirm the preservation of cavernous nerves, K Kurokawa; T Suzuki; K Suzuki; N Terada; K Ito; D Yoshikawa; Y Arai; H Yamanaka, Mar. 2003, INTERNATIONAL JOURNAL OF UROLOGY, 10, 3, 136, 140

  DOI
• Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: Is it possible to identify patients likely to have good treatment outcomes?, K Kurokawa; K Ito; K Suzuki; Y Ono; T Yamamoto; T Akimoto; H Yamanaka, Nov. 2002, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 32, 11, 466, 471

  DOI
• Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, K Suzuki; N Ohtake; S Nakata; T Takei; H Matsui; Y Ono; H Nakazato; M Hasumi; H Koike; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, Nov. 2002, ANTICANCER RESEARCH, 22, 6B, 3507, 3511
• MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer, M Hasumi; K Suzuki; N Oya; K Ito; K Kurokawa; Y Fukabori; H Yamanaka, Mar. 2002, ANTICANCER RESEARCH, 22, 2B, 1205, 1208
• Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage, H Koike; K Suzuki; T Satoh; N Ohtake; T Takei; S Nakata; H Yamanaka, Nov. 2003, ANTICANCER RESEARCH, 23, 6D, 4947, 4951
• Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/mL or less, K Ito; Y Kubota; T Yamamoto; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, Feb. 2001, CANCER, 91, 4, 744, 751

  DOI
• Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride, Y Shibata; Y Fukabori; K Ito; K Suzuki; H Yamanaka, Jan. 2001, JOURNAL OF UROLOGY, 165, 1, 289, 293
• Gene expression profiles of human BPH (II): Optimization of laser-capture microdissection and utilization of cDNA microarray, H Matsui; K Suzuki; M Hasumi; H Koike; H Okugi; H Nakazato; H Yamanaka, Jan. 2003, ANTICANCER RESEARCH, 23, 1A, 195, 200
• Rapidly progressive malignant epithelioid angiomyolipoma of the kidney, T Yamamoto; K Ito; K Suzuki; H Yamanaka; K Ebihara; A Sasaki, Jul. 2002, JOURNAL OF UROLOGY, 168, 1, 190, 191, Others
• Usefulness of PSA screening in outpatients with bladder cancer: Preliminary results, K Kurokawa; K Suzuki; H Okazaki; K Ito; A Shiono; Y Fukabori; H Yamanaka, May 2002, INTERNATIONAL JOURNAL OF UROLOGY, 9, 5, 237, 240

  DOI
• Gene expression profiles in human BPH: Utilization of laser-capture microdissection and quantitative real-time PCR, K Suzuki; H Matsui; M Hasumi; Y Ono; H Nakazato; H Koike; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, Nov. 2001, ANTICANCER RESEARCH, 21, 6A, 3861, 3864
• Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/mL or less, T Yamamoto; K Ito; M Ohi; Y Kubota; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, Dec. 2001, UROLOGY, 58, 6, 994, 998

  DOI
• Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues, Hironobu Okugi; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, Sep. 2006, Asia-Pacific Journal of Clinical Oncology, 2, 3, 144, 149

  DOI
• Ultrastructural changes in subepithelial capillaries and their surrounding stroma in rat prostate and seminal vesicle after castration, Y Ono; K Suzuki; H Yuasa; K Kurokawa; Y Fukabori; H Yamanaka, Sep. 2003, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 201, 1, 29, 38

  DOI
• Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, H Nakazato; K Suzuki; H Matsui; H Koike; H Okugi; N Ohtake; T Takei; S Nakata; M Hasumi; K Ito; K Kurokawa; H Yamanaka, May 2003, ANTICANCER RESEARCH, 23, 3C, 2897, 2902
• The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer, M Hasumi; K Suzuki; A Taketomi; H Matsui; T Yamamoto; K Ito; K Kurokawa; J Aoki; K Endo; H Yamanaka, Sep. 2003, ANTICANCER RESEARCH, 23, 5B, 4223, 4227
• NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer, K Suzuki; H Nakazato; H Matsui; M Hasumi; Y Shibata; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, Apr. 2001, JOURNAL OF LEUKOCYTE BIOLOGY, 69, 4, 531, 537
• Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome, K Suzuki; Y Fukabori; H Nakazato; M Hasumi; H Matsui; K Ito; K Kurokawa; H Yamanaka, Jun. 2001, INTERNATIONAL JOURNAL OF ANDROLOGY, 24, 3, 183, 188

  DOI
• A simple and reliable monitoring system to confirm the preservation of the cavernous nerves, K Kurokawa; T Suzuki; K Suzuki; K Ito; N Shimizu; Y Fukabori; H Yamanaka, May 2001, INTERNATIONAL JOURNAL OF UROLOGY, 8, 5, 231, 236

  DOI
• Usefulness of prostate-specific antigen velocity in screening for prostate cancer, K Ito; T Yamamoto; M Ohi; Y Kubota; Y Fukabori; K Kurokawa; K Suzuki; H Yamanaka, Jun. 2002, INTERNATIONAL JOURNAL OF UROLOGY, 9, 6, 316, 321

  DOI
• Malignant fibrous histiocytoma of the right spermatic cord: A case report, Y Sekine; K Ohki; K Okamoto; M Nomura; H Tomita; N Ohtake; K Suzuki; K Kurokawa; M Mashimo; K Saruki; T Morita; H Nakazato; H Yokoo; H Yamanaka, Oct. 2001, INTERNATIONAL JOURNAL OF UROLOGY, 8, 10, 581, 584

  DOI
• Incidence of bladder cancer discovered by urethrocystoscopy at prostate biopsy: extraordinary high incidence of tiny bladder cancer in elderly males., Hiroshi Okazaki; Koichi Suzuki; Takanori Suzuki; Kohei Kurokawa; Kazuto Ito; Kazuhiro Suzuki; Hidetoshi Yamanaka, May 2004, The Tohoku journal of experimental medicine, 203, 1, 31, 6

  DOI
• Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia, K Ito; Y Fukabori; Y Shibata; K Suzuki; M Mieda; K Gotanda; S Honma; H Yamanaka, Oct. 2000, EUROPEAN JOURNAL OF ENDOCRINOLOGY, 143, 4, 543, 554
• Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: Evaluation of mass screening populations, K Ito; Y Kubota; K Suzuki; N Shimizu; Y Fukabori; K Kurokawa; K Imai; H Yamanaka, May 2000, UROLOGY, 55, 5, 705, 709
• Changes in the endocrine environment of the human prostate transition zone with aging: Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition, Y Shibata; K Ito; K Suzuki; K Nakano; Y Fukabori; R Suzuki; Y Kawabe; S Honma; H Yamanaka, Jan. 2000, PROSTATE, 42, 1, 45, 55

  DOI
• Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, K. Suzuki; K. Ito; H. Okazaki; Y. Ono; K. Kurokawa; T. Suzuki; H. Yamanaka, 1998, International Urology and Nephrology, 30, 6, 725, 730

  DOI
• Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: Analysis by Western blot and immunohistochemistry, K Suzuki; K Ito; K Kurokawa; T Suzuki; N Shimizu; Y Fukabori; S Honma; H Yamanaka, Nov. 1997, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 183, 3, 159, 172

  DOI
• Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: Changes in prostate volume and histopathological findings, K Suzuki; K Ito; Y Tamura; T Suzuki; S Honma; H Yamanaka, May 1996, PROSTATE, 28, 5, 328, 337

  DOI
• Editorial comment, Kazuhiro Suzuki, Feb. 2008, International Journal of Urology, 15, 2, 161, Report scientific journal

  DOI
• Editorial comment, Kazuhiro Suzuki, Jan. 2008, International Journal of Urology, 15, 1, 105, Report scientific journal

  DOI
• Lead time of prostate cancer detected in population based screening for prostate cancer in Japan., Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Hiroyuki Takechi; Masaru Ohi; Yasuhiro Shibata; Kazuhiro Suzuki, Oct. 2007, The Journal of urology, 178, 4 Pt 1, 1258, 63

  DOI
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan, Yoshitaka Sekine; Kazuto Ito; Takumi Yamamoto; Haruki Nakazato; Yasuhiro Shibata; Motoaki Hatori; Kazuhiro Suzuki, Apr. 2007, JOURNAL OF UROLOGY, 177, 4, 536, 537, Summary international conference

  DOI
• Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response, TA Fehniger; MH Shah; MJ Turner; JB VanDeusen; SP Whitman; MA Cooper; K Suzuki; M Wechser; F Goodsaid; MA Caligiuri, Apr. 1999, JOURNAL OF IMMUNOLOGY, 162, 8, 4511, 4520
• Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: Analysis by Western blot and immunohistochemistry, K Suzuki; K Ito; K Kurokawa; T Suzuki; N Shimizu; Y Fukabori; S Honma; H Yamanaka, Nov. 1997, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 183, 3, 159, 172

  DOI
• Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: Changes in prostate volume and histopathological findings, K Suzuki; K Ito; Y Tamura; T Suzuki; S Honma; H Yamanaka, May 1996, PROSTATE, 28, 5, 328, 337

  DOI
• Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-gamma production in vivo, TA Fehniger; HX Yu; MA Cooper; K Suzuki; MH Shah; MA Caligiuri, Feb. 2000, JOURNAL OF IMMUNOLOGY, 164, 4, 1643, 1647
• Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, K. Suzuki; K. Ito; H. Okazaki; Y. Ono; K. Kurokawa; T. Suzuki; H. Yamanaka, 1998, International Urology and Nephrology, 30, 6, 725, 730

  DOI
• Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer, K Ito; T Yamamoto; Y Kubota; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, Aug. 2000, UROLOGY, 56, 2, 278, 282

  DOI
• ENDOCRINE ENVIRONMENT OF BENIGN PROSTATIC HYPERPLASIA - PROSTATE SIZE AND VOLUME ARE CORRELATED WITH SERUM ESTROGEN CONCENTRATION, K SUZUKI; K ITO; Y ICHINOSE; K KUROKAWA; T SUZUKI; K IMAI; H YAMANAKA; S HONMA, Mar. 1995, SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 29, 1, 65, 68
• SYNERGISTIC EFFECTS OF ESTROGEN AND ANDROGEN ON THE PROSTATE - EFFECTS OF ESTROGEN ON ANDROGEN-RECEPTORS AND ESTROGEN-RECEPTORS, BRDU UPTAKE, IMMUNOHISTOCHEMICAL STUDY OF AR, AND RESPONSES TO ANTIANDROGENS, K SUZUKI; K ITO; T SUZUKI; S HONMA; H YAMANAKA, Mar. 1995, PROSTATE, 26, 3, 151, 163
• Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer., Okamura K; Koike H; Sekine Y; Matsui H; Suzuki K, 2009, Cancer Epidemiolo, 33, 2, 137, 141

  DOI
• Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Sekine Y; Furuya Y; Nishii M; Koike H; Matsui H; Suzuki K, 2008, Biochem Biophys Res Commun., 372, 2, 356, 361

  DOI
• Epidemiology of prostate cancer and benign prostatic hyperplasia, Kazuhiro Suzuki, 2009, JMAJ, 52, 6, 478
• Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy, K Suzuki; H Okazaki; Y Ono; K Kurokawa; T Suzuki; E Onuma; H Takanashi; Y Mamiya; H Yamanaka, Oct. 1998, PROSTATE, 37, 2, 70, 76

  DOI
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related induces in men with total PSA in the 2.0-10.0ng/ml range., 2012, World J Urol

  DOI
• Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate., Masahiko Okamoto; Hitoshi Ishikawa; Takeshi Ebara; Hiroyuki Kato; Tomoaki Tamaki; Tetsuo Akimoto; Kazuto Ito; Mai Miyakubo; Takumi Yamamoto; Kazuhiro Suzuki; Takeo Takahashi; Takashi Nakano, 01 Feb. 2012, International journal of radiation oncology, biology, physics, 82, 2, e211-7, e217

  DOI
• Serous borderline tumor of the paratestis in a child., 2012, BJUI.org
• Lower urinary tract symptoms of neurological origin in urological practice, Tomohiro Magari; Yoshitatsu Fukabori; Haruyuki Ogura; Kazuhiro Suzuki, Apr. 2013, Clinical Autonomic Research, 23, 2, 67, 72

  DOI
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., 2012
• HDL and Sphingosine-I-Phosphate Activate Stat3 in Prostate Cancer DU145 Cells Via ERK1/2 and SIP Receptors, and Promote Cell Migration and Invasion (vol 71, pg 690, 2011), Yoshitaka Sekine; Kazuhiro Suzuki; Alan T. Remaley, Sep. 2011, PROSTATE, 71, 13, 1480, 1480, Others

  DOI
• HIGH FAT DIET REDUCES THE EXPRESSION OF GLUTATHIONE PEROXIDASE 3 IN MOUSE PROSTATE, Yoshitaka Sekine; Yosuke Furuya; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki; Alan Remaley, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, E293, E294, Summary international conference

  DOI
• The investigation of ureteral sympathetic innevation, using semi-serial sections: why dose the alpha1-adrenergic receptor antagonist work well for ureteral stones?, 2010, Int Urol Nephrol

  DOI
• Chronic expanding hematoma in the retroperitoneal space: A case report, Takahiro Syuto; Motoaki Hatori; Nomura Masashi; Yoshitaka Sekine; Kazuhiro Suzuki, 18 Nov. 2013, BMC Urology, 13, 60

  DOI
• Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist., Yoshiyuki Miyazawa; Haruo Kato; Seiji Arai; Yosuke Furuya; Yoshitaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2015, Basic and clinical andrology, 25, 1, 7, 7

  DOI
• Chlormadinone acetate is effective for hot flush during androgen deprivation therapy., Hidekazu Koike; Yasuyuki Morikawa; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2013, Prostate international, 1, 3, 113, 6

  DOI
• Simple method for preventing inguinal hernias after radical retropubic prostatectomy., Hidekazu Koike; Hiroshi Matsui; Yasuyuki Morikawa; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2013, Prostate international, 1, 2, 76, 80

  DOI
• High-density lipoprotein and prostate cancer: an overview., Kazuhiko Kotani; Yoshitaka Sekine; Shizukiyo Ishikawa; Imoh Z Ikpot; Kazuhiro Suzuki; Alan T Remaley, 05 Sep. 2013, Journal of epidemiology, 23, 5, 313, 9

  DOI
• Lower urinary tract symptoms of neurological origin in urological practice, Tomohiro Magari; Yoshitatsu Fukabori; Haruyuki Ogura; Kazuhiro Suzuki, Apr. 2013, Clinical Autonomic Research, 23, 2, 67, 72

  DOI
• Androgen receptor coactivator p120 subtype beta is highly expressed in prostate cancer, Muramatasu, Kazumichi; Matsui, Hiroshi; Sekine, Yoshitaka; Koike, Hidekazu; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013, Prostate International, 1, 1, 10-15.

  DOI
• 家族性前立腺癌の遺伝子解析と臨床応用の可能性, 松井 博; 大竹 伸明; 中田 誠司; 栗原 聰太; 小池 秀和; 鈴木 和浩, 2016, 3, 1, 53, 60
• Growing teratoma syndromeの1例, 馬場 恭子; 関根 芳岳; 栗原 聰太; 小池 秀和; 松井 博; 中里 晴樹; 柴田 康博; 伊藤 一人; 鈴木 和浩; 西井 昌弘; 真下 透; 岡村 桂吾; 平戸 純子, 2016, 107, 2, 115, 120

  DOI
• 泌尿器疾患におけるBone Management Bone Scan Index(BSI)による骨転移の評価, 鈴木 和浩; 堀越 浩幸; 溝上 敦, Oct. 2015, Prostate Journal, 2, 2, 241, 244
• DECREASING SURVIVIN BY YM155 REVERSES RAPAMYCIN RESISTANCE IN RENAL CANCER, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, Apr. 2015, JOURNAL OF UROLOGY, 193, 4, E458, E458, Summary international conference
• 血中dihydrotestosteroneレベルはPSA3-10 ng/mLの男性においてGleason score 7-10の前立腺癌を予測する独立した因子である, 三好 康秀; 梅本 晋; 上村 博司; 柴田 康博; 鈴木 和浩; 窪田 吉信; 矢尾 正祐, Apr. 2015, 日本泌尿器科学会総会, 103回, 493, 493
• 総排泄腔外反症に有棘細胞癌を合併した一例, 大津 晃; 宮尾 武士; 小池 秀和; 馬場 恭子; 青木 雅典; 栗原 聰太; 宮澤 慶行; 加藤 春雄; 周東 孝浩; 新井 誠二; 古谷 洋介; 新田 貴士; 野村 昌史; 関根 芳岳; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩; 牧口 貴哉; 森田 廣樹; 古作 望; 松本 和久; 富田 光; 山本 巧; 林 雅道, 2015, 106, 4, 274, 279

  DOI
• Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels., Kohei Okamoto; Yositaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2015, Basic and clinical andrology, 25, 3, 3

  DOI
• 精索静脈瘤に対する術中インドシアニングリーン蛍光血管造影下顕微鏡下低位結紮術の有用性：予備的検討, 柴田 康博; 栗原 聰太; 新井 誠二; 宮澤 慶行; 加藤 春雄; 小池 秀和; 伊藤 一人; 中村 哲也; 鈴木 和浩, 2015, 106, 4, 293, 298

  DOI
• 前立腺癌に対する放射線療法Multi-Disciplinary Teamとしての取り組み, 鈴木 和浩; 松井 博; 河村 英将; 平戸 純子; 渋谷 圭; 谷山 奈保子; 橋本 智美; 金井 達明; 中野 隆史; 大野 達也, 2015, 42, 1, 32, 35
• 前立腺癌に対する重粒子線治療 ホルモン療法の役割, 鈴木 和浩; 松井 博; 河村 英将; 大野 達也, 2015, 42, 2, 159, 163
• Development of prostate cancer in a patient with primary hypogonadism :intratumoural steroidogenesis in prostate cancer tissue, 新井 誠二; 柴田 康博; 関根 芳岳; 伊藤 一人; 鈴木 和浩; 中村 保宏; 笹野 公伸; 柏木 文蔵; 上井 崇智; 都丸 行雄; 宮代 好通; 本間 誠次郎; 橋本 貢士, 01 Aug. 2014, The Kitakanto medical journal = 北関東医学, 64, 3, 262, 262
• 日本人の去勢抵抗性前立腺癌患者におけるカバジタキセルの第I相臨床試験(TED11576), 小坂 威雄; 向井 博文; 高橋 俊二; 植村 天受; 上村 博司; 西山 博之; 鈴木 和浩; 筧 善行; 沖原 宏治; 並木 俊一; 小川 修; 加藤 真史; 大野 桂司; 中井 康友, Jun. 2014, 49, 3, 1434, 1434
• 原発性性腺機能低下症患者に発生した前立腺癌 前立腺癌組織内アンドロゲン合成に関する検討, 新井 誠二; 柴田 康博; 中村 保宏; 柏木 文蔵; 上井 崇智; 登丸 行雄; 宮代 好通; 本間 誠次郎; 橋本 貢士; 関根 芳岳; 伊藤 一人; 笹野 公伸; 鈴木 和浩, May 2014, 泌尿器外科, 27, 臨増, 765, 765
• 前立腺癌患者の初回内分泌療法の成績と診断時年齢 地域差と治療施設の特徴を踏まえて, 稲元 輝生; 東 治人; 樋之津 史郎; 塚本 泰司; 大家 基嗣; 小川 修; 北村 唯一; 鈴木 和浩; 内藤 誠二; 並木 幹夫; 西村 和郎; 平尾 佳彦; 宇佐美 道之; 村井 勝; 赤座 英之, Apr. 2014, 102回, 478, 478
• スニチニブ大量内服による自殺企図を来した腎癌症例における薬物動態の検討, 新井誠二; 松井博; 大木亮; 小池秀和; 柴田康博; 伊藤一人; 鈴木和浩; 坡下真大; 山本康次郎; 勝山善彦; 大森栄, 01 Feb. 2014, Kitakanto Medical Journal, 64, 1, 71

  DOI
• 初回内分泌療法を施行された前立腺癌患者における治療パターンと診断時年齢の評価, 稲元 輝生; 東 治人; 樋之津 史郎; 塚本 泰司; 大家 基嗣; 小川 修; 鈴木 和浩; 内藤 誠二; 並木 幹夫; 西村 和郎; 平尾 佳彦; 村井 勝; 赤座 英之; J-CaP(Japan study; group of; ProstateCancer)研究会, Oct. 2013, 75, 増刊, 119, 119
• 前立腺癌患者の初回内分泌療法と診断時年齢, 稲元 輝生; 東 治人; 樋之津 史郎; 塚本 泰司; 大家 基嗣; 小川 修; 北村 唯一; 鈴木 和浩; 内藤 誠二; 並木 幹夫; 西村 和郎; 平尾 佳彦; 宇佐美 道之; 村井 勝; 赤座 英之, Sep. 2013, 48, 3, 1498, 1498
• 前立腺癌患者の初回内分泌療法と診断時年齢の関係, 稲元輝生; 東治人; 樋之津史郎; 塚本泰司; 大家基嗣; 小川修; 北村唯一; 鈴木和浩; 内藤誠二; 並木幹夫; 西村和郎; 平尾佳彦; 宇佐美道之; 村井勝; 赤座英之, 15 Jun. 2013, 泌尿器外科, 26, 6, 960, 963
• 前立腺がんの重粒子線治療はどこまでエビデンスがあるのか?, 松井 博; 加藤 弘之; 神沼 拓也; 伊藤 一人; 鈴木 和浩; 大野 達也, 2013, 12, 5, 515, 521
• HIGH-FAT DIET INCREASES RENAL CANCER GROWTH ACCOMPANIED BY LEPTIN INCREASE, AND SURVIVIN INHIBITION IS EFFECTIVE FOR SIMVASTATIN RESISTANT RENAL CANCER, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Yosuke Furuya; Yasuyuki Morikawa; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2012, JOURNAL OF UROLOGY, 187, 4, E59, E60, Summary international conference
• ANDROGEN PRODUCTION IN PERIPROSTATIC ADIPOSE TISSUE IN PROSTATE CANCER PATIENTS, Seiji Arai; Yasuhiro Shibata; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Seijiro Honma; Kazuhiro Suzuki, Apr. 2012, JOURNAL OF UROLOGY, 187, 4, E389, E390, Summary international conference
• HIGH-FAT DIET INCREASED RENAL CANCER GROWTH, AND THE ANTITUMOR SENSITIZATION EFFECT DUE TO SURVIVIN INHIBITION IN SIMVASTATIN TREATMENT FOR RENAL CANCER CELLS, Hidekazu Koike; Yoshitaka Sekine; Takashi Nitta; Yosuke Furuya; Yasuyuki Morikawa; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, E96, E96, Summary international conference
• EXPRESSION OF GENES ENCODING ENZYMES INVOLVED IN ANDROGEN SYNTHESIS IN HUMAN ADIPOSE TISSUE POSSIBILITY OF ADIPOSE TISSUE AS THE THIRD ORGAN PRODUCING ACTIVE ANDROGEN IN PROSTATE CANCER PATIENTS-, Seiji Arai; Yasuhiro Shibata; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Seijiro Honma; Kazuhiro Suzuki, Apr. 2011, JOURNAL OF UROLOGY, 185, 4, E58, E58, Summary international conference
• NOVEL CANDIDATE GENE FOR PROSTATE CANCER (PC) SUSCEPTIBILITY, FARNECYL-DIPHOSPHATE FARNECYLTRANSFERASE 1 (FDFT1): ASSOCIATIONS OF FDFT1 GENE VARIANTS WITH PC RISK, AND FDFT1 PROTEIN FUNCTION EVALUATION IN PC CELLS, Hiroshi Matsui; Yuji Fukuma; Tatsuya Hamano; Hidekazu Koike; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, Apr. 2010, JOURNAL OF UROLOGY, 183, 4, E267, E267, Summary international conference
• HIGH DENSITY LIPOPROTEIN INDUCES PROLIFERATION AND MIGRATION OF HUMAN PROSTATE ANDROGEN INDEPENDENT CANCER CELLS VIA ATP-BINDING CASSETTE TRANSPORTER A1 BY A CHOLESTEROL-INDEPENDENT MECHANISM, Yoshitaka Sekine; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki; Alan Remaley, Apr. 2010, JOURNAL OF UROLOGY, 183, 4, E42, E43, Summary international conference
• STATIN INHIBITS THE PROLIFERATION OF HUMAN RENAL CANCER CELLS VIA DOWN-REGULATION OF THE SURVIVIN THROUGH IGF-1 SIGNALING, Hidekazu Koike; Yasuyuki Morikawa; Takashi Nitta; Yosuke Furuya; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, Apr. 2010, JOURNAL OF UROLOGY, 183, 4, E32, E32, Summary international conference
• OP-170 下大静脈腫瘍血栓を伴う腎細胞癌症例の臨床的検討(腎腫瘍/手術1,一般演題口演,第98回日本泌尿器科学会総会), 廣野 正法; 鈴木 和浩; 伊藤 一人; 小林 幹男; 篠原 信雄; 公文 裕巳; 早川 正道; 内藤 誠二; 大圏 誠一郎; 福井 巌; 錦戸 雅春; 木村 剛; 五十嵐 辰男, 20 Feb. 2010, 101, 2
• 酢酸クロルマジノンによる前立腺肥大症患者の血中PSA値に与える影響, 柴田 康博; 鈴木 和浩; 平尾 佳彦; 藤本 清秀; 大橋 靖雄; 小川 良雄; 冨士 幸蔵; 七条 武志; 植村 天受; 辻 秀憲; 朴 英哲, Feb. 2010, 101, 2, 305, 305
• 新しい治療：重粒子線治療の意義/位置づけ., 石川 仁; 辻 比呂志; 加藤 弘之; 中野 隆史; 伊藤 一人; 鈴木 和浩; 島崎 淳; 鎌田 正, 2010, 23, 8, 1057, 1059
• 下大静脈腫瘍血栓を伴う腎細胞癌症例の臨床的検討, 廣野 正法; 鈴木 和浩; 伊藤 一人; 小林 幹男; 篠原 信雄; 公文 裕巳; 早川 正道; 内藤 誠二; 大園 誠一郎; 福井 巌; 金武 洋; 近藤 幸尋, Sep. 2009, 日本癌治療学会誌, 44, 2, 540, 540
• SURVIVIN IS ASSOCIATED WITH CELL PROLIFERATION AND PLAYS A ROLE IN 1A,25-DIHYDROXYVITAMIN D-3 INDUCED CELL GROWTH INHIBITION IN PROSTATE CANCER, Hidekazu Koike; Yoshitaka Sekine; Yasuyuki Morikawa; Seiji Arai; Yosuke Huruya; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, Apr. 2009, JOURNAL OF UROLOGY, 181, 4, 52, 53, Summary international conference
• FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE 1 IS ASSOCIATED WITH THE GROWTH OF RENAL CANCER: ASSOCIATION WITH ANTICANCER EFFECT OF STATIN, Hidekazu Koike; Yoshitaka Sekine; Yasuyuki Morikawa; Yosuke Furuya; Hiroshi Matsui; Kazuhiro Suzuki, Apr. 2009, JOURNAL OF UROLOGY, 181, 4, 154, 154, Summary international conference
• USEFULNESS OF REAL-TIME TRANSRECTAL ULTRASOUND NAVIGATION DURING HOLMIUM LASER ENUCLEATION OF THE PROSTATE, Yasuhiro Shibata; Seiji Arai; Hidekazu Koike; Motoaki Hatori; Kazuto Ito; Kazuhiro Suzuki, Apr. 2009, JOURNAL OF UROLOGY, 181, 4, 764, 764, Summary international conference
• 高齢者の腎細胞癌に対する体腔鏡下腎摘除術の検討, 野村昌史; 小池秀和; 松井博; 柴田康博; 羽鳥基明; 伊藤一人; 小林幹男; 鈴木和浩, 2009, 59, 4, 333, 336

  DOI
• Survivin and its spliced isoforms gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Hidekazu Koike; Keigo Okamura; Yoshitaka Sekine; Kazuhiro Suzuki, Apr. 2008, JOURNAL OF UROLOGY, 179, 4, 211, 211, Summary international conference
• 再燃抵抗性前立腺癌に対するドセタキセル療法の検討, 小池秀和; 中里晴樹; 新井誠二; 森川泰如; 関根芳岳; 野村昌史; 西井昌弘; 曲友弘; 松井博; 山本巧; 柴田康博; 羽鳥基明; 伊藤一人; 鈴木和浩, 2008, 21, 8, 1123, 1126
• 【前立腺がん放射線療法の進歩】 放射線治療の合併症・QOL評価・改善のための工夫 前立腺癌に対する外照射併用高線量率組織内照射後の急性反応 Geometrical optimizationとanatomy based inverse optimizationの比較, 秋元 哲夫; 加藤 弘之; 白井 克幸; 田巻 倫明; 原田 耕作; 山本 巧; 伊藤 一人; 鈴木 和浩; 中野 隆史, Aug. 2006, 泌尿器外科, 19, 8, 975, 979
• HER-2 gene polymorphism at codon 655 in familial prostate cancer in a Japanese population, Sekine Y; Hasumi M; Ohtake N; Nakata S; Nakazato H; Koike H; Suzuki K, 2005, Asia-Pacific Journal of Clinical Oncology, 1, 4, 133, 137
• Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia., Kashiwagi B; Shibata Y; Ono Y; Suzuki R; Honma S; Suzuki K, 2005, J Androl, 26, 5, 586, 591
• Genomewide linkage analysis of familial prostate cancer in the Japanese population., Matsui H; Suzuki K; Ohtake N; Nakata S; Takeuchi T; Yamanaka H; Inoue I, 2004, J Hum Genet., 49, 1, 9, 15

  DOI
• 腎移植患者の腎機能,QOLに対する貧血管理の関与, 田中 俊之; 高原 史郎; 守山 敏樹; 羽鳥 基明; 児島 康行; 小角 幸人; 市丸 直嗣; 蓮見 勝; 川口 拓也; 鈴木 和浩; 奥山 明彦; 山中 英壽, Feb. 2003, 日本泌尿器科学会雑誌, 94, 2, 204, 204
• 4. 前立腺癌に対する外照射併用高線量率組織内照射の初期経験, 秋元 哲夫; 鈴木 和浩; 山中 英壽; 北本 佳住; 桜井 英幸; 中野 隆史; 清塚 誠; 石川 仁; 三橋 紀夫; 伊藤 一人; 山本 巧, 2002, 15(8):944-947
• 前立腺癌に対する外照射併用高線量率組織内照射法, 秋元 哲夫; 黒川 公平; 鈴木 和浩; 山中 英寿; 北本 佳住; 桜井 英幸; 中野 隆史; 斎藤 淳一; 原島 浩一; 三橋 紀夫; 伊藤 一人; 山本 巧, 2002, 47(12):1708-1714

Books etc

• 男性生殖腺, 2004
• レーザーキャプチャーマイクロダイセクションと核酸の解析, 2002
• 前立腺がんの確定診断, 2008
• 前立腺癌検診ガイドライン, 2008
• 前立腺がん検診ガイドライン2010版, 2009
• 前立腺癌, 2011
• 前立腺癌診療ガイドライン2012年版 疫学, 2012
• がん骨転移のバイオロジーとマネージメント：がん治療による骨量減少（ＣＴＩＢＬ）, 2012
• 去勢抵抗性前立腺がん 薬物治療UPDATE, 2015
• 癌と骨, 2013

Presentations

• 広汎性子宮全摘術における術中膀胱神経温存法の改善, 第41回日本癌治療学会総会, 2003
• Impact of body mass index on serum PSA levels in Japanease males, 21th Annual EAU congress, 2006
• Positive effect of prostaglandin on regulation of prostate blood flow- Investigation of the key factor in the signaling pathway of the prostate blood flow-, 100th AUA annual meeting, 2005
• Chronic ischemia induces abnormal growth in the ventral prostate of the rats, 100th AUA annual meeting, 2005
• Administration of extract of the mushroom phellinus linteus induces prostate enlargement with an increase in the stromal component in experimentally developed rat benign prostatic hyperplasia, 100th AUA annual meeting, 2005
• Comprehensive analysis of genetic polymorphisms involved in prostate cancer developement and progression in a high risk Japanese population, 100th AUA annual meeting, 2005
• Cnosequences of RNASEL gene in familial prostate cancer in Japan, 98th AUA annual meeting, 2003
• Genetic polymorphism of HPC2/ELAC2 is not associated with familial prostate cancer risk in japan, 2003
• Familial prostate cancer, the 18th international symposiumu controvesies in prostate cancer: diagnosis and treatment, 2006
• Multigenic involvement in familial prostate cancer risk in a Japanease population, 98th AUA annual meeting, 2003
• Effects of new steroidal aromatase inhibitor TZA-2237 on hormone induced benign prostatic hyperplasia in the canine, 10th International Congress of Endocrinology, 1996
• A model for the number of cores per prostate biopsy based on age and prostate volume in Japanese patients., The 17th Japan-Korea Urological Congress, 2000
• 前立腺癌スクリーニングにおけるPSA，PSA velocity (PSAV)の使用法, 第65回日本泌尿器科学会東部総会, 2000
• Long-term screening for prostate cancer in men with initial PSA levels of 4.0ng/ml or less., Annual Meeting of The American Urological Association, 2000
• The correlation of prostate-specific antigen prior to prostate cancer detection and clinicopathological features., The 5th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer., 2000
• Changes in the baseline PSA in Japanese men participated in the population-based screening for prostate cancer between 1988 and 2003., ２２ｔｈ European Association of Urology Annual Meeting, 2009
• PSA kinetics in screen detected prostate cancer in Japan., 22thEuropean Association of Urology Annual Meeting, 2007
• The usefulness of [-5,-7]pro/free PSA ratio in the era undergoing multiple-core biopsies for men with PSA levels between 4 and 10ng/ml : Assessment using a receiver operating characteristic partial area index(pAUC-ROC) analysis., 22thEuropean Association of Urology Annual Meeting, 2007
• The growth inhibitory effect of mushroom extract, Phellinus linteus on prostate cancer cell line in vitro and in vivo., 102th AUA Annual Meeting, 2007
• Evaluation of adrenal androgen and estrogen levels in the prostatic tissue with prostate cancer or benign prostatic hyperplasia., 102th AUA annual meeting, 2007
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., 102th AUA annual meeting, 2007
• Japanese Prospective Cohort Study of Screening for Prostate Cancer(JPSPC)：The study concept and the first analyses on compliance and contamination for the PSA test(Gunma section), 102th AUA annual meeting, 2007
• Seasonally changes in the serum PSA levels in men participated in the population-based screening for prostate cancer in Japan., 23th EAU annual meeting, 2008
• Japanese Prospective Cohort Study of Screening for Prostate Cancer (JPSPC): The Study Concept and the First Analyses on Compliance and Contamination for the PSA test (Gunma section)., 23th EAU annual meeting, 2008
• Impact of pretreatment factors, biopsy Gleason grade volume index and post treatment nadir PSA on cause-specific and overall survival in patients with stage IV prostate cancer., 2nd World congress on controversies in Urology, 2009
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., 24th EAU annual meeting, 2009
• Survivin is associated with cell proliferation and plays a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., 24th EAU annual meeting, 2009
• Farnesyl-diphosphate farnesyltransferase 1 is associated with the growth of renal cancer: Association with anticancer effect of statin., 24th EAU annual meeting, 2009
• Association between common sequence variants in the farnesyl-diphosphate farnesyltransferase 1(FDFT1) gene and the prostate cancer risk in the Japanese population., 104th AUA annual meeting, 2008
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., 103th AUA annual meeting, 2008
• HDL and sphingosine-1-phosphate activate signal transducer and activator of transcription 3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors., AACR 101st Annual Meeting 2010, 2010
• Diagnostic significance of [-2]proPSA and volume adjusted PSA-related indices in Japanese men with total PSA in the 2.0 to 10.0 ng/mL range., The 105th Annual Meeting of American Urological Association, 2010
• Statin inhibits the proliferation of human prenal cancer cells via down-regulation of the survivin through IGF-1 signaling., The 105th Annual Meeting of American Urological Association, 2010
• Detection of membrane androgen-binding site in living rat prostate and evaluation of its role in prostate blood flow regulation., 2010
• Prediction of future castration resistant prostate cancer by pre-treatment prostate tissue androgen content., AUA 106th annual Meeting, 2011
• High density lipoprotein induces proliferation and migration of human prostate androgen independent cancer cells via ATP-binding cassette transporter A1 by A cholesterol-independent mechanism., 2010
• Expression of genes encoding enzymes involved in androgen synthesis in human adipose tissue -possibility of adipose tissue as the third organ producing active androgen in prostate cancer patients-, 2011
• High-fat diet increased renal cancer growth, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer cells., AUA 106th annual Meeting, 2011
• High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., AUA 106th annual Meeting, 2011
• Predictive impact of free PSA/total PSA (%fPSA) on the development of prostate cancer in men with baseline PSA lower than 2.0ng/mL: baseline PSA-adjusted case control study., International urology meeting 31th, 2011
• Androgen production in periprostatic adipose tissue in prostate cancer patients., AUA 107th annual Meeting, 2012
• High-fat diet increases renal cancer growth accompanied by leptin increase, and survivin inhibition is effective for simvastatin resistant renal cancer., AUA 107th annual Meeting, 2012
• Some techniques to achieve high enucleation efficiency when performing holmium laser enucleation of the prostate., AUA 107th annual Meeting, 2012
• Simple method of preventing postradical retropubic prostatectomy inguinal hernia., 27th Annual EAU Congress, 2012
• High-fat diet increased leptin, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer., 27th Annual EAU Congress, 2012
• Androgen production in periprostatic adipose tissue in prostate cancer patients., 27th Annual EAU Congress, 2012
• Evaluation of adrenal androgens and estrogen levels in the prostatic tissue with prostate cancer or benign prostatic hyperplasia., 15th International Congress on Hormonal Steroids and Hormones & Cancer, 2012
• Impact of pre-treatment prostate tissue androgen content on the prediciton of future castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy., 15th International Congress on Hormonal Steroids and Hormones & Cancer, 2012
• Effects of LH-RH agonist on hormonal and cognitive function of prostate cancer patients in relation to testicular and adrenal androgens., 15th International Congress on Hormonal Steroids and Hormones & Cancer symposium, 2012
• Impact of body mass index on serum PSA levels in Japanease males, 21th Annual EAU congress, 2006
• Positive effect of prostaglandin on regulation of prostate blood flow- Investigation of the key factor in the signaling pathway of the prostate blood flow-, 100th AUA annual meeting, 2005
• Chronic ischemia induces abnormal growth in the ventral prostate of the rats, 100th AUA annual meeting, 2005
• Administration of extract of the mushroom phellinus linteus induces prostate enlargement with an increase in the stromal component in experimentally developed rat benign prostatic hyperplasia, 100th AUA annual meeting, 2005
• Comprehensive analysis of genetic polymorphisms involved in prostate cancer developement and progression in a high risk Japanese population, 100th AUA annual meeting, 2005
• Cnosequences of RNASEL gene in familial prostate cancer in Japan, 98th AUA annual meeting, 2003
• Genetic polymorphism of HPC2/ELAC2 is not associated with familial prostate cancer risk in japan, 2003
• Familial prostate cancer, the 18th international symposiumu controvesies in prostate cancer: diagnosis and treatment, 2006
• Multigenic involvement in familial prostate cancer risk in a Japanease population, 98th AUA annual meeting, 2003
• Effects of new steroidal aromatase inhibitor TZA-2237 on hormone induced benign prostatic hyperplasia in the canine, 10th International Congress of Endocrinology, 1996
• A model for the number of cores per prostate biopsy based on age and prostate volume in Japanese patients., The 17th Japan-Korea Urological Congress, 2000
• Long-term screening for prostate cancer in men with initial PSA levels of 4.0ng/ml or less., Annual Meeting of The American Urological Association, 2000
• The correlation of prostate-specific antigen prior to prostate cancer detection and clinicopathological features., The 5th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer., 2000
• Changes in the baseline PSA in Japanese men participated in the population-based screening for prostate cancer between 1988 and 2003., ２２ｔｈ European Association of Urology Annual Meeting, 2009
• PSA kinetics in screen detected prostate cancer in Japan., 22thEuropean Association of Urology Annual Meeting, 2007
• The usefulness of [-5,-7]pro/free PSA ratio in the era undergoing multiple-core biopsies for men with PSA levels between 4 and 10ng/ml : Assessment using a receiver operating characteristic partial area index(pAUC-ROC) analysis., 22thEuropean Association of Urology Annual Meeting, 2007
• The growth inhibitory effect of mushroom extract, Phellinus linteus on prostate cancer cell line in vitro and in vivo., 102th AUA Annual Meeting, 2007
• Evaluation of adrenal androgen and estrogen levels in the prostatic tissue with prostate cancer or benign prostatic hyperplasia., 102th AUA annual meeting, 2007
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., 102th AUA annual meeting, 2007
• Japanese Prospective Cohort Study of Screening for Prostate Cancer(JPSPC)：The study concept and the first analyses on compliance and contamination for the PSA test(Gunma section), 102th AUA annual meeting, 2007
• Seasonally changes in the serum PSA levels in men participated in the population-based screening for prostate cancer in Japan., 23th EAU annual meeting, 2008
• Japanese Prospective Cohort Study of Screening for Prostate Cancer (JPSPC): The Study Concept and the First Analyses on Compliance and Contamination for the PSA test (Gunma section)., 23th EAU annual meeting, 2008
• Impact of pretreatment factors, biopsy Gleason grade volume index and post treatment nadir PSA on cause-specific and overall survival in patients with stage IV prostate cancer., 2nd World congress on controversies in Urology, 2009
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., 24th EAU annual meeting, 2009
• Survivin is associated with cell proliferation and plays a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., 24th EAU annual meeting, 2009
• Farnesyl-diphosphate farnesyltransferase 1 is associated with the growth of renal cancer: Association with anticancer effect of statin., 24th EAU annual meeting, 2009
• Association between common sequence variants in the farnesyl-diphosphate farnesyltransferase 1(FDFT1) gene and the prostate cancer risk in the Japanese population., 104th AUA annual meeting, 2008
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., 103th AUA annual meeting, 2008
• HDL and sphingosine-1-phosphate activate signal transducer and activator of transcription 3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors., AACR 101st Annual Meeting 2010, 2010
• Diagnostic significance of [-2]proPSA and volume adjusted PSA-related indices in Japanese men with total PSA in the 2.0 to 10.0 ng/mL range., The 105th Annual Meeting of American Urological Association, 2010
• Statin inhibits the proliferation of human prenal cancer cells via down-regulation of the survivin through IGF-1 signaling., The 105th Annual Meeting of American Urological Association, 2010
• Detection of membrane androgen-binding site in living rat prostate and evaluation of its role in prostate blood flow regulation., 2010
• High density lipoprotein induces proliferation and migration of human prostate androgen independent cancer cells via ATP-binding cassette transporter A1 by A cholesterol-independent mechanism., 2010
• Expression of genes encoding enzymes involved in androgen synthesis in human adipose tissue -possibility of adipose tissue as the third organ producing active androgen in prostate cancer patients-, 2011
• High-fat diet increased renal cancer growth, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer cells., AUA 106th annual Meeting, 2011
• Prediction of future castration resistant prostate cancer by pre-treatment prostate tissue androgen content., AUA 106th annual Meeting, 2011
• High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., AUA 106th annual Meeting, 2011
• Predictive impact of free PSA/total PSA (%fPSA) on the development of prostate cancer in men with baseline PSA lower than 2.0ng/mL: baseline PSA-adjusted case control study., International urology meeting 31th, 2011
• Androgen production in periprostatic adipose tissue in prostate cancer patients., AUA 107th annual Meeting, 2012
• High-fat diet increases renal cancer growth accompanied by leptin increase, and survivin inhibition is effective for simvastatin resistant renal cancer., AUA 107th annual Meeting, 2012
• Some techniques to achieve high enucleation efficiency when performing holmium laser enucleation of the prostate., AUA 107th annual Meeting, 2012
• Simple method of preventing postradical retropubic prostatectomy inguinal hernia., 27th Annual EAU Congress, 2012
• High-fat diet increased leptin, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer., 27th Annual EAU Congress, 2012
• Androgen production in periprostatic adipose tissue in prostate cancer patients., 27th Annual EAU Congress, 2012
• Evaluation of adrenal androgens and estrogen levels in the prostatic tissue with prostate cancer or benign prostatic hyperplasia., 15th International Congress on Hormonal Steroids and Hormones & Cancer, 2012
• Impact of pre-treatment prostate tissue androgen content on the prediciton of future castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy., 15th International Congress on Hormonal Steroids and Hormones & Cancer, 2012
• Effects of LH-RH agonist on hormonal and cognitive function of prostate cancer patients in relation to testicular and adrenal androgens., 15th International Congress on Hormonal Steroids and Hormones & Cancer symposium, 2012

Industrial Property Rights

• Patent right

Awards

• 1997
• 2002

Social Contribution

Social Contribution

• 第９０回日本泌尿器科学会東部総会, 2024, 2025
• 日本泌尿器科学会群馬地方会, 2024, 2024
• ぐんま地域医療会議, 2024, 2024
• 群馬県臓器移植地域推進会議, 2024, 2024
• 公益財団法人前立腺研究財団　理事会, 2024, 2024
• 前立腺シンポジウム, 2024, 2024
• 市民公開講座, 2022, 2022
• 前立腺シンポジウム, 2022, 2022
• 日本泌尿器科学会群馬地方会, 2022, 2022　(Target:　Others)
• 群馬県臓器移植推進会議, 2022, 2022

Academic Contribution

• 第９０回日本泌尿器科学会東部総会会長, 2024, 2025
• 日本泌尿器科学会代議員, 2024, 2024
• 前立腺シンポジウム運営委員長, 2024, 2024
• 公益財団前立腺研究財団専務理事, 2024, 2024
• 前立腺研究財団理事, Academic society etc, 2023, 2023
• 前立腺シンポジウム運営委員長, Competition etc, 09 Dec. 2023, 10 Dec. 2023
• 前立腺シンポジウム運営委員長, Academic society etc, 2022, 2022
• 前立腺研究財団, Academic society etc, 2022, 2022
• 日本泌尿器科学会代議員, Academic society etc, 2022, 2022
• 日本泌尿器科学会代議員, Academic society etc, 2023, 2023